data_2kff_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kff _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.7 t90 . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.071 -0.715 . . . . 0.68 109.071 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.528 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 48.1 t -54.42 -32.05 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.053 -0.521 . . . . 2.03 111.996 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.82 -22.09 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.386 -0.37 . . . . 1.68 111.311 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.58 -10.05 62.93 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.301 -0.952 . . . . 0.62 112.74 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 52.4 pttt -93.98 -18.59 21.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 117.289 0.545 . . . . 3.19 111.426 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -136.67 33.71 2.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.265 1.031 . . . . 1.71 109.218 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.608 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 6.4 tmtm? -75.07 -46.08 4.76 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.528 -1.215 . . . . 1.9 111.908 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.6 Cg_endo -50.86 -26.37 17.85 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.803 2.335 . . . . 1.06 113.257 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.5 m -76.03 -46.84 27.26 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.929 -0.308 . . . . 1.49 111.091 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.766 ' HH ' ' HD1' ' A' ' 111' ' ' HIS . 2.6 m-85 -72.62 -22.32 60.98 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.858 -0.793 . . . . 0.8 108.858 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.452 ' OD2' ' HE2' ' A' ' 58' ' ' TYR . 28.3 t70 -71.29 -43.21 67.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.546 -1.207 . . . . 1.03 109.452 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.29 -43.89 97.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.149 -0.932 . . . . 2.15 109.991 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.5 -30.8 51.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.014 -0.539 . . . . 1.46 110.457 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HE1' HG12 ' A' ' 67' ' ' ILE . 79.9 t80 -65.06 -40.87 95.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.889 -0.596 . . . . 0.37 110.072 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.452 ' HE2' ' OD2' ' A' ' 54' ' ' ASP . 57.8 m-85 -72.88 -23.44 60.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.676 -0.693 . . . . 1.18 111.904 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.5 p -79.8 -2.36 42.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.799 -0.36 . . . . 1.32 111.451 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 83.0 mt -105.19 7.22 33.57 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.077 -0.249 . . . . 1.17 111.038 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 t 65.87 84.0 0.18 Allowed Pre-proline 0 C--O 1.234 0.268 0 O-C-N 123.844 0.715 . . . . 1.81 111.076 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -85.31 114.1 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.453 2.102 . . . . 0.59 112.61 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -89.12 137.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.724 -0.671 . . . . 1.89 109.869 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 p30 46.13 23.64 0.21 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.943 0.897 . . . . 1.98 112.663 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.21 6.55 61.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.349 -0.453 . . . . 0.65 113.643 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.467 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -134.36 174.61 10.34 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.312 0.577 . . . . 2.43 110.837 177.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.482 HD13 ' CD1' ' A' ' 106' ' ' PHE . 16.8 pt -123.56 148.58 27.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.322 -0.854 . . . . 1.1 109.574 172.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.9 p -83.37 179.2 7.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.584 -0.734 . . . . 1.06 110.114 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.11 -34.07 77.71 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.751 -0.737 . . . . 0.36 112.272 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.41 96.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.138 0.494 . . . . 1.17 112.12 -176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.2 m120 -76.03 -47.1 26.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.342 0.592 . . . . 1.65 110.244 -172.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.59 -22.88 63.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.023 -0.535 . . . . 1.09 110.247 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.475 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 41.5 ttmt -68.18 -54.36 18.44 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.242 -0.435 . . . . 2.11 109.976 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 17.5 ptpt -59.22 -33.15 70.65 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.82 0.343 . . . . 1.93 110.23 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.609 ' CD ' ' HZ2' ' A' ' 78' ' ' LYS . 14.1 tp10 -60.45 -53.48 57.01 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.321 0.581 . . . . 1.78 110.132 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 1.057 ' HB3' HD23 ' A' ' 86' ' ' LEU . 54.6 mtt -70.73 -22.6 62.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.671 . . . . 1.67 110.852 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 73' ' ' LYS . 3.9 t -63.17 -47.17 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.927 -0.579 . . . . 2.23 110.581 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.609 ' HZ2' ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -94.61 -1.61 52.93 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.386 -0.926 . . . . 3.79 111.792 -175.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.0 p -66.89 -19.75 65.79 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.817 0.342 . . . . 0.98 110.178 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.4 tptt 75.58 22.97 1.51 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.879 0.872 . . . . 3.38 111.443 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.6 ' HB2' HD21 ' A' ' 86' ' ' LEU . 11.2 mp -92.0 151.45 41.93 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.306 -0.257 . . . . 2.04 110.306 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.565 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 14.5 Cg_endo -59.94 148.18 89.79 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.649 2.233 . . . . 0.38 112.731 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -55.93 -39.49 71.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.454 -0.794 . . . . 2.05 111.188 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 m -61.1 -45.95 92.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.996 -0.547 . . . . 1.47 111.374 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.485 ' CG2' ' HG2' ' A' ' 82' ' ' PRO . 55.0 t -64.45 -42.22 94.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 1.08 110.376 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 1.057 HD23 ' HB3' ' A' ' 76' ' ' MET . 64.0 mt -57.65 -46.4 84.24 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.051 0.453 . . . . 1.07 110.695 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.658 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -64.84 -34.65 90.46 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.832 -0.699 . . . . 0.41 112.13 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -70.54 -41.43 72.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.272 0.558 . . . . 1.89 110.455 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.617 HG21 HD13 ' A' ' 112' ' ' LEU . 83.7 mt -62.38 -42.93 97.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.625 -0.716 . . . . 1.14 110.937 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -59.39 -40.69 87.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.966 0.412 . . . . 0.46 110.077 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -62.99 -25.96 68.62 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.54 -0.754 . . . . 3.03 111.026 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.407 ' HB3' HD21 ' A' ' 126' ' ' LEU . 66.1 mt -90.35 -33.28 16.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.296 -0.411 . . . . 2.15 111.336 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.32 -43.63 63.84 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.83 0.678 . . . . 1.22 112.83 -170.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -88.35 68.85 9.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.43 0.633 . . . . 0.5 110.156 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.11 -21.69 29.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.297 -0.865 . . . . 1.21 109.699 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -79.7 -23.37 42.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.882 -1.054 . . . . 1.46 110.754 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 59.91 51.85 5.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.219 -0.9 . . . . 3.22 111.907 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.52 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 11.8 p-10 -118.63 7.54 11.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.969 0.414 . . . . 0.56 109.997 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.78 -1.51 30.0 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.987 -0.625 . . . . 0.55 112.79 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.52 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 64.2 mt -123.77 155.68 37.48 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.807 -0.442 . . . . 1.17 109.807 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -110.16 110.78 21.76 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.501 -0.48 . . . . 1.08 110.53 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.97 169.08 15.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.103 -0.702 . . . . 1.85 109.103 168.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.8 -29.89 65.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.593 -0.276 . . . . 0.85 111.115 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.07 -51.92 61.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.847 0.832 . . . . 2.08 109.579 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -71.31 -35.98 71.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.536 -1.211 . . . . 0.48 110.966 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 67' ' ' ILE . 58.8 t80 -70.51 -36.37 73.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.19 -0.459 . . . . 0.51 110.279 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.74 84.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.86 110.184 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -64.23 -46.52 83.47 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.989 -0.551 . . . . 1.97 109.552 177.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.46 94.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.3 -0.864 . . . . 1.06 111.296 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.03 -31.55 72.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.17 -0.468 . . . . 0.92 111.101 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.766 ' HD1' ' HH ' ' A' ' 53' ' ' TYR . 78.9 t60 -66.25 -40.69 90.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.932 -0.395 . . . . 0.39 109.932 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.617 HD13 HG21 ' A' ' 89' ' ' ILE . 89.4 mt -65.6 -39.47 91.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.882 -0.599 . . . . 1.07 110.438 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.5 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 62.7 mt -70.66 -37.77 70.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.002 -0.545 . . . . 1.39 110.927 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 26.1 ttpp -63.2 -45.78 90.08 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.913 -0.315 . . . . 2.25 110.532 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.61 -35.24 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.095 -0.642 . . . . 1.26 110.465 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.628 ' HD3' HD21 ' A' ' 122' ' ' LEU . 25.0 mmmt -56.21 -45.6 79.81 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.39 -0.368 . . . . 2.47 111.163 171.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 84.1 mt -67.2 -33.85 76.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.272 0.558 . . . . 1.34 110.646 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.6 mt-10 -78.0 4.39 12.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.663 -0.698 . . . . 1.98 111.386 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.65 34.91 14.65 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.99 -0.624 . . . . 0.88 112.54 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -122.91 171.42 9.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.806 0.336 . . . . 1.23 110.25 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -111.82 150.55 30.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.062 -0.517 . . . . 3.06 109.804 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.628 HD21 ' HD3' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -95.69 138.35 21.79 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.216 -1.031 . . . . 1.75 108.216 173.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.79 -9.76 17.5 Favored 'Trans proline' 0 N--CA 1.473 0.297 0 C-N-CA 122.947 2.431 . . . . 1.05 114.095 -171.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.86 17.57 10.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.585 0.707 . . . . 1.44 110.489 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.03 161.68 34.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.906 -1.043 . . . . 1.97 108.85 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 92' ' ' LEU . 96.3 mt -110.52 90.81 10.9 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.916 -0.314 . . . . 1.25 111.346 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.31 158.95 54.65 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.691 2.26 . . . . 0.59 111.553 171.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.13 -7.79 5.42 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.521 2.814 . . . . 1.02 114.241 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -108.42 -2.59 18.94 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.367 -0.533 . . . . 1.05 111.191 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.405 ' O ' HD21 ' A' ' 108' ' ' LEU . 1.9 mm? -101.7 -36.67 8.64 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.117 0.484 . . . . 1.9 110.358 173.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 7.7 p -78.43 124.27 85.55 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.681 -0.69 . . . . 1.96 111.005 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 131' ' ' VAL . 22.1 Cg_exo . . . . . 0 N--CA 1.46 -0.491 0 C-N-CA 122.743 2.295 . . . . 1.11 111.707 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.658 HD22 ' HA2' ' A' ' 87' ' ' GLY . 27.0 t-20 . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 110.28 -0.267 . . . . 1.1 110.28 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 8.0 Cg_exo -73.14 -2.87 12.7 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.53 2.82 . . . . 1.05 113.028 -176.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.475 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 96.8 m-85 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.46 -0.336 . . . . 0.68 110.867 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.497 ' HD1' ' O ' ' A' ' 129' ' ' HIS . 10.2 t90 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 109.112 -0.699 . . . . 0.68 109.112 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -69.34 5.2 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.746 0.647 . . . . 2.03 112.746 -172.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.401 HG12 ' CE2' ' A' ' 53' ' ' TYR . 97.0 t -105.97 -19.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.96 0.409 . . . . 1.68 110.292 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.555 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -68.39 -18.2 71.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.634 -0.793 . . . . 0.62 111.557 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -74.76 -27.4 60.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.54 -0.33 . . . . 3.19 111.292 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -127.61 33.49 4.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.909 0.385 . . . . 1.71 110.612 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 6.8 mmmm -64.62 -45.27 76.14 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.837 0.68 . . . . 1.9 112.837 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.5 Cg_endo -49.85 -35.22 39.21 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 122.397 2.064 . . . . 1.06 112.415 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.434 ' O ' HG13 ' A' ' 56' ' ' ILE . 11.5 m -73.53 -46.43 47.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.517 -0.31 . . . . 1.49 111.302 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.401 ' CE2' HG12 ' A' ' 46' ' ' VAL . 14.9 m-85 -71.56 -23.28 61.72 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.766 -0.457 . . . . 0.8 109.766 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.423 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 15.2 t70 -73.86 -44.52 55.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.47 -0.786 . . . . 1.03 109.265 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 59' ' ' THR . 35.3 tt0 -57.02 -46.54 82.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.143 -0.935 . . . . 2.15 110.358 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 52' ' ' THR . 58.9 mt -67.11 -49.21 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.137 -0.483 . . . . 1.46 110.789 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.456 ' HE1' HG12 ' A' ' 67' ' ' ILE . 77.8 t80 -51.25 -46.44 62.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.853 -0.612 . . . . 0.37 111.682 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.423 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 29.3 m-85 -74.19 -12.37 60.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.684 0.624 . . . . 1.18 112.684 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 55' ' ' GLU . 70.1 p -90.96 4.37 52.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.114 0.483 . . . . 1.32 110.737 177.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 82.3 mt -105.91 6.58 31.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.768 -0.456 . . . . 1.17 109.768 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.7 m 65.59 82.49 0.2 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.185 -0.916 . . . . 1.81 111.43 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -92.04 113.84 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.737 2.291 . . . . 0.59 113.287 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.8 146.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.625 -0.88 . . . . 1.89 108.625 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 p30 50.33 22.35 0.98 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.746 0.818 . . . . 1.98 112.136 -174.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.61 29.62 47.64 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.238 -0.506 . . . . 0.65 111.872 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.72 ' HE2' ' HB3' ' A' ' 102' ' ' ASP . 32.4 ttmt -156.19 146.81 21.82 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.902 0.382 . . . . 2.43 110.719 -173.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.456 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.5 pt -103.14 156.31 5.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.224 0.535 . . . . 1.1 110.43 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 73.2 p -89.39 178.1 6.41 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.602 -0.726 . . . . 1.06 109.972 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.668 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -65.19 -17.62 63.95 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.979 -0.629 . . . . 0.36 112.299 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.73 -47.29 63.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.216 0.531 . . . . 1.17 111.332 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.633 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.3 m120 -73.79 -41.45 62.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.587 -0.733 . . . . 1.65 110.367 -173.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.4 -19.79 60.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.188 -0.46 . . . . 1.09 110.193 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.668 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 3.6 ttmp? -68.38 -51.59 42.54 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.754 -0.461 . . . . 2.11 109.754 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.514 ' HA ' HG21 ' A' ' 77' ' ' VAL . 18.6 ptpt -63.33 -32.94 74.5 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.965 -0.562 . . . . 1.93 110.391 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.53 -53.82 51.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.792 -0.447 . . . . 1.78 109.792 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 57.5 mtt -69.5 -33.61 73.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.032 -0.531 . . . . 1.67 112.198 -173.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 74' ' ' LYS . 30.9 m -77.0 -19.04 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.644 -0.422 . . . . 2.23 109.914 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 12.7 mptt -87.47 -12.33 46.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.911 -0.586 . . . . 3.79 110.453 174.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.5 m -86.75 -5.1 59.22 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.876 -0.602 . . . . 0.98 111.092 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.4 mptt 68.24 29.0 6.22 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.297 0.639 . . . . 3.38 111.786 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.673 HD12 HG22 ' A' ' 113' ' ' ILE . 24.3 mt -98.14 143.38 26.17 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.428 -0.351 . . . . 2.04 111.068 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.487 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.5 Cg_endo -61.64 150.9 83.57 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.257 2.638 . . . . 0.38 113.51 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -55.99 -42.27 76.11 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.697 -0.683 . . . . 2.05 111.85 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.1 m -58.04 -54.13 50.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.306 -0.406 . . . . 1.47 110.909 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 47.0 t -57.71 -44.13 85.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.103 -0.499 . . . . 1.08 110.87 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 81' ' ' LEU . 56.6 mt -63.42 -36.04 82.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 1.07 111.229 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.751 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -60.59 -42.71 99.31 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.846 -0.692 . . . . 0.41 111.656 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 20.6 mtpp -68.47 -46.18 70.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.5 -0.35 . . . . 1.89 110.353 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.2 mt -56.83 -52.13 58.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 123.512 0.507 . . . . 1.14 110.85 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -60.43 -53.66 54.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.448 -0.342 . . . . 0.46 111.66 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -65.1 -23.28 67.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.038 0.447 . . . . 3.03 111.238 -172.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.656 HD22 HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -92.75 -39.45 11.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.849 -0.614 . . . . 2.15 110.229 -177.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.475 ' N ' ' HG ' ' A' ' 92' ' ' LEU . . . -70.28 -39.28 74.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 1.22 111.047 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.581 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 47.0 t0 -74.47 93.47 2.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.658 -0.867 . . . . 0.5 108.658 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.69 HG21 ' HD2' ' A' ' 132' ' ' PRO . 32.5 t -69.29 -51.07 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.337 -0.847 . . . . 1.21 110.28 -174.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -76.34 -21.24 56.4 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.278 -0.873 . . . . 1.46 111.225 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.581 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 40.8 mttp 56.71 65.78 1.33 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.131 -0.94 . . . . 3.22 110.74 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -108.93 10.97 26.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.256 -1.338 . . . . 0.56 109.832 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.56 11.78 80.3 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.313 -0.858 . . . . 0.55 111.879 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 33.8 mt -144.28 161.55 38.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.344 -0.613 . . . . 1.17 109.344 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.1 mt -124.8 115.47 20.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.163 -0.31 . . . . 1.08 110.163 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.72 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 1.7 p30 -77.82 -176.41 4.41 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.303 -0.629 . . . . 1.85 109.303 171.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -63.62 -27.02 68.95 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.934 -0.306 . . . . 0.85 111.474 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 86.7 mt-10 -85.03 -39.07 18.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.212 -0.195 . . . . 2.08 110.918 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -69.34 -37.5 77.7 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.256 0.55 . . . . 0.48 110.182 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -66.86 -42.38 85.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.749 -0.659 . . . . 0.51 109.886 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.08 91.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 0.86 110.831 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -61.29 -46.82 88.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.814 -0.63 . . . . 1.97 109.728 177.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.11 -49.33 78.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 1.06 111.636 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -33.47 76.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.92 110.856 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 115' ' ' VAL . 38.7 t60 -67.72 -36.39 80.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.036 -0.357 . . . . 0.39 110.036 177.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.656 HD13 HD22 ' A' ' 92' ' ' LEU . 91.8 mt -66.15 -39.25 89.68 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.927 -0.579 . . . . 1.07 110.587 176.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.673 HG22 HD12 ' A' ' 81' ' ' LEU . 54.9 mt -69.07 -37.69 77.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.747 -0.66 . . . . 1.39 110.326 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 42.1 tttp -61.88 -47.32 85.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.992 -0.549 . . . . 2.25 110.686 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 111' ' ' HIS . 6.7 m -68.11 -31.16 50.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 120.547 -0.461 . . . . 1.26 111.322 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -56.14 -45.07 79.75 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.066 -0.253 . . . . 2.47 110.385 168.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.74 -29.78 63.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.263 -0.426 . . . . 1.34 110.885 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.555 ' HB2' ' HD2' ' A' ' 120' ' ' HIS . 59.7 mm-40 -65.95 -21.96 66.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.873 -0.603 . . . . 1.98 110.489 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.52 36.03 3.92 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.752 -0.737 . . . . 0.88 112.13 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.555 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 74.4 m-70 -126.96 150.07 49.55 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.847 -0.427 . . . . 1.23 109.847 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -95.95 130.0 43.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.942 0.401 . . . . 3.06 110.725 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.95 134.63 49.47 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.048 -0.524 . . . . 1.75 110.005 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.01 2.7 6.34 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.908 2.405 . . . . 1.05 113.745 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.78 22.68 10.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.427 0.632 . . . . 1.44 110.306 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.86 162.12 32.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.194 -0.912 . . . . 1.97 109.882 -172.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 52.1 mt -112.69 94.0 26.4 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 123.262 0.351 . . . . 1.25 111.781 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.915 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 14.0 Cg_endo -58.63 153.31 49.87 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.866 2.377 . . . . 0.59 111.333 169.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.35 -10.03 17.33 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.921 2.414 . . . . 1.02 113.308 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.497 ' O ' ' HD1' ' A' ' 44' ' ' TRP . 26.4 p-80 -108.4 1.51 21.79 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.159 -0.338 . . . . 1.05 110.397 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.915 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 1.4 mp -103.85 -7.63 20.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.885 0.374 . . . . 1.9 111.038 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -87.42 117.8 69.03 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.248 -0.433 . . . . 1.96 110.887 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.69 ' HD2' HG21 ' A' ' 95' ' ' VAL . 53.1 Cg_exo . . . . . 0 C--O 1.237 0.445 0 C-N-CA 122.943 2.429 . . . . 1.11 111.952 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.751 HD22 ' HA2' ' A' ' 87' ' ' GLY . 25.2 t-20 . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.991 0.424 . . . . 1.1 110.176 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 7.4 Cg_exo -73.42 -1.45 10.68 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.521 2.814 . . . . 1.05 112.948 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.497 -0.32 . . . . 0.68 111.662 -175.84 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 108.809 -0.812 . . . . 0.68 108.809 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.2 m -66.73 -1.15 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.83 -0.623 . . . . 2.03 112.521 -171.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.5 -17.51 7.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.139 -0.482 . . . . 1.68 110.275 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.31 -10.56 74.69 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.634 -0.793 . . . . 0.62 112.549 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -89.28 -28.11 20.12 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.653 -0.322 . . . . 3.19 111.362 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -112.58 33.13 5.14 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.72 -0.844 . . . . 1.71 108.72 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 9.1 tmtt? -72.47 -49.98 8.45 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 114.76 -1.109 . . . . 1.9 112.313 -169.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.5 Cg_endo -54.35 -29.58 58.79 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.628 2.219 . . . . 1.06 113.235 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.0 m -70.28 -39.5 74.86 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.036 0.446 . . . . 1.49 110.335 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -70.91 -22.97 62.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.23 -0.441 . . . . 0.8 109.955 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.46 -44.69 70.7 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.129 0.49 . . . . 1.03 110.018 172.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -57.6 -42.2 82.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.346 -0.843 . . . . 2.15 110.267 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.404 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 50.2 mt -79.19 -28.88 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 1.46 111.18 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -71.37 -45.84 61.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.246 0.546 . . . . 0.37 110.686 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -76.48 -13.08 60.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.78 -0.645 . . . . 1.18 112.065 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.2 p -94.09 1.57 56.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.128 0.49 . . . . 1.32 111.214 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 58.2 mt -110.02 8.82 24.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.0 -0.545 . . . . 1.17 110.125 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 m 67.79 82.2 0.19 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.317 -0.856 . . . . 1.81 111.54 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -90.46 116.68 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.629 2.219 . . . . 0.59 112.555 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -88.37 134.62 27.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.628 -0.508 . . . . 1.89 109.628 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 47.05 25.7 0.53 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.792 0.837 . . . . 1.98 112.749 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.93 19.75 33.05 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.333 -0.46 . . . . 0.65 112.509 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.491 ' HG3' ' HA ' ' A' ' 102' ' ' ASP . 31.1 ttmt -150.52 144.46 25.35 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 110.453 -0.203 . . . . 2.43 110.453 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.469 HD11 ' CD1' ' A' ' 106' ' ' PHE . 19.8 pt -100.43 149.37 6.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 120.55 -0.46 . . . . 1.1 110.355 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.514 ' HA ' HD23 ' A' ' 100' ' ' LEU . 81.4 p -76.66 166.82 22.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.068 -0.515 . . . . 1.06 110.034 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.89 -32.52 70.52 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.589 -0.815 . . . . 0.36 112.103 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -49.18 -55.75 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.375 0.509 . . . . 1.17 112.375 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -70.68 -41.86 71.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.172 0.51 . . . . 1.65 110.989 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.492 ' CB ' HD11 ' A' ' 101' ' ' LEU . . . -71.36 -33.41 69.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.916 -0.584 . . . . 1.09 110.582 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.58 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 28.1 ttpp -63.9 -52.65 58.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.91 -0.587 . . . . 2.11 110.727 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.602 ' O ' HG23 ' A' ' 77' ' ' VAL . 17.3 ptmt -62.93 -32.89 74.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.983 -0.553 . . . . 1.93 110.607 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.562 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 35.3 tp10 -62.54 -38.88 91.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.307 0.575 . . . . 1.78 110.204 175.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.903 ' HB3' HD22 ' A' ' 86' ' ' LEU . 50.7 mtt -77.07 -20.47 55.78 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.632 -0.427 . . . . 1.67 111.67 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 74' ' ' LYS . 9.9 m -81.09 -23.45 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.045 -0.662 . . . . 2.23 110.747 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -87.15 -11.12 50.94 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.364 -0.534 . . . . 3.79 110.232 170.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 76' ' ' MET . 52.7 m -69.5 -17.48 63.6 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.948 -0.569 . . . . 0.98 110.061 169.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 17.5 tptp 69.27 24.25 5.99 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.645 -0.707 . . . . 3.38 111.65 171.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.595 ' HB2' HD23 ' A' ' 86' ' ' LEU . 59.0 mt -100.78 153.34 37.79 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.807 -0.633 . . . . 2.04 110.004 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.478 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 12.1 Cg_endo -57.36 141.7 94.85 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.813 2.342 . . . . 0.38 112.39 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -59.45 -34.2 72.24 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.139 -0.482 . . . . 2.05 111.252 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -47.85 83.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.154 -0.475 . . . . 1.47 110.822 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.685 HG12 ' HD2' ' A' ' 116' ' ' LYS . 75.8 t -63.72 -41.73 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.588 -0.733 . . . . 1.08 110.477 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 76' ' ' MET . 57.5 mt -58.8 -45.85 88.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.098 0.475 . . . . 1.07 110.392 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.54 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -60.91 -37.79 94.34 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.845 -0.616 . . . . 0.41 112.235 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.557 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 46.2 mtpt -69.53 -39.74 77.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.955 0.407 . . . . 1.89 110.418 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.93 -37.91 80.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.711 -0.677 . . . . 1.14 110.252 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.484 ' CZ3' ' HG ' ' A' ' 101' ' ' LEU . 31.1 t-105 -61.88 -46.04 91.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.246 -0.434 . . . . 0.46 110.356 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -59.79 -37.0 77.89 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.212 0.529 . . . . 3.03 110.641 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 86.2 mt -70.22 -41.99 72.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.473 -0.785 . . . . 2.15 110.748 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -73.59 -43.72 58.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.646 -0.707 . . . . 1.22 111.737 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.582 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 35.6 t0 -84.13 81.58 8.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.369 0.604 . . . . 0.5 109.955 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.462 HG22 ' HD2' ' A' ' 132' ' ' PRO . 13.5 t -69.2 -44.31 80.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.271 -0.877 . . . . 1.21 110.64 -176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -17.94 60.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.372 -0.831 . . . . 1.46 111.108 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.823 ' HZ1' ' HB3' ' A' ' 97' ' ' LYS . 9.8 mtpm? 58.07 56.88 4.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.39 -0.823 . . . . 3.22 111.001 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -106.92 10.17 30.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.66 -0.7 . . . . 0.56 111.042 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.06 10.12 72.76 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.025 -0.607 . . . . 0.55 112.341 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 68' ' ' THR . 66.9 mt -139.3 152.84 47.56 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.387 -0.968 . . . . 1.17 108.387 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' ' 72' ' ' ALA . 19.6 mt -99.69 110.73 23.12 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.588 -0.845 . . . . 1.08 110.285 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.737 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 12.7 t70 -70.73 171.99 9.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.779 -1.1 . . . . 1.85 108.422 173.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.551 ' CG ' ' HZ1' ' A' ' 50' ' ' LYS . 11.8 t70 -58.64 -43.26 89.67 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.625 0.25 . . . . 0.85 111.266 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 31.5 mt-10 -61.51 -44.38 97.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.797 0.808 . . . . 2.08 109.856 176.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.737 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 15.1 mt-10 -68.2 -39.39 82.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.452 -1.249 . . . . 0.48 110.521 -173.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.469 ' CD1' HD11 ' A' ' 67' ' ' ILE . 65.8 t80 -68.28 -42.67 79.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.296 -0.411 . . . . 0.51 110.215 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.27 93.72 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.751 -0.658 . . . . 0.86 110.272 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.01 -45.48 93.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.754 -0.657 . . . . 1.97 110.137 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.502 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -57.37 -47.78 80.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.451 -0.795 . . . . 1.06 111.364 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -28.88 67.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.418 -0.355 . . . . 0.92 111.249 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -68.48 -37.88 80.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.192 0.52 . . . . 0.39 110.093 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.455 ' HA ' HG23 ' A' ' 115' ' ' VAL . 59.7 mt -69.05 -36.39 77.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 1.07 110.247 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 109' ' ' ALA . 46.4 mm -59.25 -44.25 91.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.02 -0.536 . . . . 1.39 110.163 173.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.558 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 49.8 tttp -63.85 -47.38 80.94 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.82 -0.627 . . . . 2.25 111.111 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' A' ' 112' ' ' LEU . 14.7 m -64.29 -36.7 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.358 -0.537 . . . . 1.26 111.496 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.685 ' HD2' HG12 ' A' ' 85' ' ' VAL . 2.1 mmtm -56.35 -42.79 78.33 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 121.299 -0.161 . . . . 2.47 111.317 170.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 98.0 mt -71.52 -34.01 69.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.763 0.316 . . . . 1.34 110.836 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 81.0 mm-40 -68.85 -14.06 62.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 1.98 110.473 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.84 17.41 58.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.84 -0.695 . . . . 0.88 112.436 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -103.24 164.06 11.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.717 0.294 . . . . 1.23 110.301 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -88.68 140.53 29.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.214 0.53 . . . . 3.06 112.145 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.521 HD22 ' HG2' ' A' ' 116' ' ' LYS . 4.1 pp -110.51 127.04 27.65 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 107.266 -1.383 . . . . 1.75 107.266 165.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 1.8 Cg_endo -74.53 -15.12 22.16 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.375 2.05 . . . . 1.05 113.743 -166.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.416 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . . . 69.51 19.12 7.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.669 0.747 . . . . 1.44 109.663 -170.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -124.42 156.9 36.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.962 -1.017 . . . . 1.97 108.639 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.8 mt -116.49 96.22 47.53 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.834 0.349 . . . . 1.25 111.577 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.37 155.11 70.45 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.615 2.21 . . . . 0.59 111.65 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.09 -26.92 27.41 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.252 2.635 . . . . 1.02 113.689 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -91.84 18.4 7.79 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.998 0.369 . . . . 1.05 111.998 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 44.7 mt -129.94 3.41 4.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.664 -0.244 . . . . 1.9 111.015 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.6 t -87.55 116.58 66.61 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.404 . . . . 1.96 111.028 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.49 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 77.1 Cg_exo . . . . . 0 C--O 1.234 0.314 0 C-N-CA 123.05 2.5 . . . . 1.11 111.885 176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.54 HD22 ' HA2' ' A' ' 87' ' ' GLY . 45.1 t-20 . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 109.247 -0.649 . . . . 1.1 109.247 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.48 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 38.3 Cg_endo -67.11 -14.72 44.38 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.106 2.537 . . . . 1.05 113.64 -175.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 62.6 m-85 . . . . . 0 C--N 1.327 -0.373 0 N-CA-C 111.724 0.268 . . . . 0.68 111.724 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.475 ' CZ2' ' HB3' ' A' ' 132' ' ' PRO . 5.2 t90 . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.318 -0.623 . . . . 0.68 109.318 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.21 -17.9 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 2.03 112.116 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.32 -18.15 15.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.19 0.519 . . . . 1.68 110.047 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.3 -13.1 73.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.793 -0.718 . . . . 0.62 112.104 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -78.64 -29.21 45.7 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.198 0.523 . . . . 3.19 110.484 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -128.5 33.24 4.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.372 -0.831 . . . . 1.71 109.934 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 4.0 tmtm? -72.26 -47.95 10.29 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.282 -0.872 . . . . 1.9 111.914 -174.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.4 Cg_endo -53.23 -29.56 47.22 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.545 2.163 . . . . 1.06 113.151 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.4 m -71.92 -44.14 64.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.801 0.334 . . . . 1.49 110.482 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -70.43 -22.6 62.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.422 -0.585 . . . . 0.8 109.422 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.43 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 7.9 t70 -72.96 -44.96 60.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.534 -0.757 . . . . 1.03 109.851 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.91 -43.03 95.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.941 -1.027 . . . . 2.15 110.799 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.14 -33.73 56.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.247 0.546 . . . . 1.46 110.575 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.514 ' HE1' HG12 ' A' ' 67' ' ' ILE . 71.0 t80 -64.03 -49.27 73.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.37 110.596 -175.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.43 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 43.1 m-85 -70.47 -21.51 62.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.811 -0.632 . . . . 1.18 112.532 -174.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.7 p -79.18 -0.48 32.06 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.507 -0.477 . . . . 1.32 111.502 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 94.0 mt -105.42 7.28 33.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.533 -0.303 . . . . 1.17 111.116 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 t 63.09 89.91 0.1 OUTLIER Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 115.921 -0.581 . . . . 1.81 111.179 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -84.67 117.62 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.361 2.041 . . . . 0.59 112.954 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.18 128.02 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.585 . . . . 1.89 110.02 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.59 21.48 12.75 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.643 -0.503 . . . . 1.98 109.643 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.05 3.53 90.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.808 -0.711 . . . . 0.65 112.443 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -125.32 143.41 50.98 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.686 0.279 . . . . 2.43 110.415 177.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.514 HG12 ' HE1' ' A' ' 57' ' ' PHE . 9.6 pt -84.14 143.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 119.996 -0.682 . . . . 1.1 110.505 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.5 p -74.74 162.7 28.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.044 -0.98 . . . . 1.06 110.624 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -56.78 -31.07 60.49 Favored Glycine 0 C--O 1.218 -0.863 0 C-N-CA 120.905 -0.664 . . . . 0.36 112.173 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.1 -53.45 53.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.459 0.54 . . . . 1.17 112.459 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 58.6 m-80 -79.54 -35.7 39.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.118 -0.492 . . . . 1.65 111.693 -171.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.99 -26.88 65.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.156 0.503 . . . . 1.09 109.768 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.56 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 38.7 ttmt -68.56 -54.62 15.5 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.579 -0.737 . . . . 2.11 110.367 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 18.2 ptpt -58.02 -38.94 77.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 1.93 110.416 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.04 -44.99 94.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.184 0.516 . . . . 1.78 110.167 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.873 ' HB3' HD21 ' A' ' 86' ' ' LEU . 42.9 mtt -67.41 -27.9 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 1.67 110.777 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 73' ' ' LYS . 55.7 t -70.66 -38.09 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.289 0.566 . . . . 2.23 109.65 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 16.9 mmtp -72.04 -13.01 61.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.776 -0.647 . . . . 3.79 110.749 176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.8 m -80.9 -14.79 57.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.98 110.591 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mptt 72.24 18.92 4.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.648 0.779 . . . . 3.38 111.875 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.566 ' HB2' HD22 ' A' ' 86' ' ' LEU . 3.9 mm? -87.19 144.48 36.22 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.985 0.422 . . . . 2.04 110.5 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.546 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.0 Cg_endo -61.19 151.39 79.19 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.137 2.558 . . . . 0.38 112.713 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -58.65 -33.94 70.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.933 -0.576 . . . . 2.05 111.495 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.3 m -60.56 -51.28 70.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.198 0.523 . . . . 1.47 110.473 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.617 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 71.5 t -64.13 -40.24 88.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.745 -0.661 . . . . 1.08 110.76 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.873 HD21 ' HB3' ' A' ' 76' ' ' MET . 58.7 mt -61.73 -41.24 97.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.968 -0.56 . . . . 1.07 110.817 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.514 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -62.21 -42.07 99.72 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.116 -0.564 . . . . 0.41 111.924 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 51.0 mtpt -57.41 -51.39 69.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.159 0.504 . . . . 1.89 110.447 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.513 HG12 HD21 ' A' ' 122' ' ' LEU . 84.6 mt -64.54 -38.27 82.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.47 -0.787 . . . . 1.14 111.333 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -62.05 -49.06 77.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.714 0.292 . . . . 0.46 110.903 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -64.35 -24.63 67.71 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.124 -0.489 . . . . 3.03 111.308 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.569 ' O ' HD13 ' A' ' 126' ' ' LEU . 88.2 mt -88.61 -48.64 7.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.511 . . . . 2.15 111.379 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.417 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -64.68 -36.46 84.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.842 -0.617 . . . . 1.22 111.067 -173.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.578 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 42.7 t0 -79.68 82.74 5.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.8 -0.815 . . . . 0.5 108.8 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.4 t -71.28 -40.63 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.65 -0.704 . . . . 1.21 109.956 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -81.42 -18.0 46.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 1.46 110.207 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.578 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 22.6 mttp 59.96 59.12 2.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.065 -0.971 . . . . 3.22 110.942 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.6 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 14.4 p-10 -107.78 8.96 29.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.908 -1.042 . . . . 0.56 110.023 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.54 9.03 81.84 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.756 -0.656 . . . . 0.55 111.876 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 66' ' ' LYS . 60.1 mt -139.27 167.93 20.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.621 -0.511 . . . . 1.17 109.621 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.2 mt -124.96 116.48 22.24 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.174 -0.306 . . . . 1.08 110.174 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.459 ' CA ' ' HG3' ' A' ' 66' ' ' LYS . 3.0 p30 -78.75 177.86 8.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.137 -0.69 . . . . 1.85 109.137 171.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -61.16 -25.39 66.98 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.6 0.593 . . . . 0.85 112.6 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -81.63 -40.25 23.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 2.08 110.311 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.452 ' HG3' ' OD2' ' A' ' 102' ' ' ASP . 20.0 mt-10 -67.58 -36.55 81.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.368 0.604 . . . . 0.48 109.486 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.473 ' CD1' HD12 ' A' ' 67' ' ' ILE . 31.8 t80 -74.21 -33.15 63.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.838 -0.619 . . . . 0.51 110.171 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.33 94.33 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.279 0.562 . . . . 0.86 109.861 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 93' ' ' ALA . 16.0 tp -61.26 -44.91 96.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.221 -0.9 . . . . 1.97 110.035 176.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.06 -49.99 72.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.666 -0.697 . . . . 1.06 110.92 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -39.24 87.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 0.92 111.038 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -69.05 -38.46 79.13 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.947 -0.301 . . . . 0.39 110.749 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.703 ' HB3' HD22 ' A' ' 122' ' ' LEU . 92.8 mt -66.94 -38.59 86.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.257 -0.429 . . . . 1.07 110.907 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.45 HD13 ' HG2' ' A' ' 76' ' ' MET . 79.9 mt -70.37 -32.94 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.101 0.477 . . . . 1.39 110.049 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 4.0 tppp? -59.04 -53.32 59.71 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 115.919 -0.582 . . . . 2.25 110.514 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.3 m -64.14 -34.64 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 121.11 -0.236 . . . . 1.26 111.391 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 116' ' ' LYS . 27.0 mmmt -53.59 -48.89 68.82 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.596 0.236 . . . . 2.47 111.446 167.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.3 -22.62 62.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.902 0.382 . . . . 1.34 110.942 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 6.2 mm-40 -75.35 -2.4 28.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.924 -0.58 . . . . 1.98 110.771 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.5 35.81 11.45 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.65 -0.786 . . . . 0.88 111.988 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -130.87 172.48 11.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.988 0.423 . . . . 1.23 110.594 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -122.46 121.9 37.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.679 -0.691 . . . . 3.06 109.846 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.703 HD22 ' HB3' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -60.87 146.6 86.75 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.052 -0.522 . . . . 1.75 110.097 169.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.74 6.12 2.57 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.51 2.14 . . . . 1.05 113.225 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.452 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 60.38 17.79 7.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.813 -0.631 . . . . 1.44 111.763 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -136.17 166.9 22.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.359 -0.608 . . . . 1.97 109.359 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 92' ' ' LEU . 82.1 mt -114.88 93.17 33.12 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.701 0.286 . . . . 1.25 111.618 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.655 ' HD2' HD11 ' A' ' 130' ' ' LEU . 34.4 Cg_endo -66.44 166.22 22.4 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.797 2.331 . . . . 0.59 111.537 169.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.69 3.42 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.237 2.625 . . . . 1.02 114.334 -176.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -114.03 6.7 16.55 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.545 -0.462 . . . . 1.05 111.219 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.655 HD11 ' HD2' ' A' ' 127' ' ' PRO . 42.3 mt -115.9 -34.31 4.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.497 -0.32 . . . . 1.9 110.912 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.57 115.18 43.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.855 -0.424 . . . . 1.96 109.855 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 37.1 Cg_endo . . . . . 0 C--O 1.236 0.419 0 C-N-CA 122.734 2.289 . . . . 1.11 112.612 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.514 HD22 ' HA2' ' A' ' 87' ' ' GLY . 47.4 t-20 . . . . . 0 CA--C 1.528 0.118 0 N-CA-C 109.715 -0.476 . . . . 1.1 109.715 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 24.4 Cg_exo -64.36 -16.41 54.96 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.16 2.573 . . . . 1.05 113.393 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.56 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 82.5 m-85 . . . . . 0 C--N 1.328 -0.331 0 N-CA-C 111.739 0.274 . . . . 0.68 111.739 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.5 t90 . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 108.272 -1.01 . . . . 0.68 108.272 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.544 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 87.2 t -50.76 -33.03 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.682 -0.69 . . . . 2.03 112.192 -174.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 t -70.26 -17.86 21.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.073 -0.512 . . . . 1.68 111.516 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.14 -17.15 71.68 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.879 -0.677 . . . . 0.62 112.347 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 46.9 pttt -87.25 -29.41 21.7 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.181 -0.608 . . . . 3.19 111.191 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -108.11 31.14 5.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.339 -0.985 . . . . 1.71 108.339 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 11.0 tmtt? -78.27 -47.27 2.06 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.584 -0.735 . . . . 1.9 111.963 -170.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.6 Cg_endo -51.1 -33.12 42.18 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.275 1.983 . . . . 1.06 112.748 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.9 m -71.35 -45.75 62.16 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.904 0.383 . . . . 1.49 111.069 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.424 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 9.6 m-85 -72.26 -22.7 61.19 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.508 -0.553 . . . . 0.8 109.508 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.413 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 5.9 t70 -71.62 -44.31 64.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.301 -0.863 . . . . 1.03 109.32 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.32 -53.8 54.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.42 -0.809 . . . . 2.15 110.058 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.37 -36.83 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.973 0.416 . . . . 1.46 110.951 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.48 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 86.5 t80 -62.1 -42.04 98.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.361 0.601 . . . . 0.37 110.015 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.413 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 24.8 m-85 -81.21 -22.97 38.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.511 -0.768 . . . . 1.18 112.243 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.7 p -75.82 -10.78 59.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 1.32 111.082 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 79.3 mt -99.31 5.48 46.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.164 -0.471 . . . . 1.17 111.098 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.2 t 65.25 81.41 0.22 Allowed Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 123.711 0.632 . . . . 1.81 111.405 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.66 131.42 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.199 1.933 . . . . 0.59 112.422 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 m -99.93 140.82 18.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.891 -0.595 . . . . 1.89 109.909 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 45.45 33.04 1.2 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.484 0.714 . . . . 1.98 112.311 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.8 19.29 73.47 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.104 -0.498 . . . . 0.65 114.026 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 2.6 mtmm -145.84 159.84 42.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.771 -0.455 . . . . 2.43 109.771 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.462 HD11 ' CD1' ' A' ' 106' ' ' PHE . 23.8 pt -107.2 148.37 11.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.437 -0.505 . . . . 1.1 110.099 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.589 ' HA ' HD22 ' A' ' 100' ' ' LEU . 73.2 p -76.85 167.04 22.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.692 -0.686 . . . . 1.06 110.074 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.44 -33.16 58.45 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.87 -0.681 . . . . 0.36 112.708 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.01 59.92 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.347 0.499 . . . . 1.17 112.347 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -69.61 -46.81 65.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.573 -0.74 . . . . 1.65 110.625 -170.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.55 72.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.789 -0.641 . . . . 1.09 110.905 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.54 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 36.1 ttmt -61.55 -57.12 13.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 2.11 110.683 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.478 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 56.4 pttt -62.77 -31.26 72.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 1.93 110.708 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.71 -44.42 93.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 1.78 109.643 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.76 ' HB3' HD22 ' A' ' 86' ' ' LEU . 43.1 mtt -67.49 -30.67 70.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.806 -0.634 . . . . 1.67 111.151 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -70.59 -34.93 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.672 0.749 . . . . 2.23 109.339 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 4.3 mptp? -78.44 -12.12 59.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.925 -1.034 . . . . 3.79 110.838 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 49.3 m -76.47 -13.17 60.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 0.98 110.518 175.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 79' ' ' SER . 69.8 mmtt 73.28 16.68 4.12 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.66 -0.7 . . . . 3.38 111.523 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.611 ' HB2' HD23 ' A' ' 86' ' ' LEU . 79.8 mt -93.08 147.02 33.05 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 2.04 110.922 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.534 ' HG2' HG22 ' A' ' 85' ' ' VAL . 11.2 Cg_endo -56.45 149.04 59.15 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.64 2.893 . . . . 0.38 112.848 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -56.13 -38.95 71.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.766 -0.652 . . . . 2.05 111.36 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -62.28 -46.85 86.96 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.984 -0.553 . . . . 1.47 111.618 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.721 ' HA ' ' HZ2' ' A' ' 88' ' ' LYS . 95.8 t -64.25 -45.37 96.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 109.972 -0.381 . . . . 1.08 109.972 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.7 mt -58.79 -42.84 89.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 1.07 111.153 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.82 -40.75 93.45 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.999 -0.62 . . . . 0.41 112.145 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.721 ' HZ2' ' HA ' ' A' ' 85' ' ' VAL . 30.8 mtmm -72.04 -37.82 69.64 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.612 -0.346 . . . . 1.89 110.473 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.1 mt -63.1 -43.97 99.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.346 . . . . 1.14 110.407 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -63.75 -41.22 98.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.497 -0.319 . . . . 0.46 110.208 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.67 -29.83 70.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.243 -0.435 . . . . 3.03 111.095 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.431 ' HB3' HD21 ' A' ' 126' ' ' LEU . 85.5 mt -89.99 -46.91 8.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.102 -0.499 . . . . 2.15 111.363 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -65.46 -42.97 91.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.985 -0.552 . . . . 1.22 111.574 -173.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.68 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 47.3 t0 -86.24 87.99 7.53 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.248 -1.019 . . . . 0.5 108.248 175.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.506 HG23 ' HD2' ' A' ' 132' ' ' PRO . 15.1 t -68.72 -43.71 82.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.435 -0.802 . . . . 1.21 110.259 -174.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.46 -21.5 30.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.314 -0.857 . . . . 1.46 110.56 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.68 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 48.3 mttp 60.22 73.86 0.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.82 . . . . 3.22 111.462 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.609 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 14.7 p-10 -121.6 9.9 10.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.61 -1.177 . . . . 0.56 111.058 -173.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.94 1.21 67.09 Favored Glycine 0 CA--C 1.516 0.109 0 C-N-CA 120.676 -0.773 . . . . 0.55 112.114 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.609 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 42.9 mt -127.73 152.45 47.72 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.108 -0.701 . . . . 1.17 109.108 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.2 mt -114.2 120.42 40.41 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.803 -0.443 . . . . 1.08 109.803 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.411 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 15.7 m-20 -68.45 173.62 4.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.24 -1.022 . . . . 1.85 108.24 171.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -63.62 -26.91 68.89 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.641 -0.503 . . . . 0.85 109.641 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -66.22 -56.06 13.14 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.352 0.596 . . . . 2.08 109.865 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.489 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 13.6 mt-10 -66.49 -34.5 78.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.93 -1.032 . . . . 0.48 110.574 -171.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.462 ' CD1' HD11 ' A' ' 67' ' ' ILE . 55.7 t80 -71.17 -43.11 68.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.332 -0.394 . . . . 0.51 110.214 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.424 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -60.98 -39.27 89.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.86 110.575 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -47.9 83.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.865 -0.607 . . . . 1.97 109.491 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.87 -47.33 85.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.804 -0.635 . . . . 1.06 110.791 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -34.32 77.63 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.155 -0.475 . . . . 0.92 111.315 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -68.41 -40.37 81.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.764 0.316 . . . . 0.39 110.387 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.684 ' HB3' HD23 ' A' ' 122' ' ' LEU . 95.0 mt -68.58 -41.54 79.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.275 0.56 . . . . 1.07 110.551 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.54 HD12 ' HG2' ' A' ' 76' ' ' MET . 96.0 mt -65.86 -38.66 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.902 -0.59 . . . . 1.39 109.872 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.717 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 13.9 ttpp -57.69 -53.43 58.3 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.844 -0.616 . . . . 2.25 110.211 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.8 m -62.79 -38.64 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 112.055 0.391 . . . . 1.26 112.055 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.643 ' HD2' HG13 ' A' ' 85' ' ' VAL . 1.1 mmpm? -51.58 -40.97 60.8 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.468 0.175 . . . . 2.47 111.393 169.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.4 mt -78.97 -29.16 43.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.465 -0.334 . . . . 1.34 111.511 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.717 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 10.8 mm-40 -67.37 -24.53 65.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.075 0.464 . . . . 1.98 110.223 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.68 16.75 23.37 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.916 -0.659 . . . . 0.88 111.595 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -108.76 162.44 14.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.237 -0.653 . . . . 1.23 109.237 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.475 ' CD ' ' HZ1' ' A' ' 116' ' ' LYS . 60.1 mm-40 -108.7 129.1 55.35 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.873 0.368 . . . . 3.06 111.249 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.684 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -77.76 139.78 62.71 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 115.956 -0.566 . . . . 1.75 109.902 172.045 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.11 -4.4 14.8 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.31 2.007 . . . . 1.05 113.692 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.408 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 64.44 20.39 12.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.377 0.608 . . . . 1.44 110.347 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -131.05 163.53 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.836 . . . . 1.97 109.4 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 92' ' ' LEU . 77.2 mt -110.08 96.1 24.1 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.735 -0.211 . . . . 1.25 111.04 174.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 30.3 Cg_endo -65.37 159.12 49.0 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.602 2.201 . . . . 0.59 111.649 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.41 -7.89 9.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.192 2.595 . . . . 1.02 114.138 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -111.22 11.09 21.78 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.094 -0.379 . . . . 1.05 111.488 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.8 mt -118.74 -26.2 6.16 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.953 -0.299 . . . . 1.9 111.301 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.38 116.93 20.02 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.717 -0.22 . . . . 1.96 110.92 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.506 ' HD2' HG23 ' A' ' 95' ' ' VAL . 86.5 Cg_exo . . . . . 0 C--N 1.346 0.418 0 C-N-CA 123.929 3.086 . . . . 1.11 113.506 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 53.0 t-20 . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 109.709 -0.478 . . . . 1.1 109.709 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 24.7 Cg_exo -64.06 -16.66 56.19 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.106 2.537 . . . . 1.05 113.327 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.54 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 95.0 m-85 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.895 0.379 . . . . 0.68 110.885 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 108.395 -0.965 . . . . 0.68 108.395 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.51 -40.85 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 121.818 0.818 . . . . 2.03 110.66 -166.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.7 m -91.53 0.44 9.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.484 -1.235 . . . . 1.68 111.339 -172.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.06 -31.49 20.07 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.586 -1.406 . . . . 0.62 109.586 169.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -81.17 -29.61 34.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.974 -0.613 . . . . 3.19 109.974 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.36 32.49 4.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.85 -0.796 . . . . 1.71 108.85 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.638 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 11.4 tmtt? -81.53 -47.12 1.07 Allowed Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 113.303 0.853 . . . . 1.9 113.303 -169.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.7 Cg_endo -44.16 -37.86 10.29 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 123.142 2.561 . . . . 1.06 113.845 -176.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -70.63 -46.67 62.89 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 120.965 0.412 . . . . 1.49 111.346 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.869 ' HH ' ' HD1' ' A' ' 111' ' ' HIS . 2.6 m-85 -72.82 -22.3 60.83 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.092 -0.707 . . . . 0.8 109.092 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -75.32 -42.03 55.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.814 -1.085 . . . . 1.03 109.475 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.54 -55.22 31.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.446 -0.797 . . . . 2.15 109.814 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.19 -26.26 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.826 -0.624 . . . . 1.46 111.389 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -69.58 -50.37 45.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.223 0.535 . . . . 0.37 110.259 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -74.33 -23.63 59.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.913 -0.585 . . . . 1.18 111.859 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.3 p -74.67 -1.52 22.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.844 0.354 . . . . 1.32 111.619 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 95.9 mt -108.49 6.07 25.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.852 -0.425 . . . . 1.17 109.852 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.8 m 63.17 86.86 0.14 Allowed Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 115.379 -0.828 . . . . 1.81 111.754 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -88.51 138.86 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.753 2.302 . . . . 0.59 112.972 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.516 HG13 ' ND2' ' A' ' 64' ' ' ASN . 14.7 t -118.01 132.09 68.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.799 -0.637 . . . . 1.89 109.917 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.516 ' ND2' HG13 ' A' ' 63' ' ' VAL . 44.6 m-80 62.71 20.02 11.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.47 0.708 . . . . 1.98 110.471 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.16 13.26 60.63 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.151 -0.931 . . . . 0.65 112.029 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HE2' ' OD2' ' A' ' 102' ' ' ASP . 94.2 mttt -136.25 171.17 14.88 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.383 0.611 . . . . 2.43 111.642 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.489 HD11 ' CD1' ' A' ' 106' ' ' PHE . 26.7 pt -121.62 143.11 35.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.927 -1.033 . . . . 1.1 109.449 171.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.1 p -78.31 171.42 15.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.179 -0.464 . . . . 1.06 110.112 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.35 -29.7 53.63 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 120.927 -0.654 . . . . 0.36 112.258 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.97 83.41 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.033 0.444 . . . . 1.17 111.843 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.646 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.4 m120 -76.73 -42.35 41.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.777 -0.647 . . . . 1.65 110.343 -170.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -69.15 -29.94 68.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.868 -0.606 . . . . 1.09 110.545 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 63.0 tttt -68.85 -50.18 52.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.215 -0.448 . . . . 2.11 110.838 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.481 ' HA ' HG21 ' A' ' 77' ' ' VAL . 17.3 ptpt -61.42 -39.01 89.23 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.036 0.446 . . . . 1.93 110.465 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.55 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 18.5 tp10 -61.42 -49.28 77.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.518 . . . . 1.78 110.237 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 1.002 ' HB3' HD21 ' A' ' 86' ' ' LEU . 49.8 mtt -65.46 -32.36 73.93 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.209 0.448 . . . . 1.67 112.209 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' A' ' 74' ' ' LYS . 33.5 m -78.75 -16.54 13.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.362 -0.535 . . . . 2.23 111.54 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.55 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -95.54 -9.05 33.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.335 -0.546 . . . . 3.79 110.201 172.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 70.9 m -74.19 -2.43 24.72 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.46 0.541 . . . . 0.98 112.46 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 79' ' ' SER . 5.7 mptp? 74.95 16.9 2.84 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.889 0.476 . . . . 3.38 112.26 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.481 ' HB2' HD22 ' A' ' 86' ' ' LEU . 10.9 mp -99.37 147.05 32.79 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-O 120.854 0.359 . . . . 2.04 111.144 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.538 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.2 Cg_endo -62.4 148.83 92.65 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.87 2.38 . . . . 0.38 112.575 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -53.41 -39.1 64.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.454 -0.794 . . . . 2.05 111.51 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.5 m -62.45 -52.72 62.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.475 . . . . 1.47 111.302 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.498 ' CG2' ' HG2' ' A' ' 82' ' ' PRO . 69.1 t -58.75 -38.54 72.74 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.051 0 CA-C-O 120.617 0.246 . . . . 1.08 110.629 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 1.002 HD21 ' HB3' ' A' ' 76' ' ' MET . 82.3 mt -59.98 -42.42 94.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 1.07 110.818 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.64 -42.29 98.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.852 -0.69 . . . . 0.41 111.792 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 55.3 mtpt -61.26 -46.76 89.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.832 0.349 . . . . 1.89 110.398 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 112' ' ' LEU . 82.6 mt -62.46 -44.48 99.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 1.14 111.311 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -57.33 -45.74 83.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.65 0.262 . . . . 0.46 110.774 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.08 -28.45 69.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.11 0.481 . . . . 3.03 110.907 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.469 ' HB3' HD22 ' A' ' 126' ' ' LEU . 46.3 mt -94.52 -16.77 23.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 2.15 111.856 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.27 -42.38 11.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.569 -0.287 . . . . 1.22 111.133 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -86.42 84.62 7.4 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.115 -0.698 . . . . 0.5 109.115 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.456 HG22 ' HD2' ' A' ' 132' ' ' PRO . 10.7 t -70.87 -36.69 65.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.595 -0.729 . . . . 1.21 110.856 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.64 -11.39 57.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.008 -0.542 . . . . 1.46 110.473 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt 55.57 53.96 9.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.959 -1.019 . . . . 3.22 111.167 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 13.2 p-10 -109.91 7.86 24.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.059 -0.519 . . . . 0.56 110.583 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.91 1.35 67.42 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.12 -0.562 . . . . 0.55 112.083 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.421 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 74.9 mt -127.05 144.55 51.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.013 0.435 . . . . 1.17 109.902 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 67.3 mt -104.55 113.45 27.04 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.413 -0.515 . . . . 1.08 110.095 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.424 ' OD2' ' HE2' ' A' ' 66' ' ' LYS . 4.2 m-20 -69.35 172.29 7.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.558 -0.904 . . . . 1.85 108.558 169.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -60.27 -30.92 69.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.549 0.214 . . . . 0.85 110.721 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -71.79 -45.28 62.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.107 0.479 . . . . 2.08 110.866 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -70.7 -33.0 70.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.919 0.39 . . . . 0.48 110.747 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.489 ' CD1' HD11 ' A' ' 67' ' ' ILE . 27.7 t80 -75.16 -30.98 60.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.79 -0.448 . . . . 0.51 109.79 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.79 82.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.195 0.522 . . . . 0.86 110.039 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -65.09 -51.25 62.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 1.97 110.556 175.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.37 -50.57 69.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.702 -0.681 . . . . 1.06 110.822 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.449 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -61.82 -33.81 74.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.618 -0.719 . . . . 0.92 111.298 -178.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.869 ' HD1' ' HH ' ' A' ' 53' ' ' TYR . 69.3 t60 -68.41 -42.97 78.23 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.8 -0.36 . . . . 0.39 110.855 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.504 HD11 HG21 ' A' ' 89' ' ' ILE . 72.6 mt -65.59 -38.39 89.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.208 0.527 . . . . 1.07 110.504 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.65 HD13 ' HG2' ' A' ' 76' ' ' MET . 66.6 mt -68.39 -41.03 83.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.042 -0.526 . . . . 1.39 110.592 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 32.4 ttpt -59.09 -48.99 79.59 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.64 -0.255 . . . . 2.25 110.408 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.8 m -63.44 -36.01 74.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 120.642 -0.423 . . . . 1.26 111.119 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.795 ' HD3' HD21 ' A' ' 122' ' ' LEU . 3.9 mmmp? -58.19 -37.88 75.64 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.444 -0.502 . . . . 2.47 110.703 172.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.6 -22.78 59.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 1.34 110.916 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 13.6 mt-10 -83.5 2.14 38.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.194 -0.457 . . . . 1.98 110.55 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.77 23.7 45.09 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.784 -0.722 . . . . 0.88 111.848 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.596 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 90.4 m-70 -117.92 161.27 20.05 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.725 -0.472 . . . . 1.23 109.725 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -115.64 149.04 38.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.34 -0.391 . . . . 3.06 109.975 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.795 HD21 ' HD3' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -89.66 146.77 36.27 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.124 -0.695 . . . . 1.75 109.124 -178.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -66.62 -6.85 16.35 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.783 2.322 . . . . 1.05 112.937 -172.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.81 18.52 9.69 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.469 -0.787 . . . . 1.44 110.773 -176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -135.64 163.7 29.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.2 -0.667 . . . . 1.97 109.2 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 92' ' ' LEU . 96.0 mt -111.98 92.72 18.77 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 111.633 0.234 . . . . 1.25 111.633 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.499 ' HD2' HD11 ' A' ' 130' ' ' LEU . 17.6 Cg_endo -58.86 153.61 49.49 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.395 2.064 . . . . 0.59 111.568 171.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.47 -33.27 46.55 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.508 2.805 . . . . 1.02 114.146 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -82.64 7.21 15.37 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.336 0.495 . . . . 1.05 112.336 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.5 ' O ' HD22 ' A' ' 108' ' ' LEU . 49.2 mt -111.38 -29.12 7.92 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.891 -0.324 . . . . 1.9 111.243 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.411 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 39.3 t -65.52 120.39 67.76 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.5 -0.318 . . . . 1.96 110.838 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 95' ' ' VAL . 10.0 Cg_endo . . . . . 0 C--O 1.239 0.562 0 C-N-CA 123.092 2.528 . . . . 1.11 112.387 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.01 0.434 . . . . 1.1 110.67 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.45 -7.85 20.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.45 2.767 . . . . 1.05 113.154 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 90.9 m-85 . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 112.008 0.373 . . . . 0.68 112.008 -177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.9 t90 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 109.411 -0.588 . . . . 0.68 109.411 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.18 -23.45 11.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.309 0.485 . . . . 2.03 112.309 -168.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -88.28 0.22 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.315 -0.554 . . . . 1.68 111.271 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 -25.5 68.57 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.952 -0.642 . . . . 0.62 112.166 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HG3' ' OD1' ' A' ' 49' ' ' ASP . 15.5 pttp -80.21 -27.76 38.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.611 0.243 . . . . 3.19 111.523 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.574 ' OD1' ' HG3' ' A' ' 48' ' ' LYS . 1.2 m-20 -104.13 31.98 4.25 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.725 -0.472 . . . . 1.71 109.725 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -79.84 -51.24 1.16 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 113.275 0.843 . . . . 1.9 113.275 -172.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.5 -26.56 54.85 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.056 1.837 . . . . 1.06 112.743 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.41 -45.45 46.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.717 0.294 . . . . 1.49 110.912 177.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -70.36 -24.05 62.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.1 -0.704 . . . . 0.8 109.1 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.551 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -73.75 -43.76 58.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.083 -0.962 . . . . 1.03 110.262 176.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.94 -38.03 75.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.865 -0.607 . . . . 2.15 110.229 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.1 mt -75.53 -35.39 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.573 0.702 . . . . 1.46 110.641 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.52 ' CZ ' ' HA ' ' A' ' 66' ' ' LYS . 62.3 t80 -63.54 -43.06 98.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.287 -0.869 . . . . 0.37 111.018 -176.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.551 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 30.8 m-85 -67.64 -23.29 65.33 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.363 0.505 . . . . 1.18 112.363 -177.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.1 p -85.37 8.68 17.9 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.532 -0.467 . . . . 1.32 111.742 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 95.1 mt -112.23 6.9 19.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.29 -0.413 . . . . 1.17 111.105 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t 65.84 88.48 0.11 Allowed Pre-proline 0 N--CA 1.469 0.479 0 O-C-N 123.547 0.529 . . . . 1.81 111.009 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -94.06 132.28 0.73 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.925 2.417 . . . . 0.59 113.428 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.0 134.1 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.288 -0.869 . . . . 1.89 109.429 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 62.62 26.94 15.95 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.851 0.358 . . . . 1.98 110.719 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.6 36.31 67.83 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.611 -0.804 . . . . 0.65 111.916 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.808 ' HB3' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -168.04 175.65 6.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.59 0.233 . . . . 2.43 110.67 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.7 pt -131.35 155.36 41.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.215 0.531 . . . . 1.1 112.122 -172.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.46 ' HA ' HD23 ' A' ' 100' ' ' LEU . 40.9 p -79.19 166.92 21.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.069 -0.969 . . . . 1.06 110.4 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.417 ' HA3' ' HG3' ' B' ' 150' ' ' PRO . . . -59.19 -27.52 62.86 Favored Glycine 0 C--O 1.221 -0.662 0 C-N-CA 120.991 -0.624 . . . . 0.36 112.99 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.22 82.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.39 0.515 . . . . 1.17 112.39 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -76.13 -42.43 46.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.18 -0.464 . . . . 1.65 110.238 -172.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.81 71.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 1.09 110.161 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 59.7 tttt -69.3 -54.76 12.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.979 -0.555 . . . . 2.11 110.495 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 17.3 ptpt -57.78 -34.41 69.56 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.888 -0.325 . . . . 1.93 110.74 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.428 ' CD ' ' HZ2' ' A' ' 78' ' ' LYS . 9.8 tp10 -64.77 -53.5 46.09 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.404 0.621 . . . . 1.78 110.425 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.678 ' HB3' HD23 ' A' ' 86' ' ' LEU . 93.0 mtp -68.96 -24.89 64.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.503 -0.772 . . . . 1.67 112.142 -173.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.508 HG22 ' HA ' ' A' ' 74' ' ' LYS . 35.6 m -87.47 -35.91 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-O 121.067 0.461 . . . . 2.23 110.821 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -79.52 -8.19 58.98 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.482 0.658 . . . . 3.79 109.624 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.5 m -69.86 -11.34 60.79 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.5 -0.773 . . . . 0.98 110.502 168.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 71.68 44.77 0.48 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.504 0.722 . . . . 3.38 111.862 177.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.454 ' HB2' HD21 ' A' ' 86' ' ' LEU . 86.9 mt -119.62 146.86 42.43 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.117 -0.492 . . . . 2.04 109.852 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.5 Cg_endo -58.99 141.22 98.1 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.986 2.457 . . . . 0.38 112.955 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -62.64 -30.52 71.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.614 -0.721 . . . . 2.05 111.644 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.0 m -61.12 -53.13 60.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 1.47 110.085 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 t -55.41 -45.84 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.829 -0.623 . . . . 1.08 110.927 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.678 HD23 ' HB3' ' A' ' 76' ' ' MET . 77.1 mt -60.77 -42.12 96.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 1.07 110.721 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.35 -33.79 88.18 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.701 -0.681 . . . . 0.41 112.358 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 33.1 mttt -68.0 -45.29 74.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.911 0.386 . . . . 1.89 110.077 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.588 HG23 HD11 ' A' ' 112' ' ' LEU . 81.9 mt -59.58 -44.33 92.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.863 -0.608 . . . . 1.14 111.463 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -60.18 -39.82 87.82 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.921 -0.4 . . . . 0.46 109.921 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -64.82 -23.01 67.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 3.03 111.172 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.671 ' HB3' HD22 ' A' ' 126' ' ' LEU . 70.9 mt -93.39 -38.52 11.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.615 -0.721 . . . . 2.15 110.722 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.755 ' HA ' HD21 ' A' ' 108' ' ' LEU . . . -78.93 -42.64 26.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 1.22 111.819 -173.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.634 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 25.3 t0 -86.42 73.53 10.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.286 0.565 . . . . 0.5 109.565 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.8 t -64.65 -37.89 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 115.29 -0.868 . . . . 1.21 110.798 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.39 -20.4 61.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.526 -0.761 . . . . 1.46 109.926 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 96.4 mttt 56.83 37.79 29.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.838 0.828 . . . . 3.22 109.333 -175.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.602 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.2 p-10 -89.59 8.95 28.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.654 -1.157 . . . . 0.56 110.972 -174.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.38 -2.96 26.35 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.055 -0.593 . . . . 0.55 112.572 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.602 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 36.1 mt -125.81 146.74 49.67 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.649 -0.5 . . . . 1.17 109.649 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.6 mt -105.74 112.4 25.45 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.282 -0.636 . . . . 1.08 109.282 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.808 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . 2.0 p30 -75.31 176.44 7.42 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.489 -0.484 . . . . 1.85 109.723 174.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -59.19 -28.76 66.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.697 -0.228 . . . . 0.85 111.538 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.402 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . 7.7 mm-40 -76.08 -50.39 14.85 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.877 0.37 . . . . 2.08 110.689 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.634 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 49.3 mt-10 -58.09 -43.17 86.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.257 0.551 . . . . 0.48 110.61 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -69.94 -29.57 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.835 -0.62 . . . . 0.51 110.115 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.47 -43.34 90.61 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.425 0.631 . . . . 0.86 109.889 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.755 HD21 ' HA ' ' A' ' 93' ' ' ALA . 23.7 tp -62.89 -46.45 87.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.452 -0.794 . . . . 1.97 110.369 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.4 -44.79 89.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.54 -0.754 . . . . 1.06 111.074 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -65.41 -33.36 75.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.059 -0.518 . . . . 0.92 111.506 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -67.86 -40.23 83.68 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.904 -0.319 . . . . 0.39 110.241 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.798 ' HB3' HD21 ' A' ' 122' ' ' LEU . 96.4 mt -65.76 -36.3 83.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 1.07 110.629 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.502 HD11 ' HE1' ' A' ' 76' ' ' MET . 73.7 mt -71.8 -38.06 64.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.094 -0.503 . . . . 1.39 110.777 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -57.61 -49.8 75.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.366 -0.379 . . . . 2.25 110.388 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 120' ' ' HIS . 13.9 m -67.16 -40.17 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 120.563 -0.455 . . . . 1.26 111.291 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -51.55 -47.28 63.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.806 0.275 . . . . 2.47 111.339 171.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.71 -35.94 75.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 1.34 110.722 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -74.19 -5.35 41.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.83 -0.623 . . . . 1.98 111.805 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.36 30.55 9.83 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.175 -1.012 . . . . 0.88 112.544 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 90.6 m-70 -126.44 117.39 22.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.103 0.477 . . . . 1.23 109.946 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -78.01 117.2 19.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.57 -0.741 . . . . 3.06 110.526 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.798 HD21 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -60.59 141.17 92.29 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 1.75 110.437 173.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.65 -1.77 10.84 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.449 2.099 . . . . 1.05 113.764 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.26 24.27 14.22 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.512 0.508 . . . . 1.44 110.769 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -133.67 158.5 43.1 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.352 -0.61 . . . . 1.97 109.352 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 92' ' ' LEU . 94.5 mt -111.81 92.34 17.29 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 111.926 0.343 . . . . 1.25 111.926 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.611 ' HD2' HD13 ' A' ' 130' ' ' LEU . 35.3 Cg_endo -66.95 160.4 47.3 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.46 2.107 . . . . 0.59 110.968 167.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.49 -42.23 28.88 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.124 2.55 . . . . 1.02 113.828 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -77.86 10.19 2.98 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.761 0.652 . . . . 1.05 112.761 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.611 HD13 ' HD2' ' A' ' 127' ' ' PRO . 52.8 mt -122.23 3.46 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.215 -0.194 . . . . 1.9 111.287 176.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.6 115.62 64.87 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 121.164 -0.215 . . . . 1.96 110.733 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.904 2.403 . . . . 1.11 112.307 179.361 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 22.3 p30 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.227 0.537 . . . . 1.1 111.885 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.417 ' HG3' ' HA3' ' A' ' 69' ' ' GLY . 34.4 Cg_endo -66.05 -3.69 8.9 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.382 2.721 . . . . 1.05 113.581 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.449 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 80.3 m-85 . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 111.981 0.364 . . . . 0.68 111.981 -173.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.6 t90 . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 108.042 -1.095 . . . . 0.68 108.042 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.5 t -56.62 -24.07 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.896 -0.593 . . . . 2.03 112.118 -171.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -76.54 -23.05 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.765 0.316 . . . . 1.68 111.169 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.74 -18.68 70.55 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.573 -0.822 . . . . 0.62 112.465 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -18.33 23.73 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.143 -0.623 . . . . 3.19 111.733 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -121.22 31.99 6.12 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.95 -0.759 . . . . 1.71 108.95 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 8.7 tmtm? -74.86 -47.43 4.95 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 1.9 111.774 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 49.0 Cg_exo -56.04 -27.67 65.62 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.967 1.778 . . . . 1.06 112.56 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 m -75.71 -46.32 31.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.604 -0.271 . . . . 1.49 111.142 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -70.34 -23.06 62.75 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.679 -0.86 . . . . 0.8 108.679 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.75 -44.68 63.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.733 -1.121 . . . . 1.03 109.862 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.86 -40.79 89.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.027 -0.988 . . . . 2.15 110.055 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.26 -38.37 77.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.01 -0.541 . . . . 1.46 110.797 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.403 ' HE1' HG12 ' A' ' 67' ' ' ILE . 83.1 t80 -62.27 -41.13 98.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.924 -0.58 . . . . 0.37 110.631 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -82.08 14.59 2.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.451 -0.795 . . . . 1.18 112.416 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.1 p -113.7 2.06 15.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.144 0.497 . . . . 1.32 110.988 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 89.0 mt -108.51 14.6 24.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.766 -0.652 . . . . 1.17 111.147 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.8 t 61.2 80.92 0.25 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.722 -0.672 . . . . 1.81 111.575 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -85.63 105.65 0.86 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.514 2.142 . . . . 0.59 113.134 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.3 m -89.78 135.36 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.717 -0.674 . . . . 1.89 109.839 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 62.4 21.06 12.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.19 -0.459 . . . . 1.98 110.412 -174.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.51 9.48 83.32 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.572 -0.823 . . . . 0.65 111.873 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 56.7 mtmt -138.33 148.52 44.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.368 . . . . 2.43 110.947 -177.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' A' ' 106' ' ' PHE . 11.3 pt -97.34 144.16 11.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.017 0.437 . . . . 1.1 110.701 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.541 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 12.1 p -71.18 161.6 30.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.295 -0.866 . . . . 1.06 110.837 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.26 -32.22 60.12 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.135 -0.555 . . . . 0.36 112.021 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.634 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -49.85 -65.81 0.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.559 0.344 . . . . 1.17 111.72 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 48.0 m-80 -69.45 -39.46 77.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.089 -0.505 . . . . 1.65 111.717 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.11 97.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.422 -0.354 . . . . 1.09 110.38 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.515 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 34.4 ttpt -62.43 -42.28 99.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.469 -0.567 . . . . 2.11 109.469 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.634 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 52.0 mtpt -51.8 -55.53 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.5 -0.773 . . . . 1.93 110.916 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -59.07 -46.53 88.02 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.348 0.595 . . . . 1.78 110.657 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.689 ' HB3' HD22 ' A' ' 86' ' ' LEU . 84.3 mtp -64.69 -29.22 70.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.846 -0.615 . . . . 1.67 110.992 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.21 -37.37 45.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.239 0.542 . . . . 2.23 109.897 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -80.86 2.91 24.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.91 -0.586 . . . . 3.79 111.061 177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m -77.56 -10.24 59.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.307 -0.406 . . . . 0.98 110.338 169.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 69.68 21.37 6.6 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.299 0.639 . . . . 3.38 111.615 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' HB2' HD23 ' A' ' 86' ' ' LEU . 94.2 mt -100.8 153.14 37.9 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.614 -0.721 . . . . 2.04 110.964 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.495 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 9.8 Cg_endo -54.82 141.12 77.67 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.155 2.57 . . . . 0.38 112.631 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -63.95 -28.43 69.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.463 -0.789 . . . . 2.05 111.443 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 p -67.22 -44.73 78.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.842 0.353 . . . . 1.47 110.887 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.46 -44.3 98.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 1.08 110.01 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.689 HD22 ' HB3' ' A' ' 76' ' ' MET . 78.4 mt -60.75 -41.41 95.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.767 -0.651 . . . . 1.07 110.489 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.6 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -57.17 -49.73 69.94 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.697 -0.683 . . . . 0.41 111.541 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.496 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 93.6 mttt -56.05 -51.05 69.22 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 122.518 0.327 . . . . 1.89 110.974 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 112' ' ' LEU . 83.0 mt -55.52 -42.67 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.695 -0.684 . . . . 1.14 111.217 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.435 ' HB3' ' ND2' ' B' ' 149' ' ' ASN . 15.0 t-105 -61.93 -44.91 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.478 -0.328 . . . . 0.46 110.956 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 60.7 mttm -63.28 -22.82 67.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 3.03 110.961 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 126' ' ' LEU . 27.7 mt -93.51 -38.01 11.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 2.15 110.528 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 105' ' ' GLU . . . -72.61 -42.67 64.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.713 -0.676 . . . . 1.22 111.019 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.497 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 44.2 t0 -81.46 78.94 8.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.897 -0.779 . . . . 0.5 108.897 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.13 -36.04 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.493 -0.776 . . . . 1.21 110.827 -174.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.17 -11.08 57.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 1.46 109.727 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.497 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 62.2 mtpt 51.63 66.04 1.31 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.808 -1.087 . . . . 3.22 111.564 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.491 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 10.5 p-10 -115.31 9.2 15.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.335 -0.848 . . . . 0.56 110.412 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.16 2.76 67.45 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.882 -0.675 . . . . 0.55 112.183 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.541 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 81.2 mt -131.73 164.75 25.29 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.377 -0.601 . . . . 1.17 109.377 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.1 mt -120.56 116.65 25.79 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.649 -0.42 . . . . 1.08 110.482 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.44 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.7 p30 -78.62 -176.89 5.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.144 -0.688 . . . . 1.85 109.144 170.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -66.4 -29.6 69.79 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.961 -0.295 . . . . 0.85 111.528 -176.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -69.55 -53.83 17.04 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.213 -0.662 . . . . 2.08 109.213 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 28.7 mt-10 -63.06 -39.6 95.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.919 -1.037 . . . . 0.48 111.436 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.469 ' CD1' HD13 ' A' ' 67' ' ' ILE . 48.6 t80 -69.48 -40.36 77.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.51 110.249 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.58 75.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.92 -0.582 . . . . 0.86 110.373 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -63.85 -48.44 76.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.947 -0.569 . . . . 1.97 109.475 175.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.78 76.71 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.617 -0.72 . . . . 1.06 110.611 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.31 -28.36 69.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.711 -0.677 . . . . 0.92 111.543 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 56.8 t60 -81.24 -32.67 33.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.815 -0.354 . . . . 0.39 110.871 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 89' ' ' ILE . 93.4 mt -71.12 -37.28 72.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.331 0.586 . . . . 1.07 109.568 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.486 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 76.0 mt -70.78 -32.73 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.905 -0.589 . . . . 1.39 109.941 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 14.3 tppt? -53.4 -55.42 25.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.044 -0.526 . . . . 2.25 110.728 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.3 m -65.94 -36.31 77.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 120.563 -0.455 . . . . 1.26 111.47 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HG2' HD22 ' A' ' 122' ' ' LEU . 25.7 mmmt -58.67 -42.03 87.53 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.562 -0.455 . . . . 2.47 111.702 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 81.6 mt -70.09 -22.32 63.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 1.34 110.97 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.455 ' HB2' ' CD2' ' A' ' 120' ' ' HIS . 49.1 mt-10 -82.73 -8.17 59.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.914 -0.584 . . . . 1.98 110.893 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.56 30.16 16.68 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.576 -0.821 . . . . 0.88 111.861 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.455 ' CD2' ' HB2' ' A' ' 118' ' ' GLU . 66.8 m-70 -110.24 174.08 6.03 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.646 -0.501 . . . . 1.23 109.646 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' A' ' 121' ' ' GLU . 16.2 mm-40 -109.21 136.69 48.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.79 -0.641 . . . . 3.06 109.535 171.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.439 HD22 ' HG2' ' A' ' 116' ' ' LYS . 1.3 pp -82.93 139.59 43.0 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.335 -0.617 . . . . 1.75 109.335 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.53 -13.97 36.64 Favored 'Trans proline' 0 N--CA 1.476 0.467 0 C-N-CA 123.332 2.688 . . . . 1.05 113.694 -169.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.53 16.42 9.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.645 -0.707 . . . . 1.44 111.425 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -136.26 171.54 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.304 -0.628 . . . . 1.97 109.304 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.852 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 98.9 mt -115.85 90.51 27.54 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.505 -0.316 . . . . 1.25 110.794 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.65 154.85 66.63 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.478 2.119 . . . . 0.59 111.723 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -50.27 -24.36 11.5 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.583 2.856 . . . . 1.02 114.969 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -96.31 5.27 51.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.952 0.406 . . . . 1.05 111.508 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.433 ' O ' HD22 ' A' ' 108' ' ' LEU . 64.8 mt -123.61 -34.08 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.29 -0.414 . . . . 1.9 110.786 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.852 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.8 p -77.61 121.55 84.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.026 0.441 . . . . 1.96 110.654 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 131' ' ' VAL . 12.4 Cg_endo . . . . . 0 N--CA 1.462 -0.331 0 C-N-CA 122.754 2.303 . . . . 1.11 112.065 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.593 HD22 ' HA2' ' A' ' 87' ' ' GLY . 24.8 t-20 . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 109.729 -0.471 . . . . 1.1 109.729 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 16.5 Cg_exo -68.46 -6.87 18.67 Favored 'Trans proline' 0 N--CA 1.474 0.326 0 C-N-CA 123.361 2.707 . . . . 1.05 113.284 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.515 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 99.2 m-85 . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 121.182 0.515 . . . . 0.68 110.196 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.3 t90 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 108.31 -0.996 . . . . 0.68 108.31 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.5 t -53.31 -35.68 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.513 0.56 . . . . 2.03 112.513 -172.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 31.3 t -72.16 -17.0 18.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.372 -0.376 . . . . 1.68 111.26 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.55 -1.25 52.0 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.366 -0.921 . . . . 0.62 112.188 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -86.55 -31.04 21.44 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.22 0.533 . . . . 3.19 110.878 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -141.39 35.16 1.67 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 122.224 1.011 . . . . 1.71 110.229 -172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 15.1 tmtt? -76.86 -42.56 2.82 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 114.015 -1.448 . . . . 1.9 111.535 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 50' ' ' LYS . 82.2 Cg_exo -46.21 -35.0 14.55 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.726 2.284 . . . . 1.06 113.598 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.577 ' O ' HG12 ' A' ' 56' ' ' ILE . 9.3 m -69.83 -45.66 67.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.732 -0.387 . . . . 1.49 110.449 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -72.16 -22.76 61.25 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.467 -0.568 . . . . 0.8 109.467 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.475 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 18.0 t70 -67.2 -41.18 86.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.137 -0.938 . . . . 1.03 109.078 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -66.85 -35.59 80.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.21 -0.904 . . . . 2.15 110.239 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 52' ' ' THR . 23.0 mm -66.03 -31.48 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.731 0.777 . . . . 1.46 109.707 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.471 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 87.6 t80 -72.91 -45.55 57.53 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.094 -0.957 . . . . 0.37 110.804 -175.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 51.2 m-85 -75.49 -19.89 59.1 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.114 -0.493 . . . . 1.18 111.952 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.2 p -83.45 -5.16 59.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 1.32 111.164 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.62 8.98 39.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 1.17 111.246 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.1 t 64.32 83.41 0.2 Allowed Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 123.743 0.652 . . . . 1.81 110.955 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.43 118.13 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.766 2.311 . . . . 0.59 112.812 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.91 134.7 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.744 . . . . 1.89 110.66 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 57.92 19.92 6.24 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.457 0.703 . . . . 1.98 111.377 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.71 7.27 63.17 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.907 -0.588 . . . . 0.65 112.258 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 54.4 mtmt -137.45 173.42 11.68 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 110.111 -0.329 . . . . 2.43 110.111 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.42 HD13 ' CD1' ' A' ' 106' ' ' PHE . 25.0 pt -118.39 154.12 20.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.87 -0.418 . . . . 1.1 109.87 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.579 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 70.7 p -80.95 166.94 20.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.896 -0.593 . . . . 1.06 110.201 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.519 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -58.87 -22.46 54.39 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.642 -0.79 . . . . 0.36 111.888 175.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.552 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -61.42 -59.91 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 1.17 111.556 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -65.8 -42.75 90.33 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.689 -0.687 . . . . 1.65 111.332 -170.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.16 -36.14 83.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 1.09 110.522 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 32.0 tttp -62.27 -43.39 98.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.894 -0.594 . . . . 2.11 110.019 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 24.8 mtpt -58.76 -51.1 71.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.687 -0.688 . . . . 1.93 110.576 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -57.98 -43.7 86.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.529 0.681 . . . . 1.78 110.457 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.735 ' HB3' HD23 ' A' ' 86' ' ' LEU . 94.4 mtp -69.16 -26.91 65.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.792 -0.64 . . . . 1.67 112.276 -175.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 74' ' ' LYS . 25.6 m -83.16 -22.82 8.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 120.126 -0.63 . . . . 2.23 109.602 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 5.6 mptp? -77.6 -12.94 60.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 3.79 110.099 173.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.0 m -75.2 -7.93 55.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.98 111.62 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? 67.39 34.66 4.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.986 0.422 . . . . 3.38 111.374 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 86' ' ' LEU . 95.3 mt -112.74 146.65 35.49 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.106 -0.497 . . . . 2.04 110.982 -176.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.4 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.7 Cg_endo -61.62 153.14 69.05 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.064 2.509 . . . . 0.38 112.854 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -59.62 -32.74 70.7 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.948 -0.569 . . . . 2.05 111.601 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.456 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -64.73 -50.47 66.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.922 0.391 . . . . 1.47 110.951 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.44 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . 42.8 t -60.27 -44.26 95.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 1.08 110.418 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' A' ' 76' ' ' MET . 86.4 mt -63.84 -38.84 92.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.809 -0.632 . . . . 1.07 110.774 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.637 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -60.88 -42.68 99.71 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.039 -0.6 . . . . 0.41 112.551 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 84' ' ' THR . 41.1 mtmt -68.18 -42.9 79.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.744 -0.095 . . . . 1.89 110.744 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.571 HD11 ' HZ2' ' A' ' 116' ' ' LYS . 93.8 mt -55.83 -52.2 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.384 0.428 . . . . 1.14 111.071 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.519 ' CH2' ' HA2' ' A' ' 69' ' ' GLY . 39.0 t-105 -62.98 -49.59 74.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.794 0.331 . . . . 0.46 111.348 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -59.64 -30.93 69.06 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.139 -0.482 . . . . 3.03 111.232 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.482 HD22 HD12 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -92.53 -41.02 10.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 2.15 111.2 -176.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.45 ' N ' ' HG ' ' A' ' 92' ' ' LEU . . . -69.53 -36.32 76.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.536 0.569 . . . . 1.22 112.536 -175.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.592 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 42.5 t0 -74.18 95.47 2.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.895 -0.779 . . . . 0.5 108.895 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 t -79.75 -39.91 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 1.21 110.942 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -80.68 -13.92 58.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 1.46 109.68 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.592 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 6.1 mtpp 51.64 72.91 0.34 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.496 -1.229 . . . . 3.22 111.31 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.62 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.1 p-10 -128.33 9.1 6.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.962 -1.017 . . . . 0.56 110.825 -175.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.23 10.84 70.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.55 111.841 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 43.8 mt -134.31 157.45 46.3 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.217 -0.66 . . . . 1.17 109.217 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.0 mt -121.77 118.81 29.97 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.776 -0.37 . . . . 1.08 110.196 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -74.67 -177.63 3.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.077 -0.712 . . . . 1.85 109.077 168.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -66.08 -27.05 67.78 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.088 0.403 . . . . 0.85 112.088 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 85.7 mt-10 -75.89 -47.32 25.87 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.749 -0.463 . . . . 2.08 109.749 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -66.3 -37.7 86.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.89 -0.596 . . . . 0.48 110.492 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 67' ' ' ILE . 23.7 t80 -70.34 -38.56 74.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.168 -0.469 . . . . 0.51 110.303 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.88 99.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.045 -0.525 . . . . 0.86 110.401 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -59.38 -49.88 76.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 1.97 109.574 177.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -55.61 -46.92 77.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.905 -0.589 . . . . 1.06 111.552 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -66.68 -38.4 86.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.446 . . . . 0.92 111.407 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -64.92 -32.61 74.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.098 0.475 . . . . 0.39 109.934 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.708 ' HB3' HD23 ' A' ' 122' ' ' LEU . 97.8 mt -67.09 -35.02 78.9 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.954 -0.567 . . . . 1.07 109.997 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 109' ' ' ALA . 38.7 mm -61.26 -47.1 95.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.158 -0.682 . . . . 1.39 109.158 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -59.06 -44.06 91.79 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.417 -0.811 . . . . 2.25 112.033 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 112' ' ' LEU . 11.6 m -64.56 -38.79 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 120.062 -0.655 . . . . 1.26 111.344 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.594 ' HE3' HD22 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -51.97 -48.51 64.32 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 120.526 -0.47 . . . . 2.47 111.262 167.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.38 -29.37 68.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.933 -0.576 . . . . 1.34 111.23 -177.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -70.91 -20.01 62.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.968 -0.56 . . . . 1.98 111.233 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.39 22.67 10.24 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.693 -0.765 . . . . 0.88 112.004 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -119.36 158.57 25.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.589 -0.523 . . . . 1.23 109.589 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.9 130.61 55.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.201 0.524 . . . . 3.06 110.564 174.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.708 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -68.79 146.5 97.55 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 1.75 110.407 172.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 2.2 Cg_endo -80.22 1.7 9.05 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.719 2.279 . . . . 1.05 112.86 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 64.53 19.69 11.89 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.985 -0.552 . . . . 1.44 110.892 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -133.85 169.72 16.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.696 -0.684 . . . . 1.97 109.383 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.6 mt -111.97 91.26 15.04 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 123.082 0.239 . . . . 1.25 111.516 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.54 154.41 72.09 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.71 2.273 . . . . 0.59 111.208 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.27 -40.24 52.34 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.537 2.825 . . . . 1.02 113.77 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -79.14 7.65 7.17 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.088 0.403 . . . . 1.05 112.088 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.422 ' O ' HD22 ' A' ' 108' ' ' LEU . 70.5 mt -126.34 5.61 7.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.547 0.213 . . . . 1.9 111.557 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.32 118.31 69.75 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.033 -0.267 . . . . 1.96 110.915 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.458 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 64.5 Cg_exo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 123.139 2.56 . . . . 1.11 112.135 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.637 HD22 ' HA2' ' A' ' 87' ' ' GLY . 48.6 t-20 . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 109.448 -0.575 . . . . 1.1 109.448 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.59 -3.14 8.62 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.45 2.766 . . . . 1.05 113.684 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 83.6 m-85 . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.987 0.422 . . . . 0.68 110.533 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.8 t90 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 108.703 -0.851 . . . . 0.68 108.703 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 m -57.57 -26.71 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.578 -0.737 . . . . 2.03 112.172 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.488 ' HA ' ' OD1' ' A' ' 49' ' ' ASP . 24.1 t -73.41 -16.34 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.032 -0.531 . . . . 1.68 111.227 -174.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.01 -8.81 58.82 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.604 -0.808 . . . . 0.62 112.396 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -93.88 -28.78 15.65 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.395 0.617 . . . . 3.19 110.721 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.488 ' OD1' ' HA ' ' A' ' 46' ' ' VAL . 10.8 p-10 -120.94 33.7 5.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.211 -0.904 . . . . 1.71 109.714 -172.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.06 -46.51 0.47 Allowed Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 114.391 -1.277 . . . . 1.9 112.263 -174.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.39 -26.61 8.84 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 122.754 2.303 . . . . 1.06 114.06 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -68.83 -45.86 70.04 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.384 0.611 . . . . 1.49 110.126 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -78.14 -20.72 51.49 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.706 -0.679 . . . . 0.8 109.178 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.6 -45.19 94.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.614 -0.721 . . . . 1.03 109.505 173.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -62.05 -50.0 73.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.203 -0.908 . . . . 2.15 110.089 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.9 mt -60.71 -35.42 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.063 -0.517 . . . . 1.46 111.008 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.491 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 92.6 t80 -65.13 -40.33 94.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.637 -0.71 . . . . 0.37 110.05 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -74.75 -25.01 58.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.959 -0.564 . . . . 1.18 111.726 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.6 p -82.53 1.87 35.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.088 0.47 . . . . 1.32 111.374 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.75 1.85 23.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.714 -0.476 . . . . 1.17 109.714 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.5 m 63.3 88.88 0.11 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.054 -0.975 . . . . 1.81 111.593 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -86.92 122.5 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.71 2.273 . . . . 0.59 112.592 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.9 m -101.2 130.9 49.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.001 -0.545 . . . . 1.89 109.781 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 65.91 21.85 11.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.002 -0.545 . . . . 1.98 110.046 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.18 1.53 78.85 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.912 -0.586 . . . . 0.65 112.549 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.615 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 51.5 mtmt -135.59 156.44 48.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.021 -0.363 . . . . 2.43 110.021 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.54 HD12 ' CD1' ' A' ' 106' ' ' PHE . 15.4 pt -102.33 146.14 10.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 120.57 -0.452 . . . . 1.1 110.663 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.569 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 68.5 p -73.16 163.97 27.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.089 -0.505 . . . . 1.06 110.293 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.99 -24.76 55.24 Favored Glycine 0 C--O 1.221 -0.708 0 C-N-CA 120.796 -0.716 . . . . 0.36 112.469 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -59.35 -58.07 10.21 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.119 0.485 . . . . 1.17 111.601 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.446 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -67.54 -41.12 84.8 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.719 -0.673 . . . . 1.65 110.363 -173.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.449 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -65.29 -31.54 72.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.483 -0.781 . . . . 1.09 110.524 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.439 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 70.9 tttt -67.86 -43.48 79.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.213 -0.449 . . . . 2.11 109.954 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.722 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.9 mtmt -55.29 -49.12 72.92 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.515 -0.766 . . . . 1.93 110.106 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.622 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 28.9 tp10 -57.92 -44.21 86.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.325 0.583 . . . . 1.78 110.749 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.577 ' HB3' HD23 ' A' ' 86' ' ' LEU . 23.9 mmt -63.9 -36.48 84.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.923 -0.58 . . . . 1.67 111.884 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -81.16 -35.75 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.435 -0.506 . . . . 2.23 111.674 -173.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -81.93 -8.34 59.67 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 119.99 -0.684 . . . . 3.79 110.97 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.0 m -75.35 -20.35 59.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.163 0.506 . . . . 0.98 109.716 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.648 ' HZ1' ' HB3' ' A' ' 80' ' ' LYS . 5.1 mmmp? 69.6 51.01 0.48 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.038 -0.983 . . . . 3.38 111.775 175.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.479 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.8 mp -110.99 145.31 32.17 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.872 -1.058 . . . . 2.04 109.018 170.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.93 146.7 94.96 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.998 2.465 . . . . 0.38 112.427 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -56.73 -31.16 64.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.26 -0.427 . . . . 2.05 111.724 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.8 m -62.51 -48.63 78.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.135 0.493 . . . . 1.47 110.267 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.697 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 69.1 t -66.51 -43.06 91.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 1.08 110.212 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 76' ' ' MET . 80.9 mt -59.87 -36.39 76.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.055 -0.52 . . . . 1.07 110.196 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.893 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -61.7 -46.07 94.98 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.739 -0.664 . . . . 0.41 112.043 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.697 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 17.7 mtpp -61.17 -47.32 86.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.361 -0.237 . . . . 1.89 110.361 177.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.77 -48.42 88.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.873 -0.603 . . . . 1.14 111.357 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -64.04 -48.97 74.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.915 0.388 . . . . 0.46 111.179 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.24 -27.82 68.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.894 -0.594 . . . . 3.03 111.353 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.619 HD21 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -94.32 -33.21 13.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.863 -0.608 . . . . 2.15 111.331 -177.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.491 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -73.48 -42.49 61.8 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.137 0.421 . . . . 1.22 112.137 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.618 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 50.6 t0 -78.16 95.55 4.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.869 -0.789 . . . . 0.5 108.869 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 t -70.38 -44.44 77.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.406 -0.816 . . . . 1.21 110.38 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.35 -17.18 31.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.317 -0.856 . . . . 1.46 110.755 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.618 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 50.8 mttp 58.03 73.39 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.152 0.977 . . . . 3.22 112.094 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.443 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 12.9 p-10 -117.67 10.21 13.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.291 -1.322 . . . . 0.56 110.576 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.29 -0.88 62.36 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.054 -0.593 . . . . 0.55 112.156 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.569 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 47.5 mt -129.87 149.42 51.61 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.054 -0.721 . . . . 1.17 109.054 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.7 mt -98.99 112.31 24.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.359 0.6 . . . . 1.08 109.858 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.646 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 7.5 t70 -70.39 166.3 20.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.826 -1.079 . . . . 1.85 109.122 173.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -57.47 -37.99 73.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 118.006 0.366 . . . . 0.85 111.692 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.696 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 81.3 mt-10 -70.98 -40.38 71.94 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.671 -0.412 . . . . 2.08 110.663 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.646 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 18.2 mt-10 -70.68 -31.94 69.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.48 110.697 -174.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.54 ' CD1' HD12 ' A' ' 67' ' ' ILE . 66.8 t80 -74.37 -44.39 52.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.788 -0.642 . . . . 0.51 109.887 177.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.7 87.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.742 -0.663 . . . . 0.86 109.82 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 18.3 tp -60.57 -50.56 73.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.437 -0.801 . . . . 1.97 109.834 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -56.9 -46.64 81.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 1.06 111.155 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.85 -34.41 75.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.177 -0.465 . . . . 0.92 111.355 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.411 ' CG ' HG21 ' A' ' 46' ' ' VAL . 40.9 t60 -65.41 -39.14 91.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.696 -0.483 . . . . 0.39 109.696 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.619 HD13 HD21 ' A' ' 92' ' ' LEU . 74.9 mt -63.69 -43.34 96.93 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.957 -0.565 . . . . 1.07 110.044 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.478 HD13 ' SD ' ' A' ' 76' ' ' MET . 33.7 mm -54.08 -50.58 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.637 -0.711 . . . . 1.39 110.115 173.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 27.3 ttpp -58.51 -49.95 75.52 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.548 -0.751 . . . . 2.25 111.435 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.7 m -61.51 -40.1 85.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.537 -0.465 . . . . 1.26 111.217 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.526 ' HG2' HD22 ' A' ' 122' ' ' LEU . 24.8 mmmt -58.71 -40.56 84.04 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.221 -0.192 . . . . 2.47 111.403 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 92.6 mt -71.19 -32.24 68.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.168 0.508 . . . . 1.34 110.868 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.555 ' HB2' ' HD2' ' A' ' 120' ' ' HIS . 47.1 mt-10 -77.72 2.29 17.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.842 -0.617 . . . . 1.98 111.106 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.12 24.18 41.86 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.781 -0.723 . . . . 0.88 112.401 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.555 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 84.3 m-70 -114.53 175.13 5.62 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.502 -0.555 . . . . 1.23 109.502 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -117.96 136.55 53.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.955 0.407 . . . . 3.06 111.195 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.0 pp -89.41 134.33 32.95 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.44 -0.578 . . . . 1.75 109.44 173.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 37.3 Cg_exo -60.93 -18.66 58.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.168 2.579 . . . . 1.05 113.768 -172.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.0 17.87 11.27 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.822 -0.626 . . . . 1.44 110.94 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -133.95 173.81 11.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.236 -0.893 . . . . 1.97 108.635 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.4 mt -113.2 90.46 16.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.817 0.302 . . . . 1.25 111.817 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.74 160.53 37.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.504 2.136 . . . . 0.59 110.712 169.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.71 -34.3 53.26 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.278 2.652 . . . . 1.02 113.711 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -86.94 -2.16 58.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.733 -0.387 . . . . 1.05 111.659 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -99.37 -25.7 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.979 0.418 . . . . 1.9 110.356 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.88 119.56 73.93 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.849 -0.614 . . . . 1.96 111.163 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.696 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 51.6 Cg_exo . . . . . 0 CA--C 1.533 0.449 0 C-N-CA 123.291 2.661 . . . . 1.11 112.716 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.893 HD22 ' HA2' ' A' ' 87' ' ' GLY . 33.6 t-20 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 121.031 0.443 . . . . 1.1 111.565 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.09 -4.87 15.11 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.919 3.08 . . . . 1.05 113.302 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.549 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 72.4 m-85 . . . . . 0 C--N 1.331 -0.205 0 N-CA-C 112.055 0.391 . . . . 0.68 112.055 -175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.648 -0.581 . . . . 9.81 111.648 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -68.47 -53.16 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.924 2.416 . . . . 8.99 112.519 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.19 -67.7 0.98 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.994 0.426 . . . . 9.36 111.165 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.24 -50.1 3.3 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.538 -0.839 . . . . 6.15 111.907 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -65.07 -59.5 4.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.045 0.45 . . . . 6.1 110.214 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.32 93.85 6.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.76 -0.654 . . . . 3.94 109.949 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -124.96 68.9 1.11 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.567 -0.901 . . . . 3.28 108.567 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 p -93.97 143.88 10.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.202 -0.908 . . . . 2.52 111.088 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.18 113.68 17.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.813 -0.631 . . . . 2.49 110.963 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -71.26 113.0 7.84 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.071 -0.715 . . . . 0.68 109.071 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.528 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 48.1 t -54.42 -32.05 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.053 -0.521 . . . . 2.03 111.996 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.82 -22.09 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.386 -0.37 . . . . 1.68 111.311 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.58 -10.05 62.93 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.301 -0.952 . . . . 0.62 112.74 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 52.4 pttt -93.98 -18.59 21.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 117.289 0.545 . . . . 3.19 111.426 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -136.67 33.71 2.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.265 1.031 . . . . 1.71 109.218 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.608 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 6.4 tmtm? -75.07 -46.08 4.76 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.528 -1.215 . . . . 1.9 111.908 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.6 Cg_endo -50.86 -26.37 17.85 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.803 2.335 . . . . 1.06 113.257 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.5 m -76.03 -46.84 27.26 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.929 -0.308 . . . . 1.49 111.091 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.766 ' HH ' ' HD1' ' A' ' 111' ' ' HIS . 2.6 m-85 -72.62 -22.32 60.98 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.858 -0.793 . . . . 0.8 108.858 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.452 ' OD2' ' HE2' ' A' ' 58' ' ' TYR . 28.3 t70 -71.29 -43.21 67.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.546 -1.207 . . . . 1.03 109.452 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.29 -43.89 97.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.149 -0.932 . . . . 2.15 109.991 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.5 -30.8 51.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.014 -0.539 . . . . 1.46 110.457 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HE1' HG12 ' A' ' 67' ' ' ILE . 79.9 t80 -65.06 -40.87 95.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.889 -0.596 . . . . 0.37 110.072 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.452 ' HE2' ' OD2' ' A' ' 54' ' ' ASP . 57.8 m-85 -72.88 -23.44 60.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.676 -0.693 . . . . 1.18 111.904 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.5 p -79.8 -2.36 42.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.799 -0.36 . . . . 1.32 111.451 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 83.0 mt -105.19 7.22 33.57 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.077 -0.249 . . . . 1.17 111.038 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 t 65.87 84.0 0.18 Allowed Pre-proline 0 C--O 1.234 0.268 0 O-C-N 123.844 0.715 . . . . 1.81 111.076 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -85.31 114.1 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.453 2.102 . . . . 0.59 112.61 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -89.12 137.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.724 -0.671 . . . . 1.89 109.869 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 p30 46.13 23.64 0.21 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.943 0.897 . . . . 1.98 112.663 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.21 6.55 61.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.349 -0.453 . . . . 0.65 113.643 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.467 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -134.36 174.61 10.34 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.312 0.577 . . . . 2.43 110.837 177.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.482 HD13 ' CD1' ' A' ' 106' ' ' PHE . 16.8 pt -123.56 148.58 27.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.322 -0.854 . . . . 1.1 109.574 172.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.9 p -83.37 179.2 7.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.584 -0.734 . . . . 1.06 110.114 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.11 -34.07 77.71 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.751 -0.737 . . . . 0.36 112.272 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.41 96.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.138 0.494 . . . . 1.17 112.12 -176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.2 m120 -76.03 -47.1 26.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.342 0.592 . . . . 1.65 110.244 -172.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.59 -22.88 63.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.023 -0.535 . . . . 1.09 110.247 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.475 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 41.5 ttmt -68.18 -54.36 18.44 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.242 -0.435 . . . . 2.11 109.976 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 17.5 ptpt -59.22 -33.15 70.65 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.82 0.343 . . . . 1.93 110.23 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.609 ' CD ' ' HZ2' ' A' ' 78' ' ' LYS . 14.1 tp10 -60.45 -53.48 57.01 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.321 0.581 . . . . 1.78 110.132 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 1.057 ' HB3' HD23 ' A' ' 86' ' ' LEU . 54.6 mtt -70.73 -22.6 62.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.671 . . . . 1.67 110.852 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 73' ' ' LYS . 3.9 t -63.17 -47.17 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.927 -0.579 . . . . 2.23 110.581 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.609 ' HZ2' ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -94.61 -1.61 52.93 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.386 -0.926 . . . . 3.79 111.792 -175.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.0 p -66.89 -19.75 65.79 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.817 0.342 . . . . 0.98 110.178 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.4 tptt 75.58 22.97 1.51 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.879 0.872 . . . . 3.38 111.443 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.6 ' HB2' HD21 ' A' ' 86' ' ' LEU . 11.2 mp -92.0 151.45 41.93 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.306 -0.257 . . . . 2.04 110.306 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.565 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 14.5 Cg_endo -59.94 148.18 89.79 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.649 2.233 . . . . 0.38 112.731 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -55.93 -39.49 71.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.454 -0.794 . . . . 2.05 111.188 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 m -61.1 -45.95 92.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.996 -0.547 . . . . 1.47 111.374 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.485 ' CG2' ' HG2' ' A' ' 82' ' ' PRO . 55.0 t -64.45 -42.22 94.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 1.08 110.376 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 1.057 HD23 ' HB3' ' A' ' 76' ' ' MET . 64.0 mt -57.65 -46.4 84.24 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.051 0.453 . . . . 1.07 110.695 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.658 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -64.84 -34.65 90.46 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.832 -0.699 . . . . 0.41 112.13 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -70.54 -41.43 72.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.272 0.558 . . . . 1.89 110.455 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.617 HG21 HD13 ' A' ' 112' ' ' LEU . 83.7 mt -62.38 -42.93 97.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.625 -0.716 . . . . 1.14 110.937 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -59.39 -40.69 87.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.966 0.412 . . . . 0.46 110.077 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -62.99 -25.96 68.62 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.54 -0.754 . . . . 3.03 111.026 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.407 ' HB3' HD21 ' A' ' 126' ' ' LEU . 66.1 mt -90.35 -33.28 16.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.296 -0.411 . . . . 2.15 111.336 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.32 -43.63 63.84 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.83 0.678 . . . . 1.22 112.83 -170.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.618 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 23.3 t0 -88.35 68.85 9.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.43 0.633 . . . . 0.5 110.156 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.483 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 2.7 t -66.11 -21.69 29.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.297 -0.865 . . . . 1.21 109.699 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -79.7 -23.37 42.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.882 -1.054 . . . . 1.46 110.754 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 59.91 51.85 5.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.219 -0.9 . . . . 3.22 111.907 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.693 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 11.8 p-10 -118.63 7.54 11.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.969 0.414 . . . . 0.56 109.997 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.78 -1.51 30.0 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.987 -0.625 . . . . 0.55 112.79 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.52 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 64.2 mt -123.77 155.68 37.48 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.807 -0.442 . . . . 1.17 109.807 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -110.16 110.78 21.76 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.501 -0.48 . . . . 1.08 110.53 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.97 169.08 15.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.103 -0.702 . . . . 1.85 109.103 168.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.8 -29.89 65.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.593 -0.276 . . . . 0.85 111.115 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.07 -51.92 61.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.847 0.832 . . . . 2.08 109.579 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -71.31 -35.98 71.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.536 -1.211 . . . . 0.48 110.966 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 67' ' ' ILE . 58.8 t80 -70.51 -36.37 73.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.19 -0.459 . . . . 0.51 110.279 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.74 84.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.86 110.184 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -64.23 -46.52 83.47 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.989 -0.551 . . . . 1.97 109.552 177.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.46 94.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.3 -0.864 . . . . 1.06 111.296 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.03 -31.55 72.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.17 -0.468 . . . . 0.92 111.101 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.766 ' HD1' ' HH ' ' A' ' 53' ' ' TYR . 78.9 t60 -66.25 -40.69 90.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.932 -0.395 . . . . 0.39 109.932 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.617 HD13 HG21 ' A' ' 89' ' ' ILE . 89.4 mt -65.6 -39.47 91.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.882 -0.599 . . . . 1.07 110.438 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.5 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 62.7 mt -70.66 -37.77 70.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.002 -0.545 . . . . 1.39 110.927 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 26.1 ttpp -63.2 -45.78 90.08 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.913 -0.315 . . . . 2.25 110.532 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.61 -35.24 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.095 -0.642 . . . . 1.26 110.465 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.628 ' HD3' HD21 ' A' ' 122' ' ' LEU . 25.0 mmmt -56.21 -45.6 79.81 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.39 -0.368 . . . . 2.47 111.163 171.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 84.1 mt -67.2 -33.85 76.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.272 0.558 . . . . 1.34 110.646 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.6 mt-10 -78.0 4.39 12.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.663 -0.698 . . . . 1.98 111.386 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.65 34.91 14.65 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.99 -0.624 . . . . 0.88 112.54 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -122.91 171.42 9.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.806 0.336 . . . . 1.23 110.25 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -111.82 150.55 30.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.062 -0.517 . . . . 3.06 109.804 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.628 HD21 ' HD3' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -95.69 138.35 21.79 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.216 -1.031 . . . . 1.75 108.216 173.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.79 -9.76 17.5 Favored 'Trans proline' 0 N--CA 1.473 0.297 0 C-N-CA 122.947 2.431 . . . . 1.05 114.095 -171.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.86 17.57 10.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.585 0.707 . . . . 1.44 110.489 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.03 161.68 34.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.906 -1.043 . . . . 1.97 108.85 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 92' ' ' LEU . 96.3 mt -110.52 90.81 10.9 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.916 -0.314 . . . . 1.25 111.346 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.31 158.95 54.65 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.691 2.26 . . . . 0.59 111.553 171.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.13 -7.79 5.42 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.521 2.814 . . . . 1.02 114.241 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -108.42 -2.59 18.94 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.367 -0.533 . . . . 1.05 111.191 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.405 ' O ' HD21 ' A' ' 108' ' ' LEU . 1.9 mm? -101.7 -36.67 8.64 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.117 0.484 . . . . 1.9 110.358 173.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 7.7 p -78.43 124.27 85.55 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.681 -0.69 . . . . 1.96 111.005 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 131' ' ' VAL . 22.1 Cg_exo -64.29 132.44 33.8 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.743 2.295 . . . . 1.11 111.707 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.39 -1.99 5.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.097 2.531 . . . . 1.73 112.125 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 132' ' ' PRO . 33.3 t -78.06 -11.93 59.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.361 -0.836 . . . . 1.91 110.574 -177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.483 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 1.8 mptp? -112.83 10.13 19.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.35 -0.387 . . . . 1.77 111.148 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -98.73 92.25 5.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.505 -0.316 . . . . 4.66 110.17 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -96.46 116.25 28.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.535 -0.302 . . . . 5.55 110.227 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -110.15 134.46 52.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.219 -0.446 . . . . 7.09 110.827 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--O 1.244 0.792 0 CA-C-O 118.207 -0.901 . . . . 8.21 108.868 169.579 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.78 0.324 . . . . 13.73 110.284 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' B' ' 145' ' ' TYR . 25.1 t30 -139.63 -54.8 0.56 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.032 -0.531 . . . . 8.4 109.738 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' B' ' 144' ' ' ASN . 52.4 m-85 70.9 157.9 0.18 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.033 0.833 . . . . 10.39 112.446 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -82.29 94.79 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.103 -0.953 . . . . 5.36 110.373 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 20.9 t -70.29 118.01 12.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.139 -0.482 . . . . 3.87 110.55 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 3.0 m -106.53 20.02 19.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.751 0.786 . . . . 2.0 109.677 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.658 HD22 ' HA2' ' A' ' 87' ' ' GLY . 27.0 t-20 -99.23 110.62 58.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.506 -0.77 . . . . 1.1 110.28 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 8.0 Cg_exo -73.14 -2.87 12.7 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.53 2.82 . . . . 1.05 113.028 -176.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.475 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 96.8 m-85 -91.72 -19.73 22.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.46 -0.336 . . . . 0.68 110.867 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 10.2 t -114.39 -42.73 3.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.752 -0.379 . . . . 2.36 111.149 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 64.22 -67.2 0.11 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.465 0.706 . . . . 3.77 112.395 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? . . . . . 0 C--O 1.245 0.843 0 C-N-CA 123.959 0.904 . . . . 6.78 110.783 -179.065 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.693 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.798 -0.521 . . . . 9.81 111.798 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.13 162.94 37.77 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.682 2.255 . . . . 8.99 111.913 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 tt -88.67 -52.88 4.91 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.626 -0.509 . . . . 9.36 109.626 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.62 119.64 2.3 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.836 -0.906 . . . . 6.15 110.836 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.0 t -108.17 70.56 0.77 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.122 0.461 . . . . 6.1 111.708 -171.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -118.62 111.78 19.0 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.173 -0.677 . . . . 3.94 109.173 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -98.27 106.1 18.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.423 -0.353 . . . . 3.28 110.368 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.17 134.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.159 0.504 . . . . 2.52 111.76 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.48 111.14 23.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.8 -0.636 . . . . 2.49 110.476 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.497 ' HD1' ' O ' ' A' ' 129' ' ' HIS . 10.2 t90 -84.99 107.88 17.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.112 -0.699 . . . . 0.68 109.112 176.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -69.34 5.2 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.746 0.647 . . . . 2.03 112.746 -172.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.401 HG12 ' CE2' ' A' ' 53' ' ' TYR . 97.0 t -105.97 -19.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.96 0.409 . . . . 1.68 110.292 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.555 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -68.39 -18.2 71.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.634 -0.793 . . . . 0.62 111.557 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -74.76 -27.4 60.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.54 -0.33 . . . . 3.19 111.292 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -127.61 33.49 4.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.909 0.385 . . . . 1.71 110.612 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.616 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 6.8 mmmm -64.62 -45.27 76.14 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.837 0.68 . . . . 1.9 112.837 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.5 Cg_endo -49.85 -35.22 39.21 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 122.397 2.064 . . . . 1.06 112.415 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.434 ' O ' HG13 ' A' ' 56' ' ' ILE . 11.5 m -73.53 -46.43 47.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.517 -0.31 . . . . 1.49 111.302 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.401 ' CE2' HG12 ' A' ' 46' ' ' VAL . 14.9 m-85 -71.56 -23.28 61.72 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.766 -0.457 . . . . 0.8 109.766 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.423 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 15.2 t70 -73.86 -44.52 55.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.47 -0.786 . . . . 1.03 109.265 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 59' ' ' THR . 35.3 tt0 -57.02 -46.54 82.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.143 -0.935 . . . . 2.15 110.358 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 52' ' ' THR . 58.9 mt -67.11 -49.21 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.137 -0.483 . . . . 1.46 110.789 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.456 ' HE1' HG12 ' A' ' 67' ' ' ILE . 77.8 t80 -51.25 -46.44 62.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.853 -0.612 . . . . 0.37 111.682 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.423 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 29.3 m-85 -74.19 -12.37 60.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.684 0.624 . . . . 1.18 112.684 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 55' ' ' GLU . 70.1 p -90.96 4.37 52.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.114 0.483 . . . . 1.32 110.737 177.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 82.3 mt -105.91 6.58 31.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.768 -0.456 . . . . 1.17 109.768 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.7 m 65.59 82.49 0.2 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.185 -0.916 . . . . 1.81 111.43 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -92.04 113.84 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.737 2.291 . . . . 0.59 113.287 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.8 146.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.625 -0.88 . . . . 1.89 108.625 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 p30 50.33 22.35 0.98 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.746 0.818 . . . . 1.98 112.136 -174.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.61 29.62 47.64 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.238 -0.506 . . . . 0.65 111.872 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.72 ' HE2' ' HB3' ' A' ' 102' ' ' ASP . 32.4 ttmt -156.19 146.81 21.82 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.902 0.382 . . . . 2.43 110.719 -173.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.456 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.5 pt -103.14 156.31 5.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.224 0.535 . . . . 1.1 110.43 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 73.2 p -89.39 178.1 6.41 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.602 -0.726 . . . . 1.06 109.972 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.668 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -65.19 -17.62 63.95 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.979 -0.629 . . . . 0.36 112.299 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.73 -47.29 63.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.216 0.531 . . . . 1.17 111.332 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.633 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.3 m120 -73.79 -41.45 62.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.587 -0.733 . . . . 1.65 110.367 -173.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.4 -19.79 60.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.188 -0.46 . . . . 1.09 110.193 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.668 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 3.6 ttmp? -68.38 -51.59 42.54 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.754 -0.461 . . . . 2.11 109.754 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.514 ' HA ' HG21 ' A' ' 77' ' ' VAL . 18.6 ptpt -63.33 -32.94 74.5 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.965 -0.562 . . . . 1.93 110.391 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.53 -53.82 51.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.792 -0.447 . . . . 1.78 109.792 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 57.5 mtt -69.5 -33.61 73.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.032 -0.531 . . . . 1.67 112.198 -173.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 74' ' ' LYS . 30.9 m -77.0 -19.04 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.644 -0.422 . . . . 2.23 109.914 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 12.7 mptt -87.47 -12.33 46.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.911 -0.586 . . . . 3.79 110.453 174.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.5 m -86.75 -5.1 59.22 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.876 -0.602 . . . . 0.98 111.092 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.4 mptt 68.24 29.0 6.22 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.297 0.639 . . . . 3.38 111.786 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.673 HD12 HG22 ' A' ' 113' ' ' ILE . 24.3 mt -98.14 143.38 26.17 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.428 -0.351 . . . . 2.04 111.068 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.487 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.5 Cg_endo -61.64 150.9 83.57 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.257 2.638 . . . . 0.38 113.51 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -55.99 -42.27 76.11 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.697 -0.683 . . . . 2.05 111.85 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.1 m -58.04 -54.13 50.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.306 -0.406 . . . . 1.47 110.909 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 47.0 t -57.71 -44.13 85.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.103 -0.499 . . . . 1.08 110.87 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 81' ' ' LEU . 56.6 mt -63.42 -36.04 82.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 1.07 111.229 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.751 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -60.59 -42.71 99.31 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.846 -0.692 . . . . 0.41 111.656 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 20.6 mtpp -68.47 -46.18 70.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.5 -0.35 . . . . 1.89 110.353 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.2 mt -56.83 -52.13 58.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 123.512 0.507 . . . . 1.14 110.85 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -60.43 -53.66 54.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.448 -0.342 . . . . 0.46 111.66 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -65.1 -23.28 67.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.038 0.447 . . . . 3.03 111.238 -172.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.656 HD22 HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -92.75 -39.45 11.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.849 -0.614 . . . . 2.15 110.229 -177.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.475 ' N ' ' HG ' ' A' ' 92' ' ' LEU . . . -70.28 -39.28 74.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 1.22 111.047 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.653 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 47.0 t0 -74.47 93.47 2.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.658 -0.867 . . . . 0.5 108.658 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.69 HG21 ' HD2' ' A' ' 132' ' ' PRO . 32.5 t -69.29 -51.07 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.337 -0.847 . . . . 1.21 110.28 -174.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.612 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 1.8 p30 -76.34 -21.24 56.4 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.278 -0.873 . . . . 1.46 111.225 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.581 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 40.8 mttp 56.71 65.78 1.33 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.131 -0.94 . . . . 3.22 110.74 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 23.1 p-10 -108.93 10.97 26.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.256 -1.338 . . . . 0.56 109.832 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.56 11.78 80.3 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.313 -0.858 . . . . 0.55 111.879 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 33.8 mt -144.28 161.55 38.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.344 -0.613 . . . . 1.17 109.344 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.1 mt -124.8 115.47 20.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.163 -0.31 . . . . 1.08 110.163 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.72 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 1.7 p30 -77.82 -176.41 4.41 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.303 -0.629 . . . . 1.85 109.303 171.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -63.62 -27.02 68.95 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.934 -0.306 . . . . 0.85 111.474 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 86.7 mt-10 -85.03 -39.07 18.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.212 -0.195 . . . . 2.08 110.918 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -69.34 -37.5 77.7 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.256 0.55 . . . . 0.48 110.182 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -66.86 -42.38 85.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.749 -0.659 . . . . 0.51 109.886 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.08 91.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 0.86 110.831 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -61.29 -46.82 88.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.814 -0.63 . . . . 1.97 109.728 177.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.11 -49.33 78.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 1.06 111.636 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -33.47 76.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.92 110.856 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 115' ' ' VAL . 38.7 t60 -67.72 -36.39 80.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.036 -0.357 . . . . 0.39 110.036 177.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.656 HD13 HD22 ' A' ' 92' ' ' LEU . 91.8 mt -66.15 -39.25 89.68 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.927 -0.579 . . . . 1.07 110.587 176.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.673 HG22 HD12 ' A' ' 81' ' ' LEU . 54.9 mt -69.07 -37.69 77.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.747 -0.66 . . . . 1.39 110.326 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 42.1 tttp -61.88 -47.32 85.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.992 -0.549 . . . . 2.25 110.686 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 111' ' ' HIS . 6.7 m -68.11 -31.16 50.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 120.547 -0.461 . . . . 1.26 111.322 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -56.14 -45.07 79.75 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.066 -0.253 . . . . 2.47 110.385 168.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.74 -29.78 63.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.263 -0.426 . . . . 1.34 110.885 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.555 ' HB2' ' HD2' ' A' ' 120' ' ' HIS . 59.7 mm-40 -65.95 -21.96 66.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.873 -0.603 . . . . 1.98 110.489 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.52 36.03 3.92 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.752 -0.737 . . . . 0.88 112.13 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.555 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 74.4 m-70 -126.96 150.07 49.55 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.847 -0.427 . . . . 1.23 109.847 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -95.95 130.0 43.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.942 0.401 . . . . 3.06 110.725 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.95 134.63 49.47 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.048 -0.524 . . . . 1.75 110.005 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.01 2.7 6.34 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.908 2.405 . . . . 1.05 113.745 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.78 22.68 10.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.427 0.632 . . . . 1.44 110.306 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.86 162.12 32.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.194 -0.912 . . . . 1.97 109.882 -172.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 52.1 mt -112.69 94.0 26.4 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 123.262 0.351 . . . . 1.25 111.781 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.915 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 14.0 Cg_endo -58.63 153.31 49.87 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.866 2.377 . . . . 0.59 111.333 169.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.35 -10.03 17.33 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.921 2.414 . . . . 1.02 113.308 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.497 ' O ' ' HD1' ' A' ' 44' ' ' TRP . 26.4 p-80 -108.4 1.51 21.79 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.159 -0.338 . . . . 1.05 110.397 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.915 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 1.4 mp -103.85 -7.63 20.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.885 0.374 . . . . 1.9 111.038 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -87.42 117.8 69.03 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.248 -0.433 . . . . 1.96 110.887 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.69 ' HD2' HG21 ' A' ' 95' ' ' VAL . 53.1 Cg_exo -56.74 138.37 85.04 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.943 2.429 . . . . 1.11 111.952 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.97 -7.39 21.31 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 123.001 2.468 . . . . 1.73 113.484 -173.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.8 m -82.72 0.41 43.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.353 0.597 . . . . 1.91 110.225 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.524 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 3.3 mptp? -117.51 31.06 6.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.591 -0.731 . . . . 1.77 109.118 177.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 3.9 mmp_? -103.58 146.83 27.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.569 -0.741 . . . . 4.66 109.963 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -134.01 143.48 48.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.044 -0.525 . . . . 5.55 109.635 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -110.53 136.45 49.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.162 -0.681 . . . . 7.09 109.162 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 . . . . . 0 C--O 1.246 0.875 0 O-C-N 123.953 0.783 . . . . 8.21 110.968 -177.809 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 69.3 t80 . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.88 0.371 . . . . 13.73 110.738 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -121.54 163.17 19.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.412 -0.358 . . . . 8.4 110.36 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -157.86 170.19 22.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.399 -0.364 . . . . 10.39 110.321 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -133.6 113.98 13.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.135 -0.484 . . . . 5.36 109.722 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 28.3 p -93.41 75.4 4.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.914 0.388 . . . . 3.87 109.989 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -21.56 46.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 2.0 110.738 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.751 HD22 ' HA2' ' A' ' 87' ' ' GLY . 25.2 t-20 -119.23 107.06 42.02 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.991 0.424 . . . . 1.1 110.176 175.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 7.4 Cg_exo -73.42 -1.45 10.68 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.521 2.814 . . . . 1.05 112.948 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -101.1 -6.76 23.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.497 -0.32 . . . . 0.68 111.662 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.3 p -134.11 102.58 5.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.279 0.561 . . . . 2.36 111.307 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -114.5 134.08 55.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 3.77 110.434 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt . . . . . 0 C--O 1.244 0.775 0 CA-C-O 118.306 -0.854 . . . . 6.78 109.764 178.063 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.653 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.796 -0.522 . . . . 9.81 111.796 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -86.72 166.44 8.78 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.674 2.249 . . . . 8.99 112.269 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.9 tp -103.52 101.15 11.02 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.062 -0.718 . . . . 9.36 109.062 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.07 139.05 15.06 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.842 -0.694 . . . . 6.15 112.868 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.7 m -153.57 156.44 38.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.143 -0.688 . . . . 6.1 109.143 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -91.72 118.05 30.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.327 0.584 . . . . 3.94 111.08 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -94.92 75.94 3.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.091 -1.078 . . . . 3.28 108.091 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.0 p -93.97 137.33 23.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.438 -0.801 . . . . 2.52 110.458 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -94.08 104.08 16.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.163 -0.471 . . . . 2.49 110.759 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -81.55 106.72 13.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.809 -0.812 . . . . 0.68 108.809 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.2 m -66.73 -1.15 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.83 -0.623 . . . . 2.03 112.521 -171.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.5 -17.51 7.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.139 -0.482 . . . . 1.68 110.275 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.31 -10.56 74.69 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.634 -0.793 . . . . 0.62 112.549 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -89.28 -28.11 20.12 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.653 -0.322 . . . . 3.19 111.362 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -112.58 33.13 5.14 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.72 -0.844 . . . . 1.71 108.72 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 9.1 tmtt? -72.47 -49.98 8.45 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 114.76 -1.109 . . . . 1.9 112.313 -169.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.5 Cg_endo -54.35 -29.58 58.79 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.628 2.219 . . . . 1.06 113.235 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.0 m -70.28 -39.5 74.86 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.036 0.446 . . . . 1.49 110.335 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -70.91 -22.97 62.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.23 -0.441 . . . . 0.8 109.955 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.46 -44.69 70.7 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.129 0.49 . . . . 1.03 110.018 172.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -57.6 -42.2 82.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.346 -0.843 . . . . 2.15 110.267 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.404 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 50.2 mt -79.19 -28.88 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 1.46 111.18 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -71.37 -45.84 61.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.246 0.546 . . . . 0.37 110.686 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -76.48 -13.08 60.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.78 -0.645 . . . . 1.18 112.065 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.2 p -94.09 1.57 56.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.128 0.49 . . . . 1.32 111.214 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 58.2 mt -110.02 8.82 24.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.0 -0.545 . . . . 1.17 110.125 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 m 67.79 82.2 0.19 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.317 -0.856 . . . . 1.81 111.54 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -90.46 116.68 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.629 2.219 . . . . 0.59 112.555 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -88.37 134.62 27.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.628 -0.508 . . . . 1.89 109.628 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 47.05 25.7 0.53 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.792 0.837 . . . . 1.98 112.749 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.93 19.75 33.05 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.333 -0.46 . . . . 0.65 112.509 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' HG3' ' HA ' ' A' ' 102' ' ' ASP . 31.1 ttmt -150.52 144.46 25.35 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 110.453 -0.203 . . . . 2.43 110.453 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.469 HD11 ' CD1' ' A' ' 106' ' ' PHE . 19.8 pt -100.43 149.37 6.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 120.55 -0.46 . . . . 1.1 110.355 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.514 ' HA ' HD23 ' A' ' 100' ' ' LEU . 81.4 p -76.66 166.82 22.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.068 -0.515 . . . . 1.06 110.034 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.89 -32.52 70.52 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.589 -0.815 . . . . 0.36 112.103 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -49.18 -55.75 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.375 0.509 . . . . 1.17 112.375 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -70.68 -41.86 71.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.172 0.51 . . . . 1.65 110.989 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.492 ' CB ' HD11 ' A' ' 101' ' ' LEU . . . -71.36 -33.41 69.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.916 -0.584 . . . . 1.09 110.582 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.58 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 28.1 ttpp -63.9 -52.65 58.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.91 -0.587 . . . . 2.11 110.727 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.602 ' O ' HG23 ' A' ' 77' ' ' VAL . 17.3 ptmt -62.93 -32.89 74.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.983 -0.553 . . . . 1.93 110.607 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.562 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 35.3 tp10 -62.54 -38.88 91.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.307 0.575 . . . . 1.78 110.204 175.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.903 ' HB3' HD22 ' A' ' 86' ' ' LEU . 50.7 mtt -77.07 -20.47 55.78 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.632 -0.427 . . . . 1.67 111.67 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 74' ' ' LYS . 9.9 m -81.09 -23.45 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.045 -0.662 . . . . 2.23 110.747 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -87.15 -11.12 50.94 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.364 -0.534 . . . . 3.79 110.232 170.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 76' ' ' MET . 52.7 m -69.5 -17.48 63.6 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.948 -0.569 . . . . 0.98 110.061 169.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 17.5 tptp 69.27 24.25 5.99 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.645 -0.707 . . . . 3.38 111.65 171.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.595 ' HB2' HD23 ' A' ' 86' ' ' LEU . 59.0 mt -100.78 153.34 37.79 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.807 -0.633 . . . . 2.04 110.004 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.478 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 12.1 Cg_endo -57.36 141.7 94.85 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.813 2.342 . . . . 0.38 112.39 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -59.45 -34.2 72.24 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.139 -0.482 . . . . 2.05 111.252 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -47.85 83.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.154 -0.475 . . . . 1.47 110.822 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.685 HG12 ' HD2' ' A' ' 116' ' ' LYS . 75.8 t -63.72 -41.73 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.588 -0.733 . . . . 1.08 110.477 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 76' ' ' MET . 57.5 mt -58.8 -45.85 88.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.098 0.475 . . . . 1.07 110.392 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.54 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -60.91 -37.79 94.34 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.845 -0.616 . . . . 0.41 112.235 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.557 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 46.2 mtpt -69.53 -39.74 77.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.955 0.407 . . . . 1.89 110.418 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.93 -37.91 80.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.711 -0.677 . . . . 1.14 110.252 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.484 ' CZ3' ' HG ' ' A' ' 101' ' ' LEU . 31.1 t-105 -61.88 -46.04 91.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.246 -0.434 . . . . 0.46 110.356 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -59.79 -37.0 77.89 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.212 0.529 . . . . 3.03 110.641 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 86.2 mt -70.22 -41.99 72.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.473 -0.785 . . . . 2.15 110.748 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -73.59 -43.72 58.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.646 -0.707 . . . . 1.22 111.737 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.633 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 35.6 t0 -84.13 81.58 8.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.369 0.604 . . . . 0.5 109.955 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.462 HG22 ' HD2' ' A' ' 132' ' ' PRO . 13.5 t -69.2 -44.31 80.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.271 -0.877 . . . . 1.21 110.64 -176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.604 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.5 OUTLIER -75.18 -17.94 60.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.372 -0.831 . . . . 1.46 111.108 -177.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.823 ' HZ1' ' HB3' ' A' ' 97' ' ' LYS . 9.8 mtpm? 58.07 56.88 4.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.39 -0.823 . . . . 3.22 111.001 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -106.92 10.17 30.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.66 -0.7 . . . . 0.56 111.042 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.06 10.12 72.76 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.025 -0.607 . . . . 0.55 112.341 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 68' ' ' THR . 66.9 mt -139.3 152.84 47.56 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.387 -0.968 . . . . 1.17 108.387 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' ' 72' ' ' ALA . 19.6 mt -99.69 110.73 23.12 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.588 -0.845 . . . . 1.08 110.285 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.737 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 12.7 t70 -70.73 171.99 9.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.779 -1.1 . . . . 1.85 108.422 173.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.551 ' CG ' ' HZ1' ' A' ' 50' ' ' LYS . 11.8 t70 -58.64 -43.26 89.67 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.625 0.25 . . . . 0.85 111.266 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.605 ' OE1' ' HB3' ' A' ' 134' ' ' SER . 31.5 mt-10 -61.51 -44.38 97.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.797 0.808 . . . . 2.08 109.856 176.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.737 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 15.1 mt-10 -68.2 -39.39 82.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.452 -1.249 . . . . 0.48 110.521 -173.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.469 ' CD1' HD11 ' A' ' 67' ' ' ILE . 65.8 t80 -68.28 -42.67 79.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.296 -0.411 . . . . 0.51 110.215 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.27 93.72 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.751 -0.658 . . . . 0.86 110.272 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.01 -45.48 93.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.754 -0.657 . . . . 1.97 110.137 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.502 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -57.37 -47.78 80.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.451 -0.795 . . . . 1.06 111.364 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -28.88 67.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.418 -0.355 . . . . 0.92 111.249 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -68.48 -37.88 80.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.192 0.52 . . . . 0.39 110.093 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.455 ' HA ' HG23 ' A' ' 115' ' ' VAL . 59.7 mt -69.05 -36.39 77.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 1.07 110.247 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 109' ' ' ALA . 46.4 mm -59.25 -44.25 91.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.02 -0.536 . . . . 1.39 110.163 173.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.558 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 49.8 tttp -63.85 -47.38 80.94 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.82 -0.627 . . . . 2.25 111.111 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' A' ' 112' ' ' LEU . 14.7 m -64.29 -36.7 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.358 -0.537 . . . . 1.26 111.496 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.685 ' HD2' HG12 ' A' ' 85' ' ' VAL . 2.1 mmtm -56.35 -42.79 78.33 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 121.299 -0.161 . . . . 2.47 111.317 170.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 98.0 mt -71.52 -34.01 69.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.763 0.316 . . . . 1.34 110.836 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 81.0 mm-40 -68.85 -14.06 62.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 1.98 110.473 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.84 17.41 58.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.84 -0.695 . . . . 0.88 112.436 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -103.24 164.06 11.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.717 0.294 . . . . 1.23 110.301 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -88.68 140.53 29.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.214 0.53 . . . . 3.06 112.145 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.521 HD22 ' HG2' ' A' ' 116' ' ' LYS . 4.1 pp -110.51 127.04 27.65 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 107.266 -1.383 . . . . 1.75 107.266 165.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 1.8 Cg_endo -74.53 -15.12 22.16 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.375 2.05 . . . . 1.05 113.743 -166.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.416 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . . . 69.51 19.12 7.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.669 0.747 . . . . 1.44 109.663 -170.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -124.42 156.9 36.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.962 -1.017 . . . . 1.97 108.639 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.8 mt -116.49 96.22 47.53 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.834 0.349 . . . . 1.25 111.577 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.37 155.11 70.45 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.615 2.21 . . . . 0.59 111.65 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.09 -26.92 27.41 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.252 2.635 . . . . 1.02 113.689 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -91.84 18.4 7.79 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.998 0.369 . . . . 1.05 111.998 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 44.7 mt -129.94 3.41 4.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.664 -0.244 . . . . 1.9 111.015 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.6 t -87.55 116.58 66.61 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.404 . . . . 1.96 111.028 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.618 ' HB2' ' HD2' ' A' ' 135' ' ' LYS . 77.1 Cg_exo -52.04 134.16 48.58 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.05 2.5 . . . . 1.11 111.885 176.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.27 -20.88 31.86 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.878 2.385 . . . . 1.73 113.886 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.605 ' HB3' ' OE1' ' A' ' 104' ' ' GLU . 8.2 t -88.54 8.75 26.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.445 0.64 . . . . 1.91 110.168 -174.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.618 ' HD2' ' HB2' ' A' ' 132' ' ' PRO . 3.4 mptp? -113.23 3.35 15.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.731 0.777 . . . . 1.77 109.413 172.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -110.59 147.14 34.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.917 -1.038 . . . . 4.66 109.914 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -58.4 124.38 19.34 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.017 -0.734 . . . . 5.55 109.017 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -113.59 106.03 14.04 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.531 -0.304 . . . . 7.09 111.129 -171.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 . . . . . 0 C--O 1.246 0.914 0 O-C-N 124.071 0.857 . . . . 8.21 111.378 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.45 0.167 . . . . 13.73 110.778 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -73.72 -62.24 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 8.4 110.392 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -163.38 109.75 1.14 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.808 -0.812 . . . . 10.39 108.808 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.14 138.64 54.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.827 -0.624 . . . . 5.36 109.616 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 28.5 t -61.87 98.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.186 0.517 . . . . 3.87 110.838 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 13.3 t -130.5 2.38 4.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.683 -0.689 . . . . 2.0 109.923 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.54 HD22 ' HA2' ' A' ' 87' ' ' GLY . 45.1 t-20 -146.29 111.32 4.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.825 . . . . 1.1 109.247 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.48 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 38.3 Cg_endo -67.11 -14.72 44.38 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.106 2.537 . . . . 1.05 113.64 -175.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 62.6 m-85 -73.67 -37.18 65.34 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.724 0.268 . . . . 0.68 111.724 -176.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 8.5 t -163.35 85.41 0.5 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.896 0.855 . . . . 2.36 110.812 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.73 25.32 7.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.501 -0.772 . . . . 3.77 110.654 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 55.4 mttm . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.584 -0.722 . . . . 6.78 109.709 178.423 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.633 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.848 0 N-CA-C 111.959 -0.456 . . . . 9.81 111.959 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.28 -64.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.652 2.235 . . . . 8.99 111.702 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.1 mt -141.71 -51.89 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.462 0.649 . . . . 9.36 109.571 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.34 116.88 0.6 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.293 -1.123 . . . . 6.15 110.293 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -63.12 -53.27 56.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.703 0.287 . . . . 6.1 110.996 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.56 93.59 4.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.451 -0.341 . . . . 3.94 111.38 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -104.58 112.37 25.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.575 0.702 . . . . 3.28 109.405 171.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.1 t -106.47 137.72 35.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.62 -0.718 . . . . 2.52 111.043 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -111.84 138.3 48.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 2.49 110.823 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.475 ' CZ2' ' HB3' ' A' ' 132' ' ' PRO . 5.2 t90 -95.38 108.81 21.02 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.318 -0.623 . . . . 0.68 109.318 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.21 -17.9 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 2.03 112.116 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.32 -18.15 15.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.19 0.519 . . . . 1.68 110.047 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.3 -13.1 73.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.793 -0.718 . . . . 0.62 112.104 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -78.64 -29.21 45.7 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.198 0.523 . . . . 3.19 110.484 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -128.5 33.24 4.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.372 -0.831 . . . . 1.71 109.934 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.589 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 4.0 tmtm? -72.26 -47.95 10.29 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.282 -0.872 . . . . 1.9 111.914 -174.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.4 Cg_endo -53.23 -29.56 47.22 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.545 2.163 . . . . 1.06 113.151 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.4 m -71.92 -44.14 64.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.801 0.334 . . . . 1.49 110.482 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -70.43 -22.6 62.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.422 -0.585 . . . . 0.8 109.422 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.43 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 7.9 t70 -72.96 -44.96 60.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.534 -0.757 . . . . 1.03 109.851 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.91 -43.03 95.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.941 -1.027 . . . . 2.15 110.799 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.14 -33.73 56.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.247 0.546 . . . . 1.46 110.575 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.514 ' HE1' HG12 ' A' ' 67' ' ' ILE . 71.0 t80 -64.03 -49.27 73.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.37 110.596 -175.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.43 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 43.1 m-85 -70.47 -21.51 62.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.811 -0.632 . . . . 1.18 112.532 -174.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.7 p -79.18 -0.48 32.06 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.507 -0.477 . . . . 1.32 111.502 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 94.0 mt -105.42 7.28 33.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.533 -0.303 . . . . 1.17 111.116 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 t 63.09 89.91 0.1 OUTLIER Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 115.921 -0.581 . . . . 1.81 111.179 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -84.67 117.62 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.361 2.041 . . . . 0.59 112.954 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.18 128.02 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.585 . . . . 1.89 110.02 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.59 21.48 12.75 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.643 -0.503 . . . . 1.98 109.643 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.05 3.53 90.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.808 -0.711 . . . . 0.65 112.443 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -125.32 143.41 50.98 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.686 0.279 . . . . 2.43 110.415 177.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.514 HG12 ' HE1' ' A' ' 57' ' ' PHE . 9.6 pt -84.14 143.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 119.996 -0.682 . . . . 1.1 110.505 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.5 p -74.74 162.7 28.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.044 -0.98 . . . . 1.06 110.624 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -56.78 -31.07 60.49 Favored Glycine 0 C--O 1.218 -0.863 0 C-N-CA 120.905 -0.664 . . . . 0.36 112.173 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.1 -53.45 53.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.459 0.54 . . . . 1.17 112.459 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 58.6 m-80 -79.54 -35.7 39.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.118 -0.492 . . . . 1.65 111.693 -171.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.99 -26.88 65.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.156 0.503 . . . . 1.09 109.768 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.56 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 38.7 ttmt -68.56 -54.62 15.5 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.579 -0.737 . . . . 2.11 110.367 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 18.2 ptpt -58.02 -38.94 77.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 1.93 110.416 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.04 -44.99 94.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.184 0.516 . . . . 1.78 110.167 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.873 ' HB3' HD21 ' A' ' 86' ' ' LEU . 42.9 mtt -67.41 -27.9 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 1.67 110.777 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 73' ' ' LYS . 55.7 t -70.66 -38.09 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.289 0.566 . . . . 2.23 109.65 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 16.9 mmtp -72.04 -13.01 61.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.776 -0.647 . . . . 3.79 110.749 176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.8 m -80.9 -14.79 57.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.98 110.591 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mptt 72.24 18.92 4.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.648 0.779 . . . . 3.38 111.875 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.566 ' HB2' HD22 ' A' ' 86' ' ' LEU . 3.9 mm? -87.19 144.48 36.22 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.985 0.422 . . . . 2.04 110.5 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.546 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.0 Cg_endo -61.19 151.39 79.19 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.137 2.558 . . . . 0.38 112.713 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -58.65 -33.94 70.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.933 -0.576 . . . . 2.05 111.495 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.3 m -60.56 -51.28 70.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.198 0.523 . . . . 1.47 110.473 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.617 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 71.5 t -64.13 -40.24 88.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.745 -0.661 . . . . 1.08 110.76 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.873 HD21 ' HB3' ' A' ' 76' ' ' MET . 58.7 mt -61.73 -41.24 97.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.968 -0.56 . . . . 1.07 110.817 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.514 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -62.21 -42.07 99.72 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.116 -0.564 . . . . 0.41 111.924 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 51.0 mtpt -57.41 -51.39 69.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.159 0.504 . . . . 1.89 110.447 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.513 HG12 HD21 ' A' ' 122' ' ' LEU . 84.6 mt -64.54 -38.27 82.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.47 -0.787 . . . . 1.14 111.333 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -62.05 -49.06 77.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.714 0.292 . . . . 0.46 110.903 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -64.35 -24.63 67.71 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.124 -0.489 . . . . 3.03 111.308 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.569 ' O ' HD13 ' A' ' 126' ' ' LEU . 88.2 mt -88.61 -48.64 7.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.511 . . . . 2.15 111.379 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.417 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -64.68 -36.46 84.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.842 -0.617 . . . . 1.22 111.067 -173.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.645 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 42.7 t0 -79.68 82.74 5.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.8 -0.815 . . . . 0.5 108.8 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.914 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 6.4 t -71.28 -40.63 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.65 -0.704 . . . . 1.21 109.956 -174.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.622 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 14.4 p-10 -81.42 -18.0 46.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 1.46 110.207 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.578 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 22.6 mttp 59.96 59.12 2.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.065 -0.971 . . . . 3.22 110.942 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.6 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 14.4 p-10 -107.78 8.96 29.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.908 -1.042 . . . . 0.56 110.023 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.54 9.03 81.84 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.756 -0.656 . . . . 0.55 111.876 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 66' ' ' LYS . 60.1 mt -139.27 167.93 20.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.621 -0.511 . . . . 1.17 109.621 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.2 mt -124.96 116.48 22.24 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.174 -0.306 . . . . 1.08 110.174 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' CA ' ' HG3' ' A' ' 66' ' ' LYS . 3.0 p30 -78.75 177.86 8.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.137 -0.69 . . . . 1.85 109.137 171.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -61.16 -25.39 66.98 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.6 0.593 . . . . 0.85 112.6 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -81.63 -40.25 23.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 2.08 110.311 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.452 ' HG3' ' OD2' ' A' ' 102' ' ' ASP . 20.0 mt-10 -67.58 -36.55 81.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.368 0.604 . . . . 0.48 109.486 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.473 ' CD1' HD12 ' A' ' 67' ' ' ILE . 31.8 t80 -74.21 -33.15 63.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.838 -0.619 . . . . 0.51 110.171 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.33 94.33 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.279 0.562 . . . . 0.86 109.861 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 93' ' ' ALA . 16.0 tp -61.26 -44.91 96.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.221 -0.9 . . . . 1.97 110.035 176.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.06 -49.99 72.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.666 -0.697 . . . . 1.06 110.92 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -39.24 87.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 0.92 111.038 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -69.05 -38.46 79.13 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.947 -0.301 . . . . 0.39 110.749 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.703 ' HB3' HD22 ' A' ' 122' ' ' LEU . 92.8 mt -66.94 -38.59 86.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.257 -0.429 . . . . 1.07 110.907 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.45 HD13 ' HG2' ' A' ' 76' ' ' MET . 79.9 mt -70.37 -32.94 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.101 0.477 . . . . 1.39 110.049 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 4.0 tppp? -59.04 -53.32 59.71 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 115.919 -0.582 . . . . 2.25 110.514 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.3 m -64.14 -34.64 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 121.11 -0.236 . . . . 1.26 111.391 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 116' ' ' LYS . 27.0 mmmt -53.59 -48.89 68.82 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.596 0.236 . . . . 2.47 111.446 167.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.3 -22.62 62.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.902 0.382 . . . . 1.34 110.942 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 6.2 mm-40 -75.35 -2.4 28.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.924 -0.58 . . . . 1.98 110.771 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.5 35.81 11.45 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.65 -0.786 . . . . 0.88 111.988 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -130.87 172.48 11.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.988 0.423 . . . . 1.23 110.594 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -122.46 121.9 37.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.679 -0.691 . . . . 3.06 109.846 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.703 HD22 ' HB3' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -60.87 146.6 86.75 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.052 -0.522 . . . . 1.75 110.097 169.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.74 6.12 2.57 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.51 2.14 . . . . 1.05 113.225 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.452 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 60.38 17.79 7.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.813 -0.631 . . . . 1.44 111.763 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -136.17 166.9 22.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.359 -0.608 . . . . 1.97 109.359 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 92' ' ' LEU . 82.1 mt -114.88 93.17 33.12 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.701 0.286 . . . . 1.25 111.618 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.655 ' HD2' HD11 ' A' ' 130' ' ' LEU . 34.4 Cg_endo -66.44 166.22 22.4 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.797 2.331 . . . . 0.59 111.537 169.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.69 3.42 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.237 2.625 . . . . 1.02 114.334 -176.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -114.03 6.7 16.55 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.545 -0.462 . . . . 1.05 111.219 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.655 HD11 ' HD2' ' A' ' 127' ' ' PRO . 42.3 mt -115.9 -34.31 4.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.497 -0.32 . . . . 1.9 110.912 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.57 115.18 43.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.855 -0.424 . . . . 1.96 109.855 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 37.1 Cg_endo -67.28 152.76 78.81 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.734 2.289 . . . . 1.11 112.612 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.478 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 37.6 Cg_exo -61.68 -10.1 15.8 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.881 2.387 . . . . 1.73 111.635 175.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.4 t -67.02 -19.33 65.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.604 -0.726 . . . . 1.91 109.738 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.914 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 5.3 mptt -113.15 34.36 4.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.828 -0.623 . . . . 1.77 110.701 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 133' ' ' PRO . 5.6 mmp_? -102.43 128.63 48.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.215 -0.661 . . . . 4.66 109.215 170.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -78.05 109.43 12.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.188 0.518 . . . . 5.55 110.771 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -132.6 110.9 10.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.741 . . . . 7.09 109.388 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.906 -0.569 . . . . 8.21 109.475 176.403 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.68 0.276 . . . . 13.73 110.31 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -76.88 122.99 25.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.853 -0.425 . . . . 8.4 109.853 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -70.87 172.97 7.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.231 -0.44 . . . . 10.39 110.991 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -93.02 93.19 8.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.103 0.478 . . . . 5.36 110.709 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -131.07 -42.98 1.08 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.627 -0.715 . . . . 3.87 109.281 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.94 12.13 11.88 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.555 -0.748 . . . . 2.0 110.784 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.514 HD22 ' HA2' ' A' ' 87' ' ' GLY . 47.4 t-20 -98.1 119.43 62.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.999 -0.546 . . . . 1.1 109.715 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 24.4 Cg_exo -64.36 -16.41 54.96 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.16 2.573 . . . . 1.05 113.393 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.56 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 82.5 m-85 -81.69 -17.82 46.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.739 0.274 . . . . 0.68 111.739 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 10.0 t -159.82 116.94 2.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.238 0.542 . . . . 2.36 109.678 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.49 178.99 5.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 3.77 112.002 -171.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.167 -0.92 . . . . 6.78 110.421 -178.452 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.645 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.105 -0.398 . . . . 9.81 112.105 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.78 152.99 79.48 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.98 2.453 . . . . 8.99 112.564 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.0 mt 69.34 100.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.037 0.836 . . . . 9.36 111.3 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.66 -161.12 9.82 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.711 -0.757 . . . . 6.15 112.164 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.4 t -115.63 114.27 24.68 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.143 -0.688 . . . . 6.1 109.143 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -76.97 130.93 38.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.315 -0.402 . . . . 3.94 111.067 -175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -77.99 110.16 12.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.034 -0.728 . . . . 3.28 109.034 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.8 p -76.91 144.75 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 2.52 111.595 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.14 100.81 11.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 2.49 110.266 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -76.77 96.13 4.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.272 -1.01 . . . . 0.68 108.272 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.544 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 87.2 t -50.76 -33.03 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.682 -0.69 . . . . 2.03 112.192 -174.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 t -70.26 -17.86 21.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.073 -0.512 . . . . 1.68 111.516 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.14 -17.15 71.68 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.879 -0.677 . . . . 0.62 112.347 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 46.9 pttt -87.25 -29.41 21.7 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.181 -0.608 . . . . 3.19 111.191 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -108.11 31.14 5.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.339 -0.985 . . . . 1.71 108.339 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 11.0 tmtt? -78.27 -47.27 2.06 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.584 -0.735 . . . . 1.9 111.963 -170.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.6 Cg_endo -51.1 -33.12 42.18 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.275 1.983 . . . . 1.06 112.748 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.9 m -71.35 -45.75 62.16 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.904 0.383 . . . . 1.49 111.069 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.424 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 9.6 m-85 -72.26 -22.7 61.19 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.508 -0.553 . . . . 0.8 109.508 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 5.9 t70 -71.62 -44.31 64.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.301 -0.863 . . . . 1.03 109.32 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.32 -53.8 54.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.42 -0.809 . . . . 2.15 110.058 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.37 -36.83 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.973 0.416 . . . . 1.46 110.951 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.48 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 86.5 t80 -62.1 -42.04 98.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.361 0.601 . . . . 0.37 110.015 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.413 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 24.8 m-85 -81.21 -22.97 38.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.511 -0.768 . . . . 1.18 112.243 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.7 p -75.82 -10.78 59.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 1.32 111.082 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 79.3 mt -99.31 5.48 46.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.164 -0.471 . . . . 1.17 111.098 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.2 t 65.25 81.41 0.22 Allowed Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 123.711 0.632 . . . . 1.81 111.405 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.66 131.42 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.199 1.933 . . . . 0.59 112.422 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 m -99.93 140.82 18.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.891 -0.595 . . . . 1.89 109.909 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 45.45 33.04 1.2 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.484 0.714 . . . . 1.98 112.311 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.8 19.29 73.47 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.104 -0.498 . . . . 0.65 114.026 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 2.6 mtmm -145.84 159.84 42.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.771 -0.455 . . . . 2.43 109.771 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.462 HD11 ' CD1' ' A' ' 106' ' ' PHE . 23.8 pt -107.2 148.37 11.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.437 -0.505 . . . . 1.1 110.099 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.589 ' HA ' HD22 ' A' ' 100' ' ' LEU . 73.2 p -76.85 167.04 22.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.692 -0.686 . . . . 1.06 110.074 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.44 -33.16 58.45 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.87 -0.681 . . . . 0.36 112.708 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.01 59.92 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.347 0.499 . . . . 1.17 112.347 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -69.61 -46.81 65.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.573 -0.74 . . . . 1.65 110.625 -170.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.55 72.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.789 -0.641 . . . . 1.09 110.905 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.54 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 36.1 ttmt -61.55 -57.12 13.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 2.11 110.683 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.478 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 56.4 pttt -62.77 -31.26 72.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 1.93 110.708 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.71 -44.42 93.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 1.78 109.643 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.76 ' HB3' HD22 ' A' ' 86' ' ' LEU . 43.1 mtt -67.49 -30.67 70.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.806 -0.634 . . . . 1.67 111.151 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -70.59 -34.93 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.672 0.749 . . . . 2.23 109.339 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 4.3 mptp? -78.44 -12.12 59.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.925 -1.034 . . . . 3.79 110.838 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 49.3 m -76.47 -13.17 60.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 0.98 110.518 175.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 79' ' ' SER . 69.8 mmtt 73.28 16.68 4.12 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.66 -0.7 . . . . 3.38 111.523 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.611 ' HB2' HD23 ' A' ' 86' ' ' LEU . 79.8 mt -93.08 147.02 33.05 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 2.04 110.922 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.534 ' HG2' HG22 ' A' ' 85' ' ' VAL . 11.2 Cg_endo -56.45 149.04 59.15 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.64 2.893 . . . . 0.38 112.848 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -56.13 -38.95 71.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.766 -0.652 . . . . 2.05 111.36 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -62.28 -46.85 86.96 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.984 -0.553 . . . . 1.47 111.618 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.721 ' HA ' ' HZ2' ' A' ' 88' ' ' LYS . 95.8 t -64.25 -45.37 96.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 109.972 -0.381 . . . . 1.08 109.972 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.7 mt -58.79 -42.84 89.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 1.07 111.153 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.82 -40.75 93.45 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.999 -0.62 . . . . 0.41 112.145 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.721 ' HZ2' ' HA ' ' A' ' 85' ' ' VAL . 30.8 mtmm -72.04 -37.82 69.64 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.612 -0.346 . . . . 1.89 110.473 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.1 mt -63.1 -43.97 99.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.346 . . . . 1.14 110.407 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -63.75 -41.22 98.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.497 -0.319 . . . . 0.46 110.208 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.67 -29.83 70.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.243 -0.435 . . . . 3.03 111.095 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.431 ' HB3' HD21 ' A' ' 126' ' ' LEU . 85.5 mt -89.99 -46.91 8.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.102 -0.499 . . . . 2.15 111.363 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -65.46 -42.97 91.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.985 -0.552 . . . . 1.22 111.574 -173.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.68 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 47.3 t0 -86.24 87.99 7.53 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.248 -1.019 . . . . 0.5 108.248 175.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.754 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 15.1 t -68.72 -43.71 82.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.435 -0.802 . . . . 1.21 110.259 -174.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.587 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 6.6 p-10 -84.46 -21.5 30.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.314 -0.857 . . . . 1.46 110.56 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.68 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 48.3 mttp 60.22 73.86 0.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.82 . . . . 3.22 111.462 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.609 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 14.7 p-10 -121.6 9.9 10.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.61 -1.177 . . . . 0.56 111.058 -173.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.94 1.21 67.09 Favored Glycine 0 CA--C 1.516 0.109 0 C-N-CA 120.676 -0.773 . . . . 0.55 112.114 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.609 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 42.9 mt -127.73 152.45 47.72 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.108 -0.701 . . . . 1.17 109.108 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.2 mt -114.2 120.42 40.41 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.803 -0.443 . . . . 1.08 109.803 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.411 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 15.7 m-20 -68.45 173.62 4.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.24 -1.022 . . . . 1.85 108.24 171.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -63.62 -26.91 68.89 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.641 -0.503 . . . . 0.85 109.641 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.425 ' OE1' ' HB3' ' A' ' 134' ' ' SER . 23.4 mt-10 -66.22 -56.06 13.14 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.352 0.596 . . . . 2.08 109.865 173.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.489 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 13.6 mt-10 -66.49 -34.5 78.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.93 -1.032 . . . . 0.48 110.574 -171.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.462 ' CD1' HD11 ' A' ' 67' ' ' ILE . 55.7 t80 -71.17 -43.11 68.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.332 -0.394 . . . . 0.51 110.214 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.424 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -60.98 -39.27 89.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.86 110.575 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -47.9 83.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.865 -0.607 . . . . 1.97 109.491 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.87 -47.33 85.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.804 -0.635 . . . . 1.06 110.791 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -34.32 77.63 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.155 -0.475 . . . . 0.92 111.315 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -68.41 -40.37 81.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.764 0.316 . . . . 0.39 110.387 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.684 ' HB3' HD23 ' A' ' 122' ' ' LEU . 95.0 mt -68.58 -41.54 79.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.275 0.56 . . . . 1.07 110.551 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.54 HD12 ' HG2' ' A' ' 76' ' ' MET . 96.0 mt -65.86 -38.66 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.902 -0.59 . . . . 1.39 109.872 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.717 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 13.9 ttpp -57.69 -53.43 58.3 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.844 -0.616 . . . . 2.25 110.211 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.8 m -62.79 -38.64 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 112.055 0.391 . . . . 1.26 112.055 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.643 ' HD2' HG13 ' A' ' 85' ' ' VAL . 1.1 mmpm? -51.58 -40.97 60.8 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.468 0.175 . . . . 2.47 111.393 169.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.4 mt -78.97 -29.16 43.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.465 -0.334 . . . . 1.34 111.511 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.717 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 10.8 mm-40 -67.37 -24.53 65.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.075 0.464 . . . . 1.98 110.223 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.68 16.75 23.37 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.916 -0.659 . . . . 0.88 111.595 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -108.76 162.44 14.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.237 -0.653 . . . . 1.23 109.237 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.475 ' CD ' ' HZ1' ' A' ' 116' ' ' LYS . 60.1 mm-40 -108.7 129.1 55.35 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.873 0.368 . . . . 3.06 111.249 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.684 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -77.76 139.78 62.71 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 115.956 -0.566 . . . . 1.75 109.902 172.045 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.11 -4.4 14.8 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.31 2.007 . . . . 1.05 113.692 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.408 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 64.44 20.39 12.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.377 0.608 . . . . 1.44 110.347 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -131.05 163.53 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.836 . . . . 1.97 109.4 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 92' ' ' LEU . 77.2 mt -110.08 96.1 24.1 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.735 -0.211 . . . . 1.25 111.04 174.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 30.3 Cg_endo -65.37 159.12 49.0 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.602 2.201 . . . . 0.59 111.649 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.41 -7.89 9.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.192 2.595 . . . . 1.02 114.138 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -111.22 11.09 21.78 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.094 -0.379 . . . . 1.05 111.488 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.8 mt -118.74 -26.2 6.16 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.953 -0.299 . . . . 1.9 111.301 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.817 ' HB ' HH21 ' A' ' 136' ' ' ARG . 47.5 t -60.38 116.93 20.02 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.717 -0.22 . . . . 1.96 110.92 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.55 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 86.5 Cg_exo -48.39 142.06 17.94 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.929 3.086 . . . . 1.11 113.506 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.56 -29.94 85.31 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 123.164 2.576 . . . . 1.73 113.832 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.425 ' HB3' ' OE1' ' A' ' 104' ' ' GLU . 39.8 t -84.62 -7.07 59.37 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.545 -0.462 . . . . 1.91 111.129 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.754 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 11.1 mptt -100.03 -5.02 28.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.89 0.376 . . . . 1.77 110.986 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.817 HH21 ' HB ' ' A' ' 131' ' ' VAL . 18.3 ptp180 -110.89 129.02 55.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.299 -0.41 . . . . 4.66 110.285 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -114.34 114.52 26.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.151 0.501 . . . . 5.55 110.943 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -91.09 136.21 33.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.701 -0.681 . . . . 7.09 109.914 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 C--O 1.251 1.169 0 N-CA-C 108.756 -0.831 . . . . 8.21 108.756 177.081 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 48.6 t80 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.342 -0.614 . . . . 13.73 109.342 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -85.36 166.06 16.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.905 -0.776 . . . . 8.4 108.905 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -108.18 2.54 22.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.098 0.475 . . . . 10.39 110.999 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -97.69 132.52 43.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.724 -0.671 . . . . 5.36 109.535 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' SER . . . . . 0.471 ' CB ' ' HA ' ' B' ' 153' ' ' ALA . 28.6 p -99.31 104.03 15.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.881 0.372 . . . . 3.87 110.993 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.2 m -85.12 -16.24 41.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.232 -0.44 . . . . 2.0 110.335 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 53.0 t-20 -91.69 120.7 68.0 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.709 -0.478 . . . . 1.1 109.709 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 24.7 Cg_exo -64.06 -16.66 56.19 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.106 2.537 . . . . 1.05 113.327 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.54 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 95.0 m-85 -91.3 -45.28 8.69 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.895 0.379 . . . . 0.68 110.885 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 40.7 p -106.98 103.92 13.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.204 -0.453 . . . . 2.36 110.877 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . 0.471 ' HA ' ' CB ' ' B' ' 147' ' ' SER . . . -97.98 -54.02 3.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.052 -0.522 . . . . 3.77 110.257 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 93.9 mttt . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.684 -0.674 . . . . 6.78 109.483 176.709 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.623 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.892 -0.483 . . . . 9.81 111.892 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 3.2 Cg_exo -73.87 146.73 38.14 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.946 2.43 . . . . 8.99 111.976 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.4 mt -98.93 89.8 4.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.171 -0.468 . . . . 9.36 110.141 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.18 -168.67 35.87 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.17 -0.772 . . . . 6.15 111.17 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.3 m 62.22 27.07 16.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.177 0.513 . . . . 6.1 110.881 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.12 119.31 35.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.711 -0.677 . . . . 3.94 110.754 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -123.0 141.05 52.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.788 -0.642 . . . . 3.28 110.134 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.15 140.28 16.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.602 -0.272 . . . . 2.52 110.398 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.14 105.09 5.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.397 . . . . 2.49 110.213 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -82.59 111.15 18.3 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.395 -0.965 . . . . 0.68 108.395 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.51 -40.85 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 121.818 0.818 . . . . 2.03 110.66 -166.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.7 m -91.53 0.44 9.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.484 -1.235 . . . . 1.68 111.339 -172.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.06 -31.49 20.07 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.586 -1.406 . . . . 0.62 109.586 169.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -81.17 -29.61 34.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.974 -0.613 . . . . 3.19 109.974 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.36 32.49 4.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.85 -0.796 . . . . 1.71 108.85 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.638 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 11.4 tmtt? -81.53 -47.12 1.07 Allowed Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 113.303 0.853 . . . . 1.9 113.303 -169.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.7 Cg_endo -44.16 -37.86 10.29 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 123.142 2.561 . . . . 1.06 113.845 -176.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -70.63 -46.67 62.89 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 120.965 0.412 . . . . 1.49 111.346 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.869 ' HH ' ' HD1' ' A' ' 111' ' ' HIS . 2.6 m-85 -72.82 -22.3 60.83 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.092 -0.707 . . . . 0.8 109.092 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -75.32 -42.03 55.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.814 -1.085 . . . . 1.03 109.475 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.54 -55.22 31.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.446 -0.797 . . . . 2.15 109.814 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.19 -26.26 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.826 -0.624 . . . . 1.46 111.389 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -69.58 -50.37 45.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.223 0.535 . . . . 0.37 110.259 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -74.33 -23.63 59.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.913 -0.585 . . . . 1.18 111.859 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.3 p -74.67 -1.52 22.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.844 0.354 . . . . 1.32 111.619 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 95.9 mt -108.49 6.07 25.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.852 -0.425 . . . . 1.17 109.852 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.8 m 63.17 86.86 0.14 Allowed Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 115.379 -0.828 . . . . 1.81 111.754 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -88.51 138.86 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.753 2.302 . . . . 0.59 112.972 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.516 HG13 ' ND2' ' A' ' 64' ' ' ASN . 14.7 t -118.01 132.09 68.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.799 -0.637 . . . . 1.89 109.917 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.516 ' ND2' HG13 ' A' ' 63' ' ' VAL . 44.6 m-80 62.71 20.02 11.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.47 0.708 . . . . 1.98 110.471 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.16 13.26 60.63 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.151 -0.931 . . . . 0.65 112.029 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HE2' ' OD2' ' A' ' 102' ' ' ASP . 94.2 mttt -136.25 171.17 14.88 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.383 0.611 . . . . 2.43 111.642 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.489 HD11 ' CD1' ' A' ' 106' ' ' PHE . 26.7 pt -121.62 143.11 35.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.927 -1.033 . . . . 1.1 109.449 171.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.1 p -78.31 171.42 15.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.179 -0.464 . . . . 1.06 110.112 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.35 -29.7 53.63 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 120.927 -0.654 . . . . 0.36 112.258 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.97 83.41 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.033 0.444 . . . . 1.17 111.843 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.646 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.4 m120 -76.73 -42.35 41.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.777 -0.647 . . . . 1.65 110.343 -170.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -69.15 -29.94 68.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.868 -0.606 . . . . 1.09 110.545 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 63.0 tttt -68.85 -50.18 52.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.215 -0.448 . . . . 2.11 110.838 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.481 ' HA ' HG21 ' A' ' 77' ' ' VAL . 17.3 ptpt -61.42 -39.01 89.23 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.036 0.446 . . . . 1.93 110.465 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.55 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 18.5 tp10 -61.42 -49.28 77.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.518 . . . . 1.78 110.237 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 1.002 ' HB3' HD21 ' A' ' 86' ' ' LEU . 49.8 mtt -65.46 -32.36 73.93 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.209 0.448 . . . . 1.67 112.209 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' A' ' 74' ' ' LYS . 33.5 m -78.75 -16.54 13.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.362 -0.535 . . . . 2.23 111.54 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.55 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -95.54 -9.05 33.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.335 -0.546 . . . . 3.79 110.201 172.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 70.9 m -74.19 -2.43 24.72 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.46 0.541 . . . . 0.98 112.46 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 79' ' ' SER . 5.7 mptp? 74.95 16.9 2.84 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.889 0.476 . . . . 3.38 112.26 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.481 ' HB2' HD22 ' A' ' 86' ' ' LEU . 10.9 mp -99.37 147.05 32.79 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-O 120.854 0.359 . . . . 2.04 111.144 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.538 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.2 Cg_endo -62.4 148.83 92.65 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.87 2.38 . . . . 0.38 112.575 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -53.41 -39.1 64.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.454 -0.794 . . . . 2.05 111.51 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.5 m -62.45 -52.72 62.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.475 . . . . 1.47 111.302 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.498 ' CG2' ' HG2' ' A' ' 82' ' ' PRO . 69.1 t -58.75 -38.54 72.74 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.051 0 CA-C-O 120.617 0.246 . . . . 1.08 110.629 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 1.002 HD21 ' HB3' ' A' ' 76' ' ' MET . 82.3 mt -59.98 -42.42 94.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 1.07 110.818 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.64 -42.29 98.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.852 -0.69 . . . . 0.41 111.792 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 55.3 mtpt -61.26 -46.76 89.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.832 0.349 . . . . 1.89 110.398 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 112' ' ' LEU . 82.6 mt -62.46 -44.48 99.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 1.14 111.311 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -57.33 -45.74 83.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.65 0.262 . . . . 0.46 110.774 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.08 -28.45 69.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.11 0.481 . . . . 3.03 110.907 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.469 ' HB3' HD22 ' A' ' 126' ' ' LEU . 46.3 mt -94.52 -16.77 23.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 2.15 111.856 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.27 -42.38 11.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.569 -0.287 . . . . 1.22 111.133 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.66 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 31.4 t0 -86.42 84.62 7.4 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.115 -0.698 . . . . 0.5 109.115 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.456 HG22 ' HD2' ' A' ' 132' ' ' PRO . 10.7 t -70.87 -36.69 65.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.595 -0.729 . . . . 1.21 110.856 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 11.1 p-10 -83.64 -11.39 57.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.008 -0.542 . . . . 1.46 110.473 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.832 ' HZ1' ' HH ' ' B' ' 145' ' ' TYR . 55.4 mtpt 55.57 53.96 9.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.959 -1.019 . . . . 3.22 111.167 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 13.2 p-10 -109.91 7.86 24.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.059 -0.519 . . . . 0.56 110.583 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.91 1.35 67.42 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.12 -0.562 . . . . 0.55 112.083 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.421 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 74.9 mt -127.05 144.55 51.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.013 0.435 . . . . 1.17 109.902 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 67.3 mt -104.55 113.45 27.04 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.413 -0.515 . . . . 1.08 110.095 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.424 ' OD2' ' HE2' ' A' ' 66' ' ' LYS . 4.2 m-20 -69.35 172.29 7.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.558 -0.904 . . . . 1.85 108.558 169.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -60.27 -30.92 69.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.549 0.214 . . . . 0.85 110.721 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -71.79 -45.28 62.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.107 0.479 . . . . 2.08 110.866 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -70.7 -33.0 70.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.919 0.39 . . . . 0.48 110.747 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.489 ' CD1' HD11 ' A' ' 67' ' ' ILE . 27.7 t80 -75.16 -30.98 60.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.79 -0.448 . . . . 0.51 109.79 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.79 82.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.195 0.522 . . . . 0.86 110.039 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -65.09 -51.25 62.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 1.97 110.556 175.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.37 -50.57 69.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.702 -0.681 . . . . 1.06 110.822 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.449 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -61.82 -33.81 74.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.618 -0.719 . . . . 0.92 111.298 -178.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.869 ' HD1' ' HH ' ' A' ' 53' ' ' TYR . 69.3 t60 -68.41 -42.97 78.23 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.8 -0.36 . . . . 0.39 110.855 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.504 HD11 HG21 ' A' ' 89' ' ' ILE . 72.6 mt -65.59 -38.39 89.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.208 0.527 . . . . 1.07 110.504 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.65 HD13 ' HG2' ' A' ' 76' ' ' MET . 66.6 mt -68.39 -41.03 83.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.042 -0.526 . . . . 1.39 110.592 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 32.4 ttpt -59.09 -48.99 79.59 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.64 -0.255 . . . . 2.25 110.408 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.8 m -63.44 -36.01 74.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 120.642 -0.423 . . . . 1.26 111.119 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.795 ' HD3' HD21 ' A' ' 122' ' ' LEU . 3.9 mmmp? -58.19 -37.88 75.64 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.444 -0.502 . . . . 2.47 110.703 172.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.6 -22.78 59.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 1.34 110.916 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 13.6 mt-10 -83.5 2.14 38.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.194 -0.457 . . . . 1.98 110.55 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.77 23.7 45.09 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.784 -0.722 . . . . 0.88 111.848 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.596 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 90.4 m-70 -117.92 161.27 20.05 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.725 -0.472 . . . . 1.23 109.725 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -115.64 149.04 38.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.34 -0.391 . . . . 3.06 109.975 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.795 HD21 ' HD3' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -89.66 146.77 36.27 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.124 -0.695 . . . . 1.75 109.124 -178.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -66.62 -6.85 16.35 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.783 2.322 . . . . 1.05 112.937 -172.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.81 18.52 9.69 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.469 -0.787 . . . . 1.44 110.773 -176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -135.64 163.7 29.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.2 -0.667 . . . . 1.97 109.2 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 92' ' ' LEU . 96.0 mt -111.98 92.72 18.77 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 111.633 0.234 . . . . 1.25 111.633 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.499 ' HD2' HD11 ' A' ' 130' ' ' LEU . 17.6 Cg_endo -58.86 153.61 49.49 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.395 2.064 . . . . 0.59 111.568 171.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.47 -33.27 46.55 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.508 2.805 . . . . 1.02 114.146 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -82.64 7.21 15.37 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.336 0.495 . . . . 1.05 112.336 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.5 ' O ' HD22 ' A' ' 108' ' ' LEU . 49.2 mt -111.38 -29.12 7.92 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.891 -0.324 . . . . 1.9 111.243 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.411 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 39.3 t -65.52 120.39 67.76 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.5 -0.318 . . . . 1.96 110.838 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.675 ' HG2' ' HD3' ' A' ' 135' ' ' LYS . 10.0 Cg_endo -53.26 142.96 54.79 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 123.092 2.528 . . . . 1.11 112.387 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.521 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 14.1 Cg_exo -68.35 -14.73 40.88 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.236 2.624 . . . . 1.73 113.219 -172.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.6 p -79.69 -18.98 50.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.097 0.475 . . . . 1.91 110.21 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.675 ' HD3' ' HG2' ' A' ' 132' ' ' PRO . 2.2 mptp? -106.59 34.56 3.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.968 -0.56 . . . . 1.77 110.195 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.625 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 3.3 mmp_? -91.48 150.67 21.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.263 0.554 . . . . 4.66 111.114 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -119.84 137.91 53.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.304 -0.862 . . . . 5.55 108.688 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -100.4 137.71 38.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.09 0.471 . . . . 7.09 110.905 -174.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.063 -0.97 . . . . 8.21 108.965 175.183 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.544 0.211 . . . . 13.73 111.048 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -97.88 128.12 44.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.707 0.289 . . . . 8.4 111.065 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.832 ' HH ' ' HZ1' ' A' ' 97' ' ' LYS . 12.5 t80 61.73 84.44 0.14 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.359 -0.837 . . . . 10.39 111.361 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.48 -49.3 0.31 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.544 -0.753 . . . . 5.36 110.67 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 47.2 m -131.51 97.65 4.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.928 0.395 . . . . 3.87 110.044 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 12.8 p -113.09 -41.28 3.75 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.386 0.513 . . . . 2.0 112.386 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -73.91 114.61 34.32 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 121.01 0.434 . . . . 1.1 110.67 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.45 -7.85 20.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.45 2.767 . . . . 1.05 113.154 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 90.9 m-85 -94.48 -45.84 7.25 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.008 0.373 . . . . 0.68 112.008 -177.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.7 t -158.07 165.58 34.67 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.74 -0.384 . . . . 2.36 111.393 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -168.7 -33.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.472 -0.785 . . . . 3.77 110.258 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp . . . . . 0 C--O 1.245 0.846 0 O-C-N 123.828 0.705 . . . . 6.78 110.856 -177.79 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.66 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 111.891 -0.483 . . . . 9.81 111.891 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 38.5 Cg_exo -59.96 141.74 97.08 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.928 2.418 . . . . 8.99 111.538 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 9.9 mp 72.83 -30.97 0.22 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.176 0.59 . . . . 9.36 111.925 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 36' ' ' PRO . . . 121.37 -142.98 15.75 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.56 -0.616 . . . . 6.15 111.56 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 t -156.39 119.49 4.19 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.989 -0.374 . . . . 6.1 109.989 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -84.21 92.37 7.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.844 0.831 . . . . 3.94 109.587 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -108.6 108.92 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.093 -0.958 . . . . 3.28 109.246 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.06 146.42 6.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.743 -0.662 . . . . 2.52 111.192 -173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -141.97 148.32 38.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 2.49 109.28 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -93.78 128.64 40.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.411 -0.588 . . . . 0.68 109.411 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.18 -23.45 11.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.309 0.485 . . . . 2.03 112.309 -168.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -88.28 0.22 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.315 -0.554 . . . . 1.68 111.271 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 -25.5 68.57 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.952 -0.642 . . . . 0.62 112.166 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HG3' ' OD1' ' A' ' 49' ' ' ASP . 15.5 pttp -80.21 -27.76 38.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.611 0.243 . . . . 3.19 111.523 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.574 ' OD1' ' HG3' ' A' ' 48' ' ' LYS . 1.2 m-20 -104.13 31.98 4.25 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.725 -0.472 . . . . 1.71 109.725 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -79.84 -51.24 1.16 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 113.275 0.843 . . . . 1.9 113.275 -172.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.5 -26.56 54.85 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.056 1.837 . . . . 1.06 112.743 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.41 -45.45 46.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.717 0.294 . . . . 1.49 110.912 177.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -70.36 -24.05 62.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.1 -0.704 . . . . 0.8 109.1 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.551 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -73.75 -43.76 58.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.083 -0.962 . . . . 1.03 110.262 176.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.94 -38.03 75.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.865 -0.607 . . . . 2.15 110.229 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.1 mt -75.53 -35.39 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.573 0.702 . . . . 1.46 110.641 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.52 ' CZ ' ' HA ' ' A' ' 66' ' ' LYS . 62.3 t80 -63.54 -43.06 98.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.287 -0.869 . . . . 0.37 111.018 -176.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.551 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 30.8 m-85 -67.64 -23.29 65.33 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.363 0.505 . . . . 1.18 112.363 -177.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.1 p -85.37 8.68 17.9 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.532 -0.467 . . . . 1.32 111.742 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 95.1 mt -112.23 6.9 19.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.29 -0.413 . . . . 1.17 111.105 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t 65.84 88.48 0.11 Allowed Pre-proline 0 N--CA 1.469 0.479 0 O-C-N 123.547 0.529 . . . . 1.81 111.009 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -94.06 132.28 0.73 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.925 2.417 . . . . 0.59 113.428 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.0 134.1 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.288 -0.869 . . . . 1.89 109.429 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 62.62 26.94 15.95 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.851 0.358 . . . . 1.98 110.719 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.6 36.31 67.83 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.611 -0.804 . . . . 0.65 111.916 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.808 ' HB3' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -168.04 175.65 6.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.59 0.233 . . . . 2.43 110.67 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.7 pt -131.35 155.36 41.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.215 0.531 . . . . 1.1 112.122 -172.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.46 ' HA ' HD23 ' A' ' 100' ' ' LEU . 40.9 p -79.19 166.92 21.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.069 -0.969 . . . . 1.06 110.4 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.417 ' HA3' ' HG3' ' B' ' 150' ' ' PRO . . . -59.19 -27.52 62.86 Favored Glycine 0 C--O 1.221 -0.662 0 C-N-CA 120.991 -0.624 . . . . 0.36 112.99 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.22 82.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.39 0.515 . . . . 1.17 112.39 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -76.13 -42.43 46.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.18 -0.464 . . . . 1.65 110.238 -172.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.81 71.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 1.09 110.161 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 59.7 tttt -69.3 -54.76 12.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.979 -0.555 . . . . 2.11 110.495 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 17.3 ptpt -57.78 -34.41 69.56 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.888 -0.325 . . . . 1.93 110.74 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.428 ' CD ' ' HZ2' ' A' ' 78' ' ' LYS . 9.8 tp10 -64.77 -53.5 46.09 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.404 0.621 . . . . 1.78 110.425 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.678 ' HB3' HD23 ' A' ' 86' ' ' LEU . 93.0 mtp -68.96 -24.89 64.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.503 -0.772 . . . . 1.67 112.142 -173.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.508 HG22 ' HA ' ' A' ' 74' ' ' LYS . 35.6 m -87.47 -35.91 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-O 121.067 0.461 . . . . 2.23 110.821 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -79.52 -8.19 58.98 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.482 0.658 . . . . 3.79 109.624 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.5 m -69.86 -11.34 60.79 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.5 -0.773 . . . . 0.98 110.502 168.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 71.68 44.77 0.48 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.504 0.722 . . . . 3.38 111.862 177.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.454 ' HB2' HD21 ' A' ' 86' ' ' LEU . 86.9 mt -119.62 146.86 42.43 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.117 -0.492 . . . . 2.04 109.852 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.5 Cg_endo -58.99 141.22 98.1 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.986 2.457 . . . . 0.38 112.955 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -62.64 -30.52 71.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.614 -0.721 . . . . 2.05 111.644 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.0 m -61.12 -53.13 60.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 1.47 110.085 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 t -55.41 -45.84 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.829 -0.623 . . . . 1.08 110.927 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.678 HD23 ' HB3' ' A' ' 76' ' ' MET . 77.1 mt -60.77 -42.12 96.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 1.07 110.721 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.35 -33.79 88.18 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.701 -0.681 . . . . 0.41 112.358 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 33.1 mttt -68.0 -45.29 74.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.911 0.386 . . . . 1.89 110.077 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.588 HG23 HD11 ' A' ' 112' ' ' LEU . 81.9 mt -59.58 -44.33 92.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.863 -0.608 . . . . 1.14 111.463 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -60.18 -39.82 87.82 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.921 -0.4 . . . . 0.46 109.921 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -64.82 -23.01 67.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 3.03 111.172 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.671 ' HB3' HD22 ' A' ' 126' ' ' LEU . 70.9 mt -93.39 -38.52 11.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.615 -0.721 . . . . 2.15 110.722 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.755 ' HA ' HD21 ' A' ' 108' ' ' LEU . . . -78.93 -42.64 26.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 1.22 111.819 -173.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.634 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 25.3 t0 -86.42 73.53 10.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.286 0.565 . . . . 0.5 109.565 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 12.8 t -64.65 -37.89 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 115.29 -0.868 . . . . 1.21 110.798 -175.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.512 ' OD2' ' HG3' ' A' ' 135' ' ' LYS . 0.7 OUTLIER -72.39 -20.4 61.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.526 -0.761 . . . . 1.46 109.926 -178.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 96.4 mttt 56.83 37.79 29.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.838 0.828 . . . . 3.22 109.333 -175.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.602 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.2 p-10 -89.59 8.95 28.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.654 -1.157 . . . . 0.56 110.972 -174.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.38 -2.96 26.35 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.055 -0.593 . . . . 0.55 112.572 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.602 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 36.1 mt -125.81 146.74 49.67 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.649 -0.5 . . . . 1.17 109.649 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.6 mt -105.74 112.4 25.45 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.282 -0.636 . . . . 1.08 109.282 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.808 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . 2.0 p30 -75.31 176.44 7.42 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.489 -0.484 . . . . 1.85 109.723 174.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -59.19 -28.76 66.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.697 -0.228 . . . . 0.85 111.538 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.402 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . 7.7 mm-40 -76.08 -50.39 14.85 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.877 0.37 . . . . 2.08 110.689 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.634 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 49.3 mt-10 -58.09 -43.17 86.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.257 0.551 . . . . 0.48 110.61 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -69.94 -29.57 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.835 -0.62 . . . . 0.51 110.115 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.47 -43.34 90.61 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.425 0.631 . . . . 0.86 109.889 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.755 HD21 ' HA ' ' A' ' 93' ' ' ALA . 23.7 tp -62.89 -46.45 87.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.452 -0.794 . . . . 1.97 110.369 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.4 -44.79 89.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.54 -0.754 . . . . 1.06 111.074 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -65.41 -33.36 75.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.059 -0.518 . . . . 0.92 111.506 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -67.86 -40.23 83.68 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.904 -0.319 . . . . 0.39 110.241 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.798 ' HB3' HD21 ' A' ' 122' ' ' LEU . 96.4 mt -65.76 -36.3 83.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 1.07 110.629 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.502 HD11 ' HE1' ' A' ' 76' ' ' MET . 73.7 mt -71.8 -38.06 64.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.094 -0.503 . . . . 1.39 110.777 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -57.61 -49.8 75.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.366 -0.379 . . . . 2.25 110.388 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 120' ' ' HIS . 13.9 m -67.16 -40.17 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 120.563 -0.455 . . . . 1.26 111.291 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -51.55 -47.28 63.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.806 0.275 . . . . 2.47 111.339 171.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.71 -35.94 75.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 1.34 110.722 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -74.19 -5.35 41.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.83 -0.623 . . . . 1.98 111.805 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.36 30.55 9.83 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.175 -1.012 . . . . 0.88 112.544 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 90.6 m-70 -126.44 117.39 22.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.103 0.477 . . . . 1.23 109.946 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -78.01 117.2 19.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.57 -0.741 . . . . 3.06 110.526 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.798 HD21 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -60.59 141.17 92.29 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 1.75 110.437 173.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.65 -1.77 10.84 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.449 2.099 . . . . 1.05 113.764 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.26 24.27 14.22 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.512 0.508 . . . . 1.44 110.769 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -133.67 158.5 43.1 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.352 -0.61 . . . . 1.97 109.352 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 92' ' ' LEU . 94.5 mt -111.81 92.34 17.29 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 111.926 0.343 . . . . 1.25 111.926 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.611 ' HD2' HD13 ' A' ' 130' ' ' LEU . 35.3 Cg_endo -66.95 160.4 47.3 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.46 2.107 . . . . 0.59 110.968 167.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.49 -42.23 28.88 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.124 2.55 . . . . 1.02 113.828 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -77.86 10.19 2.98 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.761 0.652 . . . . 1.05 112.761 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.611 HD13 ' HD2' ' A' ' 127' ' ' PRO . 52.8 mt -122.23 3.46 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.215 -0.194 . . . . 1.9 111.287 176.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.6 115.62 64.87 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 121.164 -0.215 . . . . 1.96 110.733 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.692 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 51.9 Cg_exo -55.24 122.99 12.71 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.904 2.403 . . . . 1.11 112.307 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 12.6 Cg_exo -69.7 -4.85 14.82 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.309 2.672 . . . . 1.73 112.679 -176.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.5 t -75.08 -20.76 59.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.638 0.732 . . . . 1.91 109.265 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.692 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -95.83 27.49 3.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.445 -0.798 . . . . 1.77 109.67 -176.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.434 ' HA ' ' HE ' ' A' ' 136' ' ' ARG . 2.7 mmp_? -103.22 90.86 3.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 4.66 109.856 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -119.49 136.08 54.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.279 -0.419 . . . . 5.55 110.674 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -95.47 105.92 17.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.063 -0.517 . . . . 7.09 110.055 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--O 1.25 1.101 0 CA-C-N 115.317 -0.856 . . . . 8.21 110.729 178.443 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 120.84 0.352 . . . . 13.73 110.541 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -108.24 -51.11 2.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.673 -0.492 . . . . 8.4 109.673 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 55.41 89.86 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.549 -0.75 . . . . 10.39 112.32 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -75.96 137.62 40.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.424 -0.807 . . . . 5.36 111.093 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 5.0 p -107.84 52.93 0.7 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.594 0.711 . . . . 3.87 109.778 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.22 33.81 0.24 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.794 -1.094 . . . . 2.0 112.904 -169.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -122.38 151.29 59.15 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 121.634 -0.667 . . . . 1.1 111.885 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.417 ' HG3' ' HA3' ' A' ' 69' ' ' GLY . 34.4 Cg_endo -66.05 -3.69 8.9 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.382 2.721 . . . . 1.05 113.581 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.449 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 80.3 m-85 -82.27 -10.78 58.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.981 0.364 . . . . 0.68 111.981 -173.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.1 t -137.78 13.83 2.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.069 0.462 . . . . 2.36 110.8 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.34 -20.82 3.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.394 0.516 . . . . 3.77 112.394 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 47.9 tptt . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.416 -0.802 . . . . 6.78 111.003 -174.507 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.616 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 111.533 -0.627 . . . . 9.81 111.533 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 38' ' ' GLY . 38.0 Cg_endo -67.43 -25.12 42.05 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.583 2.189 . . . . 8.99 112.544 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 69.0 mt 71.72 -33.19 0.26 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.596 0.758 . . . . 9.36 111.883 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 36' ' ' PRO . . . 114.07 -23.71 12.52 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.654 -0.784 . . . . 6.15 112.327 176.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.0 m 57.3 39.76 28.26 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.131 0.491 . . . . 6.1 110.92 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.93 113.68 13.7 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.578 -0.737 . . . . 3.94 109.641 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -127.72 121.53 30.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.058 -0.519 . . . . 3.28 109.952 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 83.5 t -86.95 111.72 22.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.805 0.336 . . . . 2.52 110.339 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -82.06 135.97 35.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.089 -0.505 . . . . 2.49 111.035 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -88.03 105.09 17.24 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.042 -1.095 . . . . 0.68 108.042 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.5 t -56.62 -24.07 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.896 -0.593 . . . . 2.03 112.118 -171.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -76.54 -23.05 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.765 0.316 . . . . 1.68 111.169 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.74 -18.68 70.55 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.573 -0.822 . . . . 0.62 112.465 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -18.33 23.73 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.143 -0.623 . . . . 3.19 111.733 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -121.22 31.99 6.12 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.95 -0.759 . . . . 1.71 108.95 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 8.7 tmtm? -74.86 -47.43 4.95 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 1.9 111.774 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 49.0 Cg_exo -56.04 -27.67 65.62 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.967 1.778 . . . . 1.06 112.56 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 m -75.71 -46.32 31.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.604 -0.271 . . . . 1.49 111.142 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -70.34 -23.06 62.75 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.679 -0.86 . . . . 0.8 108.679 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.75 -44.68 63.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.733 -1.121 . . . . 1.03 109.862 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.86 -40.79 89.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.027 -0.988 . . . . 2.15 110.055 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.26 -38.37 77.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.01 -0.541 . . . . 1.46 110.797 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.403 ' HE1' HG12 ' A' ' 67' ' ' ILE . 83.1 t80 -62.27 -41.13 98.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.924 -0.58 . . . . 0.37 110.631 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -82.08 14.59 2.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.451 -0.795 . . . . 1.18 112.416 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.1 p -113.7 2.06 15.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.144 0.497 . . . . 1.32 110.988 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 89.0 mt -108.51 14.6 24.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.766 -0.652 . . . . 1.17 111.147 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.8 t 61.2 80.92 0.25 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.722 -0.672 . . . . 1.81 111.575 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -85.63 105.65 0.86 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.514 2.142 . . . . 0.59 113.134 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.3 m -89.78 135.36 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.717 -0.674 . . . . 1.89 109.839 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 62.4 21.06 12.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.19 -0.459 . . . . 1.98 110.412 -174.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.51 9.48 83.32 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.572 -0.823 . . . . 0.65 111.873 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 56.7 mtmt -138.33 148.52 44.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.368 . . . . 2.43 110.947 -177.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' A' ' 106' ' ' PHE . 11.3 pt -97.34 144.16 11.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.017 0.437 . . . . 1.1 110.701 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.541 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 12.1 p -71.18 161.6 30.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.295 -0.866 . . . . 1.06 110.837 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.26 -32.22 60.12 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.135 -0.555 . . . . 0.36 112.021 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.634 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -49.85 -65.81 0.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.559 0.344 . . . . 1.17 111.72 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 48.0 m-80 -69.45 -39.46 77.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.089 -0.505 . . . . 1.65 111.717 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.11 97.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.422 -0.354 . . . . 1.09 110.38 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.515 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 34.4 ttpt -62.43 -42.28 99.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.469 -0.567 . . . . 2.11 109.469 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.634 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 52.0 mtpt -51.8 -55.53 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.5 -0.773 . . . . 1.93 110.916 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -59.07 -46.53 88.02 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.348 0.595 . . . . 1.78 110.657 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.689 ' HB3' HD22 ' A' ' 86' ' ' LEU . 84.3 mtp -64.69 -29.22 70.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.846 -0.615 . . . . 1.67 110.992 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.21 -37.37 45.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.239 0.542 . . . . 2.23 109.897 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -80.86 2.91 24.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.91 -0.586 . . . . 3.79 111.061 177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m -77.56 -10.24 59.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.307 -0.406 . . . . 0.98 110.338 169.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 69.68 21.37 6.6 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.299 0.639 . . . . 3.38 111.615 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' HB2' HD23 ' A' ' 86' ' ' LEU . 94.2 mt -100.8 153.14 37.9 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.614 -0.721 . . . . 2.04 110.964 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.495 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 9.8 Cg_endo -54.82 141.12 77.67 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.155 2.57 . . . . 0.38 112.631 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -63.95 -28.43 69.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.463 -0.789 . . . . 2.05 111.443 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 p -67.22 -44.73 78.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.842 0.353 . . . . 1.47 110.887 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.46 -44.3 98.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 1.08 110.01 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.689 HD22 ' HB3' ' A' ' 76' ' ' MET . 78.4 mt -60.75 -41.41 95.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.767 -0.651 . . . . 1.07 110.489 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.6 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -57.17 -49.73 69.94 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.697 -0.683 . . . . 0.41 111.541 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.496 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 93.6 mttt -56.05 -51.05 69.22 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 122.518 0.327 . . . . 1.89 110.974 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 112' ' ' LEU . 83.0 mt -55.52 -42.67 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.695 -0.684 . . . . 1.14 111.217 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.435 ' HB3' ' ND2' ' B' ' 149' ' ' ASN . 15.0 t-105 -61.93 -44.91 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.478 -0.328 . . . . 0.46 110.956 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 60.7 mttm -63.28 -22.82 67.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 3.03 110.961 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 126' ' ' LEU . 27.7 mt -93.51 -38.01 11.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 2.15 110.528 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 105' ' ' GLU . . . -72.61 -42.67 64.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.713 -0.676 . . . . 1.22 111.019 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 44.2 t0 -81.46 78.94 8.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.897 -0.779 . . . . 0.5 108.897 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.448 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 11.2 t -70.13 -36.04 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.493 -0.776 . . . . 1.21 110.827 -174.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.623 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 4.8 p-10 -84.17 -11.08 57.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 1.46 109.727 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.497 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 62.2 mtpt 51.63 66.04 1.31 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.808 -1.087 . . . . 3.22 111.564 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.593 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 10.5 p-10 -115.31 9.2 15.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.335 -0.848 . . . . 0.56 110.412 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.16 2.76 67.45 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.882 -0.675 . . . . 0.55 112.183 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.541 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 81.2 mt -131.73 164.75 25.29 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.377 -0.601 . . . . 1.17 109.377 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.1 mt -120.56 116.65 25.79 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.649 -0.42 . . . . 1.08 110.482 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.44 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.7 p30 -78.62 -176.89 5.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.144 -0.688 . . . . 1.85 109.144 170.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -66.4 -29.6 69.79 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.961 -0.295 . . . . 0.85 111.528 -176.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -69.55 -53.83 17.04 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.213 -0.662 . . . . 2.08 109.213 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 28.7 mt-10 -63.06 -39.6 95.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.919 -1.037 . . . . 0.48 111.436 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.469 ' CD1' HD13 ' A' ' 67' ' ' ILE . 48.6 t80 -69.48 -40.36 77.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.51 110.249 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.58 75.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.92 -0.582 . . . . 0.86 110.373 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -63.85 -48.44 76.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.947 -0.569 . . . . 1.97 109.475 175.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.78 76.71 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.617 -0.72 . . . . 1.06 110.611 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.31 -28.36 69.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.711 -0.677 . . . . 0.92 111.543 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 56.8 t60 -81.24 -32.67 33.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.815 -0.354 . . . . 0.39 110.871 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 89' ' ' ILE . 93.4 mt -71.12 -37.28 72.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.331 0.586 . . . . 1.07 109.568 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.486 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 76.0 mt -70.78 -32.73 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.905 -0.589 . . . . 1.39 109.941 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 14.3 tppt? -53.4 -55.42 25.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.044 -0.526 . . . . 2.25 110.728 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.3 m -65.94 -36.31 77.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 120.563 -0.455 . . . . 1.26 111.47 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HG2' HD22 ' A' ' 122' ' ' LEU . 25.7 mmmt -58.67 -42.03 87.53 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.562 -0.455 . . . . 2.47 111.702 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 81.6 mt -70.09 -22.32 63.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 1.34 110.97 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.455 ' HB2' ' CD2' ' A' ' 120' ' ' HIS . 49.1 mt-10 -82.73 -8.17 59.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.914 -0.584 . . . . 1.98 110.893 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.56 30.16 16.68 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.576 -0.821 . . . . 0.88 111.861 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.455 ' CD2' ' HB2' ' A' ' 118' ' ' GLU . 66.8 m-70 -110.24 174.08 6.03 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.646 -0.501 . . . . 1.23 109.646 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' A' ' 121' ' ' GLU . 16.2 mm-40 -109.21 136.69 48.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.79 -0.641 . . . . 3.06 109.535 171.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.439 HD22 ' HG2' ' A' ' 116' ' ' LYS . 1.3 pp -82.93 139.59 43.0 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.335 -0.617 . . . . 1.75 109.335 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.53 -13.97 36.64 Favored 'Trans proline' 0 N--CA 1.476 0.467 0 C-N-CA 123.332 2.688 . . . . 1.05 113.694 -169.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.53 16.42 9.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.645 -0.707 . . . . 1.44 111.425 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -136.26 171.54 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.304 -0.628 . . . . 1.97 109.304 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.852 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 98.9 mt -115.85 90.51 27.54 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.505 -0.316 . . . . 1.25 110.794 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.65 154.85 66.63 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.478 2.119 . . . . 0.59 111.723 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -50.27 -24.36 11.5 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.583 2.856 . . . . 1.02 114.969 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -96.31 5.27 51.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.952 0.406 . . . . 1.05 111.508 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.433 ' O ' HD22 ' A' ' 108' ' ' LEU . 64.8 mt -123.61 -34.08 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.29 -0.414 . . . . 1.9 110.786 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.852 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.8 p -77.61 121.55 84.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.026 0.441 . . . . 1.96 110.654 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 131' ' ' VAL . 12.4 Cg_endo -57.63 129.42 33.61 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.754 2.303 . . . . 1.11 112.065 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.402 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 33.5 Cg_endo -65.61 -6.12 13.12 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.463 2.775 . . . . 1.73 112.959 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 p -75.9 -12.84 60.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.938 0.399 . . . . 1.91 111.08 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.448 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 3.9 mptp? -119.76 20.32 12.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.392 -0.367 . . . . 1.77 111.017 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.402 ' NH2' ' HB3' ' A' ' 133' ' ' PRO . 17.2 mtm180 -110.29 141.36 43.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.135 -0.32 . . . . 4.66 110.135 177.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -141.24 148.53 40.03 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.035 0.445 . . . . 5.55 111.544 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -132.44 141.4 48.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.814 -0.63 . . . . 7.09 109.646 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.504 -0.76 . . . . 8.21 109.221 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.678 -0.49 . . . . 13.73 109.678 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -95.25 166.05 12.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.182 -0.463 . . . . 8.4 110.708 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -108.8 152.94 24.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.38 -0.373 . . . . 10.39 110.843 -173.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -105.18 102.18 11.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.152 -0.476 . . . . 5.36 110.518 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m 58.36 83.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.722 -0.672 . . . . 3.87 112.28 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 1.5 p -95.16 12.16 29.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.983 0.421 . . . . 2.0 111.157 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.593 HD22 ' HA2' ' A' ' 87' ' ' GLY . 24.8 t-20 -101.44 112.45 65.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.132 -0.486 . . . . 1.1 109.729 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 16.5 Cg_exo -68.46 -6.87 18.67 Favored 'Trans proline' 0 N--CA 1.474 0.326 0 C-N-CA 123.361 2.707 . . . . 1.05 113.284 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.515 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 99.2 m-85 -85.96 -36.43 19.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.182 0.515 . . . . 0.68 110.196 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 38.3 p -104.22 90.86 3.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.958 -0.565 . . . . 2.36 110.78 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -157.19 174.58 15.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.165 -0.471 . . . . 3.77 110.55 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' B' ' 154' ' ' LYS . 3.6 ptmm? . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.837 -0.601 . . . . 6.78 110.345 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.637 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.81 0 N-CA-C 111.692 -0.563 . . . . 9.81 111.692 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 2.3 Cg_endo -83.5 -12.56 8.91 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.06 2.507 . . . . 8.99 112.969 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.3 mp 63.37 15.74 8.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.012 0.525 . . . . 9.36 112.182 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.25 56.07 0.49 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.465 -0.874 . . . . 6.15 112.153 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.3 p -126.31 131.73 51.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.814 0.34 . . . . 6.1 110.89 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -107.62 105.8 15.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.811 -0.632 . . . . 3.94 109.78 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -139.56 133.75 31.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.194 0.521 . . . . 3.28 110.944 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.1 p -104.09 148.64 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.604 -0.725 . . . . 2.52 109.278 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.22 130.88 51.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.254 0.549 . . . . 2.49 111.515 -175.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -81.38 110.57 16.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.31 -0.996 . . . . 0.68 108.31 172.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.5 t -53.31 -35.68 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.513 0.56 . . . . 2.03 112.513 -172.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 31.3 t -72.16 -17.0 18.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.372 -0.376 . . . . 1.68 111.26 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.55 -1.25 52.0 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.366 -0.921 . . . . 0.62 112.188 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -86.55 -31.04 21.44 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.22 0.533 . . . . 3.19 110.878 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -141.39 35.16 1.67 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 122.224 1.011 . . . . 1.71 110.229 -172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 15.1 tmtt? -76.86 -42.56 2.82 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 114.015 -1.448 . . . . 1.9 111.535 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 50' ' ' LYS . 82.2 Cg_exo -46.21 -35.0 14.55 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.726 2.284 . . . . 1.06 113.598 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.577 ' O ' HG12 ' A' ' 56' ' ' ILE . 9.3 m -69.83 -45.66 67.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.732 -0.387 . . . . 1.49 110.449 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -72.16 -22.76 61.25 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.467 -0.568 . . . . 0.8 109.467 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.475 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 18.0 t70 -67.2 -41.18 86.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.137 -0.938 . . . . 1.03 109.078 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -66.85 -35.59 80.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.21 -0.904 . . . . 2.15 110.239 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 52' ' ' THR . 23.0 mm -66.03 -31.48 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.731 0.777 . . . . 1.46 109.707 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.471 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 87.6 t80 -72.91 -45.55 57.53 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.094 -0.957 . . . . 0.37 110.804 -175.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 51.2 m-85 -75.49 -19.89 59.1 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.114 -0.493 . . . . 1.18 111.952 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.2 p -83.45 -5.16 59.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 1.32 111.164 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.62 8.98 39.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 1.17 111.246 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.1 t 64.32 83.41 0.2 Allowed Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 123.743 0.652 . . . . 1.81 110.955 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.43 118.13 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.766 2.311 . . . . 0.59 112.812 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.91 134.7 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.744 . . . . 1.89 110.66 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 57.92 19.92 6.24 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.457 0.703 . . . . 1.98 111.377 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.71 7.27 63.17 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.907 -0.588 . . . . 0.65 112.258 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 54.4 mtmt -137.45 173.42 11.68 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 110.111 -0.329 . . . . 2.43 110.111 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.42 HD13 ' CD1' ' A' ' 106' ' ' PHE . 25.0 pt -118.39 154.12 20.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.87 -0.418 . . . . 1.1 109.87 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.579 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 70.7 p -80.95 166.94 20.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.896 -0.593 . . . . 1.06 110.201 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.519 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -58.87 -22.46 54.39 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.642 -0.79 . . . . 0.36 111.888 175.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.552 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -61.42 -59.91 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 1.17 111.556 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -65.8 -42.75 90.33 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.689 -0.687 . . . . 1.65 111.332 -170.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.16 -36.14 83.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 1.09 110.522 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 32.0 tttp -62.27 -43.39 98.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.894 -0.594 . . . . 2.11 110.019 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 24.8 mtpt -58.76 -51.1 71.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.687 -0.688 . . . . 1.93 110.576 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -57.98 -43.7 86.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.529 0.681 . . . . 1.78 110.457 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.735 ' HB3' HD23 ' A' ' 86' ' ' LEU . 94.4 mtp -69.16 -26.91 65.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.792 -0.64 . . . . 1.67 112.276 -175.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 74' ' ' LYS . 25.6 m -83.16 -22.82 8.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 120.126 -0.63 . . . . 2.23 109.602 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 5.6 mptp? -77.6 -12.94 60.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 3.79 110.099 173.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.0 m -75.2 -7.93 55.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.98 111.62 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? 67.39 34.66 4.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.986 0.422 . . . . 3.38 111.374 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 86' ' ' LEU . 95.3 mt -112.74 146.65 35.49 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.106 -0.497 . . . . 2.04 110.982 -176.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.4 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.7 Cg_endo -61.62 153.14 69.05 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.064 2.509 . . . . 0.38 112.854 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -59.62 -32.74 70.7 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.948 -0.569 . . . . 2.05 111.601 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.456 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -64.73 -50.47 66.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.922 0.391 . . . . 1.47 110.951 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.44 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . 42.8 t -60.27 -44.26 95.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 1.08 110.418 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' A' ' 76' ' ' MET . 86.4 mt -63.84 -38.84 92.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.809 -0.632 . . . . 1.07 110.774 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.637 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -60.88 -42.68 99.71 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.039 -0.6 . . . . 0.41 112.551 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 84' ' ' THR . 41.1 mtmt -68.18 -42.9 79.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.744 -0.095 . . . . 1.89 110.744 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.571 HD11 ' HZ2' ' A' ' 116' ' ' LYS . 93.8 mt -55.83 -52.2 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.384 0.428 . . . . 1.14 111.071 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.519 ' CH2' ' HA2' ' A' ' 69' ' ' GLY . 39.0 t-105 -62.98 -49.59 74.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.794 0.331 . . . . 0.46 111.348 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -59.64 -30.93 69.06 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.139 -0.482 . . . . 3.03 111.232 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.482 HD22 HD12 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -92.53 -41.02 10.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 2.15 111.2 -176.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.45 ' N ' ' HG ' ' A' ' 92' ' ' LEU . . . -69.53 -36.32 76.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.536 0.569 . . . . 1.22 112.536 -175.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.602 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 42.5 t0 -74.18 95.47 2.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.895 -0.779 . . . . 0.5 108.895 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.79 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 8.1 t -79.75 -39.91 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 1.21 110.942 -171.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -80.68 -13.92 58.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 1.46 109.68 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.592 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 6.1 mtpp 51.64 72.91 0.34 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.496 -1.229 . . . . 3.22 111.31 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.62 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.1 p-10 -128.33 9.1 6.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.962 -1.017 . . . . 0.56 110.825 -175.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.23 10.84 70.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.55 111.841 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 43.8 mt -134.31 157.45 46.3 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.217 -0.66 . . . . 1.17 109.217 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.0 mt -121.77 118.81 29.97 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.776 -0.37 . . . . 1.08 110.196 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.53 ' CG ' ' HZ2' ' A' ' 135' ' ' LYS . 2.6 p30 -74.67 -177.63 3.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.077 -0.712 . . . . 1.85 109.077 168.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -66.08 -27.05 67.78 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.088 0.403 . . . . 0.85 112.088 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 85.7 mt-10 -75.89 -47.32 25.87 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.749 -0.463 . . . . 2.08 109.749 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -66.3 -37.7 86.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.89 -0.596 . . . . 0.48 110.492 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 67' ' ' ILE . 23.7 t80 -70.34 -38.56 74.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.168 -0.469 . . . . 0.51 110.303 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.88 99.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.045 -0.525 . . . . 0.86 110.401 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -59.38 -49.88 76.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 1.97 109.574 177.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -55.61 -46.92 77.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.905 -0.589 . . . . 1.06 111.552 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -66.68 -38.4 86.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.446 . . . . 0.92 111.407 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -64.92 -32.61 74.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.098 0.475 . . . . 0.39 109.934 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.708 ' HB3' HD23 ' A' ' 122' ' ' LEU . 97.8 mt -67.09 -35.02 78.9 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.954 -0.567 . . . . 1.07 109.997 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 109' ' ' ALA . 38.7 mm -61.26 -47.1 95.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.158 -0.682 . . . . 1.39 109.158 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -59.06 -44.06 91.79 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.417 -0.811 . . . . 2.25 112.033 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 112' ' ' LEU . 11.6 m -64.56 -38.79 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 120.062 -0.655 . . . . 1.26 111.344 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.594 ' HE3' HD22 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -51.97 -48.51 64.32 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 120.526 -0.47 . . . . 2.47 111.262 167.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.38 -29.37 68.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.933 -0.576 . . . . 1.34 111.23 -177.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -70.91 -20.01 62.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.968 -0.56 . . . . 1.98 111.233 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.39 22.67 10.24 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.693 -0.765 . . . . 0.88 112.004 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -119.36 158.57 25.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.589 -0.523 . . . . 1.23 109.589 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.9 130.61 55.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.201 0.524 . . . . 3.06 110.564 174.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.708 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -68.79 146.5 97.55 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 1.75 110.407 172.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 2.2 Cg_endo -80.22 1.7 9.05 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.719 2.279 . . . . 1.05 112.86 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 64.53 19.69 11.89 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.985 -0.552 . . . . 1.44 110.892 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -133.85 169.72 16.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.696 -0.684 . . . . 1.97 109.383 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.6 mt -111.97 91.26 15.04 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 123.082 0.239 . . . . 1.25 111.516 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.54 154.41 72.09 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.71 2.273 . . . . 0.59 111.208 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.27 -40.24 52.34 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.537 2.825 . . . . 1.02 113.77 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -79.14 7.65 7.17 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.088 0.403 . . . . 1.05 112.088 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.422 ' O ' HD22 ' A' ' 108' ' ' LEU . 70.5 mt -126.34 5.61 7.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.547 0.213 . . . . 1.9 111.557 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.32 118.31 69.75 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.033 -0.267 . . . . 1.96 110.915 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.796 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 64.5 Cg_exo -53.76 124.57 16.17 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.139 2.56 . . . . 1.11 112.135 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 28.3 Cg_exo -62.58 -22.93 74.53 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.143 2.562 . . . . 1.73 114.296 -172.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 57.0 m -72.5 -15.67 61.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.199 0.523 . . . . 1.91 110.258 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.796 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 10.0 mptt -101.31 26.05 7.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.922 -0.581 . . . . 1.77 110.102 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.524 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 5.4 mmp_? -89.56 149.7 22.74 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.391 -0.596 . . . . 4.66 109.391 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -78.65 90.51 4.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.388 0.613 . . . . 5.55 110.103 -174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -91.29 121.42 33.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 7.09 110.855 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.012 -0.995 . . . . 8.21 110.852 -176.553 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 57.7 t80 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 110.295 -0.261 . . . . 13.73 110.295 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -72.07 -75.1 0.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.185 0.517 . . . . 8.4 110.156 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -125.48 -66.64 0.94 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.395 -0.965 . . . . 10.39 108.395 173.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -132.21 136.74 47.24 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.685 -0.857 . . . . 5.36 108.685 172.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 5.2 p -167.51 106.9 0.56 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.96 0.409 . . . . 3.87 111.063 -174.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.5 p -97.11 6.7 48.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.06 -0.518 . . . . 2.0 111.235 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.728 ' HB3' ' O ' ' B' ' 152' ' ' THR . 48.6 t-20 -157.54 125.41 2.79 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.915 -0.584 . . . . 1.1 109.448 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.59 -3.14 8.62 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.45 2.766 . . . . 1.05 113.684 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 83.6 m-85 -104.75 -27.19 11.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.987 0.422 . . . . 0.68 110.533 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' THR . . . . . 0.728 ' O ' ' HB3' ' B' ' 149' ' ' ASN . 3.5 t -167.38 133.78 2.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.876 -0.602 . . . . 2.36 110.433 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.9 -5.55 53.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.278 0.561 . . . . 3.77 110.215 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp . . . . . 0 C--O 1.254 1.298 0 CA-C-N 115.47 -0.786 . . . . 6.78 109.617 -177.051 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.602 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.663 -0.575 . . . . 9.81 111.663 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.57 141.15 90.45 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.855 2.37 . . . . 8.99 112.071 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.8 160.43 15.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.063 -0.517 . . . . 9.36 111.206 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.55 171.07 32.37 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.2 -1.16 . . . . 6.15 110.2 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.1 m 66.9 -166.02 0.22 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.068 0.461 . . . . 6.1 110.659 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -113.11 135.09 54.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.086 -0.507 . . . . 3.94 109.767 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.01 111.28 4.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.153 0.502 . . . . 3.28 110.984 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 p -76.66 134.76 28.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.767 -0.651 . . . . 2.52 110.843 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.73 86.94 5.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.247 -0.433 . . . . 2.49 110.975 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -80.68 98.54 7.75 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.703 -0.851 . . . . 0.68 108.703 174.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 m -57.57 -26.71 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.578 -0.737 . . . . 2.03 112.172 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.488 ' HA ' ' OD1' ' A' ' 49' ' ' ASP . 24.1 t -73.41 -16.34 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.032 -0.531 . . . . 1.68 111.227 -174.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.01 -8.81 58.82 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.604 -0.808 . . . . 0.62 112.396 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -93.88 -28.78 15.65 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.395 0.617 . . . . 3.19 110.721 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.488 ' OD1' ' HA ' ' A' ' 46' ' ' VAL . 10.8 p-10 -120.94 33.7 5.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.211 -0.904 . . . . 1.71 109.714 -172.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.06 -46.51 0.47 Allowed Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 114.391 -1.277 . . . . 1.9 112.263 -174.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.39 -26.61 8.84 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 122.754 2.303 . . . . 1.06 114.06 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -68.83 -45.86 70.04 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.384 0.611 . . . . 1.49 110.126 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -78.14 -20.72 51.49 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.706 -0.679 . . . . 0.8 109.178 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.6 -45.19 94.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.614 -0.721 . . . . 1.03 109.505 173.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -62.05 -50.0 73.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.203 -0.908 . . . . 2.15 110.089 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.9 mt -60.71 -35.42 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.063 -0.517 . . . . 1.46 111.008 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.491 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 92.6 t80 -65.13 -40.33 94.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.637 -0.71 . . . . 0.37 110.05 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -74.75 -25.01 58.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.959 -0.564 . . . . 1.18 111.726 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.6 p -82.53 1.87 35.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.088 0.47 . . . . 1.32 111.374 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.75 1.85 23.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.714 -0.476 . . . . 1.17 109.714 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.5 m 63.3 88.88 0.11 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.054 -0.975 . . . . 1.81 111.593 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -86.92 122.5 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.71 2.273 . . . . 0.59 112.592 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.9 m -101.2 130.9 49.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.001 -0.545 . . . . 1.89 109.781 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 65.91 21.85 11.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.002 -0.545 . . . . 1.98 110.046 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.18 1.53 78.85 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.912 -0.586 . . . . 0.65 112.549 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.615 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 51.5 mtmt -135.59 156.44 48.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.021 -0.363 . . . . 2.43 110.021 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.54 HD12 ' CD1' ' A' ' 106' ' ' PHE . 15.4 pt -102.33 146.14 10.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 120.57 -0.452 . . . . 1.1 110.663 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.569 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 68.5 p -73.16 163.97 27.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.089 -0.505 . . . . 1.06 110.293 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.99 -24.76 55.24 Favored Glycine 0 C--O 1.221 -0.708 0 C-N-CA 120.796 -0.716 . . . . 0.36 112.469 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -59.35 -58.07 10.21 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.119 0.485 . . . . 1.17 111.601 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.446 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -67.54 -41.12 84.8 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.719 -0.673 . . . . 1.65 110.363 -173.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.449 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -65.29 -31.54 72.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.483 -0.781 . . . . 1.09 110.524 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.439 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 70.9 tttt -67.86 -43.48 79.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.213 -0.449 . . . . 2.11 109.954 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.722 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.9 mtmt -55.29 -49.12 72.92 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.515 -0.766 . . . . 1.93 110.106 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.622 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 28.9 tp10 -57.92 -44.21 86.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.325 0.583 . . . . 1.78 110.749 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.577 ' HB3' HD23 ' A' ' 86' ' ' LEU . 23.9 mmt -63.9 -36.48 84.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.923 -0.58 . . . . 1.67 111.884 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -81.16 -35.75 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.435 -0.506 . . . . 2.23 111.674 -173.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -81.93 -8.34 59.67 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 119.99 -0.684 . . . . 3.79 110.97 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.0 m -75.35 -20.35 59.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.163 0.506 . . . . 0.98 109.716 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.648 ' HZ1' ' HB3' ' A' ' 80' ' ' LYS . 5.1 mmmp? 69.6 51.01 0.48 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.038 -0.983 . . . . 3.38 111.775 175.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.479 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.8 mp -110.99 145.31 32.17 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.872 -1.058 . . . . 2.04 109.018 170.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.93 146.7 94.96 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.998 2.465 . . . . 0.38 112.427 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -56.73 -31.16 64.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.26 -0.427 . . . . 2.05 111.724 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.8 m -62.51 -48.63 78.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.135 0.493 . . . . 1.47 110.267 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.697 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 69.1 t -66.51 -43.06 91.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 1.08 110.212 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 76' ' ' MET . 80.9 mt -59.87 -36.39 76.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.055 -0.52 . . . . 1.07 110.196 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.893 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -61.7 -46.07 94.98 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.739 -0.664 . . . . 0.41 112.043 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.697 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 17.7 mtpp -61.17 -47.32 86.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.361 -0.237 . . . . 1.89 110.361 177.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.77 -48.42 88.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.873 -0.603 . . . . 1.14 111.357 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -64.04 -48.97 74.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.915 0.388 . . . . 0.46 111.179 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.24 -27.82 68.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.894 -0.594 . . . . 3.03 111.353 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.619 HD21 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -94.32 -33.21 13.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.863 -0.608 . . . . 2.15 111.331 -177.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.491 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -73.48 -42.49 61.8 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.137 0.421 . . . . 1.22 112.137 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.639 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 50.6 t0 -78.16 95.55 4.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.869 -0.789 . . . . 0.5 108.869 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 t -70.38 -44.44 77.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.406 -0.816 . . . . 1.21 110.38 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.628 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 6.4 p-10 -88.35 -17.18 31.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.317 -0.856 . . . . 1.46 110.755 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.618 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 50.8 mttp 58.03 73.39 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.152 0.977 . . . . 3.22 112.094 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.603 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 12.9 p-10 -117.67 10.21 13.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.291 -1.322 . . . . 0.56 110.576 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.29 -0.88 62.36 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.054 -0.593 . . . . 0.55 112.156 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.569 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 47.5 mt -129.87 149.42 51.61 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.054 -0.721 . . . . 1.17 109.054 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.7 mt -98.99 112.31 24.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.359 0.6 . . . . 1.08 109.858 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.646 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 7.5 t70 -70.39 166.3 20.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.826 -1.079 . . . . 1.85 109.122 173.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -57.47 -37.99 73.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 118.006 0.366 . . . . 0.85 111.692 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.696 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 81.3 mt-10 -70.98 -40.38 71.94 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.671 -0.412 . . . . 2.08 110.663 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.646 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 18.2 mt-10 -70.68 -31.94 69.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.48 110.697 -174.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.54 ' CD1' HD12 ' A' ' 67' ' ' ILE . 66.8 t80 -74.37 -44.39 52.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.788 -0.642 . . . . 0.51 109.887 177.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.7 87.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.742 -0.663 . . . . 0.86 109.82 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 18.3 tp -60.57 -50.56 73.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.437 -0.801 . . . . 1.97 109.834 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -56.9 -46.64 81.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 1.06 111.155 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.85 -34.41 75.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.177 -0.465 . . . . 0.92 111.355 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.411 ' CG ' HG21 ' A' ' 46' ' ' VAL . 40.9 t60 -65.41 -39.14 91.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.696 -0.483 . . . . 0.39 109.696 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.619 HD13 HD21 ' A' ' 92' ' ' LEU . 74.9 mt -63.69 -43.34 96.93 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.957 -0.565 . . . . 1.07 110.044 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.478 HD13 ' SD ' ' A' ' 76' ' ' MET . 33.7 mm -54.08 -50.58 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.637 -0.711 . . . . 1.39 110.115 173.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 27.3 ttpp -58.51 -49.95 75.52 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.548 -0.751 . . . . 2.25 111.435 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.7 m -61.51 -40.1 85.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.537 -0.465 . . . . 1.26 111.217 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.526 ' HG2' HD22 ' A' ' 122' ' ' LEU . 24.8 mmmt -58.71 -40.56 84.04 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.221 -0.192 . . . . 2.47 111.403 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 92.6 mt -71.19 -32.24 68.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.168 0.508 . . . . 1.34 110.868 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.555 ' HB2' ' HD2' ' A' ' 120' ' ' HIS . 47.1 mt-10 -77.72 2.29 17.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.842 -0.617 . . . . 1.98 111.106 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.12 24.18 41.86 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.781 -0.723 . . . . 0.88 112.401 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.555 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 84.3 m-70 -114.53 175.13 5.62 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.502 -0.555 . . . . 1.23 109.502 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -117.96 136.55 53.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.955 0.407 . . . . 3.06 111.195 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.0 pp -89.41 134.33 32.95 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.44 -0.578 . . . . 1.75 109.44 173.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 37.3 Cg_exo -60.93 -18.66 58.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.168 2.579 . . . . 1.05 113.768 -172.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.0 17.87 11.27 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.822 -0.626 . . . . 1.44 110.94 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -133.95 173.81 11.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.236 -0.893 . . . . 1.97 108.635 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.4 mt -113.2 90.46 16.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.817 0.302 . . . . 1.25 111.817 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.74 160.53 37.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.504 2.136 . . . . 0.59 110.712 169.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.71 -34.3 53.26 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.278 2.652 . . . . 1.02 113.711 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -86.94 -2.16 58.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.733 -0.387 . . . . 1.05 111.659 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -99.37 -25.7 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.979 0.418 . . . . 1.9 110.356 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.88 119.56 73.93 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.849 -0.614 . . . . 1.96 111.163 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.696 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 51.6 Cg_exo -55.37 146.32 62.72 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.291 2.661 . . . . 1.11 112.716 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.43 ' HD2' ' OE2' ' A' ' 104' ' ' GLU . 33.4 Cg_exo -60.45 -21.34 67.61 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.452 2.768 . . . . 1.73 114.577 -170.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.7 m -84.1 -26.26 29.09 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.191 -0.604 . . . . 1.91 111.643 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.58 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -120.42 31.56 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 1.77 111.324 -177.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -82.26 146.47 29.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 4.66 111.162 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -92.04 142.96 26.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 5.55 110.448 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -97.71 129.22 44.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.521 -0.309 . . . . 7.09 110.672 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.365 -0.826 . . . . 8.21 109.766 171.972 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.458 -0.571 . . . . 13.73 109.458 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -113.95 -73.72 0.65 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.98 -0.288 . . . . 8.4 110.876 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 63.08 79.32 0.26 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.715 0.634 . . . . 10.39 110.798 -176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.18 -54.52 6.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.819 -0.628 . . . . 5.36 110.413 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 50.5 m -150.14 129.52 12.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.661 -0.7 . . . . 3.87 109.948 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 1.5 m -125.03 24.9 7.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.218 0.533 . . . . 2.0 110.419 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.893 HD22 ' HA2' ' A' ' 87' ' ' GLY . 33.6 t-20 -115.53 115.88 41.71 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.031 0.443 . . . . 1.1 111.565 -173.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.09 -4.87 15.11 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.919 3.08 . . . . 1.05 113.302 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.549 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 72.4 m-85 -101.47 4.98 41.75 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.055 0.391 . . . . 0.68 112.055 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 38.7 p -127.8 162.36 26.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.777 0.658 . . . . 2.36 112.777 -171.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 73.88 -92.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.113 -0.949 . . . . 3.77 112.488 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 mttp . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.2 -0.905 . . . . 6.78 110.612 -176.58 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.639 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.7 t90 . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.071 -0.715 . . . . 0.66 109.071 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 48.1 t -54.42 -32.05 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.053 -0.521 . . . . 1.41 111.996 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.82 -22.09 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.386 -0.37 . . . . 1.01 111.311 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.58 -10.05 62.93 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.301 -0.952 . . . . 0.62 112.74 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 52.4 pttt -93.98 -18.59 21.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 117.289 0.545 . . . . 2.67 111.426 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -136.67 33.71 2.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.265 1.031 . . . . 1.71 109.218 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 6.4 tmtm? -75.07 -46.08 4.76 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.528 -1.215 . . . . 1.2 111.908 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.6 Cg_endo -50.86 -26.37 17.85 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.803 2.335 . . . . 0.62 113.257 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.5 m -76.03 -46.84 27.26 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.929 -0.308 . . . . 0.72 111.091 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -72.62 -22.32 60.98 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.858 -0.793 . . . . 0.65 108.858 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 28.3 t70 -71.29 -43.21 67.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.546 -1.207 . . . . 1.03 109.452 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.29 -43.89 97.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.149 -0.932 . . . . 2.15 109.991 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.5 -30.8 51.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.014 -0.539 . . . . 0.71 110.457 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.482 ' HE1' HG12 ' A' ' 67' ' ' ILE . 79.9 t80 -65.06 -40.87 95.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.889 -0.596 . . . . 0.31 110.072 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.451 ' HE2' ' OD2' ' A' ' 54' ' ' ASP . 57.8 m-85 -72.88 -23.44 60.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.676 -0.693 . . . . 0.8 111.904 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.5 p -79.8 -2.36 42.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.799 -0.36 . . . . 0.61 111.451 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 83.0 mt -105.19 7.22 33.57 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.077 -0.249 . . . . 0.41 111.038 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 t 65.87 84.0 0.18 Allowed Pre-proline 0 C--O 1.234 0.268 0 O-C-N 123.844 0.715 . . . . 1.24 111.076 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.403 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 44.4 Cg_endo -85.31 114.1 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.453 2.102 . . . . 0.59 112.61 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -89.12 137.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.724 -0.671 . . . . 1.31 109.869 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 p30 46.13 23.64 0.21 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.943 0.897 . . . . 1.89 112.663 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.21 6.55 61.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.349 -0.453 . . . . 0.62 113.643 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -134.36 174.61 10.34 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.312 0.577 . . . . 1.81 110.837 177.119 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.493 HD11 ' CD1' ' A' ' 106' ' ' PHE . 16.8 pt -123.56 148.58 27.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.322 -0.854 . . . . 0.3 109.574 172.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.9 p -83.37 179.2 7.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.584 -0.734 . . . . 0.44 110.114 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.11 -34.07 77.71 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.751 -0.737 . . . . 0.33 112.272 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.41 96.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.138 0.494 . . . . 0.34 112.12 -176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.517 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.2 m120 -76.03 -47.1 26.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.342 0.592 . . . . 1.65 110.244 -172.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.59 -22.88 63.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.023 -0.535 . . . . 0.27 110.247 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 41.5 ttmt -68.18 -54.36 18.44 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.242 -0.435 . . . . 1.52 109.976 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 17.5 ptpt -59.22 -33.15 70.65 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.82 0.343 . . . . 1.14 110.23 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.583 ' CD ' ' HZ3' ' A' ' 78' ' ' LYS . 14.1 tp10 -60.45 -53.48 57.01 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.321 0.581 . . . . 1.78 110.132 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 1.057 ' HB3' HD22 ' A' ' 86' ' ' LEU . 54.6 mtt -70.73 -22.6 62.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.671 . . . . 0.86 110.852 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 73' ' ' LYS . 3.9 t -63.17 -47.17 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.927 -0.579 . . . . 1.52 110.581 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -94.61 -1.61 52.93 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.386 -0.926 . . . . 3.33 111.792 -175.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.0 p -66.89 -19.75 65.79 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.817 0.342 . . . . 0.91 110.178 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.4 tptt 75.58 22.97 1.51 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.879 0.872 . . . . 2.97 111.443 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 86' ' ' LEU . 11.2 mp -92.0 151.45 41.93 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.306 -0.257 . . . . 1.41 110.306 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.577 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 14.5 Cg_endo -59.94 148.18 89.79 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.649 2.233 . . . . 0.32 112.731 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -55.93 -39.49 71.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.454 -0.794 . . . . 2.05 111.188 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 m -61.1 -45.95 92.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.996 -0.547 . . . . 0.84 111.374 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.502 ' CG2' ' HG2' ' A' ' 82' ' ' PRO . 55.0 t -64.45 -42.22 94.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.26 110.376 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.057 HD22 ' HB3' ' A' ' 76' ' ' MET . 64.0 mt -57.65 -46.4 84.24 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.051 0.453 . . . . 0.29 110.695 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.678 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -64.84 -34.65 90.46 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.832 -0.699 . . . . 0.36 112.13 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -70.54 -41.43 72.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.272 0.558 . . . . 1.29 110.455 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.63 HG23 HD12 ' A' ' 112' ' ' LEU . 83.7 mt -62.38 -42.93 97.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.625 -0.716 . . . . 0.27 110.937 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -59.39 -40.69 87.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.966 0.412 . . . . 0.37 110.077 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -62.99 -25.96 68.62 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.54 -0.754 . . . . 2.54 111.026 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.436 HD11 ' HA ' ' A' ' 124' ' ' ALA . 66.1 mt -90.35 -33.28 16.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.296 -0.411 . . . . 1.5 111.336 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.32 -43.63 63.84 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.83 0.678 . . . . 0.53 112.83 -170.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -88.35 68.85 9.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.43 0.633 . . . . 0.5 110.156 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.11 -21.69 29.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.297 -0.865 . . . . 0.64 109.699 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -79.7 -23.37 42.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.882 -1.054 . . . . 1.46 110.754 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 59.91 51.85 5.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.219 -0.9 . . . . 2.74 111.907 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 11.8 p-10 -118.63 7.54 11.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.969 0.414 . . . . 0.56 109.997 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.78 -1.51 30.0 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.987 -0.625 . . . . 0.49 112.79 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.526 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 64.2 mt -123.77 155.68 37.48 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.807 -0.442 . . . . 0.53 109.807 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -110.16 110.78 21.76 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.501 -0.48 . . . . 0.33 110.53 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 2.4 m-20 -70.97 169.08 15.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.103 -0.702 . . . . 1.85 109.103 168.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.8 -29.89 65.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.593 -0.276 . . . . 0.85 111.115 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.07 -51.92 61.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.847 0.832 . . . . 2.08 109.579 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -71.31 -35.98 71.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.536 -1.211 . . . . 0.48 110.966 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.493 ' CD1' HD11 ' A' ' 67' ' ' ILE . 58.8 t80 -70.51 -36.37 73.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.19 -0.459 . . . . 0.41 110.279 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.74 84.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.23 110.184 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -64.23 -46.52 83.47 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.989 -0.551 . . . . 1.29 109.552 177.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.46 94.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.3 -0.864 . . . . 0.23 111.296 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.03 -31.55 72.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.17 -0.468 . . . . 0.77 111.101 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -66.25 -40.69 90.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.932 -0.395 . . . . 0.33 109.932 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.63 HD12 HG23 ' A' ' 89' ' ' ILE . 89.4 mt -65.6 -39.47 91.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.882 -0.599 . . . . 0.28 110.438 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 62.7 mt -70.66 -37.77 70.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.002 -0.545 . . . . 0.7 110.927 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 26.1 ttpp -63.2 -45.78 90.08 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.913 -0.315 . . . . 1.77 110.532 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.61 -35.24 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.095 -0.642 . . . . 0.53 110.465 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.658 ' HD3' HD23 ' A' ' 122' ' ' LEU . 25.0 mmmt -56.21 -45.6 79.81 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.39 -0.368 . . . . 1.89 111.163 171.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 84.1 mt -67.2 -33.85 76.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.272 0.558 . . . . 0.74 110.646 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.6 mt-10 -78.0 4.39 12.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.663 -0.698 . . . . 1.98 111.386 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.65 34.91 14.65 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.99 -0.624 . . . . 0.87 112.54 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -122.91 171.42 9.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.806 0.336 . . . . 1.07 110.25 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -111.82 150.55 30.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.062 -0.517 . . . . 3.06 109.804 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.658 HD23 ' HD3' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -95.69 138.35 21.79 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.216 -1.031 . . . . 1.09 108.216 173.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.79 -9.76 17.5 Favored 'Trans proline' 0 N--CA 1.473 0.297 0 C-N-CA 122.947 2.431 . . . . 0.8 114.095 -171.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.436 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 62.86 17.57 10.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.585 0.707 . . . . 0.64 110.489 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.03 161.68 34.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.906 -1.043 . . . . 1.97 108.85 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.414 ' HG ' HD22 ' A' ' 92' ' ' LEU . 96.3 mt -110.52 90.81 10.9 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.916 -0.314 . . . . 0.67 111.346 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 50.2 Cg_endo -70.31 158.95 54.65 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.691 2.26 . . . . 0.52 111.553 171.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 34.5 Cg_exo -59.13 -7.79 5.42 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.521 2.814 . . . . 0.63 114.241 -176.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -108.42 -2.59 18.94 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.367 -0.533 . . . . 0.86 111.191 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -101.7 -36.67 8.64 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.117 0.484 . . . . 1.19 110.358 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 7.7 p -78.43 124.27 85.55 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.681 -0.69 . . . . 1.34 111.005 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 131' ' ' VAL . 22.1 Cg_exo . . . . . 0 N--CA 1.46 -0.491 0 C-N-CA 122.743 2.295 . . . . 0.9 111.707 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.678 HD21 ' HA2' ' A' ' 87' ' ' GLY . 27.0 t-20 . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 110.28 -0.267 . . . . 0.84 110.28 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 8.0 Cg_exo -73.14 -2.87 12.7 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.53 2.82 . . . . 0.66 113.028 -176.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 96.8 m-85 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.46 -0.336 . . . . 0.68 110.867 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.494 ' HD1' ' O ' ' A' ' 129' ' ' HIS . 10.2 t90 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 109.112 -0.699 . . . . 0.66 109.112 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -69.34 5.2 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.746 0.647 . . . . 1.41 112.746 -172.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG21 HD22 ' A' ' 108' ' ' LEU . 97.0 t -105.97 -19.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.96 0.409 . . . . 1.01 110.292 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.573 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -68.39 -18.2 71.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.634 -0.793 . . . . 0.62 111.557 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -74.76 -27.4 60.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.54 -0.33 . . . . 2.67 111.292 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -127.61 33.49 4.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.909 0.385 . . . . 1.71 110.612 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.625 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 6.8 mmmm -64.62 -45.27 76.14 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.837 0.68 . . . . 1.2 112.837 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.5 Cg_endo -49.85 -35.22 39.21 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 122.397 2.064 . . . . 0.62 112.415 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 56' ' ' ILE . 11.5 m -73.53 -46.43 47.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.517 -0.31 . . . . 0.72 111.302 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -71.56 -23.28 61.72 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.766 -0.457 . . . . 0.65 109.766 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.42 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 15.2 t70 -73.86 -44.52 55.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.47 -0.786 . . . . 1.03 109.265 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 59' ' ' THR . 35.3 tt0 -57.02 -46.54 82.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.143 -0.935 . . . . 2.15 110.358 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 52' ' ' THR . 58.9 mt -67.11 -49.21 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.137 -0.483 . . . . 0.71 110.789 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.46 ' HE1' HG12 ' A' ' 67' ' ' ILE . 77.8 t80 -51.25 -46.44 62.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.853 -0.612 . . . . 0.31 111.682 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 29.3 m-85 -74.19 -12.37 60.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.684 0.624 . . . . 0.8 112.684 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 55' ' ' GLU . 70.1 p -90.96 4.37 52.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.114 0.483 . . . . 0.61 110.737 177.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 82.3 mt -105.91 6.58 31.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.768 -0.456 . . . . 0.41 109.768 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.7 m 65.59 82.49 0.2 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.185 -0.916 . . . . 1.24 111.43 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 61.5 Cg_endo -92.04 113.84 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.737 2.291 . . . . 0.59 113.287 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.8 146.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.625 -0.88 . . . . 1.31 108.625 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 p30 50.33 22.35 0.98 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.746 0.818 . . . . 1.89 112.136 -174.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.61 29.62 47.64 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.238 -0.506 . . . . 0.62 111.872 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.737 ' HE2' ' HB3' ' A' ' 102' ' ' ASP . 32.4 ttmt -156.19 146.81 21.82 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.902 0.382 . . . . 1.81 110.719 -173.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.46 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.5 pt -103.14 156.31 5.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.224 0.535 . . . . 0.3 110.43 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.419 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 73.2 p -89.39 178.1 6.41 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.602 -0.726 . . . . 0.44 109.972 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.686 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -65.19 -17.62 63.95 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.979 -0.629 . . . . 0.33 112.299 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.73 -47.29 63.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.216 0.531 . . . . 0.34 111.332 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.66 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.3 m120 -73.79 -41.45 62.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.587 -0.733 . . . . 1.65 110.367 -173.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.4 -19.79 60.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.188 -0.46 . . . . 0.27 110.193 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.686 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 3.6 ttmp? -68.38 -51.59 42.54 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.754 -0.461 . . . . 1.52 109.754 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.52 ' HA ' HG22 ' A' ' 77' ' ' VAL . 18.6 ptpt -63.33 -32.94 74.5 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.965 -0.562 . . . . 1.14 110.391 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.53 -53.82 51.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.792 -0.447 . . . . 1.78 109.792 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.424 ' HB3' HD22 ' A' ' 86' ' ' LEU . 57.5 mtt -69.5 -33.61 73.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.032 -0.531 . . . . 0.86 112.198 -173.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 74' ' ' LYS . 30.9 m -77.0 -19.04 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.644 -0.422 . . . . 1.52 109.914 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 12.7 mptt -87.47 -12.33 46.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.911 -0.586 . . . . 3.33 110.453 174.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.5 m -86.75 -5.1 59.22 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.876 -0.602 . . . . 0.91 111.092 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.4 mptt 68.24 29.0 6.22 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.297 0.639 . . . . 2.97 111.786 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.724 ' HB2' HD21 ' A' ' 86' ' ' LEU . 24.3 mt -98.14 143.38 26.17 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.428 -0.351 . . . . 1.41 111.068 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.499 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.5 Cg_endo -61.64 150.9 83.57 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.257 2.638 . . . . 0.32 113.51 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -55.99 -42.27 76.11 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.697 -0.683 . . . . 2.05 111.85 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.1 m -58.04 -54.13 50.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.306 -0.406 . . . . 0.84 110.909 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.469 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 47.0 t -57.71 -44.13 85.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.103 -0.499 . . . . 0.26 110.87 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.724 HD21 ' HB2' ' A' ' 81' ' ' LEU . 56.6 mt -63.42 -36.04 82.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.29 111.229 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.764 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.59 -42.71 99.31 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.846 -0.692 . . . . 0.36 111.656 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 20.6 mtpp -68.47 -46.18 70.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.5 -0.35 . . . . 1.29 110.353 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.465 ' HA ' HD23 ' A' ' 92' ' ' LEU . 88.2 mt -56.83 -52.13 58.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 123.512 0.507 . . . . 0.27 110.85 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -60.43 -53.66 54.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.448 -0.342 . . . . 0.37 111.66 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -65.1 -23.28 67.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.038 0.447 . . . . 2.54 111.238 -172.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -92.75 -39.45 11.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.849 -0.614 . . . . 1.5 110.229 -177.719 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.485 ' N ' ' HG ' ' A' ' 92' ' ' LEU . . . -70.28 -39.28 74.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.53 111.047 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 47.0 t0 -74.47 93.47 2.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.658 -0.867 . . . . 0.5 108.658 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.707 HG21 ' HD2' ' A' ' 132' ' ' PRO . 32.5 t -69.29 -51.07 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.337 -0.847 . . . . 0.64 110.28 -174.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -76.34 -21.24 56.4 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.278 -0.873 . . . . 1.46 111.225 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.585 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 40.8 mttp 56.71 65.78 1.33 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.131 -0.94 . . . . 2.74 110.74 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -108.93 10.97 26.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.256 -1.338 . . . . 0.56 109.832 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.56 11.78 80.3 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.313 -0.858 . . . . 0.49 111.879 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.492 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 33.8 mt -144.28 161.55 38.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.344 -0.613 . . . . 0.53 109.344 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.407 ' C ' ' HG3' ' A' ' 66' ' ' LYS . 71.1 mt -124.8 115.47 20.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.163 -0.31 . . . . 0.33 110.163 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.737 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 1.7 p30 -77.82 -176.41 4.41 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.303 -0.629 . . . . 1.85 109.303 171.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -63.62 -27.02 68.95 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.934 -0.306 . . . . 0.85 111.474 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 86.7 mt-10 -85.03 -39.07 18.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.212 -0.195 . . . . 2.08 110.918 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -69.34 -37.5 77.7 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.256 0.55 . . . . 0.48 110.182 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -66.86 -42.38 85.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.749 -0.659 . . . . 0.41 109.886 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.08 91.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 0.23 110.831 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -61.29 -46.82 88.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.814 -0.63 . . . . 1.29 109.728 177.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.11 -49.33 78.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.23 111.636 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.4 -33.47 76.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.77 110.856 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.43 ' O ' HG22 ' A' ' 115' ' ' VAL . 38.7 t60 -67.72 -36.39 80.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.036 -0.357 . . . . 0.33 110.036 177.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.586 HD13 HD21 ' A' ' 92' ' ' LEU . 91.8 mt -66.15 -39.25 89.68 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.927 -0.579 . . . . 0.28 110.587 176.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 81' ' ' LEU . 54.9 mt -69.07 -37.69 77.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.747 -0.66 . . . . 0.7 110.326 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 42.1 tttp -61.88 -47.32 85.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.992 -0.549 . . . . 1.77 110.686 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 111' ' ' HIS . 6.7 m -68.11 -31.16 50.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 120.547 -0.461 . . . . 0.53 111.322 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 116' ' ' LYS . 25.5 mmmt -56.14 -45.07 79.75 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.066 -0.253 . . . . 1.89 110.385 168.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.74 -29.78 63.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.263 -0.426 . . . . 0.74 110.885 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 59.7 mm-40 -65.95 -21.96 66.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.873 -0.603 . . . . 1.98 110.489 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.52 36.03 3.92 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.752 -0.737 . . . . 0.87 112.13 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -126.96 150.07 49.55 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.847 -0.427 . . . . 1.07 109.847 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -95.95 130.0 43.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.942 0.401 . . . . 3.06 110.725 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.44 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -81.95 134.63 49.47 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.048 -0.524 . . . . 1.09 110.005 174.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.01 2.7 6.34 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.908 2.405 . . . . 0.8 113.745 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.575 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 58.78 22.68 10.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.427 0.632 . . . . 0.64 110.306 -176.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.86 162.12 32.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.194 -0.912 . . . . 1.97 109.882 -172.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 52.1 mt -112.69 94.0 26.4 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 123.262 0.351 . . . . 0.67 111.781 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.91 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 14.0 Cg_endo -58.63 153.31 49.87 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.866 2.377 . . . . 0.52 111.333 169.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.35 -10.03 17.33 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.921 2.414 . . . . 0.63 113.308 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.494 ' O ' ' HD1' ' A' ' 44' ' ' TRP . 26.4 p-80 -108.4 1.51 21.79 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.159 -0.338 . . . . 0.86 110.397 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.91 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 1.4 mp -103.85 -7.63 20.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.885 0.374 . . . . 1.19 111.038 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -87.42 117.8 69.03 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.248 -0.433 . . . . 1.34 110.887 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.707 ' HD2' HG21 ' A' ' 95' ' ' VAL . 53.1 Cg_exo . . . . . 0 C--O 1.237 0.445 0 C-N-CA 122.943 2.429 . . . . 0.9 111.952 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.764 HD21 ' HA2' ' A' ' 87' ' ' GLY . 25.2 t-20 . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.991 0.424 . . . . 0.84 110.176 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 7.4 Cg_exo -73.42 -1.45 10.68 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.521 2.814 . . . . 0.66 112.948 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.497 -0.32 . . . . 0.68 111.662 -175.84 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 108.809 -0.812 . . . . 0.66 108.809 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.2 m -66.73 -1.15 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.83 -0.623 . . . . 1.41 112.521 -171.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.5 -17.51 7.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.139 -0.482 . . . . 1.01 110.275 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.31 -10.56 74.69 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.634 -0.793 . . . . 0.62 112.549 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -89.28 -28.11 20.12 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.653 -0.322 . . . . 2.67 111.362 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -112.58 33.13 5.14 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.72 -0.844 . . . . 1.71 108.72 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.561 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 9.1 tmtt? -72.47 -49.98 8.45 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 114.76 -1.109 . . . . 1.2 112.313 -169.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.5 Cg_endo -54.35 -29.58 58.79 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.628 2.219 . . . . 0.62 113.235 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.0 m -70.28 -39.5 74.86 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.036 0.446 . . . . 0.72 110.335 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -70.91 -22.97 62.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.23 -0.441 . . . . 0.65 109.955 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.46 -44.69 70.7 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.129 0.49 . . . . 1.03 110.018 172.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -57.6 -42.2 82.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.346 -0.843 . . . . 2.15 110.267 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.412 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 50.2 mt -79.19 -28.88 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 0.71 111.18 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -71.37 -45.84 61.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.246 0.546 . . . . 0.31 110.686 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -76.48 -13.08 60.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.78 -0.645 . . . . 0.8 112.065 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.2 p -94.09 1.57 56.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.128 0.49 . . . . 0.61 111.214 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 58.2 mt -110.02 8.82 24.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.0 -0.545 . . . . 0.41 110.125 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 m 67.79 82.2 0.19 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.317 -0.856 . . . . 1.24 111.54 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -90.46 116.68 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.629 2.219 . . . . 0.59 112.555 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -88.37 134.62 27.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.628 -0.508 . . . . 1.31 109.628 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 47.05 25.7 0.53 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.792 0.837 . . . . 1.89 112.749 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.93 19.75 33.05 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.333 -0.46 . . . . 0.62 112.509 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 66' ' ' LYS . 31.1 ttmt -150.52 144.46 25.35 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 110.453 -0.203 . . . . 1.81 110.453 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.483 HD11 ' CD1' ' A' ' 106' ' ' PHE . 19.8 pt -100.43 149.37 6.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 120.55 -0.46 . . . . 0.3 110.355 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.555 ' HA ' HD22 ' A' ' 100' ' ' LEU . 81.4 p -76.66 166.82 22.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.068 -0.515 . . . . 0.44 110.034 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.89 -32.52 70.52 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.589 -0.815 . . . . 0.33 112.103 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.502 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -49.18 -55.75 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.375 0.509 . . . . 0.34 112.375 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -70.68 -41.86 71.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.172 0.51 . . . . 1.65 110.989 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.487 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -71.36 -33.41 69.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.916 -0.584 . . . . 0.27 110.582 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.582 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 28.1 ttpp -63.9 -52.65 58.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.91 -0.587 . . . . 1.52 110.727 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.601 ' O ' HG22 ' A' ' 77' ' ' VAL . 17.3 ptmt -62.93 -32.89 74.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.983 -0.553 . . . . 1.14 110.607 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.583 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 35.3 tp10 -62.54 -38.88 91.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.307 0.575 . . . . 1.78 110.204 175.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.915 ' HB3' HD22 ' A' ' 86' ' ' LEU . 50.7 mtt -77.07 -20.47 55.78 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.632 -0.427 . . . . 0.86 111.67 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 74' ' ' LYS . 9.9 m -81.09 -23.45 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.045 -0.662 . . . . 1.52 110.747 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -87.15 -11.12 50.94 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.364 -0.534 . . . . 3.33 110.232 170.411 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.7 m -69.5 -17.48 63.6 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.948 -0.569 . . . . 0.91 110.061 169.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 17.5 tptp 69.27 24.25 5.99 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.645 -0.707 . . . . 2.97 111.65 171.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.625 ' HB2' HD21 ' A' ' 86' ' ' LEU . 59.0 mt -100.78 153.34 37.79 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.807 -0.633 . . . . 1.41 110.004 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.49 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 12.1 Cg_endo -57.36 141.7 94.85 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.813 2.342 . . . . 0.32 112.39 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -59.45 -34.2 72.24 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.139 -0.482 . . . . 2.05 111.252 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -47.85 83.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.154 -0.475 . . . . 0.84 110.822 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.696 HG11 ' HD2' ' A' ' 116' ' ' LYS . 75.8 t -63.72 -41.73 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.588 -0.733 . . . . 0.26 110.477 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.915 HD22 ' HB3' ' A' ' 76' ' ' MET . 57.5 mt -58.8 -45.85 88.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.098 0.475 . . . . 0.29 110.392 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.581 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.91 -37.79 94.34 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.845 -0.616 . . . . 0.36 112.235 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.568 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 46.2 mtpt -69.53 -39.74 77.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.955 0.407 . . . . 1.29 110.418 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.93 -37.91 80.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.711 -0.677 . . . . 0.27 110.252 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.485 ' CZ3' ' HG ' ' A' ' 101' ' ' LEU . 31.1 t-105 -61.88 -46.04 91.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.246 -0.434 . . . . 0.37 110.356 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -59.79 -37.0 77.89 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.212 0.529 . . . . 2.54 110.641 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 86.2 mt -70.22 -41.99 72.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.473 -0.785 . . . . 1.5 110.748 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -73.59 -43.72 58.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.646 -0.707 . . . . 0.53 111.737 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.587 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 35.6 t0 -84.13 81.58 8.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.369 0.604 . . . . 0.5 109.955 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.475 HG21 ' HD2' ' A' ' 132' ' ' PRO . 13.5 t -69.2 -44.31 80.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.271 -0.877 . . . . 0.64 110.64 -176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -17.94 60.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.372 -0.831 . . . . 1.46 111.108 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.587 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 9.8 mtpm? 58.07 56.88 4.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.39 -0.823 . . . . 2.74 111.001 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -106.92 10.17 30.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.66 -0.7 . . . . 0.56 111.042 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.06 10.12 72.76 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.025 -0.607 . . . . 0.49 112.341 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' A' ' 68' ' ' THR . 66.9 mt -139.3 152.84 47.56 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.387 -0.968 . . . . 0.53 108.387 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.487 HD12 ' CB ' ' A' ' 72' ' ' ALA . 19.6 mt -99.69 110.73 23.12 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.588 -0.845 . . . . 0.33 110.285 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.757 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 12.7 t70 -70.73 171.99 9.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.779 -1.1 . . . . 1.85 108.422 173.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.64 -43.26 89.67 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.625 0.25 . . . . 0.85 111.266 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 31.5 mt-10 -61.51 -44.38 97.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.797 0.808 . . . . 2.08 109.856 176.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.757 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 15.1 mt-10 -68.2 -39.39 82.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.452 -1.249 . . . . 0.48 110.521 -173.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CD1' HD11 ' A' ' 67' ' ' ILE . 65.8 t80 -68.28 -42.67 79.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.296 -0.411 . . . . 0.41 110.215 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.27 93.72 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.751 -0.658 . . . . 0.23 110.272 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 93' ' ' ALA . 17.8 tp -62.01 -45.48 93.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.754 -0.657 . . . . 1.29 110.137 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.518 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -57.37 -47.78 80.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.451 -0.795 . . . . 0.23 111.364 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -68.53 -28.88 67.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.418 -0.355 . . . . 0.77 111.249 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -68.48 -37.88 80.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.192 0.52 . . . . 0.33 110.093 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HA ' HG22 ' A' ' 115' ' ' VAL . 59.7 mt -69.05 -36.39 77.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 0.28 110.247 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 109' ' ' ALA . 46.4 mm -59.25 -44.25 91.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.02 -0.536 . . . . 0.7 110.163 173.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 49.8 tttp -63.85 -47.38 80.94 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.82 -0.627 . . . . 1.77 111.111 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 112' ' ' LEU . 14.7 m -64.29 -36.7 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.358 -0.537 . . . . 0.53 111.496 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.696 ' HD2' HG11 ' A' ' 85' ' ' VAL . 2.1 mmtm -56.35 -42.79 78.33 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 121.299 -0.161 . . . . 1.89 111.317 170.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 98.0 mt -71.52 -34.01 69.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.763 0.316 . . . . 0.74 110.836 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 81.0 mm-40 -68.85 -14.06 62.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 1.98 110.473 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.84 17.41 58.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.84 -0.695 . . . . 0.87 112.436 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -103.24 164.06 11.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.717 0.294 . . . . 1.07 110.301 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -88.68 140.53 29.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.214 0.53 . . . . 3.06 112.145 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.585 HD23 ' HG2' ' A' ' 116' ' ' LYS . 4.1 pp -110.51 127.04 27.65 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 107.266 -1.383 . . . . 1.09 107.266 165.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 1.8 Cg_endo -74.53 -15.12 22.16 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.375 2.05 . . . . 0.8 113.743 -166.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.477 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . . . 69.51 19.12 7.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.669 0.747 . . . . 0.64 109.663 -170.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -124.42 156.9 36.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.962 -1.017 . . . . 1.97 108.639 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 87.8 mt -116.49 96.22 47.53 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.834 0.349 . . . . 0.67 111.577 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 29.5 Cg_endo -65.37 155.11 70.45 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.615 2.21 . . . . 0.52 111.65 173.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.09 -26.92 27.41 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.252 2.635 . . . . 0.63 113.689 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -91.84 18.4 7.79 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.998 0.369 . . . . 0.86 111.998 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 44.7 mt -129.94 3.41 4.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.664 -0.244 . . . . 1.19 111.015 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.6 t -87.55 116.58 66.61 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.404 . . . . 1.34 111.028 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.513 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 77.1 Cg_exo . . . . . 0 C--O 1.234 0.314 0 C-N-CA 123.05 2.5 . . . . 0.9 111.885 176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.581 HD21 ' HA2' ' A' ' 87' ' ' GLY . 45.1 t-20 . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 109.247 -0.649 . . . . 0.84 109.247 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 38.3 Cg_endo -67.11 -14.72 44.38 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.106 2.537 . . . . 0.66 113.64 -175.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.582 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 62.6 m-85 . . . . . 0 C--N 1.327 -0.373 0 N-CA-C 111.724 0.268 . . . . 0.68 111.724 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' ' HB3' ' A' ' 132' ' ' PRO . 5.2 t90 . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.318 -0.623 . . . . 0.66 109.318 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.21 -17.9 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 1.41 112.116 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.32 -18.15 15.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.19 0.519 . . . . 1.01 110.047 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.3 -13.1 73.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.793 -0.718 . . . . 0.62 112.104 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -78.64 -29.21 45.7 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.198 0.523 . . . . 2.67 110.484 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -128.5 33.24 4.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.372 -0.831 . . . . 1.71 109.934 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 4.0 tmtm? -72.26 -47.95 10.29 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.282 -0.872 . . . . 1.2 111.914 -174.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.4 Cg_endo -53.23 -29.56 47.22 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.545 2.163 . . . . 0.62 113.151 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.4 m -71.92 -44.14 64.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.801 0.334 . . . . 0.72 110.482 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -70.43 -22.6 62.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.422 -0.585 . . . . 0.65 109.422 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.428 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 7.9 t70 -72.96 -44.96 60.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.534 -0.757 . . . . 1.03 109.851 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.91 -43.03 95.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.941 -1.027 . . . . 2.15 110.799 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.14 -33.73 56.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.247 0.546 . . . . 0.71 110.575 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.522 ' HE1' HG12 ' A' ' 67' ' ' ILE . 71.0 t80 -64.03 -49.27 73.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.31 110.596 -175.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.428 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 43.1 m-85 -70.47 -21.51 62.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.811 -0.632 . . . . 0.8 112.532 -174.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.7 p -79.18 -0.48 32.06 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.507 -0.477 . . . . 0.61 111.502 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 94.0 mt -105.42 7.28 33.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.533 -0.303 . . . . 0.41 111.116 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 t 63.09 89.91 0.1 OUTLIER Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 115.921 -0.581 . . . . 1.24 111.179 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -84.67 117.62 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.361 2.041 . . . . 0.59 112.954 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.18 128.02 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.585 . . . . 1.31 110.02 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 m120 63.59 21.48 12.75 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.643 -0.503 . . . . 1.89 109.643 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.05 3.53 90.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.808 -0.711 . . . . 0.62 112.443 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -125.32 143.41 50.98 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.686 0.279 . . . . 1.81 110.415 177.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.522 HG12 ' HE1' ' A' ' 57' ' ' PHE . 9.6 pt -84.14 143.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 119.996 -0.682 . . . . 0.3 110.505 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.5 p -74.74 162.7 28.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.044 -0.98 . . . . 0.44 110.624 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -56.78 -31.07 60.49 Favored Glycine 0 C--O 1.218 -0.863 0 C-N-CA 120.905 -0.664 . . . . 0.33 112.173 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.1 -53.45 53.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.459 0.54 . . . . 0.34 112.459 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.59 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 58.6 m-80 -79.54 -35.7 39.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.118 -0.492 . . . . 1.65 111.693 -171.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.99 -26.88 65.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.156 0.503 . . . . 0.27 109.768 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.574 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 38.7 ttmt -68.56 -54.62 15.5 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.579 -0.737 . . . . 1.52 110.367 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 18.2 ptpt -58.02 -38.94 77.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 1.14 110.416 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.04 -44.99 94.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.184 0.516 . . . . 1.78 110.167 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.89 ' HB3' HD22 ' A' ' 86' ' ' LEU . 42.9 mtt -67.41 -27.9 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.86 110.777 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 73' ' ' LYS . 55.7 t -70.66 -38.09 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.289 0.566 . . . . 1.52 109.65 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 16.9 mmtp -72.04 -13.01 61.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.776 -0.647 . . . . 3.33 110.749 176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.8 m -80.9 -14.79 57.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.91 110.591 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mptt 72.24 18.92 4.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.648 0.779 . . . . 2.97 111.875 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.589 ' HB2' HD21 ' A' ' 86' ' ' LEU . 3.9 mm? -87.19 144.48 36.22 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.985 0.422 . . . . 1.41 110.5 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.557 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.0 Cg_endo -61.19 151.39 79.19 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.137 2.558 . . . . 0.32 112.713 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -58.65 -33.94 70.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.933 -0.576 . . . . 2.05 111.495 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.3 m -60.56 -51.28 70.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.198 0.523 . . . . 0.84 110.473 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.636 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 71.5 t -64.13 -40.24 88.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.745 -0.661 . . . . 0.26 110.76 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.89 HD22 ' HB3' ' A' ' 76' ' ' MET . 58.7 mt -61.73 -41.24 97.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.968 -0.56 . . . . 0.29 110.817 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.556 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -62.21 -42.07 99.72 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.116 -0.564 . . . . 0.36 111.924 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.636 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 51.0 mtpt -57.41 -51.39 69.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.159 0.504 . . . . 1.29 110.447 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.53 HG12 HD21 ' A' ' 122' ' ' LEU . 84.6 mt -64.54 -38.27 82.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.47 -0.787 . . . . 0.27 111.333 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -62.05 -49.06 77.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.714 0.292 . . . . 0.37 110.903 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -64.35 -24.63 67.71 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.124 -0.489 . . . . 2.54 111.308 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.578 ' O ' HD11 ' A' ' 126' ' ' LEU . 88.2 mt -88.61 -48.64 7.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.511 . . . . 1.5 111.379 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -64.68 -36.46 84.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.842 -0.617 . . . . 0.53 111.067 -173.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.591 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 42.7 t0 -79.68 82.74 5.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.8 -0.815 . . . . 0.5 108.8 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.4 t -71.28 -40.63 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.65 -0.704 . . . . 0.64 109.956 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -81.42 -18.0 46.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 1.46 110.207 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.591 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 22.6 mttp 59.96 59.12 2.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.065 -0.971 . . . . 2.74 110.942 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 14.4 p-10 -107.78 8.96 29.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.908 -1.042 . . . . 0.56 110.023 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.54 9.03 81.84 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.756 -0.656 . . . . 0.49 111.876 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 66' ' ' LYS . 60.1 mt -139.27 167.93 20.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.621 -0.511 . . . . 0.53 109.621 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.2 mt -124.96 116.48 22.24 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.174 -0.306 . . . . 0.33 110.174 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.468 ' CA ' ' HG3' ' A' ' 66' ' ' LYS . 3.0 p30 -78.75 177.86 8.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.137 -0.69 . . . . 1.85 109.137 171.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -61.16 -25.39 66.98 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.6 0.593 . . . . 0.85 112.6 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -81.63 -40.25 23.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 2.08 110.311 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.461 ' HG3' ' OD2' ' A' ' 102' ' ' ASP . 20.0 mt-10 -67.58 -36.55 81.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.368 0.604 . . . . 0.48 109.486 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' A' ' 67' ' ' ILE . 31.8 t80 -74.21 -33.15 63.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.838 -0.619 . . . . 0.41 110.171 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.33 94.33 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.279 0.562 . . . . 0.23 109.861 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 93' ' ' ALA . 16.0 tp -61.26 -44.91 96.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.221 -0.9 . . . . 1.29 110.035 176.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.06 -49.99 72.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.666 -0.697 . . . . 0.23 110.92 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -39.24 87.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 0.77 111.038 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -69.05 -38.46 79.13 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.947 -0.301 . . . . 0.33 110.749 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.702 ' HB3' HD23 ' A' ' 122' ' ' LEU . 92.8 mt -66.94 -38.59 86.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.257 -0.429 . . . . 0.28 110.907 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 76' ' ' MET . 79.9 mt -70.37 -32.94 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.101 0.477 . . . . 0.7 110.049 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 4.0 tppp? -59.04 -53.32 59.71 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 115.919 -0.582 . . . . 1.77 110.514 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.3 m -64.14 -34.64 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 121.11 -0.236 . . . . 0.53 111.391 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 116' ' ' LYS . 27.0 mmmt -53.59 -48.89 68.82 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.596 0.236 . . . . 1.89 111.446 167.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.3 -22.62 62.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.902 0.382 . . . . 0.74 110.942 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 6.2 mm-40 -75.35 -2.4 28.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.924 -0.58 . . . . 1.98 110.771 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.5 35.81 11.45 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.65 -0.786 . . . . 0.87 111.988 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -130.87 172.48 11.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.988 0.423 . . . . 1.07 110.594 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -122.46 121.9 37.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.679 -0.691 . . . . 3.06 109.846 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -60.87 146.6 86.75 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.052 -0.522 . . . . 1.09 110.097 169.319 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.74 6.12 2.57 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.51 2.14 . . . . 0.8 113.225 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.509 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 60.38 17.79 7.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.813 -0.631 . . . . 0.64 111.763 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -136.17 166.9 22.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.359 -0.608 . . . . 1.97 109.359 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.578 HD11 ' O ' ' A' ' 92' ' ' LEU . 82.1 mt -114.88 93.17 33.12 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.701 0.286 . . . . 0.67 111.618 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.663 ' HD2' HD12 ' A' ' 130' ' ' LEU . 34.4 Cg_endo -66.44 166.22 22.4 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.797 2.331 . . . . 0.52 111.537 169.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.69 3.42 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.237 2.625 . . . . 0.63 114.334 -176.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -114.03 6.7 16.55 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.545 -0.462 . . . . 0.86 111.219 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.663 HD12 ' HD2' ' A' ' 127' ' ' PRO . 42.3 mt -115.9 -34.31 4.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.497 -0.32 . . . . 1.19 110.912 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.57 115.18 43.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.855 -0.424 . . . . 1.34 109.855 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 37.1 Cg_endo . . . . . 0 C--O 1.236 0.419 0 C-N-CA 122.734 2.289 . . . . 0.9 112.612 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.556 HD21 ' HA2' ' A' ' 87' ' ' GLY . 47.4 t-20 . . . . . 0 CA--C 1.528 0.118 0 N-CA-C 109.715 -0.476 . . . . 0.84 109.715 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 24.4 Cg_exo -64.36 -16.41 54.96 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.16 2.573 . . . . 0.66 113.393 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 82.5 m-85 . . . . . 0 C--N 1.328 -0.331 0 N-CA-C 111.739 0.274 . . . . 0.68 111.739 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.5 t90 . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 108.272 -1.01 . . . . 0.66 108.272 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.553 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 87.2 t -50.76 -33.03 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.682 -0.69 . . . . 1.41 112.192 -174.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.448 HG21 HD22 ' A' ' 108' ' ' LEU . 22.1 t -70.26 -17.86 21.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.073 -0.512 . . . . 1.01 111.516 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.14 -17.15 71.68 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.879 -0.677 . . . . 0.62 112.347 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 46.9 pttt -87.25 -29.41 21.7 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.181 -0.608 . . . . 2.67 111.191 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -108.11 31.14 5.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.339 -0.985 . . . . 1.71 108.339 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 11.0 tmtt? -78.27 -47.27 2.06 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.584 -0.735 . . . . 1.2 111.963 -170.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.6 Cg_endo -51.1 -33.12 42.18 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.275 1.983 . . . . 0.62 112.748 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.9 m -71.35 -45.75 62.16 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.904 0.383 . . . . 0.72 111.069 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.433 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 9.6 m-85 -72.26 -22.7 61.19 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.508 -0.553 . . . . 0.65 109.508 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.413 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 5.9 t70 -71.62 -44.31 64.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.301 -0.863 . . . . 1.03 109.32 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.32 -53.8 54.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.42 -0.809 . . . . 2.15 110.058 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.37 -36.83 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.973 0.416 . . . . 0.71 110.951 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.468 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 86.5 t80 -62.1 -42.04 98.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.361 0.601 . . . . 0.31 110.015 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.413 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 24.8 m-85 -81.21 -22.97 38.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.511 -0.768 . . . . 0.8 112.243 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.7 p -75.82 -10.78 59.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.61 111.082 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 79.3 mt -99.31 5.48 46.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.164 -0.471 . . . . 0.41 111.098 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.2 t 65.25 81.41 0.22 Allowed Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 123.711 0.632 . . . . 1.24 111.405 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.66 131.42 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.199 1.933 . . . . 0.59 112.422 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 m -99.93 140.82 18.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.891 -0.595 . . . . 1.31 109.909 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.403 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 2.5 p-10 45.45 33.04 1.2 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.484 0.714 . . . . 1.89 112.311 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.8 19.29 73.47 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.104 -0.498 . . . . 0.62 114.026 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 2.6 mtmm -145.84 159.84 42.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.771 -0.455 . . . . 1.81 109.771 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.452 HD11 ' CD1' ' A' ' 106' ' ' PHE . 23.8 pt -107.2 148.37 11.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.437 -0.505 . . . . 0.3 110.099 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.601 ' HA ' HD23 ' A' ' 100' ' ' LEU . 73.2 p -76.85 167.04 22.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.692 -0.686 . . . . 0.44 110.074 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.44 -33.16 58.45 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.87 -0.681 . . . . 0.33 112.708 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.01 59.92 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.347 0.499 . . . . 0.34 112.347 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.536 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -69.61 -46.81 65.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.573 -0.74 . . . . 1.65 110.625 -170.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.55 72.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.789 -0.641 . . . . 0.27 110.905 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.551 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 36.1 ttmt -61.55 -57.12 13.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 1.52 110.683 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 56.4 pttt -62.77 -31.26 72.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 1.14 110.708 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.71 -44.42 93.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 1.78 109.643 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.782 ' HB3' HD22 ' A' ' 86' ' ' LEU . 43.1 mtt -67.49 -30.67 70.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.806 -0.634 . . . . 0.86 111.151 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -70.59 -34.93 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.672 0.749 . . . . 1.52 109.339 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 4.3 mptp? -78.44 -12.12 59.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.925 -1.034 . . . . 3.33 110.838 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 49.3 m -76.47 -13.17 60.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 0.91 110.518 175.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 79' ' ' SER . 69.8 mmtt 73.28 16.68 4.12 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.66 -0.7 . . . . 2.97 111.523 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.662 ' HB2' HD21 ' A' ' 86' ' ' LEU . 79.8 mt -93.08 147.02 33.05 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 1.41 110.922 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.528 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 11.2 Cg_endo -56.45 149.04 59.15 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.64 2.893 . . . . 0.32 112.848 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -56.13 -38.95 71.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.766 -0.652 . . . . 2.05 111.36 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -62.28 -46.85 86.96 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.984 -0.553 . . . . 0.84 111.618 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.702 HG11 ' HD2' ' A' ' 116' ' ' LYS . 95.8 t -64.25 -45.37 96.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 109.972 -0.381 . . . . 0.26 109.972 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.782 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.7 mt -58.79 -42.84 89.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.29 111.153 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.82 -40.75 93.45 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.999 -0.62 . . . . 0.36 112.145 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' NZ ' ' HA ' ' A' ' 85' ' ' VAL . 30.8 mtmm -72.04 -37.82 69.64 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.612 -0.346 . . . . 1.29 110.473 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.1 mt -63.1 -43.97 99.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.346 . . . . 0.27 110.407 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -63.75 -41.22 98.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.497 -0.319 . . . . 0.37 110.208 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.67 -29.83 70.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.243 -0.435 . . . . 2.54 111.095 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.473 ' HB3' HD21 ' A' ' 126' ' ' LEU . 85.5 mt -89.99 -46.91 8.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.102 -0.499 . . . . 1.5 111.363 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.501 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -65.46 -42.97 91.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.985 -0.552 . . . . 0.53 111.574 -173.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.694 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 47.3 t0 -86.24 87.99 7.53 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.248 -1.019 . . . . 0.5 108.248 175.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.536 HG21 ' HD2' ' A' ' 132' ' ' PRO . 15.1 t -68.72 -43.71 82.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.435 -0.802 . . . . 0.64 110.259 -174.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.46 -21.5 30.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.314 -0.857 . . . . 1.46 110.56 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.694 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 48.3 mttp 60.22 73.86 0.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.82 . . . . 2.74 111.462 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.615 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 14.7 p-10 -121.6 9.9 10.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.61 -1.177 . . . . 0.56 111.058 -173.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.94 1.21 67.09 Favored Glycine 0 CA--C 1.516 0.109 0 C-N-CA 120.676 -0.773 . . . . 0.49 112.114 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.615 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 42.9 mt -127.73 152.45 47.72 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.108 -0.701 . . . . 0.53 109.108 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.2 mt -114.2 120.42 40.41 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.803 -0.443 . . . . 0.33 109.803 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.419 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 15.7 m-20 -68.45 173.62 4.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.24 -1.022 . . . . 1.85 108.24 171.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -63.62 -26.91 68.89 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.641 -0.503 . . . . 0.85 109.641 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 23.4 mt-10 -66.22 -56.06 13.14 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.352 0.596 . . . . 2.08 109.865 173.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.501 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 13.6 mt-10 -66.49 -34.5 78.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.93 -1.032 . . . . 0.48 110.574 -171.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.452 ' CD1' HD11 ' A' ' 67' ' ' ILE . 55.7 t80 -71.17 -43.11 68.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.332 -0.394 . . . . 0.41 110.214 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.433 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -60.98 -39.27 89.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.23 110.575 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.448 HD22 HG21 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -61.26 -47.9 83.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.865 -0.607 . . . . 1.29 109.491 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.87 -47.33 85.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.804 -0.635 . . . . 0.23 110.791 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -63.75 -34.32 77.63 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.155 -0.475 . . . . 0.77 111.315 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -68.41 -40.37 81.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.764 0.316 . . . . 0.33 110.387 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.705 ' HB3' HD23 ' A' ' 122' ' ' LEU . 95.0 mt -68.58 -41.54 79.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.275 0.56 . . . . 0.28 110.551 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.548 HD11 ' HG2' ' A' ' 76' ' ' MET . 96.0 mt -65.86 -38.66 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.902 -0.59 . . . . 0.7 109.872 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.727 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 13.9 ttpp -57.69 -53.43 58.3 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.844 -0.616 . . . . 1.77 110.211 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.8 m -62.79 -38.64 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 112.055 0.391 . . . . 0.53 112.055 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.702 ' HD2' HG11 ' A' ' 85' ' ' VAL . 1.1 mmpm? -51.58 -40.97 60.8 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.468 0.175 . . . . 1.89 111.393 169.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 92.4 mt -78.97 -29.16 43.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.465 -0.334 . . . . 0.74 111.511 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.727 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 10.8 mm-40 -67.37 -24.53 65.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.075 0.464 . . . . 1.98 110.223 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.68 16.75 23.37 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.916 -0.659 . . . . 0.87 111.595 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -108.76 162.44 14.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.237 -0.653 . . . . 1.07 109.237 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.449 ' CD ' ' HZ1' ' A' ' 116' ' ' LYS . 60.1 mm-40 -108.7 129.1 55.35 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.873 0.368 . . . . 3.06 111.249 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -77.76 139.78 62.71 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 115.956 -0.566 . . . . 1.09 109.902 172.045 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.11 -4.4 14.8 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.31 2.007 . . . . 0.8 113.692 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.463 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 64.44 20.39 12.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.377 0.608 . . . . 0.64 110.347 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -131.05 163.53 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.836 . . . . 1.97 109.4 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 92' ' ' LEU . 77.2 mt -110.08 96.1 24.1 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.735 -0.211 . . . . 0.67 111.04 174.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 30.3 Cg_endo -65.37 159.12 49.0 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.602 2.201 . . . . 0.52 111.649 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.41 -7.89 9.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.192 2.595 . . . . 0.63 114.138 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -111.22 11.09 21.78 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.094 -0.379 . . . . 0.86 111.488 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.8 mt -118.74 -26.2 6.16 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.953 -0.299 . . . . 1.19 111.301 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.38 116.93 20.02 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.717 -0.22 . . . . 1.34 110.92 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.536 ' HD2' HG21 ' A' ' 95' ' ' VAL . 86.5 Cg_exo . . . . . 0 C--N 1.346 0.418 0 C-N-CA 123.929 3.086 . . . . 0.9 113.506 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 53.0 t-20 . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 109.709 -0.478 . . . . 0.84 109.709 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 24.7 Cg_exo -64.06 -16.66 56.19 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.106 2.537 . . . . 0.66 113.327 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 95.0 m-85 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.895 0.379 . . . . 0.68 110.885 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 108.395 -0.965 . . . . 0.66 108.395 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.51 -40.85 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 121.818 0.818 . . . . 1.41 110.66 -166.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.445 HG21 HD22 ' A' ' 108' ' ' LEU . 18.7 m -91.53 0.44 9.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.484 -1.235 . . . . 1.01 111.339 -172.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.06 -31.49 20.07 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.586 -1.406 . . . . 0.62 109.586 169.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -81.17 -29.61 34.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.974 -0.613 . . . . 2.67 109.974 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.36 32.49 4.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.85 -0.796 . . . . 1.71 108.85 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.644 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 11.4 tmtt? -81.53 -47.12 1.07 Allowed Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 113.303 0.853 . . . . 1.2 113.303 -169.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.7 Cg_endo -44.16 -37.86 10.29 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 123.142 2.561 . . . . 0.62 113.845 -176.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -70.63 -46.67 62.89 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 120.965 0.412 . . . . 0.72 111.346 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 2.6 m-85 -72.82 -22.3 60.83 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.092 -0.707 . . . . 0.65 109.092 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -75.32 -42.03 55.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.814 -1.085 . . . . 1.03 109.475 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.54 -55.22 31.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.446 -0.797 . . . . 2.15 109.814 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.19 -26.26 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.826 -0.624 . . . . 0.71 111.389 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.409 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 87.4 t80 -69.58 -50.37 45.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.223 0.535 . . . . 0.31 110.259 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -74.33 -23.63 59.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.913 -0.585 . . . . 0.8 111.859 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.3 p -74.67 -1.52 22.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.844 0.354 . . . . 0.61 111.619 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.67 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 95.9 mt -108.49 6.07 25.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.852 -0.425 . . . . 0.41 109.852 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.8 m 63.17 86.86 0.14 Allowed Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 115.379 -0.828 . . . . 1.24 111.754 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -88.51 138.86 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.753 2.302 . . . . 0.59 112.972 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.404 HG12 ' OD1' ' A' ' 64' ' ' ASN . 14.7 t -118.01 132.09 68.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.799 -0.637 . . . . 1.31 109.917 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.404 ' OD1' HG12 ' A' ' 63' ' ' VAL . 21.4 m120 62.71 20.02 11.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.47 0.708 . . . . 1.89 110.471 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.16 13.26 60.63 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.151 -0.931 . . . . 0.62 112.029 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HE2' ' OD2' ' A' ' 102' ' ' ASP . 94.2 mttt -136.25 171.17 14.88 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.383 0.611 . . . . 1.81 111.642 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 106' ' ' PHE . 26.7 pt -121.62 143.11 35.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.927 -1.033 . . . . 0.3 109.449 171.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.1 p -78.31 171.42 15.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.179 -0.464 . . . . 0.44 110.112 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.35 -29.7 53.63 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 120.927 -0.654 . . . . 0.33 112.258 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.97 83.41 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.033 0.444 . . . . 0.34 111.843 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.67 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.4 m120 -76.73 -42.35 41.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.777 -0.647 . . . . 1.65 110.343 -170.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -69.15 -29.94 68.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.868 -0.606 . . . . 0.27 110.545 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.598 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 63.0 tttt -68.85 -50.18 52.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.215 -0.448 . . . . 1.52 110.838 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HA ' HG22 ' A' ' 77' ' ' VAL . 17.3 ptpt -61.42 -39.01 89.23 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.036 0.446 . . . . 1.14 110.465 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.56 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 18.5 tp10 -61.42 -49.28 77.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.518 . . . . 1.78 110.237 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.972 ' HB3' HD22 ' A' ' 86' ' ' LEU . 49.8 mtt -65.46 -32.36 73.93 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.209 0.448 . . . . 0.86 112.209 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 74' ' ' LYS . 33.5 m -78.75 -16.54 13.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.362 -0.535 . . . . 1.52 111.54 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.56 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -95.54 -9.05 33.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.335 -0.546 . . . . 3.33 110.201 172.372 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 70.9 m -74.19 -2.43 24.72 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.46 0.541 . . . . 0.91 112.46 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 79' ' ' SER . 5.7 mptp? 74.95 16.9 2.84 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.889 0.476 . . . . 2.97 112.26 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.477 ' HB2' HD21 ' A' ' 86' ' ' LEU . 10.9 mp -99.37 147.05 32.79 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-O 120.854 0.359 . . . . 1.41 111.144 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.2 Cg_endo -62.4 148.83 92.65 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.87 2.38 . . . . 0.32 112.575 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -53.41 -39.1 64.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.454 -0.794 . . . . 2.05 111.51 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.5 m -62.45 -52.72 62.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.475 . . . . 0.84 111.302 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.52 ' CG2' ' HG2' ' A' ' 82' ' ' PRO . 69.1 t -58.75 -38.54 72.74 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.051 0 CA-C-O 120.617 0.246 . . . . 0.26 110.629 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.972 HD22 ' HB3' ' A' ' 76' ' ' MET . 82.3 mt -59.98 -42.42 94.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.29 110.818 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.64 -42.29 98.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.852 -0.69 . . . . 0.36 111.792 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 55.3 mtpt -61.26 -46.76 89.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.832 0.349 . . . . 1.29 110.398 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.52 HG23 HD12 ' A' ' 112' ' ' LEU . 82.6 mt -62.46 -44.48 99.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.27 111.311 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -57.33 -45.74 83.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.65 0.262 . . . . 0.37 110.774 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.08 -28.45 69.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.11 0.481 . . . . 2.54 110.907 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 126' ' ' LEU . 46.3 mt -94.52 -16.77 23.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 1.5 111.856 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.27 -42.38 11.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.569 -0.287 . . . . 0.53 111.133 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -86.42 84.62 7.4 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.115 -0.698 . . . . 0.5 109.115 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.473 HG21 ' HD2' ' A' ' 132' ' ' PRO . 10.7 t -70.87 -36.69 65.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.595 -0.729 . . . . 0.64 110.856 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.64 -11.39 57.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.008 -0.542 . . . . 1.46 110.473 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt 55.57 53.96 9.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.959 -1.019 . . . . 2.74 111.167 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 13.2 p-10 -109.91 7.86 24.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.059 -0.519 . . . . 0.56 110.583 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.91 1.35 67.42 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.12 -0.562 . . . . 0.49 112.083 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 74.9 mt -127.05 144.55 51.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.013 0.435 . . . . 0.53 109.902 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 67.3 mt -104.55 113.45 27.04 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.413 -0.515 . . . . 0.33 110.095 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.442 ' OD2' ' HE2' ' A' ' 66' ' ' LYS . 4.2 m-20 -69.35 172.29 7.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.558 -0.904 . . . . 1.85 108.558 169.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -60.27 -30.92 69.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.549 0.214 . . . . 0.85 110.721 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -71.79 -45.28 62.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.107 0.479 . . . . 2.08 110.866 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -70.7 -33.0 70.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.919 0.39 . . . . 0.48 110.747 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' HD11 ' A' ' 67' ' ' ILE . 27.7 t80 -75.16 -30.98 60.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.79 -0.448 . . . . 0.41 109.79 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.79 82.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.195 0.522 . . . . 0.23 110.039 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.511 HD21 ' O ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -65.09 -51.25 62.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 1.29 110.556 175.709 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.37 -50.57 69.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.702 -0.681 . . . . 0.23 110.822 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -61.82 -33.81 74.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.618 -0.719 . . . . 0.77 111.298 -178.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -68.41 -42.97 78.23 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.8 -0.36 . . . . 0.33 110.855 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.52 HD12 HG23 ' A' ' 89' ' ' ILE . 72.6 mt -65.59 -38.39 89.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.208 0.527 . . . . 0.28 110.504 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.68 HD11 ' HG2' ' A' ' 76' ' ' MET . 66.6 mt -68.39 -41.03 83.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.042 -0.526 . . . . 0.7 110.592 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 32.4 ttpt -59.09 -48.99 79.59 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.64 -0.255 . . . . 1.77 110.408 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.8 m -63.44 -36.01 74.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 120.642 -0.423 . . . . 0.53 111.119 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.842 ' HD3' HD23 ' A' ' 122' ' ' LEU . 3.9 mmmp? -58.19 -37.88 75.64 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.444 -0.502 . . . . 1.89 110.703 172.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 96.1 mt -73.6 -22.78 59.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 0.74 110.916 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 13.6 mt-10 -83.5 2.14 38.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.194 -0.457 . . . . 1.98 110.55 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.77 23.7 45.09 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.784 -0.722 . . . . 0.87 111.848 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.608 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 38.4 m80 -117.92 161.27 20.05 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.725 -0.472 . . . . 1.07 109.725 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -115.64 149.04 38.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.34 -0.391 . . . . 3.06 109.975 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.842 HD23 ' HD3' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -89.66 146.77 36.27 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.124 -0.695 . . . . 1.09 109.124 -178.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -66.62 -6.85 16.35 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.783 2.322 . . . . 0.8 112.937 -172.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.81 18.52 9.69 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.469 -0.787 . . . . 0.64 110.773 -176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -135.64 163.7 29.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.2 -0.667 . . . . 1.97 109.2 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 92' ' ' LEU . 96.0 mt -111.98 92.72 18.77 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 111.633 0.234 . . . . 0.67 111.633 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.501 ' HD2' HD12 ' A' ' 130' ' ' LEU . 17.6 Cg_endo -58.86 153.61 49.49 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.395 2.064 . . . . 0.52 111.568 171.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.47 -33.27 46.55 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.508 2.805 . . . . 0.63 114.146 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -82.64 7.21 15.37 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.336 0.495 . . . . 0.86 112.336 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.511 ' O ' HD21 ' A' ' 108' ' ' LEU . 49.2 mt -111.38 -29.12 7.92 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.891 -0.324 . . . . 1.19 111.243 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 39.3 t -65.52 120.39 67.76 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.5 -0.318 . . . . 1.34 110.838 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.473 ' HD2' HG21 ' A' ' 95' ' ' VAL . 10.0 Cg_endo . . . . . 0 C--O 1.239 0.562 0 C-N-CA 123.092 2.528 . . . . 0.9 112.387 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.01 0.434 . . . . 0.84 110.67 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.45 -7.85 20.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.45 2.767 . . . . 0.66 113.154 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 90.9 m-85 . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 112.008 0.373 . . . . 0.68 112.008 -177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.9 t90 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 109.411 -0.588 . . . . 0.66 109.411 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.18 -23.45 11.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.309 0.485 . . . . 1.41 112.309 -168.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -88.28 0.22 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.315 -0.554 . . . . 1.01 111.271 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 -25.5 68.57 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.952 -0.642 . . . . 0.62 112.166 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.58 ' HG3' ' OD1' ' A' ' 49' ' ' ASP . 15.5 pttp -80.21 -27.76 38.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.611 0.243 . . . . 2.67 111.523 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.58 ' OD1' ' HG3' ' A' ' 48' ' ' LYS . 1.2 m-20 -104.13 31.98 4.25 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.725 -0.472 . . . . 1.71 109.725 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -79.84 -51.24 1.16 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 113.275 0.843 . . . . 1.2 113.275 -172.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.5 -26.56 54.85 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.056 1.837 . . . . 0.62 112.743 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.41 -45.45 46.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.717 0.294 . . . . 0.72 110.912 177.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.4 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 11.4 m-30 -70.36 -24.05 62.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.1 -0.704 . . . . 0.65 109.1 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.553 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -73.75 -43.76 58.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.083 -0.962 . . . . 1.03 110.262 176.673 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.94 -38.03 75.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.865 -0.607 . . . . 2.15 110.229 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.1 mt -75.53 -35.39 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.573 0.702 . . . . 0.71 110.641 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 66' ' ' LYS . 62.3 t80 -63.54 -43.06 98.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.287 -0.869 . . . . 0.31 111.018 -176.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.553 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 30.8 m-85 -67.64 -23.29 65.33 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.363 0.505 . . . . 0.8 112.363 -177.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.1 p -85.37 8.68 17.9 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.532 -0.467 . . . . 0.61 111.742 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 95.1 mt -112.23 6.9 19.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.29 -0.413 . . . . 0.41 111.105 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t 65.84 88.48 0.11 Allowed Pre-proline 0 N--CA 1.469 0.479 0 O-C-N 123.547 0.529 . . . . 1.24 111.009 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -94.06 132.28 0.73 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.925 2.417 . . . . 0.59 113.428 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.0 134.1 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.288 -0.869 . . . . 1.31 109.429 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 62.62 26.94 15.95 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.851 0.358 . . . . 1.89 110.719 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.6 36.31 67.83 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.611 -0.804 . . . . 0.62 111.916 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.856 ' HB3' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -168.04 175.65 6.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.59 0.233 . . . . 1.81 110.67 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.7 pt -131.35 155.36 41.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.215 0.531 . . . . 0.3 112.122 -172.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.465 ' HA ' HD23 ' A' ' 100' ' ' LEU . 40.9 p -79.19 166.92 21.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.069 -0.969 . . . . 0.44 110.4 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.44 ' HA3' ' HG3' ' B' ' 150' ' ' PRO . . . -59.19 -27.52 62.86 Favored Glycine 0 C--O 1.221 -0.662 0 C-N-CA 120.991 -0.624 . . . . 0.33 112.99 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.22 82.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.39 0.515 . . . . 0.34 112.39 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.488 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -76.13 -42.43 46.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.18 -0.464 . . . . 1.65 110.238 -172.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.81 71.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.27 110.161 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 59.7 tttt -69.3 -54.76 12.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.979 -0.555 . . . . 1.52 110.495 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 17.3 ptpt -57.78 -34.41 69.56 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.888 -0.325 . . . . 1.14 110.74 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.77 -53.5 46.09 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.404 0.621 . . . . 1.78 110.425 175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.695 ' HB3' HD22 ' A' ' 86' ' ' LEU . 93.0 mtp -68.96 -24.89 64.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.503 -0.772 . . . . 0.86 112.142 -173.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 74' ' ' LYS . 35.6 m -87.47 -35.91 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-O 121.067 0.461 . . . . 1.52 110.821 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -79.52 -8.19 58.98 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.482 0.658 . . . . 3.33 109.624 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.5 m -69.86 -11.34 60.79 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.5 -0.773 . . . . 0.91 110.502 168.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 71.68 44.77 0.48 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.504 0.722 . . . . 2.97 111.862 177.455 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.471 ' HB2' HD21 ' A' ' 86' ' ' LEU . 86.9 mt -119.62 146.86 42.43 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.117 -0.492 . . . . 1.41 109.852 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.557 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.5 Cg_endo -58.99 141.22 98.1 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.986 2.457 . . . . 0.32 112.955 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -62.64 -30.52 71.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.614 -0.721 . . . . 2.05 111.644 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.0 m -61.12 -53.13 60.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 0.84 110.085 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 t -55.41 -45.84 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.829 -0.623 . . . . 0.26 110.927 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 76' ' ' MET . 77.1 mt -60.77 -42.12 96.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.29 110.721 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.35 -33.79 88.18 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.701 -0.681 . . . . 0.36 112.358 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 33.1 mttt -68.0 -45.29 74.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.911 0.386 . . . . 1.29 110.077 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.619 HG23 HD12 ' A' ' 112' ' ' LEU . 81.9 mt -59.58 -44.33 92.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.863 -0.608 . . . . 0.27 111.463 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -60.18 -39.82 87.82 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.921 -0.4 . . . . 0.37 109.921 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -64.82 -23.01 67.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 2.54 111.172 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.665 ' HB3' HD21 ' A' ' 126' ' ' LEU . 70.9 mt -93.39 -38.52 11.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.615 -0.721 . . . . 1.5 110.722 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.758 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -78.93 -42.64 26.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.53 111.819 -173.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 25.3 t0 -86.42 73.53 10.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.286 0.565 . . . . 0.5 109.565 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.8 t -64.65 -37.89 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 115.29 -0.868 . . . . 0.64 110.798 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.39 -20.4 61.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.526 -0.761 . . . . 1.46 109.926 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 96.4 mttt 56.83 37.79 29.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.838 0.828 . . . . 2.74 109.333 -175.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.2 p-10 -89.59 8.95 28.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.654 -1.157 . . . . 0.56 110.972 -174.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.38 -2.96 26.35 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.055 -0.593 . . . . 0.49 112.572 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 36.1 mt -125.81 146.74 49.67 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.649 -0.5 . . . . 0.53 109.649 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.6 mt -105.74 112.4 25.45 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.282 -0.636 . . . . 0.33 109.282 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.856 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . 2.0 p30 -75.31 176.44 7.42 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.489 -0.484 . . . . 1.85 109.723 174.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -59.19 -28.76 66.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.697 -0.228 . . . . 0.85 111.538 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.404 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . 7.7 mm-40 -76.08 -50.39 14.85 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.877 0.37 . . . . 2.08 110.689 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.649 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 49.3 mt-10 -58.09 -43.17 86.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.257 0.551 . . . . 0.48 110.61 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HD2' ' HB2' ' A' ' 57' ' ' PHE . 33.3 t80 -69.94 -29.57 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.835 -0.62 . . . . 0.41 110.115 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -65.47 -43.34 90.61 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.425 0.631 . . . . 0.23 109.889 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.758 HD23 ' HA ' ' A' ' 93' ' ' ALA . 23.7 tp -62.89 -46.45 87.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.452 -0.794 . . . . 1.29 110.369 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.4 -44.79 89.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.54 -0.754 . . . . 0.23 111.074 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -65.41 -33.36 75.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.059 -0.518 . . . . 0.77 111.506 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -67.86 -40.23 83.68 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.904 -0.319 . . . . 0.33 110.241 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.798 ' HB3' HD23 ' A' ' 122' ' ' LEU . 96.4 mt -65.76 -36.3 83.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 0.28 110.629 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.8 -38.06 64.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.094 -0.503 . . . . 0.7 110.777 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -57.61 -49.8 75.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.366 -0.379 . . . . 1.77 110.388 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 120' ' ' HIS . 13.9 m -67.16 -40.17 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 120.563 -0.455 . . . . 0.53 111.291 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -51.55 -47.28 63.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.806 0.275 . . . . 1.89 111.339 171.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.71 -35.94 75.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.74 110.722 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -74.19 -5.35 41.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.83 -0.623 . . . . 1.98 111.805 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.36 30.55 9.83 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.175 -1.012 . . . . 0.87 112.544 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 90.6 m-70 -126.44 117.39 22.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.103 0.477 . . . . 1.07 109.946 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -78.01 117.2 19.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.57 -0.741 . . . . 3.06 110.526 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.798 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -60.59 141.17 92.29 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 1.09 110.437 173.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.65 -1.77 10.84 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.449 2.099 . . . . 0.8 113.764 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 63.26 24.27 14.22 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.512 0.508 . . . . 0.64 110.769 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -133.67 158.5 43.1 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.352 -0.61 . . . . 1.97 109.352 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 92' ' ' LEU . 94.5 mt -111.81 92.34 17.29 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 111.926 0.343 . . . . 0.67 111.926 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.634 ' HD2' HD12 ' A' ' 130' ' ' LEU . 35.3 Cg_endo -66.95 160.4 47.3 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.46 2.107 . . . . 0.52 110.968 167.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.49 -42.23 28.88 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.124 2.55 . . . . 0.63 113.828 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -77.86 10.19 2.98 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.761 0.652 . . . . 0.86 112.761 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.634 HD12 ' HD2' ' A' ' 127' ' ' PRO . 52.8 mt -122.23 3.46 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.215 -0.194 . . . . 1.19 111.287 176.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.6 115.62 64.87 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 121.164 -0.215 . . . . 1.34 110.733 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.904 2.403 . . . . 0.9 112.307 179.361 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.406 ' HB2' ' HD2' ' B' ' 150' ' ' PRO . 22.3 p30 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.227 0.537 . . . . 0.84 111.885 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.44 ' HG3' ' HA3' ' A' ' 69' ' ' GLY . 34.4 Cg_endo -66.05 -3.69 8.9 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.382 2.721 . . . . 0.66 113.581 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.46 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 80.3 m-85 . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 111.981 0.364 . . . . 0.68 111.981 -173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.6 t90 . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 108.042 -1.095 . . . . 0.66 108.042 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.5 t -56.62 -24.07 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.896 -0.593 . . . . 1.41 112.118 -171.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.434 HG21 HD22 ' A' ' 108' ' ' LEU . 97.4 t -76.54 -23.05 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.765 0.316 . . . . 1.01 111.169 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.74 -18.68 70.55 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.573 -0.822 . . . . 0.62 112.465 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -18.33 23.73 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.143 -0.623 . . . . 2.67 111.733 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -121.22 31.99 6.12 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.95 -0.759 . . . . 1.71 108.95 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 8.7 tmtm? -74.86 -47.43 4.95 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 1.2 111.774 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 49.0 Cg_exo -56.04 -27.67 65.62 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.967 1.778 . . . . 0.62 112.56 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 m -75.71 -46.32 31.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.604 -0.271 . . . . 0.72 111.142 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -70.34 -23.06 62.75 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.679 -0.86 . . . . 0.65 108.679 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.75 -44.68 63.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.733 -1.121 . . . . 1.03 109.862 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.86 -40.79 89.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.027 -0.988 . . . . 2.15 110.055 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.26 -38.37 77.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.01 -0.541 . . . . 0.71 110.797 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HE1' HG12 ' A' ' 67' ' ' ILE . 83.1 t80 -62.27 -41.13 98.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.924 -0.58 . . . . 0.31 110.631 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -82.08 14.59 2.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.451 -0.795 . . . . 0.8 112.416 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.1 p -113.7 2.06 15.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.144 0.497 . . . . 0.61 110.988 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 89.0 mt -108.51 14.6 24.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.766 -0.652 . . . . 0.41 111.147 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.8 t 61.2 80.92 0.25 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.722 -0.672 . . . . 1.24 111.575 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -85.63 105.65 0.86 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.514 2.142 . . . . 0.59 113.134 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.3 m -89.78 135.36 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.717 -0.674 . . . . 1.31 109.839 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 62.4 21.06 12.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.19 -0.459 . . . . 1.89 110.412 -174.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.51 9.48 83.32 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.572 -0.823 . . . . 0.62 111.873 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 56.7 mtmt -138.33 148.52 44.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.368 . . . . 1.81 110.947 -177.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.476 HD11 ' CD1' ' A' ' 106' ' ' PHE . 11.3 pt -97.34 144.16 11.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.017 0.437 . . . . 0.3 110.701 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.548 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 12.1 p -71.18 161.6 30.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.295 -0.866 . . . . 0.44 110.837 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.26 -32.22 60.12 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.135 -0.555 . . . . 0.33 112.021 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.63 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -49.85 -65.81 0.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.559 0.344 . . . . 0.34 111.72 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 48.0 m-80 -69.45 -39.46 77.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.089 -0.505 . . . . 1.65 111.717 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.11 97.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.422 -0.354 . . . . 0.27 110.38 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 34.4 ttpt -62.43 -42.28 99.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.469 -0.567 . . . . 1.52 109.469 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 52.0 mtpt -51.8 -55.53 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.5 -0.773 . . . . 1.14 110.916 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -59.07 -46.53 88.02 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.348 0.595 . . . . 1.78 110.657 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.713 ' HB3' HD22 ' A' ' 86' ' ' LEU . 84.3 mtp -64.69 -29.22 70.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.846 -0.615 . . . . 0.86 110.992 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.21 -37.37 45.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.239 0.542 . . . . 1.52 109.897 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -80.86 2.91 24.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.91 -0.586 . . . . 3.33 111.061 177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m -77.56 -10.24 59.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.307 -0.406 . . . . 0.91 110.338 169.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 69.68 21.37 6.6 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.299 0.639 . . . . 2.97 111.615 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.471 ' HB2' HD21 ' A' ' 86' ' ' LEU . 94.2 mt -100.8 153.14 37.9 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.614 -0.721 . . . . 1.41 110.964 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.503 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 9.8 Cg_endo -54.82 141.12 77.67 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.155 2.57 . . . . 0.32 112.631 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -63.95 -28.43 69.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.463 -0.789 . . . . 2.05 111.443 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 p -67.22 -44.73 78.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.842 0.353 . . . . 0.84 110.887 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.46 -44.3 98.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.26 110.01 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 76' ' ' MET . 78.4 mt -60.75 -41.41 95.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.767 -0.651 . . . . 0.29 110.489 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.612 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -57.17 -49.73 69.94 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.697 -0.683 . . . . 0.36 111.541 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.504 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 93.6 mttt -56.05 -51.05 69.22 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 122.518 0.327 . . . . 1.29 110.974 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.631 HG23 HD12 ' A' ' 112' ' ' LEU . 83.0 mt -55.52 -42.67 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.695 -0.684 . . . . 0.27 111.217 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.437 ' HB3' ' ND2' ' B' ' 149' ' ' ASN . 15.0 t-105 -61.93 -44.91 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.478 -0.328 . . . . 0.37 110.956 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 60.7 mttm -63.28 -22.82 67.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 2.54 110.961 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.568 ' O ' HD11 ' A' ' 126' ' ' LEU . 27.7 mt -93.51 -38.01 11.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 1.5 110.528 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -72.61 -42.67 64.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.713 -0.676 . . . . 0.53 111.019 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.508 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 44.2 t0 -81.46 78.94 8.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.897 -0.779 . . . . 0.5 108.897 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.13 -36.04 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.493 -0.776 . . . . 0.64 110.827 -174.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.17 -11.08 57.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 1.46 109.727 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.508 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 62.2 mtpt 51.63 66.04 1.31 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.808 -1.087 . . . . 2.74 111.564 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 10.5 p-10 -115.31 9.2 15.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.335 -0.848 . . . . 0.56 110.412 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.16 2.76 67.45 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.882 -0.675 . . . . 0.49 112.183 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.548 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 81.2 mt -131.73 164.75 25.29 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.377 -0.601 . . . . 0.53 109.377 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.1 mt -120.56 116.65 25.79 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.649 -0.42 . . . . 0.33 110.482 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.479 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.7 p30 -78.62 -176.89 5.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.144 -0.688 . . . . 1.85 109.144 170.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -66.4 -29.6 69.79 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.961 -0.295 . . . . 0.85 111.528 -176.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -69.55 -53.83 17.04 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.213 -0.662 . . . . 2.08 109.213 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.493 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 28.7 mt-10 -63.06 -39.6 95.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.919 -1.037 . . . . 0.48 111.436 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.476 ' CD1' HD11 ' A' ' 67' ' ' ILE . 48.6 t80 -69.48 -40.36 77.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.41 110.249 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.58 75.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.92 -0.582 . . . . 0.23 110.373 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -63.85 -48.44 76.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.947 -0.569 . . . . 1.29 109.475 175.553 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.78 76.71 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.617 -0.72 . . . . 0.23 110.611 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -63.31 -28.36 69.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.711 -0.677 . . . . 0.77 111.543 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 56.8 t60 -81.24 -32.67 33.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.815 -0.354 . . . . 0.33 110.871 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.631 HD12 HG23 ' A' ' 89' ' ' ILE . 93.4 mt -71.12 -37.28 72.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.331 0.586 . . . . 0.28 109.568 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.499 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 76.0 mt -70.78 -32.73 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.905 -0.589 . . . . 0.7 109.941 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 14.3 tppt? -53.4 -55.42 25.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.044 -0.526 . . . . 1.77 110.728 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.3 m -65.94 -36.31 77.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 120.563 -0.455 . . . . 0.53 111.47 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.461 ' HG2' HD23 ' A' ' 122' ' ' LEU . 25.7 mmmt -58.67 -42.03 87.53 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.562 -0.455 . . . . 1.89 111.702 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 81.6 mt -70.09 -22.32 63.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.74 110.97 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -82.73 -8.17 59.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.914 -0.584 . . . . 1.98 110.893 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.56 30.16 16.68 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.576 -0.821 . . . . 0.87 111.861 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -110.24 174.08 6.03 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.646 -0.501 . . . . 1.07 109.646 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 121' ' ' GLU . 16.2 mm-40 -109.21 136.69 48.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.79 -0.641 . . . . 3.06 109.535 171.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 116' ' ' LYS . 1.3 pp -82.93 139.59 43.0 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.335 -0.617 . . . . 1.09 109.335 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 23.7 Cg_exo -62.53 -13.97 36.64 Favored 'Trans proline' 0 N--CA 1.476 0.467 0 C-N-CA 123.332 2.688 . . . . 0.8 113.694 -169.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 63.53 16.42 9.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.645 -0.707 . . . . 0.64 111.425 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -136.26 171.54 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.304 -0.628 . . . . 1.97 109.304 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.866 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 98.9 mt -115.85 90.51 27.54 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.505 -0.316 . . . . 0.67 110.794 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.65 154.85 66.63 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.478 2.119 . . . . 0.52 111.723 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -50.27 -24.36 11.5 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.583 2.856 . . . . 0.63 114.969 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -96.31 5.27 51.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.952 0.406 . . . . 0.86 111.508 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.438 ' O ' HD21 ' A' ' 108' ' ' LEU . 64.8 mt -123.61 -34.08 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.29 -0.414 . . . . 1.19 110.786 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.866 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.8 p -77.61 121.55 84.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.026 0.441 . . . . 1.34 110.654 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 131' ' ' VAL . 12.4 Cg_endo . . . . . 0 N--CA 1.462 -0.331 0 C-N-CA 122.754 2.303 . . . . 0.9 112.065 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.612 HD21 ' HA2' ' A' ' 87' ' ' GLY . 24.8 t-20 . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 109.729 -0.471 . . . . 0.84 109.729 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 16.5 Cg_exo -68.46 -6.87 18.67 Favored 'Trans proline' 0 N--CA 1.474 0.326 0 C-N-CA 123.361 2.707 . . . . 0.66 113.284 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.538 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 99.2 m-85 . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 121.182 0.515 . . . . 0.68 110.196 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.3 t90 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 108.31 -0.996 . . . . 0.66 108.31 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.5 t -53.31 -35.68 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.513 0.56 . . . . 1.41 112.513 -172.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 31.3 t -72.16 -17.0 18.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.372 -0.376 . . . . 1.01 111.26 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.55 -1.25 52.0 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.366 -0.921 . . . . 0.62 112.188 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -86.55 -31.04 21.44 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.22 0.533 . . . . 2.67 110.878 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -141.39 35.16 1.67 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 122.224 1.011 . . . . 1.71 110.229 -172.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 15.1 tmtt? -76.86 -42.56 2.82 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 114.015 -1.448 . . . . 1.2 111.535 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 50' ' ' LYS . 82.2 Cg_exo -46.21 -35.0 14.55 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.726 2.284 . . . . 0.62 113.598 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.584 ' O ' HG12 ' A' ' 56' ' ' ILE . 9.3 m -69.83 -45.66 67.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.732 -0.387 . . . . 0.72 110.449 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -72.16 -22.76 61.25 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.467 -0.568 . . . . 0.65 109.467 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.476 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 18.0 t70 -67.2 -41.18 86.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.137 -0.938 . . . . 1.03 109.078 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -66.85 -35.59 80.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.21 -0.904 . . . . 2.15 110.239 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 52' ' ' THR . 23.0 mm -66.03 -31.48 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.731 0.777 . . . . 0.71 109.707 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 87.6 t80 -72.91 -45.55 57.53 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.094 -0.957 . . . . 0.31 110.804 -175.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.476 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 51.2 m-85 -75.49 -19.89 59.1 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.114 -0.493 . . . . 0.8 111.952 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.2 p -83.45 -5.16 59.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 0.61 111.164 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.62 8.98 39.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 0.41 111.246 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.1 t 64.32 83.41 0.2 Allowed Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 123.743 0.652 . . . . 1.24 110.955 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.43 118.13 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.766 2.311 . . . . 0.59 112.812 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.91 134.7 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.744 . . . . 1.31 110.66 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 57.92 19.92 6.24 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.457 0.703 . . . . 1.89 111.377 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.71 7.27 63.17 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.907 -0.588 . . . . 0.62 112.258 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 54.4 mtmt -137.45 173.42 11.68 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 110.111 -0.329 . . . . 1.81 110.111 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.433 HD11 ' CD1' ' A' ' 106' ' ' PHE . 25.0 pt -118.39 154.12 20.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.87 -0.418 . . . . 0.3 109.87 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.589 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 70.7 p -80.95 166.94 20.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.896 -0.593 . . . . 0.44 110.201 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.536 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -58.87 -22.46 54.39 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.642 -0.79 . . . . 0.33 111.888 175.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.57 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -61.42 -59.91 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.34 111.556 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -65.8 -42.75 90.33 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.689 -0.687 . . . . 1.65 111.332 -170.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.16 -36.14 83.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.27 110.522 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 32.0 tttp -62.27 -43.39 98.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.894 -0.594 . . . . 1.52 110.019 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.571 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 24.8 mtpt -58.76 -51.1 71.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.687 -0.688 . . . . 1.14 110.576 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -57.98 -43.7 86.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.529 0.681 . . . . 1.78 110.457 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.723 ' HB3' HD22 ' A' ' 86' ' ' LEU . 94.4 mtp -69.16 -26.91 65.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.792 -0.64 . . . . 0.86 112.276 -175.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 74' ' ' LYS . 25.6 m -83.16 -22.82 8.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 120.126 -0.63 . . . . 1.52 109.602 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 5.6 mptp? -77.6 -12.94 60.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 3.33 110.099 173.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.0 m -75.2 -7.93 55.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.91 111.62 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? 67.39 34.66 4.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.986 0.422 . . . . 2.97 111.374 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.58 ' HB2' HD21 ' A' ' 86' ' ' LEU . 95.3 mt -112.74 146.65 35.49 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.106 -0.497 . . . . 1.41 110.982 -176.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.7 Cg_endo -61.62 153.14 69.05 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.064 2.509 . . . . 0.32 112.854 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -59.62 -32.74 70.7 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.948 -0.569 . . . . 2.05 111.601 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.46 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -64.73 -50.47 66.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.922 0.391 . . . . 0.84 110.951 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . 42.8 t -60.27 -44.26 95.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.26 110.418 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.723 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.4 mt -63.84 -38.84 92.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.809 -0.632 . . . . 0.29 110.774 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.674 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.88 -42.68 99.71 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.039 -0.6 . . . . 0.36 112.551 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 85' ' ' VAL . 41.1 mtmt -68.18 -42.9 79.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.744 -0.095 . . . . 1.29 110.744 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.545 HD11 ' CE ' ' A' ' 116' ' ' LYS . 93.8 mt -55.83 -52.2 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.384 0.428 . . . . 0.27 111.071 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.536 ' CH2' ' HA2' ' A' ' 69' ' ' GLY . 39.0 t-105 -62.98 -49.59 74.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.794 0.331 . . . . 0.37 111.348 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -59.64 -30.93 69.06 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.139 -0.482 . . . . 2.54 111.232 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -92.53 -41.02 10.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 1.5 111.2 -176.369 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.464 ' N ' ' HG ' ' A' ' 92' ' ' LEU . . . -69.53 -36.32 76.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.536 0.569 . . . . 0.53 112.536 -175.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.595 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 42.5 t0 -74.18 95.47 2.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.895 -0.779 . . . . 0.5 108.895 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 t -79.75 -39.91 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.64 110.942 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -80.68 -13.92 58.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 1.46 109.68 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.595 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 6.1 mtpp 51.64 72.91 0.34 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.496 -1.229 . . . . 2.74 111.31 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.625 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.1 p-10 -128.33 9.1 6.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.962 -1.017 . . . . 0.56 110.825 -175.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.23 10.84 70.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.49 111.841 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.625 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 43.8 mt -134.31 157.45 46.3 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.217 -0.66 . . . . 0.53 109.217 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.0 mt -121.77 118.81 29.97 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.776 -0.37 . . . . 0.33 110.196 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.6 p30 -74.67 -177.63 3.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.077 -0.712 . . . . 1.85 109.077 168.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -66.08 -27.05 67.78 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.088 0.403 . . . . 0.85 112.088 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 85.7 mt-10 -75.89 -47.32 25.87 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.749 -0.463 . . . . 2.08 109.749 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -66.3 -37.7 86.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.89 -0.596 . . . . 0.48 110.492 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.433 ' CD1' HD11 ' A' ' 67' ' ' ILE . 23.7 t80 -70.34 -38.56 74.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.168 -0.469 . . . . 0.41 110.303 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.88 99.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.045 -0.525 . . . . 0.23 110.401 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -59.38 -49.88 76.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 1.29 109.574 177.448 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -55.61 -46.92 77.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.905 -0.589 . . . . 0.23 111.552 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -66.68 -38.4 86.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.446 . . . . 0.77 111.407 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -64.92 -32.61 74.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.098 0.475 . . . . 0.33 109.934 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.717 ' HB3' HD23 ' A' ' 122' ' ' LEU . 97.8 mt -67.09 -35.02 78.9 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.954 -0.567 . . . . 0.28 109.997 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 109' ' ' ALA . 38.7 mm -61.26 -47.1 95.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.158 -0.682 . . . . 0.7 109.158 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -59.06 -44.06 91.79 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.417 -0.811 . . . . 1.77 112.033 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 112' ' ' LEU . 11.6 m -64.56 -38.79 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 120.062 -0.655 . . . . 0.53 111.344 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.612 ' HE3' HD21 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -51.97 -48.51 64.32 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 120.526 -0.47 . . . . 1.89 111.262 167.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.38 -29.37 68.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.933 -0.576 . . . . 0.74 111.23 -177.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -70.91 -20.01 62.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.968 -0.56 . . . . 1.98 111.233 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.39 22.67 10.24 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.693 -0.765 . . . . 0.87 112.004 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -119.36 158.57 25.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.589 -0.523 . . . . 1.07 109.589 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.9 130.61 55.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.201 0.524 . . . . 3.06 110.564 174.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.717 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -68.79 146.5 97.55 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 1.09 110.407 172.534 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 2.2 Cg_endo -80.22 1.7 9.05 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.719 2.279 . . . . 0.8 112.86 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.488 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 64.53 19.69 11.89 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.985 -0.552 . . . . 0.64 110.892 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -133.85 169.72 16.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.696 -0.684 . . . . 1.97 109.383 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 63.6 mt -111.97 91.26 15.04 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 123.082 0.239 . . . . 0.67 111.516 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 29.0 Cg_endo -64.54 154.41 72.09 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.71 2.273 . . . . 0.52 111.208 170.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.27 -40.24 52.34 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.537 2.825 . . . . 0.63 113.77 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -79.14 7.65 7.17 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.088 0.403 . . . . 0.86 112.088 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.401 HD12 ' HG2' ' A' ' 127' ' ' PRO . 70.5 mt -126.34 5.61 7.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.547 0.213 . . . . 1.19 111.557 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.32 118.31 69.75 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.033 -0.267 . . . . 1.34 110.915 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 64.5 Cg_exo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 123.139 2.56 . . . . 0.9 112.135 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.674 HD21 ' HA2' ' A' ' 87' ' ' GLY . 48.6 t-20 . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 109.448 -0.575 . . . . 0.84 109.448 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 21.1 Cg_exo -66.59 -3.14 8.62 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.45 2.766 . . . . 0.66 113.684 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.516 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 83.6 m-85 . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.987 0.422 . . . . 0.68 110.533 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.8 t90 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 108.703 -0.851 . . . . 0.66 108.703 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 m -57.57 -26.71 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.578 -0.737 . . . . 1.41 112.172 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HA ' ' OD1' ' A' ' 49' ' ' ASP . 24.1 t -73.41 -16.34 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.032 -0.531 . . . . 1.01 111.227 -174.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.01 -8.81 58.82 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.604 -0.808 . . . . 0.62 112.396 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -93.88 -28.78 15.65 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.395 0.617 . . . . 2.67 110.721 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.501 ' OD1' ' HA ' ' A' ' 46' ' ' VAL . 10.8 p-10 -120.94 33.7 5.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.211 -0.904 . . . . 1.71 109.714 -172.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.06 -46.51 0.47 Allowed Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 114.391 -1.277 . . . . 1.2 112.263 -174.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.39 -26.61 8.84 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 122.754 2.303 . . . . 0.62 114.06 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -68.83 -45.86 70.04 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.384 0.611 . . . . 0.72 110.126 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -78.14 -20.72 51.49 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.706 -0.679 . . . . 0.65 109.178 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.6 -45.19 94.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.614 -0.721 . . . . 1.03 109.505 173.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -62.05 -50.0 73.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.203 -0.908 . . . . 2.15 110.089 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.9 mt -60.71 -35.42 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.063 -0.517 . . . . 0.71 111.008 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.499 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 92.6 t80 -65.13 -40.33 94.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.637 -0.71 . . . . 0.31 110.05 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -74.75 -25.01 58.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.959 -0.564 . . . . 0.8 111.726 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.6 p -82.53 1.87 35.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.088 0.47 . . . . 0.61 111.374 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.75 1.85 23.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.714 -0.476 . . . . 0.41 109.714 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.5 m 63.3 88.88 0.11 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.054 -0.975 . . . . 1.24 111.593 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -86.92 122.5 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.71 2.273 . . . . 0.59 112.592 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.9 m -101.2 130.9 49.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.001 -0.545 . . . . 1.31 109.781 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 65.91 21.85 11.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.002 -0.545 . . . . 1.89 110.046 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.18 1.53 78.85 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.912 -0.586 . . . . 0.62 112.549 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.64 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 51.5 mtmt -135.59 156.44 48.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.021 -0.363 . . . . 1.81 110.021 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.547 HD11 ' CD1' ' A' ' 106' ' ' PHE . 15.4 pt -102.33 146.14 10.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 120.57 -0.452 . . . . 0.3 110.663 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.581 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 68.5 p -73.16 163.97 27.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.089 -0.505 . . . . 0.44 110.293 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.99 -24.76 55.24 Favored Glycine 0 C--O 1.221 -0.708 0 C-N-CA 120.796 -0.716 . . . . 0.33 112.469 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -59.35 -58.07 10.21 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.119 0.485 . . . . 0.34 111.601 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.463 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -67.54 -41.12 84.8 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.719 -0.673 . . . . 1.65 110.363 -173.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -65.29 -31.54 72.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.483 -0.781 . . . . 0.27 110.524 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 70.9 tttt -67.86 -43.48 79.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.213 -0.449 . . . . 1.52 109.954 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.736 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.9 mtmt -55.29 -49.12 72.92 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.515 -0.766 . . . . 1.14 110.106 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 28.9 tp10 -57.92 -44.21 86.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.325 0.583 . . . . 1.78 110.749 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.602 ' HB3' HD22 ' A' ' 86' ' ' LEU . 23.9 mmt -63.9 -36.48 84.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.923 -0.58 . . . . 0.86 111.884 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -81.16 -35.75 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.435 -0.506 . . . . 1.52 111.674 -173.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.736 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -81.93 -8.34 59.67 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 119.99 -0.684 . . . . 3.33 110.97 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.0 m -75.35 -20.35 59.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.163 0.506 . . . . 0.91 109.716 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 mmmp? 69.6 51.01 0.48 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.038 -0.983 . . . . 2.97 111.775 175.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.518 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.8 mp -110.99 145.31 32.17 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.872 -1.058 . . . . 1.41 109.018 170.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 20.9 Cg_endo -62.93 146.7 94.96 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.998 2.465 . . . . 0.32 112.427 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -56.73 -31.16 64.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.26 -0.427 . . . . 2.05 111.724 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.8 m -62.51 -48.63 78.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.135 0.493 . . . . 0.84 110.267 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.707 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 69.1 t -66.51 -43.06 91.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.26 110.212 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 76' ' ' MET . 80.9 mt -59.87 -36.39 76.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.055 -0.52 . . . . 0.29 110.196 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.915 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.7 -46.07 94.98 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.739 -0.664 . . . . 0.36 112.043 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.707 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 17.7 mtpp -61.17 -47.32 86.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.361 -0.237 . . . . 1.29 110.361 177.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.422 ' HA ' HD23 ' A' ' 92' ' ' LEU . 88.6 mt -60.77 -48.42 88.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.873 -0.603 . . . . 0.27 111.357 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -64.04 -48.97 74.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.915 0.388 . . . . 0.37 111.179 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.24 -27.82 68.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.894 -0.594 . . . . 2.54 111.353 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -94.32 -33.21 13.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.863 -0.608 . . . . 1.5 111.331 -177.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -73.48 -42.49 61.8 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.137 0.421 . . . . 0.53 112.137 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.63 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 50.6 t0 -78.16 95.55 4.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.869 -0.789 . . . . 0.5 108.869 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 t -70.38 -44.44 77.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.406 -0.816 . . . . 0.64 110.38 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.35 -17.18 31.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.317 -0.856 . . . . 1.46 110.755 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 50.8 mttp 58.03 73.39 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.152 0.977 . . . . 2.74 112.094 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 12.9 p-10 -117.67 10.21 13.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.291 -1.322 . . . . 0.56 110.576 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.29 -0.88 62.36 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.054 -0.593 . . . . 0.49 112.156 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.581 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 47.5 mt -129.87 149.42 51.61 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.054 -0.721 . . . . 0.53 109.054 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.7 mt -98.99 112.31 24.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.359 0.6 . . . . 0.33 109.858 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.653 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 7.5 t70 -70.39 166.3 20.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.826 -1.079 . . . . 1.85 109.122 173.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -57.47 -37.99 73.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 118.006 0.366 . . . . 0.85 111.692 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.727 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 81.3 mt-10 -70.98 -40.38 71.94 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.671 -0.412 . . . . 2.08 110.663 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.653 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 18.2 mt-10 -70.68 -31.94 69.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.48 110.697 -174.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD1' HD11 ' A' ' 67' ' ' ILE . 66.8 t80 -74.37 -44.39 52.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.788 -0.642 . . . . 0.41 109.887 177.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.7 87.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.742 -0.663 . . . . 0.23 109.82 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 93' ' ' ALA . 18.3 tp -60.57 -50.56 73.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.437 -0.801 . . . . 1.29 109.834 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -56.9 -46.64 81.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.23 111.155 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -68.85 -34.41 75.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.177 -0.465 . . . . 0.77 111.355 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.425 ' CG ' HG22 ' A' ' 46' ' ' VAL . 40.9 t60 -65.41 -39.14 91.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.696 -0.483 . . . . 0.33 109.696 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.6 ' HB3' HD22 ' A' ' 122' ' ' LEU . 74.9 mt -63.69 -43.34 96.93 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.957 -0.565 . . . . 0.28 110.044 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.488 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 33.7 mm -54.08 -50.58 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.637 -0.711 . . . . 0.7 110.115 173.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 27.3 ttpp -58.51 -49.95 75.52 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.548 -0.751 . . . . 1.77 111.435 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.7 m -61.51 -40.1 85.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.537 -0.465 . . . . 0.53 111.217 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.545 ' HG2' HD23 ' A' ' 122' ' ' LEU . 24.8 mmmt -58.71 -40.56 84.04 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.221 -0.192 . . . . 1.89 111.403 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 92.6 mt -71.19 -32.24 68.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.168 0.508 . . . . 0.74 110.868 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 47.1 mt-10 -77.72 2.29 17.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.842 -0.617 . . . . 1.98 111.106 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.12 24.18 41.86 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.781 -0.723 . . . . 0.87 112.401 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -114.53 175.13 5.62 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.502 -0.555 . . . . 1.07 109.502 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -117.96 136.55 53.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.955 0.407 . . . . 3.06 111.195 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 112' ' ' LEU . 3.0 pp -89.41 134.33 32.95 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.44 -0.578 . . . . 1.09 109.44 173.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 37.3 Cg_exo -60.93 -18.66 58.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.168 2.579 . . . . 0.8 113.768 -172.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.427 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 65.0 17.87 11.27 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.822 -0.626 . . . . 0.64 110.94 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -133.95 173.81 11.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.236 -0.893 . . . . 1.97 108.635 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.4 mt -113.2 90.46 16.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.817 0.302 . . . . 0.67 111.817 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.74 160.53 37.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.504 2.136 . . . . 0.52 110.712 169.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.71 -34.3 53.26 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.278 2.652 . . . . 0.63 113.711 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -86.94 -2.16 58.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.733 -0.387 . . . . 0.86 111.659 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -99.37 -25.7 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.979 0.418 . . . . 1.19 110.356 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 60.4 t -70.88 119.56 73.93 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.849 -0.614 . . . . 1.34 111.163 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.727 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 51.6 Cg_exo . . . . . 0 CA--C 1.533 0.449 0 C-N-CA 123.291 2.661 . . . . 0.9 112.716 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.915 HD21 ' HA2' ' A' ' 87' ' ' GLY . 33.6 t-20 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 121.031 0.443 . . . . 0.84 111.565 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.09 -4.87 15.11 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.919 3.08 . . . . 0.66 113.302 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.561 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 72.4 m-85 . . . . . 0 C--N 1.331 -0.205 0 N-CA-C 112.055 0.391 . . . . 0.68 112.055 -175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.648 -0.581 . . . . 9.38 111.648 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -68.47 -53.16 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.924 2.416 . . . . 8.63 112.519 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.19 -67.7 0.98 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.994 0.426 . . . . 8.95 111.165 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.24 -50.1 3.3 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.538 -0.839 . . . . 5.86 111.907 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -65.07 -59.5 4.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.045 0.45 . . . . 6.0 110.214 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.32 93.85 6.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.76 -0.654 . . . . 3.94 109.949 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -124.96 68.9 1.11 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.567 -0.901 . . . . 3.28 108.567 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 p -93.97 143.88 10.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.202 -0.908 . . . . 1.89 111.088 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.18 113.68 17.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.813 -0.631 . . . . 2.49 110.963 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -71.26 113.0 7.84 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.071 -0.715 . . . . 0.66 109.071 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 48.1 t -54.42 -32.05 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.053 -0.521 . . . . 1.41 111.996 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.82 -22.09 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.386 -0.37 . . . . 1.01 111.311 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.58 -10.05 62.93 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.301 -0.952 . . . . 0.62 112.74 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 52.4 pttt -93.98 -18.59 21.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 117.289 0.545 . . . . 2.67 111.426 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -136.67 33.71 2.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.265 1.031 . . . . 1.71 109.218 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 6.4 tmtm? -75.07 -46.08 4.76 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.528 -1.215 . . . . 1.2 111.908 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.6 Cg_endo -50.86 -26.37 17.85 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.803 2.335 . . . . 0.62 113.257 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.5 m -76.03 -46.84 27.26 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.929 -0.308 . . . . 0.72 111.091 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -72.62 -22.32 60.98 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.858 -0.793 . . . . 0.65 108.858 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 28.3 t70 -71.29 -43.21 67.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.546 -1.207 . . . . 1.03 109.452 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.29 -43.89 97.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.149 -0.932 . . . . 2.15 109.991 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.5 -30.8 51.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.014 -0.539 . . . . 0.71 110.457 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.482 ' HE1' HG12 ' A' ' 67' ' ' ILE . 79.9 t80 -65.06 -40.87 95.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.889 -0.596 . . . . 0.31 110.072 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.451 ' HE2' ' OD2' ' A' ' 54' ' ' ASP . 57.8 m-85 -72.88 -23.44 60.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.676 -0.693 . . . . 0.8 111.904 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.5 p -79.8 -2.36 42.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.799 -0.36 . . . . 0.61 111.451 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 83.0 mt -105.19 7.22 33.57 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.077 -0.249 . . . . 0.41 111.038 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 t 65.87 84.0 0.18 Allowed Pre-proline 0 C--O 1.234 0.268 0 O-C-N 123.844 0.715 . . . . 1.24 111.076 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.403 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 44.4 Cg_endo -85.31 114.1 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.453 2.102 . . . . 0.59 112.61 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -89.12 137.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.724 -0.671 . . . . 1.31 109.869 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 p30 46.13 23.64 0.21 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.943 0.897 . . . . 1.89 112.663 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.21 6.55 61.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.349 -0.453 . . . . 0.62 113.643 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -134.36 174.61 10.34 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.312 0.577 . . . . 1.81 110.837 177.119 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.493 HD11 ' CD1' ' A' ' 106' ' ' PHE . 16.8 pt -123.56 148.58 27.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.322 -0.854 . . . . 0.3 109.574 172.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.9 p -83.37 179.2 7.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.584 -0.734 . . . . 0.44 110.114 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.11 -34.07 77.71 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.751 -0.737 . . . . 0.33 112.272 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.41 96.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.138 0.494 . . . . 0.34 112.12 -176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.517 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.2 m120 -76.03 -47.1 26.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.342 0.592 . . . . 1.65 110.244 -172.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.59 -22.88 63.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.023 -0.535 . . . . 0.27 110.247 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 41.5 ttmt -68.18 -54.36 18.44 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.242 -0.435 . . . . 1.52 109.976 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 17.5 ptpt -59.22 -33.15 70.65 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.82 0.343 . . . . 1.14 110.23 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.583 ' CD ' ' HZ3' ' A' ' 78' ' ' LYS . 14.1 tp10 -60.45 -53.48 57.01 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.321 0.581 . . . . 1.78 110.132 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 1.057 ' HB3' HD22 ' A' ' 86' ' ' LEU . 54.6 mtt -70.73 -22.6 62.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.671 . . . . 0.86 110.852 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 73' ' ' LYS . 3.9 t -63.17 -47.17 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.927 -0.579 . . . . 1.52 110.581 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -94.61 -1.61 52.93 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.386 -0.926 . . . . 3.33 111.792 -175.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.0 p -66.89 -19.75 65.79 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.817 0.342 . . . . 0.91 110.178 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.4 tptt 75.58 22.97 1.51 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.879 0.872 . . . . 2.97 111.443 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 86' ' ' LEU . 11.2 mp -92.0 151.45 41.93 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.306 -0.257 . . . . 1.41 110.306 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.577 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 14.5 Cg_endo -59.94 148.18 89.79 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.649 2.233 . . . . 0.32 112.731 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -55.93 -39.49 71.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.454 -0.794 . . . . 2.05 111.188 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 m -61.1 -45.95 92.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.996 -0.547 . . . . 0.84 111.374 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.502 ' CG2' ' HG2' ' A' ' 82' ' ' PRO . 55.0 t -64.45 -42.22 94.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.26 110.376 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.057 HD22 ' HB3' ' A' ' 76' ' ' MET . 64.0 mt -57.65 -46.4 84.24 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.051 0.453 . . . . 0.29 110.695 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.678 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -64.84 -34.65 90.46 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.832 -0.699 . . . . 0.36 112.13 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -70.54 -41.43 72.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.272 0.558 . . . . 1.29 110.455 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.63 HG23 HD12 ' A' ' 112' ' ' LEU . 83.7 mt -62.38 -42.93 97.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.625 -0.716 . . . . 0.27 110.937 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -59.39 -40.69 87.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.966 0.412 . . . . 0.37 110.077 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -62.99 -25.96 68.62 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.54 -0.754 . . . . 2.54 111.026 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.436 HD11 ' HA ' ' A' ' 124' ' ' ALA . 66.1 mt -90.35 -33.28 16.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.296 -0.411 . . . . 1.5 111.336 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.32 -43.63 63.84 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.83 0.678 . . . . 0.53 112.83 -170.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.618 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 23.3 t0 -88.35 68.85 9.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.43 0.633 . . . . 0.5 110.156 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.466 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 2.7 t -66.11 -21.69 29.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.297 -0.865 . . . . 0.64 109.699 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -79.7 -23.37 42.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.882 -1.054 . . . . 1.46 110.754 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 59.91 51.85 5.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.219 -0.9 . . . . 2.74 111.907 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.693 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 11.8 p-10 -118.63 7.54 11.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.969 0.414 . . . . 0.56 109.997 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.78 -1.51 30.0 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.987 -0.625 . . . . 0.49 112.79 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.526 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 64.2 mt -123.77 155.68 37.48 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.807 -0.442 . . . . 0.53 109.807 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -110.16 110.78 21.76 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.501 -0.48 . . . . 0.33 110.53 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 2.4 m-20 -70.97 169.08 15.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.103 -0.702 . . . . 1.85 109.103 168.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.8 -29.89 65.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.593 -0.276 . . . . 0.85 111.115 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.07 -51.92 61.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.847 0.832 . . . . 2.08 109.579 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -71.31 -35.98 71.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.536 -1.211 . . . . 0.48 110.966 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.493 ' CD1' HD11 ' A' ' 67' ' ' ILE . 58.8 t80 -70.51 -36.37 73.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.19 -0.459 . . . . 0.41 110.279 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.74 84.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.23 110.184 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -64.23 -46.52 83.47 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.989 -0.551 . . . . 1.29 109.552 177.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.46 94.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.3 -0.864 . . . . 0.23 111.296 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.03 -31.55 72.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.17 -0.468 . . . . 0.77 111.101 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -66.25 -40.69 90.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.932 -0.395 . . . . 0.33 109.932 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.63 HD12 HG23 ' A' ' 89' ' ' ILE . 89.4 mt -65.6 -39.47 91.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.882 -0.599 . . . . 0.28 110.438 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 62.7 mt -70.66 -37.77 70.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.002 -0.545 . . . . 0.7 110.927 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 26.1 ttpp -63.2 -45.78 90.08 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.913 -0.315 . . . . 1.77 110.532 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.61 -35.24 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.095 -0.642 . . . . 0.53 110.465 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.658 ' HD3' HD23 ' A' ' 122' ' ' LEU . 25.0 mmmt -56.21 -45.6 79.81 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.39 -0.368 . . . . 1.89 111.163 171.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 84.1 mt -67.2 -33.85 76.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.272 0.558 . . . . 0.74 110.646 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.6 mt-10 -78.0 4.39 12.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.663 -0.698 . . . . 1.98 111.386 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.65 34.91 14.65 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.99 -0.624 . . . . 0.87 112.54 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -122.91 171.42 9.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.806 0.336 . . . . 1.07 110.25 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -111.82 150.55 30.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.062 -0.517 . . . . 3.06 109.804 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.658 HD23 ' HD3' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -95.69 138.35 21.79 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.216 -1.031 . . . . 1.09 108.216 173.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.79 -9.76 17.5 Favored 'Trans proline' 0 N--CA 1.473 0.297 0 C-N-CA 122.947 2.431 . . . . 0.8 114.095 -171.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.436 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 62.86 17.57 10.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.585 0.707 . . . . 0.64 110.489 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.03 161.68 34.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.906 -1.043 . . . . 1.97 108.85 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.414 ' HG ' HD22 ' A' ' 92' ' ' LEU . 96.3 mt -110.52 90.81 10.9 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.916 -0.314 . . . . 0.67 111.346 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 50.2 Cg_endo -70.31 158.95 54.65 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.691 2.26 . . . . 0.52 111.553 171.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 34.5 Cg_exo -59.13 -7.79 5.42 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.521 2.814 . . . . 0.63 114.241 -176.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -108.42 -2.59 18.94 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.367 -0.533 . . . . 0.86 111.191 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -101.7 -36.67 8.64 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.117 0.484 . . . . 1.19 110.358 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 7.7 p -78.43 124.27 85.55 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.681 -0.69 . . . . 1.34 111.005 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 131' ' ' VAL . 22.1 Cg_exo -64.29 132.44 33.8 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.743 2.295 . . . . 0.9 111.707 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.39 -1.99 5.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.097 2.531 . . . . 1.44 112.125 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.3 t -78.06 -11.93 59.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.361 -0.836 . . . . 1.77 110.574 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.466 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 1.8 mptp? -112.83 10.13 19.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.35 -0.387 . . . . 1.2 111.148 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -98.73 92.25 5.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.505 -0.316 . . . . 3.94 110.17 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -96.46 116.25 28.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.535 -0.302 . . . . 5.08 110.227 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -110.15 134.46 52.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.219 -0.446 . . . . 6.35 110.827 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--O 1.244 0.792 0 CA-C-O 118.207 -0.901 . . . . 8.21 108.868 169.579 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.78 0.324 . . . . 12.91 110.284 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' B' ' 145' ' ' TYR . 25.1 t30 -139.63 -54.8 0.56 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.032 -0.531 . . . . 7.96 109.738 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' B' ' 144' ' ' ASN . 52.4 m-85 70.9 157.9 0.18 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.033 0.833 . . . . 10.06 112.446 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -82.29 94.79 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.103 -0.953 . . . . 5.36 110.373 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 20.9 t -70.29 118.01 12.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.139 -0.482 . . . . 3.46 110.55 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 3.0 m -106.53 20.02 19.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.751 0.786 . . . . 1.49 109.677 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.678 HD21 ' HA2' ' A' ' 87' ' ' GLY . 27.0 t-20 -99.23 110.62 58.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.506 -0.77 . . . . 0.84 110.28 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 8.0 Cg_exo -73.14 -2.87 12.7 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.53 2.82 . . . . 0.66 113.028 -176.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 96.8 m-85 -91.72 -19.73 22.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.46 -0.336 . . . . 0.68 110.867 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 10.2 t -114.39 -42.73 3.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.752 -0.379 . . . . 1.83 111.149 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 64.22 -67.2 0.11 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.465 0.706 . . . . 3.77 112.395 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? . . . . . 0 C--O 1.245 0.843 0 C-N-CA 123.959 0.904 . . . . 6.44 110.783 -179.065 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.693 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.798 -0.521 . . . . 9.38 111.798 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.13 162.94 37.77 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.682 2.255 . . . . 8.63 111.913 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 tt -88.67 -52.88 4.91 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.626 -0.509 . . . . 8.95 109.626 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.62 119.64 2.3 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.836 -0.906 . . . . 5.86 110.836 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.0 t -108.17 70.56 0.77 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.122 0.461 . . . . 6.0 111.708 -171.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -118.62 111.78 19.0 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.173 -0.677 . . . . 3.94 109.173 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -98.27 106.1 18.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.423 -0.353 . . . . 3.28 110.368 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.17 134.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.159 0.504 . . . . 1.89 111.76 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.48 111.14 23.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.8 -0.636 . . . . 2.49 110.476 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.494 ' HD1' ' O ' ' A' ' 129' ' ' HIS . 10.2 t90 -84.99 107.88 17.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.112 -0.699 . . . . 0.66 109.112 176.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -69.34 5.2 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.746 0.647 . . . . 1.41 112.746 -172.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG21 HD22 ' A' ' 108' ' ' LEU . 97.0 t -105.97 -19.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.96 0.409 . . . . 1.01 110.292 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.573 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -68.39 -18.2 71.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.634 -0.793 . . . . 0.62 111.557 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -74.76 -27.4 60.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.54 -0.33 . . . . 2.67 111.292 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -127.61 33.49 4.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.909 0.385 . . . . 1.71 110.612 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.625 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 6.8 mmmm -64.62 -45.27 76.14 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.837 0.68 . . . . 1.2 112.837 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.5 Cg_endo -49.85 -35.22 39.21 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 122.397 2.064 . . . . 0.62 112.415 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 56' ' ' ILE . 11.5 m -73.53 -46.43 47.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.517 -0.31 . . . . 0.72 111.302 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -71.56 -23.28 61.72 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.766 -0.457 . . . . 0.65 109.766 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.42 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 15.2 t70 -73.86 -44.52 55.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.47 -0.786 . . . . 1.03 109.265 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 59' ' ' THR . 35.3 tt0 -57.02 -46.54 82.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.143 -0.935 . . . . 2.15 110.358 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 52' ' ' THR . 58.9 mt -67.11 -49.21 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.137 -0.483 . . . . 0.71 110.789 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.46 ' HE1' HG12 ' A' ' 67' ' ' ILE . 77.8 t80 -51.25 -46.44 62.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.853 -0.612 . . . . 0.31 111.682 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 29.3 m-85 -74.19 -12.37 60.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.684 0.624 . . . . 0.8 112.684 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 55' ' ' GLU . 70.1 p -90.96 4.37 52.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.114 0.483 . . . . 0.61 110.737 177.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 82.3 mt -105.91 6.58 31.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.768 -0.456 . . . . 0.41 109.768 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.7 m 65.59 82.49 0.2 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.185 -0.916 . . . . 1.24 111.43 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 61.5 Cg_endo -92.04 113.84 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.737 2.291 . . . . 0.59 113.287 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.8 146.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.625 -0.88 . . . . 1.31 108.625 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 p30 50.33 22.35 0.98 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.746 0.818 . . . . 1.89 112.136 -174.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.61 29.62 47.64 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.238 -0.506 . . . . 0.62 111.872 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.737 ' HE2' ' HB3' ' A' ' 102' ' ' ASP . 32.4 ttmt -156.19 146.81 21.82 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.902 0.382 . . . . 1.81 110.719 -173.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.46 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.5 pt -103.14 156.31 5.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.224 0.535 . . . . 0.3 110.43 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.419 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 73.2 p -89.39 178.1 6.41 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.602 -0.726 . . . . 0.44 109.972 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.686 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -65.19 -17.62 63.95 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.979 -0.629 . . . . 0.33 112.299 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.73 -47.29 63.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.216 0.531 . . . . 0.34 111.332 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.66 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.3 m120 -73.79 -41.45 62.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.587 -0.733 . . . . 1.65 110.367 -173.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.4 -19.79 60.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.188 -0.46 . . . . 0.27 110.193 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.686 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 3.6 ttmp? -68.38 -51.59 42.54 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.754 -0.461 . . . . 1.52 109.754 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.52 ' HA ' HG22 ' A' ' 77' ' ' VAL . 18.6 ptpt -63.33 -32.94 74.5 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.965 -0.562 . . . . 1.14 110.391 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.53 -53.82 51.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.792 -0.447 . . . . 1.78 109.792 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.424 ' HB3' HD22 ' A' ' 86' ' ' LEU . 57.5 mtt -69.5 -33.61 73.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.032 -0.531 . . . . 0.86 112.198 -173.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 74' ' ' LYS . 30.9 m -77.0 -19.04 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.644 -0.422 . . . . 1.52 109.914 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 12.7 mptt -87.47 -12.33 46.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.911 -0.586 . . . . 3.33 110.453 174.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.5 m -86.75 -5.1 59.22 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.876 -0.602 . . . . 0.91 111.092 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.4 mptt 68.24 29.0 6.22 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.297 0.639 . . . . 2.97 111.786 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.724 ' HB2' HD21 ' A' ' 86' ' ' LEU . 24.3 mt -98.14 143.38 26.17 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.428 -0.351 . . . . 1.41 111.068 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.499 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.5 Cg_endo -61.64 150.9 83.57 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.257 2.638 . . . . 0.32 113.51 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -55.99 -42.27 76.11 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.697 -0.683 . . . . 2.05 111.85 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.1 m -58.04 -54.13 50.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.306 -0.406 . . . . 0.84 110.909 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.469 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 47.0 t -57.71 -44.13 85.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.103 -0.499 . . . . 0.26 110.87 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.724 HD21 ' HB2' ' A' ' 81' ' ' LEU . 56.6 mt -63.42 -36.04 82.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.29 111.229 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.764 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.59 -42.71 99.31 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.846 -0.692 . . . . 0.36 111.656 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 20.6 mtpp -68.47 -46.18 70.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.5 -0.35 . . . . 1.29 110.353 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.465 ' HA ' HD23 ' A' ' 92' ' ' LEU . 88.2 mt -56.83 -52.13 58.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 123.512 0.507 . . . . 0.27 110.85 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -60.43 -53.66 54.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.448 -0.342 . . . . 0.37 111.66 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -65.1 -23.28 67.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.038 0.447 . . . . 2.54 111.238 -172.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -92.75 -39.45 11.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.849 -0.614 . . . . 1.5 110.229 -177.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.485 ' N ' ' HG ' ' A' ' 92' ' ' LEU . . . -70.28 -39.28 74.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.53 111.047 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.653 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 47.0 t0 -74.47 93.47 2.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.658 -0.867 . . . . 0.5 108.658 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.707 HG21 ' HD2' ' A' ' 132' ' ' PRO . 32.5 t -69.29 -51.07 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.337 -0.847 . . . . 0.64 110.28 -174.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.612 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 1.8 p30 -76.34 -21.24 56.4 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.278 -0.873 . . . . 1.46 111.225 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.585 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 40.8 mttp 56.71 65.78 1.33 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.131 -0.94 . . . . 2.74 110.74 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 23.1 p-10 -108.93 10.97 26.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.256 -1.338 . . . . 0.56 109.832 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.56 11.78 80.3 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.313 -0.858 . . . . 0.49 111.879 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.492 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 33.8 mt -144.28 161.55 38.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.344 -0.613 . . . . 0.53 109.344 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.407 ' C ' ' HG3' ' A' ' 66' ' ' LYS . 71.1 mt -124.8 115.47 20.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.163 -0.31 . . . . 0.33 110.163 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.737 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 1.7 p30 -77.82 -176.41 4.41 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.303 -0.629 . . . . 1.85 109.303 171.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -63.62 -27.02 68.95 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.934 -0.306 . . . . 0.85 111.474 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 86.7 mt-10 -85.03 -39.07 18.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.212 -0.195 . . . . 2.08 110.918 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.424 ' HG2' ' HE3' ' A' ' 135' ' ' LYS . 21.8 mt-10 -69.34 -37.5 77.7 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.256 0.55 . . . . 0.48 110.182 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -66.86 -42.38 85.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.749 -0.659 . . . . 0.41 109.886 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.08 91.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 0.23 110.831 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -61.29 -46.82 88.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.814 -0.63 . . . . 1.29 109.728 177.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.11 -49.33 78.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.23 111.636 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.4 -33.47 76.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.77 110.856 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.43 ' O ' HG22 ' A' ' 115' ' ' VAL . 38.7 t60 -67.72 -36.39 80.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.036 -0.357 . . . . 0.33 110.036 177.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.586 HD13 HD21 ' A' ' 92' ' ' LEU . 91.8 mt -66.15 -39.25 89.68 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.927 -0.579 . . . . 0.28 110.587 176.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 81' ' ' LEU . 54.9 mt -69.07 -37.69 77.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.747 -0.66 . . . . 0.7 110.326 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 42.1 tttp -61.88 -47.32 85.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.992 -0.549 . . . . 1.77 110.686 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 111' ' ' HIS . 6.7 m -68.11 -31.16 50.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 120.547 -0.461 . . . . 0.53 111.322 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 116' ' ' LYS . 25.5 mmmt -56.14 -45.07 79.75 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.066 -0.253 . . . . 1.89 110.385 168.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.74 -29.78 63.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.263 -0.426 . . . . 0.74 110.885 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 59.7 mm-40 -65.95 -21.96 66.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.873 -0.603 . . . . 1.98 110.489 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.52 36.03 3.92 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.752 -0.737 . . . . 0.87 112.13 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -126.96 150.07 49.55 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.847 -0.427 . . . . 1.07 109.847 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -95.95 130.0 43.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.942 0.401 . . . . 3.06 110.725 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.44 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -81.95 134.63 49.47 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.048 -0.524 . . . . 1.09 110.005 174.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.01 2.7 6.34 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.908 2.405 . . . . 0.8 113.745 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.575 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 58.78 22.68 10.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.427 0.632 . . . . 0.64 110.306 -176.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.86 162.12 32.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.194 -0.912 . . . . 1.97 109.882 -172.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 52.1 mt -112.69 94.0 26.4 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 123.262 0.351 . . . . 0.67 111.781 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.91 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 14.0 Cg_endo -58.63 153.31 49.87 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.866 2.377 . . . . 0.52 111.333 169.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.35 -10.03 17.33 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.921 2.414 . . . . 0.63 113.308 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.494 ' O ' ' HD1' ' A' ' 44' ' ' TRP . 26.4 p-80 -108.4 1.51 21.79 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.159 -0.338 . . . . 0.86 110.397 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.91 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 1.4 mp -103.85 -7.63 20.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.885 0.374 . . . . 1.19 111.038 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -87.42 117.8 69.03 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.248 -0.433 . . . . 1.34 110.887 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.707 ' HD2' HG21 ' A' ' 95' ' ' VAL . 53.1 Cg_exo -56.74 138.37 85.04 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.943 2.429 . . . . 0.9 111.952 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.465 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 54.6 Cg_endo -70.97 -7.39 21.31 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 123.001 2.468 . . . . 1.44 113.484 -173.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.8 m -82.72 0.41 43.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.353 0.597 . . . . 1.77 110.225 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.536 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 3.3 mptp? -117.51 31.06 6.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.591 -0.731 . . . . 1.2 109.118 177.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' A' ' 133' ' ' PRO . 3.9 mmp_? -103.58 146.83 27.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.569 -0.741 . . . . 3.94 109.963 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -134.01 143.48 48.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.044 -0.525 . . . . 5.08 109.635 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -110.53 136.45 49.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.162 -0.681 . . . . 6.35 109.162 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 . . . . . 0 C--O 1.246 0.875 0 O-C-N 123.953 0.783 . . . . 8.21 110.968 -177.809 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 69.3 t80 . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.88 0.371 . . . . 12.91 110.738 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -121.54 163.17 19.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.412 -0.358 . . . . 7.96 110.36 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -157.86 170.19 22.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.399 -0.364 . . . . 10.06 110.321 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -133.6 113.98 13.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.135 -0.484 . . . . 5.36 109.722 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 28.3 p -93.41 75.4 4.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.914 0.388 . . . . 3.46 109.989 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -21.56 46.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 1.49 110.738 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.764 HD21 ' HA2' ' A' ' 87' ' ' GLY . 25.2 t-20 -119.23 107.06 42.02 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.991 0.424 . . . . 0.84 110.176 175.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 7.4 Cg_exo -73.42 -1.45 10.68 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.521 2.814 . . . . 0.66 112.948 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -101.1 -6.76 23.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.497 -0.32 . . . . 0.68 111.662 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.3 p -134.11 102.58 5.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.279 0.561 . . . . 1.83 111.307 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -114.5 134.08 55.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 3.77 110.434 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt . . . . . 0 C--O 1.244 0.775 0 CA-C-O 118.306 -0.854 . . . . 6.44 109.764 178.063 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.653 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.796 -0.522 . . . . 9.38 111.796 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -86.72 166.44 8.78 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.674 2.249 . . . . 8.63 112.269 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.9 tp -103.52 101.15 11.02 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.062 -0.718 . . . . 8.95 109.062 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.07 139.05 15.06 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.842 -0.694 . . . . 5.86 112.868 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.7 m -153.57 156.44 38.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.143 -0.688 . . . . 6.0 109.143 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -91.72 118.05 30.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.327 0.584 . . . . 3.94 111.08 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -94.92 75.94 3.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.091 -1.078 . . . . 3.28 108.091 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.0 p -93.97 137.33 23.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.438 -0.801 . . . . 1.89 110.458 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -94.08 104.08 16.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.163 -0.471 . . . . 2.49 110.759 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -81.55 106.72 13.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.809 -0.812 . . . . 0.66 108.809 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.2 m -66.73 -1.15 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.83 -0.623 . . . . 1.41 112.521 -171.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.5 -17.51 7.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.139 -0.482 . . . . 1.01 110.275 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.31 -10.56 74.69 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.634 -0.793 . . . . 0.62 112.549 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -89.28 -28.11 20.12 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.653 -0.322 . . . . 2.67 111.362 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -112.58 33.13 5.14 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.72 -0.844 . . . . 1.71 108.72 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.561 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 9.1 tmtt? -72.47 -49.98 8.45 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 114.76 -1.109 . . . . 1.2 112.313 -169.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.5 Cg_endo -54.35 -29.58 58.79 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.628 2.219 . . . . 0.62 113.235 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.0 m -70.28 -39.5 74.86 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.036 0.446 . . . . 0.72 110.335 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -70.91 -22.97 62.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.23 -0.441 . . . . 0.65 109.955 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.46 -44.69 70.7 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.129 0.49 . . . . 1.03 110.018 172.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -57.6 -42.2 82.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.346 -0.843 . . . . 2.15 110.267 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.412 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 50.2 mt -79.19 -28.88 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 0.71 111.18 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -71.37 -45.84 61.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.246 0.546 . . . . 0.31 110.686 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -76.48 -13.08 60.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.78 -0.645 . . . . 0.8 112.065 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.2 p -94.09 1.57 56.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.128 0.49 . . . . 0.61 111.214 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 58.2 mt -110.02 8.82 24.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.0 -0.545 . . . . 0.41 110.125 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 m 67.79 82.2 0.19 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.317 -0.856 . . . . 1.24 111.54 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -90.46 116.68 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.629 2.219 . . . . 0.59 112.555 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -88.37 134.62 27.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.628 -0.508 . . . . 1.31 109.628 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 47.05 25.7 0.53 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.792 0.837 . . . . 1.89 112.749 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.93 19.75 33.05 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.333 -0.46 . . . . 0.62 112.509 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 66' ' ' LYS . 31.1 ttmt -150.52 144.46 25.35 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 110.453 -0.203 . . . . 1.81 110.453 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.483 HD11 ' CD1' ' A' ' 106' ' ' PHE . 19.8 pt -100.43 149.37 6.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 120.55 -0.46 . . . . 0.3 110.355 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.555 ' HA ' HD22 ' A' ' 100' ' ' LEU . 81.4 p -76.66 166.82 22.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.068 -0.515 . . . . 0.44 110.034 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.89 -32.52 70.52 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.589 -0.815 . . . . 0.33 112.103 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.502 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -49.18 -55.75 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.375 0.509 . . . . 0.34 112.375 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -70.68 -41.86 71.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.172 0.51 . . . . 1.65 110.989 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.487 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -71.36 -33.41 69.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.916 -0.584 . . . . 0.27 110.582 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.582 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 28.1 ttpp -63.9 -52.65 58.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.91 -0.587 . . . . 1.52 110.727 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.601 ' O ' HG22 ' A' ' 77' ' ' VAL . 17.3 ptmt -62.93 -32.89 74.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.983 -0.553 . . . . 1.14 110.607 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.583 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 35.3 tp10 -62.54 -38.88 91.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.307 0.575 . . . . 1.78 110.204 175.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.915 ' HB3' HD22 ' A' ' 86' ' ' LEU . 50.7 mtt -77.07 -20.47 55.78 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.632 -0.427 . . . . 0.86 111.67 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 74' ' ' LYS . 9.9 m -81.09 -23.45 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.045 -0.662 . . . . 1.52 110.747 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -87.15 -11.12 50.94 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.364 -0.534 . . . . 3.33 110.232 170.411 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.7 m -69.5 -17.48 63.6 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.948 -0.569 . . . . 0.91 110.061 169.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 17.5 tptp 69.27 24.25 5.99 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.645 -0.707 . . . . 2.97 111.65 171.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.625 ' HB2' HD21 ' A' ' 86' ' ' LEU . 59.0 mt -100.78 153.34 37.79 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.807 -0.633 . . . . 1.41 110.004 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.49 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 12.1 Cg_endo -57.36 141.7 94.85 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.813 2.342 . . . . 0.32 112.39 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -59.45 -34.2 72.24 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.139 -0.482 . . . . 2.05 111.252 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -47.85 83.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.154 -0.475 . . . . 0.84 110.822 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.696 HG11 ' HD2' ' A' ' 116' ' ' LYS . 75.8 t -63.72 -41.73 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.588 -0.733 . . . . 0.26 110.477 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.915 HD22 ' HB3' ' A' ' 76' ' ' MET . 57.5 mt -58.8 -45.85 88.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.098 0.475 . . . . 0.29 110.392 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.581 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.91 -37.79 94.34 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.845 -0.616 . . . . 0.36 112.235 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.568 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 46.2 mtpt -69.53 -39.74 77.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.955 0.407 . . . . 1.29 110.418 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.93 -37.91 80.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.711 -0.677 . . . . 0.27 110.252 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.485 ' CZ3' ' HG ' ' A' ' 101' ' ' LEU . 31.1 t-105 -61.88 -46.04 91.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.246 -0.434 . . . . 0.37 110.356 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -59.79 -37.0 77.89 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.212 0.529 . . . . 2.54 110.641 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 86.2 mt -70.22 -41.99 72.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.473 -0.785 . . . . 1.5 110.748 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -73.59 -43.72 58.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.646 -0.707 . . . . 0.53 111.737 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.633 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 35.6 t0 -84.13 81.58 8.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.369 0.604 . . . . 0.5 109.955 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.475 HG21 ' HD2' ' A' ' 132' ' ' PRO . 13.5 t -69.2 -44.31 80.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.271 -0.877 . . . . 0.64 110.64 -176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.604 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.5 OUTLIER -75.18 -17.94 60.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.372 -0.831 . . . . 1.46 111.108 -177.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.587 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 9.8 mtpm? 58.07 56.88 4.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.39 -0.823 . . . . 2.74 111.001 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -106.92 10.17 30.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.66 -0.7 . . . . 0.56 111.042 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.06 10.12 72.76 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.025 -0.607 . . . . 0.49 112.341 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' A' ' 68' ' ' THR . 66.9 mt -139.3 152.84 47.56 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.387 -0.968 . . . . 0.53 108.387 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.487 HD12 ' CB ' ' A' ' 72' ' ' ALA . 19.6 mt -99.69 110.73 23.12 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.588 -0.845 . . . . 0.33 110.285 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.757 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 12.7 t70 -70.73 171.99 9.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.779 -1.1 . . . . 1.85 108.422 173.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.64 -43.26 89.67 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.625 0.25 . . . . 0.85 111.266 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.621 ' OE1' ' HB3' ' A' ' 134' ' ' SER . 31.5 mt-10 -61.51 -44.38 97.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.797 0.808 . . . . 2.08 109.856 176.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.757 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 15.1 mt-10 -68.2 -39.39 82.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.452 -1.249 . . . . 0.48 110.521 -173.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CD1' HD11 ' A' ' 67' ' ' ILE . 65.8 t80 -68.28 -42.67 79.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.296 -0.411 . . . . 0.41 110.215 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.27 93.72 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.751 -0.658 . . . . 0.23 110.272 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 93' ' ' ALA . 17.8 tp -62.01 -45.48 93.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.754 -0.657 . . . . 1.29 110.137 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.518 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -57.37 -47.78 80.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.451 -0.795 . . . . 0.23 111.364 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -68.53 -28.88 67.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.418 -0.355 . . . . 0.77 111.249 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -68.48 -37.88 80.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.192 0.52 . . . . 0.33 110.093 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HA ' HG22 ' A' ' 115' ' ' VAL . 59.7 mt -69.05 -36.39 77.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 0.28 110.247 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 109' ' ' ALA . 46.4 mm -59.25 -44.25 91.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.02 -0.536 . . . . 0.7 110.163 173.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 49.8 tttp -63.85 -47.38 80.94 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.82 -0.627 . . . . 1.77 111.111 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 112' ' ' LEU . 14.7 m -64.29 -36.7 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.358 -0.537 . . . . 0.53 111.496 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.696 ' HD2' HG11 ' A' ' 85' ' ' VAL . 2.1 mmtm -56.35 -42.79 78.33 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 121.299 -0.161 . . . . 1.89 111.317 170.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 98.0 mt -71.52 -34.01 69.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.763 0.316 . . . . 0.74 110.836 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 81.0 mm-40 -68.85 -14.06 62.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 1.98 110.473 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.84 17.41 58.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.84 -0.695 . . . . 0.87 112.436 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -103.24 164.06 11.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.717 0.294 . . . . 1.07 110.301 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -88.68 140.53 29.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.214 0.53 . . . . 3.06 112.145 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.585 HD23 ' HG2' ' A' ' 116' ' ' LYS . 4.1 pp -110.51 127.04 27.65 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 107.266 -1.383 . . . . 1.09 107.266 165.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 1.8 Cg_endo -74.53 -15.12 22.16 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.375 2.05 . . . . 0.8 113.743 -166.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.477 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . . . 69.51 19.12 7.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.669 0.747 . . . . 0.64 109.663 -170.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -124.42 156.9 36.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.962 -1.017 . . . . 1.97 108.639 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 87.8 mt -116.49 96.22 47.53 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.834 0.349 . . . . 0.67 111.577 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 29.5 Cg_endo -65.37 155.11 70.45 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.615 2.21 . . . . 0.52 111.65 173.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.09 -26.92 27.41 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.252 2.635 . . . . 0.63 113.689 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -91.84 18.4 7.79 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.998 0.369 . . . . 0.86 111.998 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 44.7 mt -129.94 3.41 4.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.664 -0.244 . . . . 1.19 111.015 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.6 t -87.55 116.58 66.61 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.404 . . . . 1.34 111.028 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.649 ' HB2' ' HD2' ' A' ' 135' ' ' LYS . 77.1 Cg_exo -52.04 134.16 48.58 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.05 2.5 . . . . 0.9 111.885 176.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 10.5 Cg_exo -70.27 -20.88 31.86 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.878 2.385 . . . . 1.44 113.886 -173.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.621 ' HB3' ' OE1' ' A' ' 104' ' ' GLU . 8.2 t -88.54 8.75 26.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.445 0.64 . . . . 1.77 110.168 -174.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.649 ' HD2' ' HB2' ' A' ' 132' ' ' PRO . 3.4 mptp? -113.23 3.35 15.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.731 0.777 . . . . 1.2 109.413 172.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -110.59 147.14 34.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.917 -1.038 . . . . 3.94 109.914 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -58.4 124.38 19.34 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.017 -0.734 . . . . 5.08 109.017 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -113.59 106.03 14.04 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.531 -0.304 . . . . 6.35 111.129 -171.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 . . . . . 0 C--O 1.246 0.914 0 O-C-N 124.071 0.857 . . . . 8.21 111.378 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.45 0.167 . . . . 12.91 110.778 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -73.72 -62.24 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 7.96 110.392 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -163.38 109.75 1.14 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.808 -0.812 . . . . 10.06 108.808 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.14 138.64 54.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.827 -0.624 . . . . 5.36 109.616 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 28.5 t -61.87 98.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.186 0.517 . . . . 3.46 110.838 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 13.3 t -130.5 2.38 4.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.683 -0.689 . . . . 1.49 109.923 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.581 HD21 ' HA2' ' A' ' 87' ' ' GLY . 45.1 t-20 -146.29 111.32 4.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.825 . . . . 0.84 109.247 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 38.3 Cg_endo -67.11 -14.72 44.38 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.106 2.537 . . . . 0.66 113.64 -175.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.582 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 62.6 m-85 -73.67 -37.18 65.34 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.724 0.268 . . . . 0.68 111.724 -176.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 8.5 t -163.35 85.41 0.5 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.896 0.855 . . . . 1.83 110.812 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.73 25.32 7.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.501 -0.772 . . . . 3.77 110.654 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 55.4 mttm . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.584 -0.722 . . . . 6.44 109.709 178.423 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.633 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.848 0 N-CA-C 111.959 -0.456 . . . . 9.38 111.959 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.28 -64.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.652 2.235 . . . . 8.63 111.702 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.1 mt -141.71 -51.89 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.462 0.649 . . . . 8.95 109.571 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.34 116.88 0.6 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.293 -1.123 . . . . 5.86 110.293 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -63.12 -53.27 56.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.703 0.287 . . . . 6.0 110.996 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.56 93.59 4.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.451 -0.341 . . . . 3.94 111.38 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -104.58 112.37 25.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.575 0.702 . . . . 3.28 109.405 171.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.1 t -106.47 137.72 35.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.62 -0.718 . . . . 1.89 111.043 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -111.84 138.3 48.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 2.49 110.823 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' ' HB3' ' A' ' 132' ' ' PRO . 5.2 t90 -95.38 108.81 21.02 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.318 -0.623 . . . . 0.66 109.318 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.21 -17.9 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 1.41 112.116 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.32 -18.15 15.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.19 0.519 . . . . 1.01 110.047 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.3 -13.1 73.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.793 -0.718 . . . . 0.62 112.104 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -78.64 -29.21 45.7 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.198 0.523 . . . . 2.67 110.484 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -128.5 33.24 4.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.372 -0.831 . . . . 1.71 109.934 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 4.0 tmtm? -72.26 -47.95 10.29 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.282 -0.872 . . . . 1.2 111.914 -174.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.4 Cg_endo -53.23 -29.56 47.22 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.545 2.163 . . . . 0.62 113.151 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.4 m -71.92 -44.14 64.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.801 0.334 . . . . 0.72 110.482 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -70.43 -22.6 62.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.422 -0.585 . . . . 0.65 109.422 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.428 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 7.9 t70 -72.96 -44.96 60.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.534 -0.757 . . . . 1.03 109.851 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.91 -43.03 95.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.941 -1.027 . . . . 2.15 110.799 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.14 -33.73 56.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.247 0.546 . . . . 0.71 110.575 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.522 ' HE1' HG12 ' A' ' 67' ' ' ILE . 71.0 t80 -64.03 -49.27 73.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.31 110.596 -175.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.428 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 43.1 m-85 -70.47 -21.51 62.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.811 -0.632 . . . . 0.8 112.532 -174.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.7 p -79.18 -0.48 32.06 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.507 -0.477 . . . . 0.61 111.502 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 94.0 mt -105.42 7.28 33.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.533 -0.303 . . . . 0.41 111.116 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 t 63.09 89.91 0.1 OUTLIER Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 115.921 -0.581 . . . . 1.24 111.179 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -84.67 117.62 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.361 2.041 . . . . 0.59 112.954 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.18 128.02 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.585 . . . . 1.31 110.02 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 m120 63.59 21.48 12.75 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.643 -0.503 . . . . 1.89 109.643 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.05 3.53 90.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.808 -0.711 . . . . 0.62 112.443 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -125.32 143.41 50.98 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.686 0.279 . . . . 1.81 110.415 177.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.522 HG12 ' HE1' ' A' ' 57' ' ' PHE . 9.6 pt -84.14 143.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 119.996 -0.682 . . . . 0.3 110.505 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.5 p -74.74 162.7 28.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.044 -0.98 . . . . 0.44 110.624 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -56.78 -31.07 60.49 Favored Glycine 0 C--O 1.218 -0.863 0 C-N-CA 120.905 -0.664 . . . . 0.33 112.173 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.1 -53.45 53.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.459 0.54 . . . . 0.34 112.459 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.59 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 58.6 m-80 -79.54 -35.7 39.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.118 -0.492 . . . . 1.65 111.693 -171.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.99 -26.88 65.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.156 0.503 . . . . 0.27 109.768 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.574 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 38.7 ttmt -68.56 -54.62 15.5 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.579 -0.737 . . . . 1.52 110.367 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 18.2 ptpt -58.02 -38.94 77.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 1.14 110.416 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.04 -44.99 94.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.184 0.516 . . . . 1.78 110.167 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.89 ' HB3' HD22 ' A' ' 86' ' ' LEU . 42.9 mtt -67.41 -27.9 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.86 110.777 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 73' ' ' LYS . 55.7 t -70.66 -38.09 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.289 0.566 . . . . 1.52 109.65 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 16.9 mmtp -72.04 -13.01 61.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.776 -0.647 . . . . 3.33 110.749 176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.8 m -80.9 -14.79 57.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.91 110.591 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mptt 72.24 18.92 4.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.648 0.779 . . . . 2.97 111.875 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.589 ' HB2' HD21 ' A' ' 86' ' ' LEU . 3.9 mm? -87.19 144.48 36.22 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.985 0.422 . . . . 1.41 110.5 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.557 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.0 Cg_endo -61.19 151.39 79.19 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.137 2.558 . . . . 0.32 112.713 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -58.65 -33.94 70.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.933 -0.576 . . . . 2.05 111.495 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.3 m -60.56 -51.28 70.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.198 0.523 . . . . 0.84 110.473 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.636 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 71.5 t -64.13 -40.24 88.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.745 -0.661 . . . . 0.26 110.76 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.89 HD22 ' HB3' ' A' ' 76' ' ' MET . 58.7 mt -61.73 -41.24 97.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.968 -0.56 . . . . 0.29 110.817 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.556 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -62.21 -42.07 99.72 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.116 -0.564 . . . . 0.36 111.924 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.636 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 51.0 mtpt -57.41 -51.39 69.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.159 0.504 . . . . 1.29 110.447 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.53 HG12 HD21 ' A' ' 122' ' ' LEU . 84.6 mt -64.54 -38.27 82.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.47 -0.787 . . . . 0.27 111.333 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -62.05 -49.06 77.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.714 0.292 . . . . 0.37 110.903 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -64.35 -24.63 67.71 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.124 -0.489 . . . . 2.54 111.308 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.578 ' O ' HD11 ' A' ' 126' ' ' LEU . 88.2 mt -88.61 -48.64 7.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.511 . . . . 1.5 111.379 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -64.68 -36.46 84.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.842 -0.617 . . . . 0.53 111.067 -173.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.645 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 42.7 t0 -79.68 82.74 5.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.8 -0.815 . . . . 0.5 108.8 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.937 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 6.4 t -71.28 -40.63 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.65 -0.704 . . . . 0.64 109.956 -174.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.622 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 14.4 p-10 -81.42 -18.0 46.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 1.46 110.207 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.591 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 22.6 mttp 59.96 59.12 2.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.065 -0.971 . . . . 2.74 110.942 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 14.4 p-10 -107.78 8.96 29.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.908 -1.042 . . . . 0.56 110.023 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.54 9.03 81.84 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.756 -0.656 . . . . 0.49 111.876 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 66' ' ' LYS . 60.1 mt -139.27 167.93 20.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.621 -0.511 . . . . 0.53 109.621 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.2 mt -124.96 116.48 22.24 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.174 -0.306 . . . . 0.33 110.174 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' CA ' ' HG3' ' A' ' 66' ' ' LYS . 3.0 p30 -78.75 177.86 8.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.137 -0.69 . . . . 1.85 109.137 171.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -61.16 -25.39 66.98 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.6 0.593 . . . . 0.85 112.6 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -81.63 -40.25 23.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 2.08 110.311 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.461 ' HG3' ' OD2' ' A' ' 102' ' ' ASP . 20.0 mt-10 -67.58 -36.55 81.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.368 0.604 . . . . 0.48 109.486 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' A' ' 67' ' ' ILE . 31.8 t80 -74.21 -33.15 63.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.838 -0.619 . . . . 0.41 110.171 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.33 94.33 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.279 0.562 . . . . 0.23 109.861 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 93' ' ' ALA . 16.0 tp -61.26 -44.91 96.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.221 -0.9 . . . . 1.29 110.035 176.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.06 -49.99 72.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.666 -0.697 . . . . 0.23 110.92 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -39.24 87.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 0.77 111.038 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -69.05 -38.46 79.13 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.947 -0.301 . . . . 0.33 110.749 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.702 ' HB3' HD23 ' A' ' 122' ' ' LEU . 92.8 mt -66.94 -38.59 86.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.257 -0.429 . . . . 0.28 110.907 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 76' ' ' MET . 79.9 mt -70.37 -32.94 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.101 0.477 . . . . 0.7 110.049 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 4.0 tppp? -59.04 -53.32 59.71 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 115.919 -0.582 . . . . 1.77 110.514 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.3 m -64.14 -34.64 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 121.11 -0.236 . . . . 0.53 111.391 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 116' ' ' LYS . 27.0 mmmt -53.59 -48.89 68.82 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.596 0.236 . . . . 1.89 111.446 167.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.3 -22.62 62.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.902 0.382 . . . . 0.74 110.942 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 6.2 mm-40 -75.35 -2.4 28.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.924 -0.58 . . . . 1.98 110.771 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.5 35.81 11.45 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.65 -0.786 . . . . 0.87 111.988 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -130.87 172.48 11.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.988 0.423 . . . . 1.07 110.594 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -122.46 121.9 37.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.679 -0.691 . . . . 3.06 109.846 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -60.87 146.6 86.75 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.052 -0.522 . . . . 1.09 110.097 169.319 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.74 6.12 2.57 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.51 2.14 . . . . 0.8 113.225 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.509 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 60.38 17.79 7.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.813 -0.631 . . . . 0.64 111.763 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -136.17 166.9 22.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.359 -0.608 . . . . 1.97 109.359 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.578 HD11 ' O ' ' A' ' 92' ' ' LEU . 82.1 mt -114.88 93.17 33.12 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.701 0.286 . . . . 0.67 111.618 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.663 ' HD2' HD12 ' A' ' 130' ' ' LEU . 34.4 Cg_endo -66.44 166.22 22.4 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.797 2.331 . . . . 0.52 111.537 169.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.69 3.42 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.237 2.625 . . . . 0.63 114.334 -176.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -114.03 6.7 16.55 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.545 -0.462 . . . . 0.86 111.219 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.663 HD12 ' HD2' ' A' ' 127' ' ' PRO . 42.3 mt -115.9 -34.31 4.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.497 -0.32 . . . . 1.19 110.912 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.57 115.18 43.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.855 -0.424 . . . . 1.34 109.855 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 37.1 Cg_endo -67.28 152.76 78.81 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.734 2.289 . . . . 0.9 112.612 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.556 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 37.6 Cg_exo -61.68 -10.1 15.8 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.881 2.387 . . . . 1.44 111.635 175.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.4 t -67.02 -19.33 65.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.604 -0.726 . . . . 1.77 109.738 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.937 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 5.3 mptt -113.15 34.36 4.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.828 -0.623 . . . . 1.2 110.701 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 133' ' ' PRO . 5.6 mmp_? -102.43 128.63 48.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.215 -0.661 . . . . 3.94 109.215 170.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -78.05 109.43 12.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.188 0.518 . . . . 5.08 110.771 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -132.6 110.9 10.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.741 . . . . 6.35 109.388 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.906 -0.569 . . . . 8.21 109.475 176.403 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.68 0.276 . . . . 12.91 110.31 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -76.88 122.99 25.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.853 -0.425 . . . . 7.96 109.853 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -70.87 172.97 7.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.231 -0.44 . . . . 10.06 110.991 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -93.02 93.19 8.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.103 0.478 . . . . 5.36 110.709 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -131.07 -42.98 1.08 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.627 -0.715 . . . . 3.46 109.281 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.94 12.13 11.88 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.555 -0.748 . . . . 1.49 110.784 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.556 HD21 ' HA2' ' A' ' 87' ' ' GLY . 47.4 t-20 -98.1 119.43 62.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.999 -0.546 . . . . 0.84 109.715 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 24.4 Cg_exo -64.36 -16.41 54.96 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.16 2.573 . . . . 0.66 113.393 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 82.5 m-85 -81.69 -17.82 46.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.739 0.274 . . . . 0.68 111.739 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 10.0 t -159.82 116.94 2.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.238 0.542 . . . . 1.83 109.678 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.49 178.99 5.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 3.77 112.002 -171.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.167 -0.92 . . . . 6.44 110.421 -178.452 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.645 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.105 -0.398 . . . . 9.38 112.105 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.78 152.99 79.48 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.98 2.453 . . . . 8.63 112.564 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.0 mt 69.34 100.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.037 0.836 . . . . 8.95 111.3 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.66 -161.12 9.82 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.711 -0.757 . . . . 5.86 112.164 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.4 t -115.63 114.27 24.68 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.143 -0.688 . . . . 6.0 109.143 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -76.97 130.93 38.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.315 -0.402 . . . . 3.94 111.067 -175.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -77.99 110.16 12.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.034 -0.728 . . . . 3.28 109.034 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.8 p -76.91 144.75 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 1.89 111.595 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.14 100.81 11.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 2.49 110.266 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -76.77 96.13 4.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.272 -1.01 . . . . 0.66 108.272 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.553 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 87.2 t -50.76 -33.03 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.682 -0.69 . . . . 1.41 112.192 -174.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.448 HG21 HD22 ' A' ' 108' ' ' LEU . 22.1 t -70.26 -17.86 21.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.073 -0.512 . . . . 1.01 111.516 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.14 -17.15 71.68 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.879 -0.677 . . . . 0.62 112.347 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 46.9 pttt -87.25 -29.41 21.7 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.181 -0.608 . . . . 2.67 111.191 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -108.11 31.14 5.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.339 -0.985 . . . . 1.71 108.339 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 11.0 tmtt? -78.27 -47.27 2.06 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.584 -0.735 . . . . 1.2 111.963 -170.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.6 Cg_endo -51.1 -33.12 42.18 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.275 1.983 . . . . 0.62 112.748 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.9 m -71.35 -45.75 62.16 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.904 0.383 . . . . 0.72 111.069 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.433 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 9.6 m-85 -72.26 -22.7 61.19 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.508 -0.553 . . . . 0.65 109.508 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 5.9 t70 -71.62 -44.31 64.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.301 -0.863 . . . . 1.03 109.32 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.32 -53.8 54.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.42 -0.809 . . . . 2.15 110.058 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.37 -36.83 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.973 0.416 . . . . 0.71 110.951 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.468 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 86.5 t80 -62.1 -42.04 98.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.361 0.601 . . . . 0.31 110.015 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.413 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 24.8 m-85 -81.21 -22.97 38.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.511 -0.768 . . . . 0.8 112.243 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.7 p -75.82 -10.78 59.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.61 111.082 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 79.3 mt -99.31 5.48 46.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.164 -0.471 . . . . 0.41 111.098 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.2 t 65.25 81.41 0.22 Allowed Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 123.711 0.632 . . . . 1.24 111.405 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.66 131.42 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.199 1.933 . . . . 0.59 112.422 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 m -99.93 140.82 18.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.891 -0.595 . . . . 1.31 109.909 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.403 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 2.5 p-10 45.45 33.04 1.2 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.484 0.714 . . . . 1.89 112.311 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.8 19.29 73.47 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.104 -0.498 . . . . 0.62 114.026 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 2.6 mtmm -145.84 159.84 42.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.771 -0.455 . . . . 1.81 109.771 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.452 HD11 ' CD1' ' A' ' 106' ' ' PHE . 23.8 pt -107.2 148.37 11.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.437 -0.505 . . . . 0.3 110.099 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.601 ' HA ' HD23 ' A' ' 100' ' ' LEU . 73.2 p -76.85 167.04 22.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.692 -0.686 . . . . 0.44 110.074 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.44 -33.16 58.45 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.87 -0.681 . . . . 0.33 112.708 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.01 59.92 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.347 0.499 . . . . 0.34 112.347 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.536 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -69.61 -46.81 65.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.573 -0.74 . . . . 1.65 110.625 -170.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.55 72.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.789 -0.641 . . . . 0.27 110.905 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.551 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 36.1 ttmt -61.55 -57.12 13.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 1.52 110.683 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 56.4 pttt -62.77 -31.26 72.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 1.14 110.708 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.71 -44.42 93.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 1.78 109.643 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.782 ' HB3' HD22 ' A' ' 86' ' ' LEU . 43.1 mtt -67.49 -30.67 70.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.806 -0.634 . . . . 0.86 111.151 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -70.59 -34.93 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.672 0.749 . . . . 1.52 109.339 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 4.3 mptp? -78.44 -12.12 59.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.925 -1.034 . . . . 3.33 110.838 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 49.3 m -76.47 -13.17 60.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 0.91 110.518 175.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 79' ' ' SER . 69.8 mmtt 73.28 16.68 4.12 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.66 -0.7 . . . . 2.97 111.523 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.662 ' HB2' HD21 ' A' ' 86' ' ' LEU . 79.8 mt -93.08 147.02 33.05 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 1.41 110.922 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.528 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 11.2 Cg_endo -56.45 149.04 59.15 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.64 2.893 . . . . 0.32 112.848 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -56.13 -38.95 71.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.766 -0.652 . . . . 2.05 111.36 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -62.28 -46.85 86.96 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.984 -0.553 . . . . 0.84 111.618 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.702 HG11 ' HD2' ' A' ' 116' ' ' LYS . 95.8 t -64.25 -45.37 96.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 109.972 -0.381 . . . . 0.26 109.972 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.782 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.7 mt -58.79 -42.84 89.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.29 111.153 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.82 -40.75 93.45 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.999 -0.62 . . . . 0.36 112.145 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' NZ ' ' HA ' ' A' ' 85' ' ' VAL . 30.8 mtmm -72.04 -37.82 69.64 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.612 -0.346 . . . . 1.29 110.473 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.1 mt -63.1 -43.97 99.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.346 . . . . 0.27 110.407 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -63.75 -41.22 98.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.497 -0.319 . . . . 0.37 110.208 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.67 -29.83 70.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.243 -0.435 . . . . 2.54 111.095 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.473 ' HB3' HD21 ' A' ' 126' ' ' LEU . 85.5 mt -89.99 -46.91 8.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.102 -0.499 . . . . 1.5 111.363 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.501 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -65.46 -42.97 91.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.985 -0.552 . . . . 0.53 111.574 -173.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.694 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 47.3 t0 -86.24 87.99 7.53 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.248 -1.019 . . . . 0.5 108.248 175.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.785 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 15.1 t -68.72 -43.71 82.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.435 -0.802 . . . . 0.64 110.259 -174.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.587 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 6.6 p-10 -84.46 -21.5 30.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.314 -0.857 . . . . 1.46 110.56 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.694 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 48.3 mttp 60.22 73.86 0.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.82 . . . . 2.74 111.462 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.615 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 14.7 p-10 -121.6 9.9 10.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.61 -1.177 . . . . 0.56 111.058 -173.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.94 1.21 67.09 Favored Glycine 0 CA--C 1.516 0.109 0 C-N-CA 120.676 -0.773 . . . . 0.49 112.114 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.615 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 42.9 mt -127.73 152.45 47.72 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.108 -0.701 . . . . 0.53 109.108 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.2 mt -114.2 120.42 40.41 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.803 -0.443 . . . . 0.33 109.803 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.419 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 15.7 m-20 -68.45 173.62 4.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.24 -1.022 . . . . 1.85 108.24 171.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -63.62 -26.91 68.89 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.641 -0.503 . . . . 0.85 109.641 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.441 ' OE1' ' HB3' ' A' ' 134' ' ' SER . 23.4 mt-10 -66.22 -56.06 13.14 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.352 0.596 . . . . 2.08 109.865 173.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.501 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 13.6 mt-10 -66.49 -34.5 78.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.93 -1.032 . . . . 0.48 110.574 -171.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.452 ' CD1' HD11 ' A' ' 67' ' ' ILE . 55.7 t80 -71.17 -43.11 68.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.332 -0.394 . . . . 0.41 110.214 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.433 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -60.98 -39.27 89.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.23 110.575 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.448 HD22 HG21 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -61.26 -47.9 83.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.865 -0.607 . . . . 1.29 109.491 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.87 -47.33 85.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.804 -0.635 . . . . 0.23 110.791 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -63.75 -34.32 77.63 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.155 -0.475 . . . . 0.77 111.315 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -68.41 -40.37 81.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.764 0.316 . . . . 0.33 110.387 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.705 ' HB3' HD23 ' A' ' 122' ' ' LEU . 95.0 mt -68.58 -41.54 79.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.275 0.56 . . . . 0.28 110.551 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.548 HD11 ' HG2' ' A' ' 76' ' ' MET . 96.0 mt -65.86 -38.66 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.902 -0.59 . . . . 0.7 109.872 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.727 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 13.9 ttpp -57.69 -53.43 58.3 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.844 -0.616 . . . . 1.77 110.211 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.8 m -62.79 -38.64 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 112.055 0.391 . . . . 0.53 112.055 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.702 ' HD2' HG11 ' A' ' 85' ' ' VAL . 1.1 mmpm? -51.58 -40.97 60.8 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.468 0.175 . . . . 1.89 111.393 169.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 92.4 mt -78.97 -29.16 43.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.465 -0.334 . . . . 0.74 111.511 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.727 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 10.8 mm-40 -67.37 -24.53 65.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.075 0.464 . . . . 1.98 110.223 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.68 16.75 23.37 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.916 -0.659 . . . . 0.87 111.595 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -108.76 162.44 14.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.237 -0.653 . . . . 1.07 109.237 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.449 ' CD ' ' HZ1' ' A' ' 116' ' ' LYS . 60.1 mm-40 -108.7 129.1 55.35 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.873 0.368 . . . . 3.06 111.249 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -77.76 139.78 62.71 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 115.956 -0.566 . . . . 1.09 109.902 172.045 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.11 -4.4 14.8 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.31 2.007 . . . . 0.8 113.692 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.463 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 64.44 20.39 12.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.377 0.608 . . . . 0.64 110.347 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -131.05 163.53 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.836 . . . . 1.97 109.4 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 92' ' ' LEU . 77.2 mt -110.08 96.1 24.1 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.735 -0.211 . . . . 0.67 111.04 174.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 30.3 Cg_endo -65.37 159.12 49.0 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.602 2.201 . . . . 0.52 111.649 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.41 -7.89 9.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.192 2.595 . . . . 0.63 114.138 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -111.22 11.09 21.78 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.094 -0.379 . . . . 0.86 111.488 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.8 mt -118.74 -26.2 6.16 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.953 -0.299 . . . . 1.19 111.301 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.84 ' HB ' HH21 ' A' ' 136' ' ' ARG . 47.5 t -60.38 116.93 20.02 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.717 -0.22 . . . . 1.34 110.92 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.585 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 86.5 Cg_exo -48.39 142.06 17.94 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.929 3.086 . . . . 0.9 113.506 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.56 -29.94 85.31 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 123.164 2.576 . . . . 1.44 113.832 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.441 ' HB3' ' OE1' ' A' ' 104' ' ' GLU . 39.8 t -84.62 -7.07 59.37 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.545 -0.462 . . . . 1.77 111.129 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.785 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 11.1 mptt -100.03 -5.02 28.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.89 0.376 . . . . 1.2 110.986 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.84 HH21 ' HB ' ' A' ' 131' ' ' VAL . 18.3 ptp180 -110.89 129.02 55.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.299 -0.41 . . . . 3.94 110.285 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -114.34 114.52 26.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.151 0.501 . . . . 5.08 110.943 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -91.09 136.21 33.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.701 -0.681 . . . . 6.35 109.914 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 C--O 1.251 1.169 0 N-CA-C 108.756 -0.831 . . . . 8.21 108.756 177.081 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 48.6 t80 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.342 -0.614 . . . . 12.91 109.342 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -85.36 166.06 16.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.905 -0.776 . . . . 7.96 108.905 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -108.18 2.54 22.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.098 0.475 . . . . 10.06 110.999 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -97.69 132.52 43.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.724 -0.671 . . . . 5.36 109.535 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.484 ' CB ' ' HA ' ' B' ' 153' ' ' ALA . 28.6 p -99.31 104.03 15.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.881 0.372 . . . . 3.46 110.993 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.2 m -85.12 -16.24 41.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.232 -0.44 . . . . 1.49 110.335 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 53.0 t-20 -91.69 120.7 68.0 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.709 -0.478 . . . . 0.84 109.709 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 24.7 Cg_exo -64.06 -16.66 56.19 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.106 2.537 . . . . 0.66 113.327 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 95.0 m-85 -91.3 -45.28 8.69 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.895 0.379 . . . . 0.68 110.885 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 40.7 p -106.98 103.92 13.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.204 -0.453 . . . . 1.83 110.877 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' ALA . . . . . 0.484 ' HA ' ' CB ' ' B' ' 147' ' ' SER . . . -97.98 -54.02 3.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.052 -0.522 . . . . 3.77 110.257 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 93.9 mttt . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.684 -0.674 . . . . 6.44 109.483 176.709 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.623 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.453 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.892 -0.483 . . . . 9.38 111.892 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.453 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 3.2 Cg_exo -73.87 146.73 38.14 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.946 2.43 . . . . 8.63 111.976 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.4 mt -98.93 89.8 4.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.171 -0.468 . . . . 8.95 110.141 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.18 -168.67 35.87 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.17 -0.772 . . . . 5.86 111.17 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.3 m 62.22 27.07 16.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.177 0.513 . . . . 6.0 110.881 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.12 119.31 35.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.711 -0.677 . . . . 3.94 110.754 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -123.0 141.05 52.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.788 -0.642 . . . . 3.28 110.134 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.15 140.28 16.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.602 -0.272 . . . . 1.89 110.398 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.14 105.09 5.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.397 . . . . 2.49 110.213 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -82.59 111.15 18.3 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.395 -0.965 . . . . 0.66 108.395 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.51 -40.85 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 121.818 0.818 . . . . 1.41 110.66 -166.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.445 HG21 HD22 ' A' ' 108' ' ' LEU . 18.7 m -91.53 0.44 9.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.484 -1.235 . . . . 1.01 111.339 -172.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.06 -31.49 20.07 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.586 -1.406 . . . . 0.62 109.586 169.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -81.17 -29.61 34.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.974 -0.613 . . . . 2.67 109.974 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.36 32.49 4.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.85 -0.796 . . . . 1.71 108.85 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.644 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 11.4 tmtt? -81.53 -47.12 1.07 Allowed Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 113.303 0.853 . . . . 1.2 113.303 -169.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.7 Cg_endo -44.16 -37.86 10.29 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 123.142 2.561 . . . . 0.62 113.845 -176.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -70.63 -46.67 62.89 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 120.965 0.412 . . . . 0.72 111.346 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 2.6 m-85 -72.82 -22.3 60.83 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.092 -0.707 . . . . 0.65 109.092 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -75.32 -42.03 55.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.814 -1.085 . . . . 1.03 109.475 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.54 -55.22 31.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.446 -0.797 . . . . 2.15 109.814 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.19 -26.26 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.826 -0.624 . . . . 0.71 111.389 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.409 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 87.4 t80 -69.58 -50.37 45.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.223 0.535 . . . . 0.31 110.259 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -74.33 -23.63 59.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.913 -0.585 . . . . 0.8 111.859 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.3 p -74.67 -1.52 22.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.844 0.354 . . . . 0.61 111.619 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.67 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 95.9 mt -108.49 6.07 25.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.852 -0.425 . . . . 0.41 109.852 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.8 m 63.17 86.86 0.14 Allowed Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 115.379 -0.828 . . . . 1.24 111.754 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -88.51 138.86 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.753 2.302 . . . . 0.59 112.972 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.404 HG12 ' OD1' ' A' ' 64' ' ' ASN . 14.7 t -118.01 132.09 68.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.799 -0.637 . . . . 1.31 109.917 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.404 ' OD1' HG12 ' A' ' 63' ' ' VAL . 21.4 m120 62.71 20.02 11.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.47 0.708 . . . . 1.89 110.471 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.16 13.26 60.63 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.151 -0.931 . . . . 0.62 112.029 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HE2' ' OD2' ' A' ' 102' ' ' ASP . 94.2 mttt -136.25 171.17 14.88 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.383 0.611 . . . . 1.81 111.642 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 106' ' ' PHE . 26.7 pt -121.62 143.11 35.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.927 -1.033 . . . . 0.3 109.449 171.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.1 p -78.31 171.42 15.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.179 -0.464 . . . . 0.44 110.112 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.35 -29.7 53.63 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 120.927 -0.654 . . . . 0.33 112.258 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.97 83.41 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.033 0.444 . . . . 0.34 111.843 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.67 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.4 m120 -76.73 -42.35 41.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.777 -0.647 . . . . 1.65 110.343 -170.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -69.15 -29.94 68.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.868 -0.606 . . . . 0.27 110.545 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.598 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 63.0 tttt -68.85 -50.18 52.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.215 -0.448 . . . . 1.52 110.838 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HA ' HG22 ' A' ' 77' ' ' VAL . 17.3 ptpt -61.42 -39.01 89.23 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.036 0.446 . . . . 1.14 110.465 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.56 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 18.5 tp10 -61.42 -49.28 77.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.518 . . . . 1.78 110.237 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.972 ' HB3' HD22 ' A' ' 86' ' ' LEU . 49.8 mtt -65.46 -32.36 73.93 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.209 0.448 . . . . 0.86 112.209 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 74' ' ' LYS . 33.5 m -78.75 -16.54 13.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.362 -0.535 . . . . 1.52 111.54 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.56 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -95.54 -9.05 33.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.335 -0.546 . . . . 3.33 110.201 172.372 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 70.9 m -74.19 -2.43 24.72 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.46 0.541 . . . . 0.91 112.46 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 79' ' ' SER . 5.7 mptp? 74.95 16.9 2.84 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.889 0.476 . . . . 2.97 112.26 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.477 ' HB2' HD21 ' A' ' 86' ' ' LEU . 10.9 mp -99.37 147.05 32.79 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-O 120.854 0.359 . . . . 1.41 111.144 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.2 Cg_endo -62.4 148.83 92.65 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.87 2.38 . . . . 0.32 112.575 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -53.41 -39.1 64.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.454 -0.794 . . . . 2.05 111.51 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.5 m -62.45 -52.72 62.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.475 . . . . 0.84 111.302 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.52 ' CG2' ' HG2' ' A' ' 82' ' ' PRO . 69.1 t -58.75 -38.54 72.74 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.051 0 CA-C-O 120.617 0.246 . . . . 0.26 110.629 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.972 HD22 ' HB3' ' A' ' 76' ' ' MET . 82.3 mt -59.98 -42.42 94.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.29 110.818 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.64 -42.29 98.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.852 -0.69 . . . . 0.36 111.792 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 55.3 mtpt -61.26 -46.76 89.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.832 0.349 . . . . 1.29 110.398 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.52 HG23 HD12 ' A' ' 112' ' ' LEU . 82.6 mt -62.46 -44.48 99.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.27 111.311 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -57.33 -45.74 83.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.65 0.262 . . . . 0.37 110.774 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.08 -28.45 69.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.11 0.481 . . . . 2.54 110.907 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 126' ' ' LEU . 46.3 mt -94.52 -16.77 23.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 1.5 111.856 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.27 -42.38 11.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.569 -0.287 . . . . 0.53 111.133 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.66 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 31.4 t0 -86.42 84.62 7.4 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.115 -0.698 . . . . 0.5 109.115 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.473 HG21 ' HD2' ' A' ' 132' ' ' PRO . 10.7 t -70.87 -36.69 65.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.595 -0.729 . . . . 0.64 110.856 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 11.1 p-10 -83.64 -11.39 57.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.008 -0.542 . . . . 1.46 110.473 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt 55.57 53.96 9.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.959 -1.019 . . . . 2.74 111.167 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 13.2 p-10 -109.91 7.86 24.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.059 -0.519 . . . . 0.56 110.583 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.91 1.35 67.42 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.12 -0.562 . . . . 0.49 112.083 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 74.9 mt -127.05 144.55 51.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.013 0.435 . . . . 0.53 109.902 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 67.3 mt -104.55 113.45 27.04 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.413 -0.515 . . . . 0.33 110.095 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.442 ' OD2' ' HE2' ' A' ' 66' ' ' LYS . 4.2 m-20 -69.35 172.29 7.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.558 -0.904 . . . . 1.85 108.558 169.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -60.27 -30.92 69.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.549 0.214 . . . . 0.85 110.721 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -71.79 -45.28 62.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.107 0.479 . . . . 2.08 110.866 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -70.7 -33.0 70.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.919 0.39 . . . . 0.48 110.747 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' HD11 ' A' ' 67' ' ' ILE . 27.7 t80 -75.16 -30.98 60.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.79 -0.448 . . . . 0.41 109.79 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.79 82.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.195 0.522 . . . . 0.23 110.039 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.511 HD21 ' O ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -65.09 -51.25 62.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 1.29 110.556 175.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.37 -50.57 69.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.702 -0.681 . . . . 0.23 110.822 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -61.82 -33.81 74.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.618 -0.719 . . . . 0.77 111.298 -178.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -68.41 -42.97 78.23 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.8 -0.36 . . . . 0.33 110.855 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.52 HD12 HG23 ' A' ' 89' ' ' ILE . 72.6 mt -65.59 -38.39 89.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.208 0.527 . . . . 0.28 110.504 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.68 HD11 ' HG2' ' A' ' 76' ' ' MET . 66.6 mt -68.39 -41.03 83.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.042 -0.526 . . . . 0.7 110.592 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 32.4 ttpt -59.09 -48.99 79.59 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.64 -0.255 . . . . 1.77 110.408 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.8 m -63.44 -36.01 74.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 120.642 -0.423 . . . . 0.53 111.119 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.842 ' HD3' HD23 ' A' ' 122' ' ' LEU . 3.9 mmmp? -58.19 -37.88 75.64 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.444 -0.502 . . . . 1.89 110.703 172.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 96.1 mt -73.6 -22.78 59.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 0.74 110.916 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 13.6 mt-10 -83.5 2.14 38.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.194 -0.457 . . . . 1.98 110.55 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.77 23.7 45.09 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.784 -0.722 . . . . 0.87 111.848 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.608 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 38.4 m80 -117.92 161.27 20.05 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.725 -0.472 . . . . 1.07 109.725 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -115.64 149.04 38.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.34 -0.391 . . . . 3.06 109.975 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.842 HD23 ' HD3' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -89.66 146.77 36.27 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.124 -0.695 . . . . 1.09 109.124 -178.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -66.62 -6.85 16.35 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.783 2.322 . . . . 0.8 112.937 -172.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.81 18.52 9.69 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.469 -0.787 . . . . 0.64 110.773 -176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -135.64 163.7 29.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.2 -0.667 . . . . 1.97 109.2 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 92' ' ' LEU . 96.0 mt -111.98 92.72 18.77 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 111.633 0.234 . . . . 0.67 111.633 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.501 ' HD2' HD12 ' A' ' 130' ' ' LEU . 17.6 Cg_endo -58.86 153.61 49.49 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.395 2.064 . . . . 0.52 111.568 171.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.47 -33.27 46.55 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.508 2.805 . . . . 0.63 114.146 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -82.64 7.21 15.37 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.336 0.495 . . . . 0.86 112.336 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.511 ' O ' HD21 ' A' ' 108' ' ' LEU . 49.2 mt -111.38 -29.12 7.92 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.891 -0.324 . . . . 1.19 111.243 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 39.3 t -65.52 120.39 67.76 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.5 -0.318 . . . . 1.34 110.838 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.705 ' HG2' ' HD3' ' A' ' 135' ' ' LYS . 10.0 Cg_endo -53.26 142.96 54.79 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 123.092 2.528 . . . . 0.9 112.387 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.627 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 14.1 Cg_exo -68.35 -14.73 40.88 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.236 2.624 . . . . 1.44 113.219 -172.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.6 p -79.69 -18.98 50.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.097 0.475 . . . . 1.77 110.21 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.705 ' HD3' ' HG2' ' A' ' 132' ' ' PRO . 2.2 mptp? -106.59 34.56 3.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.968 -0.56 . . . . 1.2 110.195 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.638 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 3.3 mmp_? -91.48 150.67 21.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.263 0.554 . . . . 3.94 111.114 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -119.84 137.91 53.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.304 -0.862 . . . . 5.08 108.688 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -100.4 137.71 38.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.09 0.471 . . . . 6.35 110.905 -174.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.063 -0.97 . . . . 8.21 108.965 175.183 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.544 0.211 . . . . 12.91 111.048 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -97.88 128.12 44.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.707 0.289 . . . . 7.96 111.065 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 12.5 t80 61.73 84.44 0.14 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.359 -0.837 . . . . 10.06 111.361 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.48 -49.3 0.31 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.544 -0.753 . . . . 5.36 110.67 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 47.2 m -131.51 97.65 4.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.928 0.395 . . . . 3.46 110.044 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 12.8 p -113.09 -41.28 3.75 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.386 0.513 . . . . 1.49 112.386 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -73.91 114.61 34.32 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 121.01 0.434 . . . . 0.84 110.67 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.45 -7.85 20.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.45 2.767 . . . . 0.66 113.154 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 90.9 m-85 -94.48 -45.84 7.25 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.008 0.373 . . . . 0.68 112.008 -177.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.7 t -158.07 165.58 34.67 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.74 -0.384 . . . . 1.83 111.393 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' B' ' 154' ' ' LYS . . . -168.7 -33.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.472 -0.785 . . . . 3.77 110.258 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' B' ' 153' ' ' ALA . 23.7 mtpp . . . . . 0 C--O 1.245 0.846 0 O-C-N 123.828 0.705 . . . . 6.44 110.856 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.66 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 111.891 -0.483 . . . . 9.38 111.891 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 38.5 Cg_exo -59.96 141.74 97.08 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.928 2.418 . . . . 8.63 111.538 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 9.9 mp 72.83 -30.97 0.22 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.176 0.59 . . . . 8.95 111.925 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 36' ' ' PRO . . . 121.37 -142.98 15.75 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.56 -0.616 . . . . 5.86 111.56 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 t -156.39 119.49 4.19 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.989 -0.374 . . . . 6.0 109.989 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -84.21 92.37 7.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.844 0.831 . . . . 3.94 109.587 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -108.6 108.92 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.093 -0.958 . . . . 3.28 109.246 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.06 146.42 6.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.743 -0.662 . . . . 1.89 111.192 -173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -141.97 148.32 38.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 2.49 109.28 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -93.78 128.64 40.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.411 -0.588 . . . . 0.66 109.411 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.18 -23.45 11.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.309 0.485 . . . . 1.41 112.309 -168.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -88.28 0.22 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.315 -0.554 . . . . 1.01 111.271 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 -25.5 68.57 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.952 -0.642 . . . . 0.62 112.166 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.58 ' HG3' ' OD1' ' A' ' 49' ' ' ASP . 15.5 pttp -80.21 -27.76 38.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.611 0.243 . . . . 2.67 111.523 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.58 ' OD1' ' HG3' ' A' ' 48' ' ' LYS . 1.2 m-20 -104.13 31.98 4.25 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.725 -0.472 . . . . 1.71 109.725 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -79.84 -51.24 1.16 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 113.275 0.843 . . . . 1.2 113.275 -172.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.5 -26.56 54.85 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.056 1.837 . . . . 0.62 112.743 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.41 -45.45 46.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.717 0.294 . . . . 0.72 110.912 177.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.4 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 11.4 m-30 -70.36 -24.05 62.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.1 -0.704 . . . . 0.65 109.1 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.553 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -73.75 -43.76 58.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.083 -0.962 . . . . 1.03 110.262 176.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.94 -38.03 75.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.865 -0.607 . . . . 2.15 110.229 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.1 mt -75.53 -35.39 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.573 0.702 . . . . 0.71 110.641 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 66' ' ' LYS . 62.3 t80 -63.54 -43.06 98.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.287 -0.869 . . . . 0.31 111.018 -176.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.553 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 30.8 m-85 -67.64 -23.29 65.33 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.363 0.505 . . . . 0.8 112.363 -177.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.1 p -85.37 8.68 17.9 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.532 -0.467 . . . . 0.61 111.742 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 95.1 mt -112.23 6.9 19.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.29 -0.413 . . . . 0.41 111.105 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t 65.84 88.48 0.11 Allowed Pre-proline 0 N--CA 1.469 0.479 0 O-C-N 123.547 0.529 . . . . 1.24 111.009 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -94.06 132.28 0.73 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.925 2.417 . . . . 0.59 113.428 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.0 134.1 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.288 -0.869 . . . . 1.31 109.429 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 62.62 26.94 15.95 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.851 0.358 . . . . 1.89 110.719 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.6 36.31 67.83 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.611 -0.804 . . . . 0.62 111.916 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.856 ' HB3' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -168.04 175.65 6.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.59 0.233 . . . . 1.81 110.67 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.7 pt -131.35 155.36 41.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.215 0.531 . . . . 0.3 112.122 -172.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.465 ' HA ' HD23 ' A' ' 100' ' ' LEU . 40.9 p -79.19 166.92 21.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.069 -0.969 . . . . 0.44 110.4 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.44 ' HA3' ' HG3' ' B' ' 150' ' ' PRO . . . -59.19 -27.52 62.86 Favored Glycine 0 C--O 1.221 -0.662 0 C-N-CA 120.991 -0.624 . . . . 0.33 112.99 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.22 82.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.39 0.515 . . . . 0.34 112.39 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.488 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -76.13 -42.43 46.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.18 -0.464 . . . . 1.65 110.238 -172.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.81 71.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.27 110.161 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 59.7 tttt -69.3 -54.76 12.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.979 -0.555 . . . . 1.52 110.495 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 17.3 ptpt -57.78 -34.41 69.56 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.888 -0.325 . . . . 1.14 110.74 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.77 -53.5 46.09 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.404 0.621 . . . . 1.78 110.425 175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.695 ' HB3' HD22 ' A' ' 86' ' ' LEU . 93.0 mtp -68.96 -24.89 64.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.503 -0.772 . . . . 0.86 112.142 -173.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 74' ' ' LYS . 35.6 m -87.47 -35.91 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-O 121.067 0.461 . . . . 1.52 110.821 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -79.52 -8.19 58.98 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.482 0.658 . . . . 3.33 109.624 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.5 m -69.86 -11.34 60.79 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.5 -0.773 . . . . 0.91 110.502 168.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 71.68 44.77 0.48 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.504 0.722 . . . . 2.97 111.862 177.455 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.471 ' HB2' HD21 ' A' ' 86' ' ' LEU . 86.9 mt -119.62 146.86 42.43 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.117 -0.492 . . . . 1.41 109.852 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.557 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.5 Cg_endo -58.99 141.22 98.1 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.986 2.457 . . . . 0.32 112.955 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -62.64 -30.52 71.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.614 -0.721 . . . . 2.05 111.644 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.0 m -61.12 -53.13 60.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 0.84 110.085 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 t -55.41 -45.84 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.829 -0.623 . . . . 0.26 110.927 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 76' ' ' MET . 77.1 mt -60.77 -42.12 96.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.29 110.721 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.35 -33.79 88.18 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.701 -0.681 . . . . 0.36 112.358 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 33.1 mttt -68.0 -45.29 74.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.911 0.386 . . . . 1.29 110.077 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.619 HG23 HD12 ' A' ' 112' ' ' LEU . 81.9 mt -59.58 -44.33 92.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.863 -0.608 . . . . 0.27 111.463 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -60.18 -39.82 87.82 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.921 -0.4 . . . . 0.37 109.921 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -64.82 -23.01 67.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 2.54 111.172 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.665 ' HB3' HD21 ' A' ' 126' ' ' LEU . 70.9 mt -93.39 -38.52 11.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.615 -0.721 . . . . 1.5 110.722 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.758 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -78.93 -42.64 26.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.53 111.819 -173.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 25.3 t0 -86.42 73.53 10.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.286 0.565 . . . . 0.5 109.565 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.593 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 12.8 t -64.65 -37.89 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 115.29 -0.868 . . . . 0.64 110.798 -175.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.52 ' OD2' ' HG3' ' A' ' 135' ' ' LYS . 0.7 OUTLIER -72.39 -20.4 61.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.526 -0.761 . . . . 1.46 109.926 -178.136 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 96.4 mttt 56.83 37.79 29.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.838 0.828 . . . . 2.74 109.333 -175.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.2 p-10 -89.59 8.95 28.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.654 -1.157 . . . . 0.56 110.972 -174.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.38 -2.96 26.35 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.055 -0.593 . . . . 0.49 112.572 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 36.1 mt -125.81 146.74 49.67 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.649 -0.5 . . . . 0.53 109.649 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.6 mt -105.74 112.4 25.45 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.282 -0.636 . . . . 0.33 109.282 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.856 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . 2.0 p30 -75.31 176.44 7.42 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.489 -0.484 . . . . 1.85 109.723 174.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -59.19 -28.76 66.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.697 -0.228 . . . . 0.85 111.538 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.404 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . 7.7 mm-40 -76.08 -50.39 14.85 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.877 0.37 . . . . 2.08 110.689 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.649 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 49.3 mt-10 -58.09 -43.17 86.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.257 0.551 . . . . 0.48 110.61 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HD2' ' HB2' ' A' ' 57' ' ' PHE . 33.3 t80 -69.94 -29.57 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.835 -0.62 . . . . 0.41 110.115 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -65.47 -43.34 90.61 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.425 0.631 . . . . 0.23 109.889 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.758 HD23 ' HA ' ' A' ' 93' ' ' ALA . 23.7 tp -62.89 -46.45 87.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.452 -0.794 . . . . 1.29 110.369 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.4 -44.79 89.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.54 -0.754 . . . . 0.23 111.074 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -65.41 -33.36 75.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.059 -0.518 . . . . 0.77 111.506 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -67.86 -40.23 83.68 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.904 -0.319 . . . . 0.33 110.241 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.798 ' HB3' HD23 ' A' ' 122' ' ' LEU . 96.4 mt -65.76 -36.3 83.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 0.28 110.629 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.8 -38.06 64.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.094 -0.503 . . . . 0.7 110.777 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -57.61 -49.8 75.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.366 -0.379 . . . . 1.77 110.388 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 120' ' ' HIS . 13.9 m -67.16 -40.17 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 120.563 -0.455 . . . . 0.53 111.291 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -51.55 -47.28 63.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.806 0.275 . . . . 1.89 111.339 171.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.71 -35.94 75.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.74 110.722 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -74.19 -5.35 41.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.83 -0.623 . . . . 1.98 111.805 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.36 30.55 9.83 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.175 -1.012 . . . . 0.87 112.544 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 90.6 m-70 -126.44 117.39 22.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.103 0.477 . . . . 1.07 109.946 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -78.01 117.2 19.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.57 -0.741 . . . . 3.06 110.526 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.798 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -60.59 141.17 92.29 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 1.09 110.437 173.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.65 -1.77 10.84 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.449 2.099 . . . . 0.8 113.764 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 63.26 24.27 14.22 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.512 0.508 . . . . 0.64 110.769 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -133.67 158.5 43.1 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.352 -0.61 . . . . 1.97 109.352 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 92' ' ' LEU . 94.5 mt -111.81 92.34 17.29 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 111.926 0.343 . . . . 0.67 111.926 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.634 ' HD2' HD12 ' A' ' 130' ' ' LEU . 35.3 Cg_endo -66.95 160.4 47.3 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.46 2.107 . . . . 0.52 110.968 167.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.49 -42.23 28.88 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.124 2.55 . . . . 0.63 113.828 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -77.86 10.19 2.98 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.761 0.652 . . . . 0.86 112.761 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.634 HD12 ' HD2' ' A' ' 127' ' ' PRO . 52.8 mt -122.23 3.46 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.215 -0.194 . . . . 1.19 111.287 176.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.6 115.62 64.87 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 121.164 -0.215 . . . . 1.34 110.733 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.724 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 51.9 Cg_exo -55.24 122.99 12.71 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.904 2.403 . . . . 0.9 112.307 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 12.6 Cg_exo -69.7 -4.85 14.82 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.309 2.672 . . . . 1.44 112.679 -176.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.5 t -75.08 -20.76 59.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.638 0.732 . . . . 1.77 109.265 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.724 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -95.83 27.49 3.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.445 -0.798 . . . . 1.2 109.67 -176.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.458 ' HA ' ' HE ' ' A' ' 136' ' ' ARG . 2.7 mmp_? -103.22 90.86 3.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 3.94 109.856 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -119.49 136.08 54.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.279 -0.419 . . . . 5.08 110.674 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -95.47 105.92 17.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.063 -0.517 . . . . 6.35 110.055 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--O 1.25 1.101 0 CA-C-N 115.317 -0.856 . . . . 8.21 110.729 178.443 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 120.84 0.352 . . . . 12.91 110.541 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -108.24 -51.11 2.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.673 -0.492 . . . . 7.96 109.673 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 55.41 89.86 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.549 -0.75 . . . . 10.06 112.32 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -75.96 137.62 40.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.424 -0.807 . . . . 5.36 111.093 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 5.0 p -107.84 52.93 0.7 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.594 0.711 . . . . 3.46 109.778 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.22 33.81 0.24 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.794 -1.094 . . . . 1.49 112.904 -169.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.406 ' HB2' ' HD2' ' B' ' 150' ' ' PRO . 22.3 p30 -122.38 151.29 59.15 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 121.634 -0.667 . . . . 0.84 111.885 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.44 ' HG3' ' HA3' ' A' ' 69' ' ' GLY . 34.4 Cg_endo -66.05 -3.69 8.9 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.382 2.721 . . . . 0.66 113.581 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.46 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 80.3 m-85 -82.27 -10.78 58.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.981 0.364 . . . . 0.68 111.981 -173.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.1 t -137.78 13.83 2.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.069 0.462 . . . . 1.83 110.8 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.34 -20.82 3.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.394 0.516 . . . . 3.77 112.394 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 47.9 tptt . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.416 -0.802 . . . . 6.44 111.003 -174.507 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.616 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 111.533 -0.627 . . . . 9.38 111.533 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.43 -25.12 42.05 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.583 2.189 . . . . 8.63 112.544 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 69.0 mt 71.72 -33.19 0.26 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.596 0.758 . . . . 8.95 111.883 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.07 -23.71 12.52 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.654 -0.784 . . . . 5.86 112.327 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.0 m 57.3 39.76 28.26 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.131 0.491 . . . . 6.0 110.92 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.93 113.68 13.7 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.578 -0.737 . . . . 3.94 109.641 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -127.72 121.53 30.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.058 -0.519 . . . . 3.28 109.952 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 83.5 t -86.95 111.72 22.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.805 0.336 . . . . 1.89 110.339 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -82.06 135.97 35.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.089 -0.505 . . . . 2.49 111.035 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -88.03 105.09 17.24 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.042 -1.095 . . . . 0.66 108.042 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.5 t -56.62 -24.07 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.896 -0.593 . . . . 1.41 112.118 -171.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.434 HG21 HD22 ' A' ' 108' ' ' LEU . 97.4 t -76.54 -23.05 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.765 0.316 . . . . 1.01 111.169 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.74 -18.68 70.55 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.573 -0.822 . . . . 0.62 112.465 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -18.33 23.73 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.143 -0.623 . . . . 2.67 111.733 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -121.22 31.99 6.12 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.95 -0.759 . . . . 1.71 108.95 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 8.7 tmtm? -74.86 -47.43 4.95 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 1.2 111.774 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 49.0 Cg_exo -56.04 -27.67 65.62 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.967 1.778 . . . . 0.62 112.56 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 m -75.71 -46.32 31.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.604 -0.271 . . . . 0.72 111.142 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -70.34 -23.06 62.75 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.679 -0.86 . . . . 0.65 108.679 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.75 -44.68 63.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.733 -1.121 . . . . 1.03 109.862 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.86 -40.79 89.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.027 -0.988 . . . . 2.15 110.055 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.26 -38.37 77.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.01 -0.541 . . . . 0.71 110.797 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HE1' HG12 ' A' ' 67' ' ' ILE . 83.1 t80 -62.27 -41.13 98.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.924 -0.58 . . . . 0.31 110.631 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -82.08 14.59 2.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.451 -0.795 . . . . 0.8 112.416 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.1 p -113.7 2.06 15.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.144 0.497 . . . . 0.61 110.988 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 89.0 mt -108.51 14.6 24.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.766 -0.652 . . . . 0.41 111.147 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.8 t 61.2 80.92 0.25 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.722 -0.672 . . . . 1.24 111.575 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -85.63 105.65 0.86 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.514 2.142 . . . . 0.59 113.134 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.3 m -89.78 135.36 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.717 -0.674 . . . . 1.31 109.839 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 62.4 21.06 12.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.19 -0.459 . . . . 1.89 110.412 -174.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.51 9.48 83.32 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.572 -0.823 . . . . 0.62 111.873 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 56.7 mtmt -138.33 148.52 44.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.368 . . . . 1.81 110.947 -177.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.476 HD11 ' CD1' ' A' ' 106' ' ' PHE . 11.3 pt -97.34 144.16 11.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.017 0.437 . . . . 0.3 110.701 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.548 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 12.1 p -71.18 161.6 30.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.295 -0.866 . . . . 0.44 110.837 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.26 -32.22 60.12 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.135 -0.555 . . . . 0.33 112.021 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.63 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -49.85 -65.81 0.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.559 0.344 . . . . 0.34 111.72 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 48.0 m-80 -69.45 -39.46 77.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.089 -0.505 . . . . 1.65 111.717 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.11 97.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.422 -0.354 . . . . 0.27 110.38 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 34.4 ttpt -62.43 -42.28 99.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.469 -0.567 . . . . 1.52 109.469 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 52.0 mtpt -51.8 -55.53 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.5 -0.773 . . . . 1.14 110.916 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -59.07 -46.53 88.02 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.348 0.595 . . . . 1.78 110.657 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.713 ' HB3' HD22 ' A' ' 86' ' ' LEU . 84.3 mtp -64.69 -29.22 70.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.846 -0.615 . . . . 0.86 110.992 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.21 -37.37 45.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.239 0.542 . . . . 1.52 109.897 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -80.86 2.91 24.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.91 -0.586 . . . . 3.33 111.061 177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m -77.56 -10.24 59.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.307 -0.406 . . . . 0.91 110.338 169.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 69.68 21.37 6.6 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.299 0.639 . . . . 2.97 111.615 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.471 ' HB2' HD21 ' A' ' 86' ' ' LEU . 94.2 mt -100.8 153.14 37.9 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.614 -0.721 . . . . 1.41 110.964 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.503 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 9.8 Cg_endo -54.82 141.12 77.67 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.155 2.57 . . . . 0.32 112.631 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -63.95 -28.43 69.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.463 -0.789 . . . . 2.05 111.443 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 p -67.22 -44.73 78.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.842 0.353 . . . . 0.84 110.887 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.46 -44.3 98.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.26 110.01 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 76' ' ' MET . 78.4 mt -60.75 -41.41 95.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.767 -0.651 . . . . 0.29 110.489 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.612 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -57.17 -49.73 69.94 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.697 -0.683 . . . . 0.36 111.541 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.504 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 93.6 mttt -56.05 -51.05 69.22 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 122.518 0.327 . . . . 1.29 110.974 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.631 HG23 HD12 ' A' ' 112' ' ' LEU . 83.0 mt -55.52 -42.67 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.695 -0.684 . . . . 0.27 111.217 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.437 ' HB3' ' ND2' ' B' ' 149' ' ' ASN . 15.0 t-105 -61.93 -44.91 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.478 -0.328 . . . . 0.37 110.956 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 60.7 mttm -63.28 -22.82 67.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 2.54 110.961 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.568 ' O ' HD11 ' A' ' 126' ' ' LEU . 27.7 mt -93.51 -38.01 11.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 1.5 110.528 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -72.61 -42.67 64.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.713 -0.676 . . . . 0.53 111.019 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 44.2 t0 -81.46 78.94 8.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.897 -0.779 . . . . 0.5 108.897 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.432 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 11.2 t -70.13 -36.04 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.493 -0.776 . . . . 0.64 110.827 -174.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.623 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 4.8 p-10 -84.17 -11.08 57.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 1.46 109.727 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.508 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 62.2 mtpt 51.63 66.04 1.31 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.808 -1.087 . . . . 2.74 111.564 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.593 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 10.5 p-10 -115.31 9.2 15.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.335 -0.848 . . . . 0.56 110.412 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.16 2.76 67.45 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.882 -0.675 . . . . 0.49 112.183 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.548 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 81.2 mt -131.73 164.75 25.29 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.377 -0.601 . . . . 0.53 109.377 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.1 mt -120.56 116.65 25.79 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.649 -0.42 . . . . 0.33 110.482 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.479 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.7 p30 -78.62 -176.89 5.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.144 -0.688 . . . . 1.85 109.144 170.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -66.4 -29.6 69.79 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.961 -0.295 . . . . 0.85 111.528 -176.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -69.55 -53.83 17.04 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.213 -0.662 . . . . 2.08 109.213 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.493 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 28.7 mt-10 -63.06 -39.6 95.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.919 -1.037 . . . . 0.48 111.436 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.476 ' CD1' HD11 ' A' ' 67' ' ' ILE . 48.6 t80 -69.48 -40.36 77.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.41 110.249 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.58 75.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.92 -0.582 . . . . 0.23 110.373 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -63.85 -48.44 76.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.947 -0.569 . . . . 1.29 109.475 175.553 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.78 76.71 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.617 -0.72 . . . . 0.23 110.611 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -63.31 -28.36 69.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.711 -0.677 . . . . 0.77 111.543 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 56.8 t60 -81.24 -32.67 33.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.815 -0.354 . . . . 0.33 110.871 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.631 HD12 HG23 ' A' ' 89' ' ' ILE . 93.4 mt -71.12 -37.28 72.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.331 0.586 . . . . 0.28 109.568 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.499 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 76.0 mt -70.78 -32.73 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.905 -0.589 . . . . 0.7 109.941 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 14.3 tppt? -53.4 -55.42 25.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.044 -0.526 . . . . 1.77 110.728 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.3 m -65.94 -36.31 77.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 120.563 -0.455 . . . . 0.53 111.47 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.461 ' HG2' HD23 ' A' ' 122' ' ' LEU . 25.7 mmmt -58.67 -42.03 87.53 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.562 -0.455 . . . . 1.89 111.702 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 81.6 mt -70.09 -22.32 63.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.74 110.97 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -82.73 -8.17 59.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.914 -0.584 . . . . 1.98 110.893 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.56 30.16 16.68 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.576 -0.821 . . . . 0.87 111.861 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -110.24 174.08 6.03 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.646 -0.501 . . . . 1.07 109.646 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 121' ' ' GLU . 16.2 mm-40 -109.21 136.69 48.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.79 -0.641 . . . . 3.06 109.535 171.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 116' ' ' LYS . 1.3 pp -82.93 139.59 43.0 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.335 -0.617 . . . . 1.09 109.335 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 23.7 Cg_exo -62.53 -13.97 36.64 Favored 'Trans proline' 0 N--CA 1.476 0.467 0 C-N-CA 123.332 2.688 . . . . 0.8 113.694 -169.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 63.53 16.42 9.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.645 -0.707 . . . . 0.64 111.425 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -136.26 171.54 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.304 -0.628 . . . . 1.97 109.304 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.866 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 98.9 mt -115.85 90.51 27.54 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.505 -0.316 . . . . 0.67 110.794 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.65 154.85 66.63 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.478 2.119 . . . . 0.52 111.723 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -50.27 -24.36 11.5 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.583 2.856 . . . . 0.63 114.969 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -96.31 5.27 51.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.952 0.406 . . . . 0.86 111.508 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.438 ' O ' HD21 ' A' ' 108' ' ' LEU . 64.8 mt -123.61 -34.08 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.29 -0.414 . . . . 1.19 110.786 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.866 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.8 p -77.61 121.55 84.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.026 0.441 . . . . 1.34 110.654 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 131' ' ' VAL . 12.4 Cg_endo -57.63 129.42 33.61 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.754 2.303 . . . . 0.9 112.065 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.41 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 33.5 Cg_endo -65.61 -6.12 13.12 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.463 2.775 . . . . 1.44 112.959 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 p -75.9 -12.84 60.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.938 0.399 . . . . 1.77 111.08 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.432 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 3.9 mptp? -119.76 20.32 12.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.392 -0.367 . . . . 1.2 111.017 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.41 ' NH2' ' HB3' ' A' ' 133' ' ' PRO . 17.2 mtm180 -110.29 141.36 43.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.135 -0.32 . . . . 3.94 110.135 177.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -141.24 148.53 40.03 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.035 0.445 . . . . 5.08 111.544 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -132.44 141.4 48.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.814 -0.63 . . . . 6.35 109.646 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.504 -0.76 . . . . 8.21 109.221 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.678 -0.49 . . . . 12.91 109.678 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -95.25 166.05 12.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.182 -0.463 . . . . 7.96 110.708 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -108.8 152.94 24.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.38 -0.373 . . . . 10.06 110.843 -173.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -105.18 102.18 11.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.152 -0.476 . . . . 5.36 110.518 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m 58.36 83.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.722 -0.672 . . . . 3.46 112.28 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 1.5 p -95.16 12.16 29.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.983 0.421 . . . . 1.49 111.157 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.612 HD21 ' HA2' ' A' ' 87' ' ' GLY . 24.8 t-20 -101.44 112.45 65.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.132 -0.486 . . . . 0.84 109.729 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 16.5 Cg_exo -68.46 -6.87 18.67 Favored 'Trans proline' 0 N--CA 1.474 0.326 0 C-N-CA 123.361 2.707 . . . . 0.66 113.284 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.538 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 99.2 m-85 -85.96 -36.43 19.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.182 0.515 . . . . 0.68 110.196 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 38.3 p -104.22 90.86 3.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.958 -0.565 . . . . 1.83 110.78 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -157.19 174.58 15.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.165 -0.471 . . . . 3.77 110.55 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' B' ' 154' ' ' LYS . 3.6 ptmm? . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.837 -0.601 . . . . 6.44 110.345 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.637 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.81 0 N-CA-C 111.692 -0.563 . . . . 9.38 111.692 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 2.3 Cg_endo -83.5 -12.56 8.91 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.06 2.507 . . . . 8.63 112.969 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.3 mp 63.37 15.74 8.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.012 0.525 . . . . 8.95 112.182 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.25 56.07 0.49 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.465 -0.874 . . . . 5.86 112.153 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.3 p -126.31 131.73 51.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.814 0.34 . . . . 6.0 110.89 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -107.62 105.8 15.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.811 -0.632 . . . . 3.94 109.78 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -139.56 133.75 31.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.194 0.521 . . . . 3.28 110.944 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.1 p -104.09 148.64 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.604 -0.725 . . . . 1.89 109.278 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.22 130.88 51.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.254 0.549 . . . . 2.49 111.515 -175.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -81.38 110.57 16.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.31 -0.996 . . . . 0.66 108.31 172.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.5 t -53.31 -35.68 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.513 0.56 . . . . 1.41 112.513 -172.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 31.3 t -72.16 -17.0 18.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.372 -0.376 . . . . 1.01 111.26 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.55 -1.25 52.0 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.366 -0.921 . . . . 0.62 112.188 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -86.55 -31.04 21.44 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.22 0.533 . . . . 2.67 110.878 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -141.39 35.16 1.67 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 122.224 1.011 . . . . 1.71 110.229 -172.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 15.1 tmtt? -76.86 -42.56 2.82 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 114.015 -1.448 . . . . 1.2 111.535 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 50' ' ' LYS . 82.2 Cg_exo -46.21 -35.0 14.55 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.726 2.284 . . . . 0.62 113.598 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.584 ' O ' HG12 ' A' ' 56' ' ' ILE . 9.3 m -69.83 -45.66 67.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.732 -0.387 . . . . 0.72 110.449 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -72.16 -22.76 61.25 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.467 -0.568 . . . . 0.65 109.467 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.476 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 18.0 t70 -67.2 -41.18 86.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.137 -0.938 . . . . 1.03 109.078 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -66.85 -35.59 80.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.21 -0.904 . . . . 2.15 110.239 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 52' ' ' THR . 23.0 mm -66.03 -31.48 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.731 0.777 . . . . 0.71 109.707 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 87.6 t80 -72.91 -45.55 57.53 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.094 -0.957 . . . . 0.31 110.804 -175.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.476 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 51.2 m-85 -75.49 -19.89 59.1 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.114 -0.493 . . . . 0.8 111.952 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.2 p -83.45 -5.16 59.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 0.61 111.164 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.62 8.98 39.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 0.41 111.246 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.1 t 64.32 83.41 0.2 Allowed Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 123.743 0.652 . . . . 1.24 110.955 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.43 118.13 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.766 2.311 . . . . 0.59 112.812 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.91 134.7 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.744 . . . . 1.31 110.66 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 57.92 19.92 6.24 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.457 0.703 . . . . 1.89 111.377 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.71 7.27 63.17 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.907 -0.588 . . . . 0.62 112.258 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 54.4 mtmt -137.45 173.42 11.68 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 110.111 -0.329 . . . . 1.81 110.111 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.433 HD11 ' CD1' ' A' ' 106' ' ' PHE . 25.0 pt -118.39 154.12 20.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.87 -0.418 . . . . 0.3 109.87 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.589 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 70.7 p -80.95 166.94 20.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.896 -0.593 . . . . 0.44 110.201 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.536 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -58.87 -22.46 54.39 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.642 -0.79 . . . . 0.33 111.888 175.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.57 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -61.42 -59.91 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.34 111.556 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -65.8 -42.75 90.33 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.689 -0.687 . . . . 1.65 111.332 -170.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.16 -36.14 83.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.27 110.522 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 32.0 tttp -62.27 -43.39 98.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.894 -0.594 . . . . 1.52 110.019 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.571 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 24.8 mtpt -58.76 -51.1 71.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.687 -0.688 . . . . 1.14 110.576 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -57.98 -43.7 86.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.529 0.681 . . . . 1.78 110.457 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.723 ' HB3' HD22 ' A' ' 86' ' ' LEU . 94.4 mtp -69.16 -26.91 65.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.792 -0.64 . . . . 0.86 112.276 -175.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 74' ' ' LYS . 25.6 m -83.16 -22.82 8.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 120.126 -0.63 . . . . 1.52 109.602 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 5.6 mptp? -77.6 -12.94 60.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 3.33 110.099 173.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.0 m -75.2 -7.93 55.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.91 111.62 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? 67.39 34.66 4.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.986 0.422 . . . . 2.97 111.374 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.58 ' HB2' HD21 ' A' ' 86' ' ' LEU . 95.3 mt -112.74 146.65 35.49 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.106 -0.497 . . . . 1.41 110.982 -176.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.7 Cg_endo -61.62 153.14 69.05 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.064 2.509 . . . . 0.32 112.854 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -59.62 -32.74 70.7 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.948 -0.569 . . . . 2.05 111.601 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.46 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -64.73 -50.47 66.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.922 0.391 . . . . 0.84 110.951 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . 42.8 t -60.27 -44.26 95.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.26 110.418 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.723 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.4 mt -63.84 -38.84 92.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.809 -0.632 . . . . 0.29 110.774 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.674 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.88 -42.68 99.71 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.039 -0.6 . . . . 0.36 112.551 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 85' ' ' VAL . 41.1 mtmt -68.18 -42.9 79.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.744 -0.095 . . . . 1.29 110.744 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.545 HD11 ' CE ' ' A' ' 116' ' ' LYS . 93.8 mt -55.83 -52.2 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.384 0.428 . . . . 0.27 111.071 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.536 ' CH2' ' HA2' ' A' ' 69' ' ' GLY . 39.0 t-105 -62.98 -49.59 74.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.794 0.331 . . . . 0.37 111.348 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -59.64 -30.93 69.06 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.139 -0.482 . . . . 2.54 111.232 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -92.53 -41.02 10.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 1.5 111.2 -176.369 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' N ' ' HG ' ' A' ' 92' ' ' LEU . . . -69.53 -36.32 76.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.536 0.569 . . . . 0.53 112.536 -175.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.602 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 42.5 t0 -74.18 95.47 2.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.895 -0.779 . . . . 0.5 108.895 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.789 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 8.1 t -79.75 -39.91 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.64 110.942 -171.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -80.68 -13.92 58.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 1.46 109.68 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.595 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 6.1 mtpp 51.64 72.91 0.34 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.496 -1.229 . . . . 2.74 111.31 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.625 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.1 p-10 -128.33 9.1 6.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.962 -1.017 . . . . 0.56 110.825 -175.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.23 10.84 70.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.49 111.841 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.625 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 43.8 mt -134.31 157.45 46.3 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.217 -0.66 . . . . 0.53 109.217 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.0 mt -121.77 118.81 29.97 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.776 -0.37 . . . . 0.33 110.196 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.6 p30 -74.67 -177.63 3.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.077 -0.712 . . . . 1.85 109.077 168.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -66.08 -27.05 67.78 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.088 0.403 . . . . 0.85 112.088 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 85.7 mt-10 -75.89 -47.32 25.87 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.749 -0.463 . . . . 2.08 109.749 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -66.3 -37.7 86.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.89 -0.596 . . . . 0.48 110.492 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.433 ' CD1' HD11 ' A' ' 67' ' ' ILE . 23.7 t80 -70.34 -38.56 74.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.168 -0.469 . . . . 0.41 110.303 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.88 99.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.045 -0.525 . . . . 0.23 110.401 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -59.38 -49.88 76.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 1.29 109.574 177.448 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -55.61 -46.92 77.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.905 -0.589 . . . . 0.23 111.552 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -66.68 -38.4 86.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.446 . . . . 0.77 111.407 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -64.92 -32.61 74.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.098 0.475 . . . . 0.33 109.934 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.717 ' HB3' HD23 ' A' ' 122' ' ' LEU . 97.8 mt -67.09 -35.02 78.9 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.954 -0.567 . . . . 0.28 109.997 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 109' ' ' ALA . 38.7 mm -61.26 -47.1 95.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.158 -0.682 . . . . 0.7 109.158 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -59.06 -44.06 91.79 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.417 -0.811 . . . . 1.77 112.033 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 112' ' ' LEU . 11.6 m -64.56 -38.79 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 120.062 -0.655 . . . . 0.53 111.344 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.612 ' HE3' HD21 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -51.97 -48.51 64.32 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 120.526 -0.47 . . . . 1.89 111.262 167.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.38 -29.37 68.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.933 -0.576 . . . . 0.74 111.23 -177.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -70.91 -20.01 62.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.968 -0.56 . . . . 1.98 111.233 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.39 22.67 10.24 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.693 -0.765 . . . . 0.87 112.004 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -119.36 158.57 25.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.589 -0.523 . . . . 1.07 109.589 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.9 130.61 55.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.201 0.524 . . . . 3.06 110.564 174.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.717 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -68.79 146.5 97.55 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 1.09 110.407 172.534 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 2.2 Cg_endo -80.22 1.7 9.05 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.719 2.279 . . . . 0.8 112.86 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.488 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 64.53 19.69 11.89 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.985 -0.552 . . . . 0.64 110.892 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -133.85 169.72 16.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.696 -0.684 . . . . 1.97 109.383 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 63.6 mt -111.97 91.26 15.04 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 123.082 0.239 . . . . 0.67 111.516 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 29.0 Cg_endo -64.54 154.41 72.09 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.71 2.273 . . . . 0.52 111.208 170.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.27 -40.24 52.34 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.537 2.825 . . . . 0.63 113.77 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -79.14 7.65 7.17 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.088 0.403 . . . . 0.86 112.088 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.401 HD12 ' HG2' ' A' ' 127' ' ' PRO . 70.5 mt -126.34 5.61 7.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.547 0.213 . . . . 1.19 111.557 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.32 118.31 69.75 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.033 -0.267 . . . . 1.34 110.915 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.837 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 64.5 Cg_exo -53.76 124.57 16.17 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.139 2.56 . . . . 0.9 112.135 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 28.3 Cg_exo -62.58 -22.93 74.53 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.143 2.562 . . . . 1.44 114.296 -172.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 57.0 m -72.5 -15.67 61.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.199 0.523 . . . . 1.77 110.258 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.837 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 10.0 mptt -101.31 26.05 7.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.922 -0.581 . . . . 1.2 110.102 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.546 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 5.4 mmp_? -89.56 149.7 22.74 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.391 -0.596 . . . . 3.94 109.391 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -78.65 90.51 4.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.388 0.613 . . . . 5.08 110.103 -174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -91.29 121.42 33.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 6.35 110.855 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.012 -0.995 . . . . 8.21 110.852 -176.553 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 57.7 t80 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 110.295 -0.261 . . . . 12.91 110.295 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -72.07 -75.1 0.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.185 0.517 . . . . 7.96 110.156 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -125.48 -66.64 0.94 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.395 -0.965 . . . . 10.06 108.395 173.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -132.21 136.74 47.24 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.685 -0.857 . . . . 5.36 108.685 172.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 5.2 p -167.51 106.9 0.56 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.96 0.409 . . . . 3.46 111.063 -174.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.5 p -97.11 6.7 48.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.06 -0.518 . . . . 1.49 111.235 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.735 ' HB3' ' O ' ' B' ' 152' ' ' THR . 48.6 t-20 -157.54 125.41 2.79 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.915 -0.584 . . . . 0.84 109.448 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 21.1 Cg_exo -66.59 -3.14 8.62 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.45 2.766 . . . . 0.66 113.684 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.516 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 83.6 m-85 -104.75 -27.19 11.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.987 0.422 . . . . 0.68 110.533 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' B' ' 149' ' ' ASN . 3.5 t -167.38 133.78 2.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.876 -0.602 . . . . 1.83 110.433 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.9 -5.55 53.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.278 0.561 . . . . 3.77 110.215 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp . . . . . 0 C--O 1.254 1.298 0 CA-C-N 115.47 -0.786 . . . . 6.44 109.617 -177.051 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.602 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.663 -0.575 . . . . 9.38 111.663 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.57 141.15 90.45 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.855 2.37 . . . . 8.63 112.071 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.8 160.43 15.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.063 -0.517 . . . . 8.95 111.206 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.55 171.07 32.37 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.2 -1.16 . . . . 5.86 110.2 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.1 m 66.9 -166.02 0.22 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.068 0.461 . . . . 6.0 110.659 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -113.11 135.09 54.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.086 -0.507 . . . . 3.94 109.767 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.01 111.28 4.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.153 0.502 . . . . 3.28 110.984 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 p -76.66 134.76 28.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.767 -0.651 . . . . 1.89 110.843 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.73 86.94 5.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.247 -0.433 . . . . 2.49 110.975 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -80.68 98.54 7.75 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.703 -0.851 . . . . 0.66 108.703 174.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 m -57.57 -26.71 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.578 -0.737 . . . . 1.41 112.172 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HA ' ' OD1' ' A' ' 49' ' ' ASP . 24.1 t -73.41 -16.34 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.032 -0.531 . . . . 1.01 111.227 -174.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.01 -8.81 58.82 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.604 -0.808 . . . . 0.62 112.396 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -93.88 -28.78 15.65 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.395 0.617 . . . . 2.67 110.721 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.501 ' OD1' ' HA ' ' A' ' 46' ' ' VAL . 10.8 p-10 -120.94 33.7 5.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.211 -0.904 . . . . 1.71 109.714 -172.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.06 -46.51 0.47 Allowed Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 114.391 -1.277 . . . . 1.2 112.263 -174.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.39 -26.61 8.84 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 122.754 2.303 . . . . 0.62 114.06 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -68.83 -45.86 70.04 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.384 0.611 . . . . 0.72 110.126 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -78.14 -20.72 51.49 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.706 -0.679 . . . . 0.65 109.178 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.6 -45.19 94.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.614 -0.721 . . . . 1.03 109.505 173.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -62.05 -50.0 73.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.203 -0.908 . . . . 2.15 110.089 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.9 mt -60.71 -35.42 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.063 -0.517 . . . . 0.71 111.008 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.499 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 92.6 t80 -65.13 -40.33 94.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.637 -0.71 . . . . 0.31 110.05 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -74.75 -25.01 58.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.959 -0.564 . . . . 0.8 111.726 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.6 p -82.53 1.87 35.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.088 0.47 . . . . 0.61 111.374 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.75 1.85 23.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.714 -0.476 . . . . 0.41 109.714 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.5 m 63.3 88.88 0.11 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.054 -0.975 . . . . 1.24 111.593 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -86.92 122.5 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.71 2.273 . . . . 0.59 112.592 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.9 m -101.2 130.9 49.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.001 -0.545 . . . . 1.31 109.781 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 65.91 21.85 11.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.002 -0.545 . . . . 1.89 110.046 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.18 1.53 78.85 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.912 -0.586 . . . . 0.62 112.549 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.64 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 51.5 mtmt -135.59 156.44 48.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.021 -0.363 . . . . 1.81 110.021 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.547 HD11 ' CD1' ' A' ' 106' ' ' PHE . 15.4 pt -102.33 146.14 10.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 120.57 -0.452 . . . . 0.3 110.663 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.581 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 68.5 p -73.16 163.97 27.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.089 -0.505 . . . . 0.44 110.293 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.99 -24.76 55.24 Favored Glycine 0 C--O 1.221 -0.708 0 C-N-CA 120.796 -0.716 . . . . 0.33 112.469 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -59.35 -58.07 10.21 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.119 0.485 . . . . 0.34 111.601 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.463 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -67.54 -41.12 84.8 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.719 -0.673 . . . . 1.65 110.363 -173.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -65.29 -31.54 72.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.483 -0.781 . . . . 0.27 110.524 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 70.9 tttt -67.86 -43.48 79.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.213 -0.449 . . . . 1.52 109.954 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.736 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.9 mtmt -55.29 -49.12 72.92 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.515 -0.766 . . . . 1.14 110.106 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 28.9 tp10 -57.92 -44.21 86.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.325 0.583 . . . . 1.78 110.749 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.602 ' HB3' HD22 ' A' ' 86' ' ' LEU . 23.9 mmt -63.9 -36.48 84.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.923 -0.58 . . . . 0.86 111.884 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -81.16 -35.75 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.435 -0.506 . . . . 1.52 111.674 -173.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.736 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -81.93 -8.34 59.67 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 119.99 -0.684 . . . . 3.33 110.97 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.0 m -75.35 -20.35 59.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.163 0.506 . . . . 0.91 109.716 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 mmmp? 69.6 51.01 0.48 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.038 -0.983 . . . . 2.97 111.775 175.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.518 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.8 mp -110.99 145.31 32.17 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.872 -1.058 . . . . 1.41 109.018 170.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 20.9 Cg_endo -62.93 146.7 94.96 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.998 2.465 . . . . 0.32 112.427 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -56.73 -31.16 64.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.26 -0.427 . . . . 2.05 111.724 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.8 m -62.51 -48.63 78.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.135 0.493 . . . . 0.84 110.267 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.707 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 69.1 t -66.51 -43.06 91.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.26 110.212 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 76' ' ' MET . 80.9 mt -59.87 -36.39 76.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.055 -0.52 . . . . 0.29 110.196 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.915 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.7 -46.07 94.98 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.739 -0.664 . . . . 0.36 112.043 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.707 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 17.7 mtpp -61.17 -47.32 86.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.361 -0.237 . . . . 1.29 110.361 177.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.422 ' HA ' HD23 ' A' ' 92' ' ' LEU . 88.6 mt -60.77 -48.42 88.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.873 -0.603 . . . . 0.27 111.357 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -64.04 -48.97 74.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.915 0.388 . . . . 0.37 111.179 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.24 -27.82 68.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.894 -0.594 . . . . 2.54 111.353 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -94.32 -33.21 13.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.863 -0.608 . . . . 1.5 111.331 -177.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -73.48 -42.49 61.8 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.137 0.421 . . . . 0.53 112.137 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.639 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 50.6 t0 -78.16 95.55 4.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.869 -0.789 . . . . 0.5 108.869 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 t -70.38 -44.44 77.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.406 -0.816 . . . . 0.64 110.38 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.628 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 6.4 p-10 -88.35 -17.18 31.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.317 -0.856 . . . . 1.46 110.755 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 50.8 mttp 58.03 73.39 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.152 0.977 . . . . 2.74 112.094 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.603 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 12.9 p-10 -117.67 10.21 13.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.291 -1.322 . . . . 0.56 110.576 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.29 -0.88 62.36 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.054 -0.593 . . . . 0.49 112.156 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.581 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 47.5 mt -129.87 149.42 51.61 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.054 -0.721 . . . . 0.53 109.054 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.7 mt -98.99 112.31 24.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.359 0.6 . . . . 0.33 109.858 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.653 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 7.5 t70 -70.39 166.3 20.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.826 -1.079 . . . . 1.85 109.122 173.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -57.47 -37.99 73.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 118.006 0.366 . . . . 0.85 111.692 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.727 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 81.3 mt-10 -70.98 -40.38 71.94 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.671 -0.412 . . . . 2.08 110.663 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.653 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 18.2 mt-10 -70.68 -31.94 69.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.48 110.697 -174.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD1' HD11 ' A' ' 67' ' ' ILE . 66.8 t80 -74.37 -44.39 52.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.788 -0.642 . . . . 0.41 109.887 177.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.7 87.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.742 -0.663 . . . . 0.23 109.82 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 93' ' ' ALA . 18.3 tp -60.57 -50.56 73.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.437 -0.801 . . . . 1.29 109.834 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -56.9 -46.64 81.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.23 111.155 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -68.85 -34.41 75.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.177 -0.465 . . . . 0.77 111.355 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.425 ' CG ' HG22 ' A' ' 46' ' ' VAL . 40.9 t60 -65.41 -39.14 91.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.696 -0.483 . . . . 0.33 109.696 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.6 ' HB3' HD22 ' A' ' 122' ' ' LEU . 74.9 mt -63.69 -43.34 96.93 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.957 -0.565 . . . . 0.28 110.044 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.488 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 33.7 mm -54.08 -50.58 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.637 -0.711 . . . . 0.7 110.115 173.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 27.3 ttpp -58.51 -49.95 75.52 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.548 -0.751 . . . . 1.77 111.435 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.7 m -61.51 -40.1 85.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.537 -0.465 . . . . 0.53 111.217 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.545 ' HG2' HD23 ' A' ' 122' ' ' LEU . 24.8 mmmt -58.71 -40.56 84.04 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.221 -0.192 . . . . 1.89 111.403 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 92.6 mt -71.19 -32.24 68.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.168 0.508 . . . . 0.74 110.868 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 47.1 mt-10 -77.72 2.29 17.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.842 -0.617 . . . . 1.98 111.106 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.12 24.18 41.86 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.781 -0.723 . . . . 0.87 112.401 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -114.53 175.13 5.62 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.502 -0.555 . . . . 1.07 109.502 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -117.96 136.55 53.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.955 0.407 . . . . 3.06 111.195 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 112' ' ' LEU . 3.0 pp -89.41 134.33 32.95 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.44 -0.578 . . . . 1.09 109.44 173.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 37.3 Cg_exo -60.93 -18.66 58.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.168 2.579 . . . . 0.8 113.768 -172.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.427 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 65.0 17.87 11.27 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.822 -0.626 . . . . 0.64 110.94 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -133.95 173.81 11.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.236 -0.893 . . . . 1.97 108.635 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.4 mt -113.2 90.46 16.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.817 0.302 . . . . 0.67 111.817 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.74 160.53 37.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.504 2.136 . . . . 0.52 110.712 169.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.71 -34.3 53.26 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.278 2.652 . . . . 0.63 113.711 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -86.94 -2.16 58.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.733 -0.387 . . . . 0.86 111.659 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -99.37 -25.7 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.979 0.418 . . . . 1.19 110.356 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 60.4 t -70.88 119.56 73.93 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.849 -0.614 . . . . 1.34 111.163 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.727 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 51.6 Cg_exo -55.37 146.32 62.72 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.291 2.661 . . . . 0.9 112.716 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 33.4 Cg_exo -60.45 -21.34 67.61 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.452 2.768 . . . . 1.44 114.577 -170.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.7 m -84.1 -26.26 29.09 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.191 -0.604 . . . . 1.77 111.643 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.619 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -120.42 31.56 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 1.2 111.324 -177.537 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -82.26 146.47 29.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 3.94 111.162 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -92.04 142.96 26.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 5.08 110.448 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -97.71 129.22 44.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.521 -0.309 . . . . 6.35 110.672 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.365 -0.826 . . . . 8.21 109.766 171.972 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.458 -0.571 . . . . 12.91 109.458 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -113.95 -73.72 0.65 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.98 -0.288 . . . . 7.96 110.876 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 63.08 79.32 0.26 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.715 0.634 . . . . 10.06 110.798 -176.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.18 -54.52 6.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.819 -0.628 . . . . 5.36 110.413 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 50.5 m -150.14 129.52 12.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.661 -0.7 . . . . 3.46 109.948 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 1.5 m -125.03 24.9 7.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.218 0.533 . . . . 1.49 110.419 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.915 HD21 ' HA2' ' A' ' 87' ' ' GLY . 33.6 t-20 -115.53 115.88 41.71 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.031 0.443 . . . . 0.84 111.565 -173.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.09 -4.87 15.11 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.919 3.08 . . . . 0.66 113.302 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.561 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 72.4 m-85 -101.47 4.98 41.75 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.055 0.391 . . . . 0.68 112.055 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 38.7 p -127.8 162.36 26.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.777 0.658 . . . . 1.83 112.777 -171.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 73.88 -92.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.113 -0.949 . . . . 3.77 112.488 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 mttp . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.2 -0.905 . . . . 6.44 110.612 -176.58 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.639 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.7 t90 . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.071 -0.715 . . . . 0.66000000000000003 109.071 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 48.1 t -54.42 -32.05 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.053 -0.521 . . . . 1.4099999999999999 111.996 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.82 -22.09 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.386 -0.37 . . . . 1.01 111.311 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.58 -10.05 62.93 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.301 -0.952 . . . . 0.62 112.74 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 52.4 pttt -93.98 -18.59 21.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 117.289 0.545 . . . . 2.6699999999999999 111.426 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -136.67 33.71 2.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.265 1.031 . . . . 1.71 109.218 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 6.4 tmtm? -75.07 -46.08 4.76 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.528 -1.215 . . . . 1.2 111.908 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.6 Cg_endo -50.86 -26.37 17.85 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.803 2.335 . . . . 0.62 113.257 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.5 m -76.03 -46.84 27.26 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.929 -0.308 . . . . 0.71999999999999997 111.091 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -72.62 -22.32 60.98 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.858 -0.793 . . . . 0.65000000000000002 108.858 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 28.3 t70 -71.29 -43.21 67.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.546 -1.207 . . . . 1.03 109.452 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.29 -43.89 97.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.149 -0.932 . . . . 2.1499999999999999 109.991 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.5 -30.8 51.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.014 -0.539 . . . . 0.70999999999999996 110.457 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.482 ' HE1' HG12 ' A' ' 67' ' ' ILE . 79.9 t80 -65.06 -40.87 95.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.889 -0.596 . . . . 0.31 110.072 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.451 ' HE2' ' OD2' ' A' ' 54' ' ' ASP . 57.8 m-85 -72.88 -23.44 60.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.676 -0.693 . . . . 0.80000000000000004 111.904 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.5 p -79.8 -2.36 42.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.799 -0.36 . . . . 0.60999999999999999 111.451 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 83.0 mt -105.19 7.22 33.57 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.077 -0.249 . . . . 0.40999999999999998 111.038 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 t 65.87 84.0 0.18 Allowed Pre-proline 0 C--O 1.234 0.268 0 O-C-N 123.844 0.715 . . . . 1.24 111.076 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.403 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 44.4 Cg_endo -85.31 114.1 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.453 2.102 . . . . 0.58999999999999997 112.61 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -89.12 137.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.724 -0.671 . . . . 1.3100000000000001 109.869 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 p30 46.13 23.64 0.21 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.943 0.897 . . . . 1.8899999999999999 112.663 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.21 6.55 61.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.349 -0.453 . . . . 0.62 113.643 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -134.36 174.61 10.34 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.312 0.577 . . . . 1.8100000000000001 110.837 177.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.493 HD11 ' CD1' ' A' ' 106' ' ' PHE . 16.8 pt -123.56 148.58 27.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.322 -0.854 . . . . 0.29999999999999999 109.574 172.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.9 p -83.37 179.2 7.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.584 -0.734 . . . . 0.44 110.114 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.11 -34.07 77.71 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.751 -0.737 . . . . 0.33000000000000002 112.272 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.41 96.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.138 0.494 . . . . 0.34000000000000002 112.12 -176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.517 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.2 m120 -76.03 -47.1 26.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.342 0.592 . . . . 1.6499999999999999 110.244 -172.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.59 -22.88 63.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.023 -0.535 . . . . 0.27000000000000002 110.247 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 41.5 ttmt -68.18 -54.36 18.44 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.242 -0.435 . . . . 1.52 109.976 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 17.5 ptpt -59.22 -33.15 70.65 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.82 0.343 . . . . 1.1399999999999999 110.23 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.583 ' CD ' ' HZ3' ' A' ' 78' ' ' LYS . 14.1 tp10 -60.45 -53.48 57.01 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.321 0.581 . . . . 1.78 110.132 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 1.057 ' HB3' HD22 ' A' ' 86' ' ' LEU . 54.6 mtt -70.73 -22.6 62.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.671 . . . . 0.85999999999999999 110.852 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 73' ' ' LYS . 3.9 t -63.17 -47.17 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.927 -0.579 . . . . 1.52 110.581 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -94.61 -1.61 52.93 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.386 -0.926 . . . . 3.3300000000000001 111.792 -175.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.0 p -66.89 -19.75 65.79 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.817 0.342 . . . . 0.91000000000000003 110.178 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.4 tptt 75.58 22.97 1.51 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.879 0.872 . . . . 2.9700000000000002 111.443 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 86' ' ' LEU . 11.2 mp -92.0 151.45 41.93 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.306 -0.257 . . . . 1.4099999999999999 110.306 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.577 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 14.5 Cg_endo -59.94 148.18 89.79 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.649 2.233 . . . . 0.32000000000000001 112.731 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -55.93 -39.49 71.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.454 -0.794 . . . . 2.0499999999999998 111.188 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 m -61.1 -45.95 92.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.996 -0.547 . . . . 0.83999999999999997 111.374 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.502 ' CG2' ' HG2' ' A' ' 82' ' ' PRO . 55.0 t -64.45 -42.22 94.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.26000000000000001 110.376 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.057 HD22 ' HB3' ' A' ' 76' ' ' MET . 64.0 mt -57.65 -46.4 84.24 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.051 0.453 . . . . 0.28999999999999998 110.695 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.678 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -64.84 -34.65 90.46 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.832 -0.699 . . . . 0.35999999999999999 112.13 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -70.54 -41.43 72.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.272 0.558 . . . . 1.29 110.455 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.63 HG23 HD12 ' A' ' 112' ' ' LEU . 83.7 mt -62.38 -42.93 97.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.625 -0.716 . . . . 0.27000000000000002 110.937 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -59.39 -40.69 87.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.966 0.412 . . . . 0.37 110.077 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -62.99 -25.96 68.62 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.54 -0.754 . . . . 2.54 111.026 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.436 HD11 ' HA ' ' A' ' 124' ' ' ALA . 66.1 mt -90.35 -33.28 16.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.296 -0.411 . . . . 1.5 111.336 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.32 -43.63 63.84 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.83 0.678 . . . . 0.53000000000000003 112.83 -170.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -88.35 68.85 9.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.43 0.633 . . . . 0.5 110.156 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.11 -21.69 29.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.297 -0.865 . . . . 0.64000000000000001 109.699 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -79.7 -23.37 42.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.882 -1.054 . . . . 1.46 110.754 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 59.91 51.85 5.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.219 -0.9 . . . . 2.7400000000000002 111.907 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 11.8 p-10 -118.63 7.54 11.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.969 0.414 . . . . 0.56000000000000005 109.997 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.78 -1.51 30.0 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.987 -0.625 . . . . 0.48999999999999999 112.79 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.526 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 64.2 mt -123.77 155.68 37.48 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.807 -0.442 . . . . 0.53000000000000003 109.807 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -110.16 110.78 21.76 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.501 -0.48 . . . . 0.33000000000000002 110.53 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 2.4 m-20 -70.97 169.08 15.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.103 -0.702 . . . . 1.8500000000000001 109.103 168.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.8 -29.89 65.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.593 -0.276 . . . . 0.84999999999999998 111.115 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.07 -51.92 61.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.847 0.832 . . . . 2.0800000000000001 109.579 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -71.31 -35.98 71.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.536 -1.211 . . . . 0.47999999999999998 110.966 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.493 ' CD1' HD11 ' A' ' 67' ' ' ILE . 58.8 t80 -70.51 -36.37 73.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.19 -0.459 . . . . 0.40999999999999998 110.279 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.74 84.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.23000000000000001 110.184 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -64.23 -46.52 83.47 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.989 -0.551 . . . . 1.29 109.552 177.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.46 94.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.3 -0.864 . . . . 0.23000000000000001 111.296 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.03 -31.55 72.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.17 -0.468 . . . . 0.77000000000000002 111.101 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -66.25 -40.69 90.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.932 -0.395 . . . . 0.33000000000000002 109.932 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.63 HD12 HG23 ' A' ' 89' ' ' ILE . 89.4 mt -65.6 -39.47 91.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.882 -0.599 . . . . 0.28000000000000003 110.438 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 62.7 mt -70.66 -37.77 70.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.002 -0.545 . . . . 0.69999999999999996 110.927 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 26.1 ttpp -63.2 -45.78 90.08 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.913 -0.315 . . . . 1.77 110.532 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.61 -35.24 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.095 -0.642 . . . . 0.53000000000000003 110.465 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.658 ' HD3' HD23 ' A' ' 122' ' ' LEU . 25.0 mmmt -56.21 -45.6 79.81 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.39 -0.368 . . . . 1.8899999999999999 111.163 171.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 84.1 mt -67.2 -33.85 76.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.272 0.558 . . . . 0.73999999999999999 110.646 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.6 mt-10 -78.0 4.39 12.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.663 -0.698 . . . . 1.98 111.386 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.65 34.91 14.65 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.99 -0.624 . . . . 0.87 112.54 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -122.91 171.42 9.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.806 0.336 . . . . 1.0700000000000001 110.25 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -111.82 150.55 30.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.062 -0.517 . . . . 3.0600000000000001 109.804 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.658 HD23 ' HD3' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -95.69 138.35 21.79 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.216 -1.031 . . . . 1.0900000000000001 108.216 173.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.79 -9.76 17.5 Favored 'Trans proline' 0 N--CA 1.473 0.297 0 C-N-CA 122.947 2.431 . . . . 0.80000000000000004 114.095 -171.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.436 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 62.86 17.57 10.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.585 0.707 . . . . 0.64000000000000001 110.489 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.03 161.68 34.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.906 -1.043 . . . . 1.97 108.85 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.414 ' HG ' HD22 ' A' ' 92' ' ' LEU . 96.3 mt -110.52 90.81 10.9 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.916 -0.314 . . . . 0.67000000000000004 111.346 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 50.2 Cg_endo -70.31 158.95 54.65 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.691 2.26 . . . . 0.52000000000000002 111.553 171.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 34.5 Cg_exo -59.13 -7.79 5.42 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.521 2.814 . . . . 0.63 114.241 -176.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -108.42 -2.59 18.94 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.367 -0.533 . . . . 0.85999999999999999 111.191 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -101.7 -36.67 8.64 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.117 0.484 . . . . 1.1899999999999999 110.358 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 7.7 p -78.43 124.27 85.55 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.681 -0.69 . . . . 1.3400000000000001 111.005 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 131' ' ' VAL . 22.1 Cg_exo . . . . . 0 N--CA 1.46 -0.491 0 C-N-CA 122.743 2.295 . . . . 0.90000000000000002 111.707 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.678 HD21 ' HA2' ' A' ' 87' ' ' GLY . 27.0 t-20 . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 110.28 -0.267 . . . . 0.83999999999999997 110.28 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 8.0 Cg_exo -73.14 -2.87 12.7 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.53 2.82 . . . . 0.66000000000000003 113.028 -176.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 96.8 m-85 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.46 -0.336 . . . . 0.68000000000000005 110.867 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.494 ' HD1' ' O ' ' A' ' 129' ' ' HIS . 10.2 t90 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 109.112 -0.699 . . . . 0.66000000000000003 109.112 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -69.34 5.2 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.746 0.647 . . . . 1.4099999999999999 112.746 -172.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG21 HD22 ' A' ' 108' ' ' LEU . 97.0 t -105.97 -19.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.96 0.409 . . . . 1.01 110.292 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.573 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -68.39 -18.2 71.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.634 -0.793 . . . . 0.62 111.557 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -74.76 -27.4 60.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.54 -0.33 . . . . 2.6699999999999999 111.292 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -127.61 33.49 4.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.909 0.385 . . . . 1.71 110.612 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.625 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 6.8 mmmm -64.62 -45.27 76.14 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.837 0.68 . . . . 1.2 112.837 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.5 Cg_endo -49.85 -35.22 39.21 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 122.397 2.064 . . . . 0.62 112.415 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 56' ' ' ILE . 11.5 m -73.53 -46.43 47.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.517 -0.31 . . . . 0.71999999999999997 111.302 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -71.56 -23.28 61.72 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.766 -0.457 . . . . 0.65000000000000002 109.766 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.42 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 15.2 t70 -73.86 -44.52 55.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.47 -0.786 . . . . 1.03 109.265 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 59' ' ' THR . 35.3 tt0 -57.02 -46.54 82.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.143 -0.935 . . . . 2.1499999999999999 110.358 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 52' ' ' THR . 58.9 mt -67.11 -49.21 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.137 -0.483 . . . . 0.70999999999999996 110.789 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.46 ' HE1' HG12 ' A' ' 67' ' ' ILE . 77.8 t80 -51.25 -46.44 62.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.853 -0.612 . . . . 0.31 111.682 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 29.3 m-85 -74.19 -12.37 60.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.684 0.624 . . . . 0.80000000000000004 112.684 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 55' ' ' GLU . 70.1 p -90.96 4.37 52.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.114 0.483 . . . . 0.60999999999999999 110.737 177.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 82.3 mt -105.91 6.58 31.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.768 -0.456 . . . . 0.40999999999999998 109.768 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.7 m 65.59 82.49 0.2 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.185 -0.916 . . . . 1.24 111.43 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 61.5 Cg_endo -92.04 113.84 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.737 2.291 . . . . 0.58999999999999997 113.287 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.8 146.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.625 -0.88 . . . . 1.3100000000000001 108.625 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 p30 50.33 22.35 0.98 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.746 0.818 . . . . 1.8899999999999999 112.136 -174.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.61 29.62 47.64 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.238 -0.506 . . . . 0.62 111.872 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.737 ' HE2' ' HB3' ' A' ' 102' ' ' ASP . 32.4 ttmt -156.19 146.81 21.82 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.902 0.382 . . . . 1.8100000000000001 110.719 -173.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.46 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.5 pt -103.14 156.31 5.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.224 0.535 . . . . 0.29999999999999999 110.43 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.419 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 73.2 p -89.39 178.1 6.41 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.602 -0.726 . . . . 0.44 109.972 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.686 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -65.19 -17.62 63.95 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.979 -0.629 . . . . 0.33000000000000002 112.299 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.73 -47.29 63.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.216 0.531 . . . . 0.34000000000000002 111.332 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.66 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.3 m120 -73.79 -41.45 62.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.587 -0.733 . . . . 1.6499999999999999 110.367 -173.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.4 -19.79 60.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.188 -0.46 . . . . 0.27000000000000002 110.193 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.686 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 3.6 ttmp? -68.38 -51.59 42.54 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.754 -0.461 . . . . 1.52 109.754 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.52 ' HA ' HG22 ' A' ' 77' ' ' VAL . 18.6 ptpt -63.33 -32.94 74.5 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.965 -0.562 . . . . 1.1399999999999999 110.391 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.53 -53.82 51.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.792 -0.447 . . . . 1.78 109.792 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.424 ' HB3' HD22 ' A' ' 86' ' ' LEU . 57.5 mtt -69.5 -33.61 73.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.032 -0.531 . . . . 0.85999999999999999 112.198 -173.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 74' ' ' LYS . 30.9 m -77.0 -19.04 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.644 -0.422 . . . . 1.52 109.914 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 12.7 mptt -87.47 -12.33 46.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.911 -0.586 . . . . 3.3300000000000001 110.453 174.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.5 m -86.75 -5.1 59.22 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.876 -0.602 . . . . 0.91000000000000003 111.092 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.4 mptt 68.24 29.0 6.22 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.297 0.639 . . . . 2.9700000000000002 111.786 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.724 ' HB2' HD21 ' A' ' 86' ' ' LEU . 24.3 mt -98.14 143.38 26.17 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.428 -0.351 . . . . 1.4099999999999999 111.068 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.499 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.5 Cg_endo -61.64 150.9 83.57 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.257 2.638 . . . . 0.32000000000000001 113.51 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -55.99 -42.27 76.11 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.697 -0.683 . . . . 2.0499999999999998 111.85 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.1 m -58.04 -54.13 50.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.306 -0.406 . . . . 0.83999999999999997 110.909 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.469 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 47.0 t -57.71 -44.13 85.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.103 -0.499 . . . . 0.26000000000000001 110.87 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.724 HD21 ' HB2' ' A' ' 81' ' ' LEU . 56.6 mt -63.42 -36.04 82.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.28999999999999998 111.229 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.764 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.59 -42.71 99.31 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.846 -0.692 . . . . 0.35999999999999999 111.656 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 20.6 mtpp -68.47 -46.18 70.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.5 -0.35 . . . . 1.29 110.353 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.465 ' HA ' HD23 ' A' ' 92' ' ' LEU . 88.2 mt -56.83 -52.13 58.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 123.512 0.507 . . . . 0.27000000000000002 110.85 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -60.43 -53.66 54.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.448 -0.342 . . . . 0.37 111.66 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -65.1 -23.28 67.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.038 0.447 . . . . 2.54 111.238 -172.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -92.75 -39.45 11.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.849 -0.614 . . . . 1.5 110.229 -177.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.485 ' N ' ' HG ' ' A' ' 92' ' ' LEU . . . -70.28 -39.28 74.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.53000000000000003 111.047 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 47.0 t0 -74.47 93.47 2.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.658 -0.867 . . . . 0.5 108.658 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.707 HG21 ' HD2' ' A' ' 132' ' ' PRO . 32.5 t -69.29 -51.07 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.337 -0.847 . . . . 0.64000000000000001 110.28 -174.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -76.34 -21.24 56.4 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.278 -0.873 . . . . 1.46 111.225 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.585 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 40.8 mttp 56.71 65.78 1.33 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.131 -0.94 . . . . 2.7400000000000002 110.74 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -108.93 10.97 26.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.256 -1.338 . . . . 0.56000000000000005 109.832 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.56 11.78 80.3 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.313 -0.858 . . . . 0.48999999999999999 111.879 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.492 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 33.8 mt -144.28 161.55 38.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.344 -0.613 . . . . 0.53000000000000003 109.344 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.407 ' C ' ' HG3' ' A' ' 66' ' ' LYS . 71.1 mt -124.8 115.47 20.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.163 -0.31 . . . . 0.33000000000000002 110.163 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.737 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 1.7 p30 -77.82 -176.41 4.41 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.303 -0.629 . . . . 1.8500000000000001 109.303 171.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -63.62 -27.02 68.95 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.934 -0.306 . . . . 0.84999999999999998 111.474 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 86.7 mt-10 -85.03 -39.07 18.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.212 -0.195 . . . . 2.0800000000000001 110.918 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -69.34 -37.5 77.7 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.256 0.55 . . . . 0.47999999999999998 110.182 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -66.86 -42.38 85.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.749 -0.659 . . . . 0.40999999999999998 109.886 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.08 91.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 0.23000000000000001 110.831 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -61.29 -46.82 88.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.814 -0.63 . . . . 1.29 109.728 177.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.11 -49.33 78.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.23000000000000001 111.636 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -33.47 76.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.77000000000000002 110.856 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.43 ' O ' HG22 ' A' ' 115' ' ' VAL . 38.7 t60 -67.72 -36.39 80.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.036 -0.357 . . . . 0.33000000000000002 110.036 177.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.586 HD13 HD21 ' A' ' 92' ' ' LEU . 91.8 mt -66.15 -39.25 89.68 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.927 -0.579 . . . . 0.28000000000000003 110.587 176.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 81' ' ' LEU . 54.9 mt -69.07 -37.69 77.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.747 -0.66 . . . . 0.69999999999999996 110.326 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 42.1 tttp -61.88 -47.32 85.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.992 -0.549 . . . . 1.77 110.686 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 111' ' ' HIS . 6.7 m -68.11 -31.16 50.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 120.547 -0.461 . . . . 0.53000000000000003 111.322 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 116' ' ' LYS . 25.5 mmmt -56.14 -45.07 79.75 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.066 -0.253 . . . . 1.8899999999999999 110.385 168.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.74 -29.78 63.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.263 -0.426 . . . . 0.73999999999999999 110.885 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.578 ' HB2' ' HD2' ' A' ' 120' ' ' HIS . 59.7 mm-40 -65.95 -21.96 66.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.873 -0.603 . . . . 1.98 110.489 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.52 36.03 3.92 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.752 -0.737 . . . . 0.87 112.13 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.578 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 74.4 m-70 -126.96 150.07 49.55 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.847 -0.427 . . . . 1.0700000000000001 109.847 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -95.95 130.0 43.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.942 0.401 . . . . 3.0600000000000001 110.725 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.44 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -81.95 134.63 49.47 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.048 -0.524 . . . . 1.0900000000000001 110.005 174.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.01 2.7 6.34 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.908 2.405 . . . . 0.80000000000000004 113.745 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.575 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 58.78 22.68 10.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.427 0.632 . . . . 0.64000000000000001 110.306 -176.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.86 162.12 32.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.194 -0.912 . . . . 1.97 109.882 -172.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 52.1 mt -112.69 94.0 26.4 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 123.262 0.351 . . . . 0.67000000000000004 111.781 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.91 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 14.0 Cg_endo -58.63 153.31 49.87 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.866 2.377 . . . . 0.52000000000000002 111.333 169.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.35 -10.03 17.33 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.921 2.414 . . . . 0.63 113.308 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.494 ' O ' ' HD1' ' A' ' 44' ' ' TRP . 26.4 p-80 -108.4 1.51 21.79 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.159 -0.338 . . . . 0.85999999999999999 110.397 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.91 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 1.4 mp -103.85 -7.63 20.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.885 0.374 . . . . 1.1899999999999999 111.038 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -87.42 117.8 69.03 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.248 -0.433 . . . . 1.3400000000000001 110.887 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.707 ' HD2' HG21 ' A' ' 95' ' ' VAL . 53.1 Cg_exo . . . . . 0 C--O 1.237 0.445 0 C-N-CA 122.943 2.429 . . . . 0.90000000000000002 111.952 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.764 HD21 ' HA2' ' A' ' 87' ' ' GLY . 25.2 t-20 . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.991 0.424 . . . . 0.83999999999999997 110.176 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 7.4 Cg_exo -73.42 -1.45 10.68 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.521 2.814 . . . . 0.66000000000000003 112.948 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.497 -0.32 . . . . 0.68000000000000005 111.662 -175.84 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 108.809 -0.812 . . . . 0.66000000000000003 108.809 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.2 m -66.73 -1.15 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.83 -0.623 . . . . 1.4099999999999999 112.521 -171.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.5 -17.51 7.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.139 -0.482 . . . . 1.01 110.275 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.31 -10.56 74.69 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.634 -0.793 . . . . 0.62 112.549 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -89.28 -28.11 20.12 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.653 -0.322 . . . . 2.6699999999999999 111.362 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -112.58 33.13 5.14 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.72 -0.844 . . . . 1.71 108.72 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.561 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 9.1 tmtt? -72.47 -49.98 8.45 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 114.76 -1.109 . . . . 1.2 112.313 -169.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.5 Cg_endo -54.35 -29.58 58.79 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.628 2.219 . . . . 0.62 113.235 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.0 m -70.28 -39.5 74.86 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.036 0.446 . . . . 0.71999999999999997 110.335 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -70.91 -22.97 62.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.23 -0.441 . . . . 0.65000000000000002 109.955 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.46 -44.69 70.7 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.129 0.49 . . . . 1.03 110.018 172.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -57.6 -42.2 82.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.346 -0.843 . . . . 2.1499999999999999 110.267 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.412 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 50.2 mt -79.19 -28.88 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 0.70999999999999996 111.18 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -71.37 -45.84 61.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.246 0.546 . . . . 0.31 110.686 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -76.48 -13.08 60.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.78 -0.645 . . . . 0.80000000000000004 112.065 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.2 p -94.09 1.57 56.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.128 0.49 . . . . 0.60999999999999999 111.214 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 58.2 mt -110.02 8.82 24.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.0 -0.545 . . . . 0.40999999999999998 110.125 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 m 67.79 82.2 0.19 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.317 -0.856 . . . . 1.24 111.54 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -90.46 116.68 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.629 2.219 . . . . 0.58999999999999997 112.555 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -88.37 134.62 27.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.628 -0.508 . . . . 1.3100000000000001 109.628 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 47.05 25.7 0.53 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.792 0.837 . . . . 1.8899999999999999 112.749 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.93 19.75 33.05 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.333 -0.46 . . . . 0.62 112.509 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 66' ' ' LYS . 31.1 ttmt -150.52 144.46 25.35 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 110.453 -0.203 . . . . 1.8100000000000001 110.453 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.483 HD11 ' CD1' ' A' ' 106' ' ' PHE . 19.8 pt -100.43 149.37 6.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 120.55 -0.46 . . . . 0.29999999999999999 110.355 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.555 ' HA ' HD22 ' A' ' 100' ' ' LEU . 81.4 p -76.66 166.82 22.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.068 -0.515 . . . . 0.44 110.034 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.89 -32.52 70.52 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.589 -0.815 . . . . 0.33000000000000002 112.103 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.502 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -49.18 -55.75 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.375 0.509 . . . . 0.34000000000000002 112.375 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -70.68 -41.86 71.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.172 0.51 . . . . 1.6499999999999999 110.989 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.487 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -71.36 -33.41 69.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.916 -0.584 . . . . 0.27000000000000002 110.582 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.582 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 28.1 ttpp -63.9 -52.65 58.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.91 -0.587 . . . . 1.52 110.727 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.601 ' O ' HG22 ' A' ' 77' ' ' VAL . 17.3 ptmt -62.93 -32.89 74.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.983 -0.553 . . . . 1.1399999999999999 110.607 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.583 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 35.3 tp10 -62.54 -38.88 91.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.307 0.575 . . . . 1.78 110.204 175.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.915 ' HB3' HD22 ' A' ' 86' ' ' LEU . 50.7 mtt -77.07 -20.47 55.78 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.632 -0.427 . . . . 0.85999999999999999 111.67 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 74' ' ' LYS . 9.9 m -81.09 -23.45 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.045 -0.662 . . . . 1.52 110.747 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -87.15 -11.12 50.94 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.364 -0.534 . . . . 3.3300000000000001 110.232 170.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.7 m -69.5 -17.48 63.6 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.948 -0.569 . . . . 0.91000000000000003 110.061 169.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 17.5 tptp 69.27 24.25 5.99 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.645 -0.707 . . . . 2.9700000000000002 111.65 171.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.625 ' HB2' HD21 ' A' ' 86' ' ' LEU . 59.0 mt -100.78 153.34 37.79 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.807 -0.633 . . . . 1.4099999999999999 110.004 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.49 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 12.1 Cg_endo -57.36 141.7 94.85 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.813 2.342 . . . . 0.32000000000000001 112.39 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -59.45 -34.2 72.24 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.139 -0.482 . . . . 2.0499999999999998 111.252 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -47.85 83.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.154 -0.475 . . . . 0.83999999999999997 110.822 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.696 HG11 ' HD2' ' A' ' 116' ' ' LYS . 75.8 t -63.72 -41.73 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.588 -0.733 . . . . 0.26000000000000001 110.477 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.915 HD22 ' HB3' ' A' ' 76' ' ' MET . 57.5 mt -58.8 -45.85 88.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.098 0.475 . . . . 0.28999999999999998 110.392 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.581 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.91 -37.79 94.34 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.845 -0.616 . . . . 0.35999999999999999 112.235 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.568 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 46.2 mtpt -69.53 -39.74 77.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.955 0.407 . . . . 1.29 110.418 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.93 -37.91 80.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.711 -0.677 . . . . 0.27000000000000002 110.252 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.485 ' CZ3' ' HG ' ' A' ' 101' ' ' LEU . 31.1 t-105 -61.88 -46.04 91.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.246 -0.434 . . . . 0.37 110.356 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -59.79 -37.0 77.89 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.212 0.529 . . . . 2.54 110.641 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 86.2 mt -70.22 -41.99 72.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.473 -0.785 . . . . 1.5 110.748 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -73.59 -43.72 58.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.646 -0.707 . . . . 0.53000000000000003 111.737 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.587 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 35.6 t0 -84.13 81.58 8.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.369 0.604 . . . . 0.5 109.955 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.475 HG21 ' HD2' ' A' ' 132' ' ' PRO . 13.5 t -69.2 -44.31 80.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.271 -0.877 . . . . 0.64000000000000001 110.64 -176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -17.94 60.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.372 -0.831 . . . . 1.46 111.108 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.587 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 9.8 mtpm? 58.07 56.88 4.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.39 -0.823 . . . . 2.7400000000000002 111.001 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -106.92 10.17 30.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.66 -0.7 . . . . 0.56000000000000005 111.042 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.06 10.12 72.76 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.025 -0.607 . . . . 0.48999999999999999 112.341 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' A' ' 68' ' ' THR . 66.9 mt -139.3 152.84 47.56 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.387 -0.968 . . . . 0.53000000000000003 108.387 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.487 HD12 ' CB ' ' A' ' 72' ' ' ALA . 19.6 mt -99.69 110.73 23.12 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.588 -0.845 . . . . 0.33000000000000002 110.285 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.757 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 12.7 t70 -70.73 171.99 9.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.779 -1.1 . . . . 1.8500000000000001 108.422 173.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.64 -43.26 89.67 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.625 0.25 . . . . 0.84999999999999998 111.266 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 31.5 mt-10 -61.51 -44.38 97.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.797 0.808 . . . . 2.0800000000000001 109.856 176.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.757 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 15.1 mt-10 -68.2 -39.39 82.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.452 -1.249 . . . . 0.47999999999999998 110.521 -173.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CD1' HD11 ' A' ' 67' ' ' ILE . 65.8 t80 -68.28 -42.67 79.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.296 -0.411 . . . . 0.40999999999999998 110.215 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.27 93.72 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.751 -0.658 . . . . 0.23000000000000001 110.272 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 93' ' ' ALA . 17.8 tp -62.01 -45.48 93.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.754 -0.657 . . . . 1.29 110.137 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.518 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -57.37 -47.78 80.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.451 -0.795 . . . . 0.23000000000000001 111.364 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -28.88 67.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.418 -0.355 . . . . 0.77000000000000002 111.249 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -68.48 -37.88 80.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.192 0.52 . . . . 0.33000000000000002 110.093 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HA ' HG22 ' A' ' 115' ' ' VAL . 59.7 mt -69.05 -36.39 77.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 0.28000000000000003 110.247 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 109' ' ' ALA . 46.4 mm -59.25 -44.25 91.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.02 -0.536 . . . . 0.69999999999999996 110.163 173.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 49.8 tttp -63.85 -47.38 80.94 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.82 -0.627 . . . . 1.77 111.111 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 112' ' ' LEU . 14.7 m -64.29 -36.7 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.358 -0.537 . . . . 0.53000000000000003 111.496 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.696 ' HD2' HG11 ' A' ' 85' ' ' VAL . 2.1 mmtm -56.35 -42.79 78.33 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 121.299 -0.161 . . . . 1.8899999999999999 111.317 170.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 98.0 mt -71.52 -34.01 69.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.763 0.316 . . . . 0.73999999999999999 110.836 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 81.0 mm-40 -68.85 -14.06 62.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 1.98 110.473 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.84 17.41 58.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.84 -0.695 . . . . 0.87 112.436 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -103.24 164.06 11.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.717 0.294 . . . . 1.0700000000000001 110.301 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -88.68 140.53 29.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.214 0.53 . . . . 3.0600000000000001 112.145 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.585 HD23 ' HG2' ' A' ' 116' ' ' LYS . 4.1 pp -110.51 127.04 27.65 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 107.266 -1.383 . . . . 1.0900000000000001 107.266 165.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 1.8 Cg_endo -74.53 -15.12 22.16 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.375 2.05 . . . . 0.80000000000000004 113.743 -166.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.477 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . . . 69.51 19.12 7.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.669 0.747 . . . . 0.64000000000000001 109.663 -170.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -124.42 156.9 36.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.962 -1.017 . . . . 1.97 108.639 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 87.8 mt -116.49 96.22 47.53 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.834 0.349 . . . . 0.67000000000000004 111.577 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 29.5 Cg_endo -65.37 155.11 70.45 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.615 2.21 . . . . 0.52000000000000002 111.65 173.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.09 -26.92 27.41 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.252 2.635 . . . . 0.63 113.689 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -91.84 18.4 7.79 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.998 0.369 . . . . 0.85999999999999999 111.998 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 44.7 mt -129.94 3.41 4.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.664 -0.244 . . . . 1.1899999999999999 111.015 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.6 t -87.55 116.58 66.61 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.404 . . . . 1.3400000000000001 111.028 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.513 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 77.1 Cg_exo . . . . . 0 C--O 1.234 0.314 0 C-N-CA 123.05 2.5 . . . . 0.90000000000000002 111.885 176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.581 HD21 ' HA2' ' A' ' 87' ' ' GLY . 45.1 t-20 . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 109.247 -0.649 . . . . 0.83999999999999997 109.247 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 38.3 Cg_endo -67.11 -14.72 44.38 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.106 2.537 . . . . 0.66000000000000003 113.64 -175.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.582 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 62.6 m-85 . . . . . 0 C--N 1.327 -0.373 0 N-CA-C 111.724 0.268 . . . . 0.68000000000000005 111.724 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' ' HB3' ' A' ' 132' ' ' PRO . 5.2 t90 . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.318 -0.623 . . . . 0.66000000000000003 109.318 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.21 -17.9 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 1.4099999999999999 112.116 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.32 -18.15 15.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.19 0.519 . . . . 1.01 110.047 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.3 -13.1 73.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.793 -0.718 . . . . 0.62 112.104 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -78.64 -29.21 45.7 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.198 0.523 . . . . 2.6699999999999999 110.484 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -128.5 33.24 4.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.372 -0.831 . . . . 1.71 109.934 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 4.0 tmtm? -72.26 -47.95 10.29 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.282 -0.872 . . . . 1.2 111.914 -174.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.4 Cg_endo -53.23 -29.56 47.22 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.545 2.163 . . . . 0.62 113.151 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.4 m -71.92 -44.14 64.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.801 0.334 . . . . 0.71999999999999997 110.482 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -70.43 -22.6 62.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.422 -0.585 . . . . 0.65000000000000002 109.422 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.428 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 7.9 t70 -72.96 -44.96 60.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.534 -0.757 . . . . 1.03 109.851 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.91 -43.03 95.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.941 -1.027 . . . . 2.1499999999999999 110.799 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.14 -33.73 56.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.247 0.546 . . . . 0.70999999999999996 110.575 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.522 ' HE1' HG12 ' A' ' 67' ' ' ILE . 71.0 t80 -64.03 -49.27 73.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.31 110.596 -175.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.428 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 43.1 m-85 -70.47 -21.51 62.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.811 -0.632 . . . . 0.80000000000000004 112.532 -174.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.7 p -79.18 -0.48 32.06 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.507 -0.477 . . . . 0.60999999999999999 111.502 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 94.0 mt -105.42 7.28 33.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.533 -0.303 . . . . 0.40999999999999998 111.116 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 t 63.09 89.91 0.1 OUTLIER Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 115.921 -0.581 . . . . 1.24 111.179 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -84.67 117.62 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.361 2.041 . . . . 0.58999999999999997 112.954 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.18 128.02 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.585 . . . . 1.3100000000000001 110.02 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.59 21.48 12.75 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.643 -0.503 . . . . 1.8899999999999999 109.643 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.05 3.53 90.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.808 -0.711 . . . . 0.62 112.443 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -125.32 143.41 50.98 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.686 0.279 . . . . 1.8100000000000001 110.415 177.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.522 HG12 ' HE1' ' A' ' 57' ' ' PHE . 9.6 pt -84.14 143.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 119.996 -0.682 . . . . 0.29999999999999999 110.505 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.5 p -74.74 162.7 28.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.044 -0.98 . . . . 0.44 110.624 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -56.78 -31.07 60.49 Favored Glycine 0 C--O 1.218 -0.863 0 C-N-CA 120.905 -0.664 . . . . 0.33000000000000002 112.173 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.1 -53.45 53.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.459 0.54 . . . . 0.34000000000000002 112.459 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.59 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 58.6 m-80 -79.54 -35.7 39.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.118 -0.492 . . . . 1.6499999999999999 111.693 -171.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.99 -26.88 65.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.156 0.503 . . . . 0.27000000000000002 109.768 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.574 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 38.7 ttmt -68.56 -54.62 15.5 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.579 -0.737 . . . . 1.52 110.367 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 18.2 ptpt -58.02 -38.94 77.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 1.1399999999999999 110.416 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.04 -44.99 94.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.184 0.516 . . . . 1.78 110.167 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.89 ' HB3' HD22 ' A' ' 86' ' ' LEU . 42.9 mtt -67.41 -27.9 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.85999999999999999 110.777 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 73' ' ' LYS . 55.7 t -70.66 -38.09 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.289 0.566 . . . . 1.52 109.65 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 16.9 mmtp -72.04 -13.01 61.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.776 -0.647 . . . . 3.3300000000000001 110.749 176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.8 m -80.9 -14.79 57.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.91000000000000003 110.591 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mptt 72.24 18.92 4.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.648 0.779 . . . . 2.9700000000000002 111.875 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.589 ' HB2' HD21 ' A' ' 86' ' ' LEU . 3.9 mm? -87.19 144.48 36.22 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.985 0.422 . . . . 1.4099999999999999 110.5 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.557 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.0 Cg_endo -61.19 151.39 79.19 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.137 2.558 . . . . 0.32000000000000001 112.713 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -58.65 -33.94 70.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.933 -0.576 . . . . 2.0499999999999998 111.495 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.3 m -60.56 -51.28 70.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.198 0.523 . . . . 0.83999999999999997 110.473 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.636 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 71.5 t -64.13 -40.24 88.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.745 -0.661 . . . . 0.26000000000000001 110.76 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.89 HD22 ' HB3' ' A' ' 76' ' ' MET . 58.7 mt -61.73 -41.24 97.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.968 -0.56 . . . . 0.28999999999999998 110.817 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.556 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -62.21 -42.07 99.72 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.116 -0.564 . . . . 0.35999999999999999 111.924 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.636 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 51.0 mtpt -57.41 -51.39 69.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.159 0.504 . . . . 1.29 110.447 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.53 HG12 HD21 ' A' ' 122' ' ' LEU . 84.6 mt -64.54 -38.27 82.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.47 -0.787 . . . . 0.27000000000000002 111.333 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -62.05 -49.06 77.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.714 0.292 . . . . 0.37 110.903 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -64.35 -24.63 67.71 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.124 -0.489 . . . . 2.54 111.308 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.578 ' O ' HD11 ' A' ' 126' ' ' LEU . 88.2 mt -88.61 -48.64 7.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.511 . . . . 1.5 111.379 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -64.68 -36.46 84.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.842 -0.617 . . . . 0.53000000000000003 111.067 -173.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.591 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 42.7 t0 -79.68 82.74 5.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.8 -0.815 . . . . 0.5 108.8 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.4 t -71.28 -40.63 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.65 -0.704 . . . . 0.64000000000000001 109.956 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -81.42 -18.0 46.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 1.46 110.207 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.591 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 22.6 mttp 59.96 59.12 2.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.065 -0.971 . . . . 2.7400000000000002 110.942 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 14.4 p-10 -107.78 8.96 29.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.908 -1.042 . . . . 0.56000000000000005 110.023 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.54 9.03 81.84 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.756 -0.656 . . . . 0.48999999999999999 111.876 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 66' ' ' LYS . 60.1 mt -139.27 167.93 20.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.621 -0.511 . . . . 0.53000000000000003 109.621 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.2 mt -124.96 116.48 22.24 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.174 -0.306 . . . . 0.33000000000000002 110.174 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.468 ' CA ' ' HG3' ' A' ' 66' ' ' LYS . 3.0 p30 -78.75 177.86 8.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.137 -0.69 . . . . 1.8500000000000001 109.137 171.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -61.16 -25.39 66.98 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.6 0.593 . . . . 0.84999999999999998 112.6 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -81.63 -40.25 23.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 2.0800000000000001 110.311 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.461 ' HG3' ' OD2' ' A' ' 102' ' ' ASP . 20.0 mt-10 -67.58 -36.55 81.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.368 0.604 . . . . 0.47999999999999998 109.486 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' A' ' 67' ' ' ILE . 31.8 t80 -74.21 -33.15 63.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.838 -0.619 . . . . 0.40999999999999998 110.171 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.33 94.33 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.279 0.562 . . . . 0.23000000000000001 109.861 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 93' ' ' ALA . 16.0 tp -61.26 -44.91 96.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.221 -0.9 . . . . 1.29 110.035 176.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.06 -49.99 72.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.666 -0.697 . . . . 0.23000000000000001 110.92 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -39.24 87.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 0.77000000000000002 111.038 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -69.05 -38.46 79.13 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.947 -0.301 . . . . 0.33000000000000002 110.749 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.702 ' HB3' HD23 ' A' ' 122' ' ' LEU . 92.8 mt -66.94 -38.59 86.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.257 -0.429 . . . . 0.28000000000000003 110.907 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 76' ' ' MET . 79.9 mt -70.37 -32.94 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.101 0.477 . . . . 0.69999999999999996 110.049 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 4.0 tppp? -59.04 -53.32 59.71 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 115.919 -0.582 . . . . 1.77 110.514 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.3 m -64.14 -34.64 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 121.11 -0.236 . . . . 0.53000000000000003 111.391 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 116' ' ' LYS . 27.0 mmmt -53.59 -48.89 68.82 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.596 0.236 . . . . 1.8899999999999999 111.446 167.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.3 -22.62 62.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.902 0.382 . . . . 0.73999999999999999 110.942 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 6.2 mm-40 -75.35 -2.4 28.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.924 -0.58 . . . . 1.98 110.771 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.5 35.81 11.45 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.65 -0.786 . . . . 0.87 111.988 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -130.87 172.48 11.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.988 0.423 . . . . 1.0700000000000001 110.594 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -122.46 121.9 37.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.679 -0.691 . . . . 3.0600000000000001 109.846 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -60.87 146.6 86.75 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.052 -0.522 . . . . 1.0900000000000001 110.097 169.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.74 6.12 2.57 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.51 2.14 . . . . 0.80000000000000004 113.225 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.509 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 60.38 17.79 7.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.813 -0.631 . . . . 0.64000000000000001 111.763 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -136.17 166.9 22.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.359 -0.608 . . . . 1.97 109.359 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.578 HD11 ' O ' ' A' ' 92' ' ' LEU . 82.1 mt -114.88 93.17 33.12 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.701 0.286 . . . . 0.67000000000000004 111.618 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.663 ' HD2' HD12 ' A' ' 130' ' ' LEU . 34.4 Cg_endo -66.44 166.22 22.4 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.797 2.331 . . . . 0.52000000000000002 111.537 169.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.69 3.42 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.237 2.625 . . . . 0.63 114.334 -176.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -114.03 6.7 16.55 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.545 -0.462 . . . . 0.85999999999999999 111.219 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.663 HD12 ' HD2' ' A' ' 127' ' ' PRO . 42.3 mt -115.9 -34.31 4.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.497 -0.32 . . . . 1.1899999999999999 110.912 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.57 115.18 43.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.855 -0.424 . . . . 1.3400000000000001 109.855 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 37.1 Cg_endo . . . . . 0 C--O 1.236 0.419 0 C-N-CA 122.734 2.289 . . . . 0.90000000000000002 112.612 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.556 HD21 ' HA2' ' A' ' 87' ' ' GLY . 47.4 t-20 . . . . . 0 CA--C 1.528 0.118 0 N-CA-C 109.715 -0.476 . . . . 0.83999999999999997 109.715 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 24.4 Cg_exo -64.36 -16.41 54.96 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.16 2.573 . . . . 0.66000000000000003 113.393 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 82.5 m-85 . . . . . 0 C--N 1.328 -0.331 0 N-CA-C 111.739 0.274 . . . . 0.68000000000000005 111.739 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.5 t90 . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 108.272 -1.01 . . . . 0.66000000000000003 108.272 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.553 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 87.2 t -50.76 -33.03 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.682 -0.69 . . . . 1.4099999999999999 112.192 -174.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.448 HG21 HD22 ' A' ' 108' ' ' LEU . 22.1 t -70.26 -17.86 21.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.073 -0.512 . . . . 1.01 111.516 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.14 -17.15 71.68 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.879 -0.677 . . . . 0.62 112.347 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 46.9 pttt -87.25 -29.41 21.7 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.181 -0.608 . . . . 2.6699999999999999 111.191 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -108.11 31.14 5.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.339 -0.985 . . . . 1.71 108.339 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 11.0 tmtt? -78.27 -47.27 2.06 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.584 -0.735 . . . . 1.2 111.963 -170.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.6 Cg_endo -51.1 -33.12 42.18 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.275 1.983 . . . . 0.62 112.748 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.9 m -71.35 -45.75 62.16 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.904 0.383 . . . . 0.71999999999999997 111.069 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.433 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 9.6 m-85 -72.26 -22.7 61.19 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.508 -0.553 . . . . 0.65000000000000002 109.508 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.413 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 5.9 t70 -71.62 -44.31 64.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.301 -0.863 . . . . 1.03 109.32 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.32 -53.8 54.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.42 -0.809 . . . . 2.1499999999999999 110.058 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.37 -36.83 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.973 0.416 . . . . 0.70999999999999996 110.951 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.468 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 86.5 t80 -62.1 -42.04 98.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.361 0.601 . . . . 0.31 110.015 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.413 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 24.8 m-85 -81.21 -22.97 38.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.511 -0.768 . . . . 0.80000000000000004 112.243 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.7 p -75.82 -10.78 59.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.60999999999999999 111.082 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 79.3 mt -99.31 5.48 46.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.164 -0.471 . . . . 0.40999999999999998 111.098 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.2 t 65.25 81.41 0.22 Allowed Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 123.711 0.632 . . . . 1.24 111.405 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.66 131.42 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.199 1.933 . . . . 0.58999999999999997 112.422 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 m -99.93 140.82 18.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.891 -0.595 . . . . 1.3100000000000001 109.909 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.403 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 2.5 p-10 45.45 33.04 1.2 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.484 0.714 . . . . 1.8899999999999999 112.311 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.8 19.29 73.47 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.104 -0.498 . . . . 0.62 114.026 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 2.6 mtmm -145.84 159.84 42.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.771 -0.455 . . . . 1.8100000000000001 109.771 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.452 HD11 ' CD1' ' A' ' 106' ' ' PHE . 23.8 pt -107.2 148.37 11.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.437 -0.505 . . . . 0.29999999999999999 110.099 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.601 ' HA ' HD23 ' A' ' 100' ' ' LEU . 73.2 p -76.85 167.04 22.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.692 -0.686 . . . . 0.44 110.074 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.44 -33.16 58.45 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.87 -0.681 . . . . 0.33000000000000002 112.708 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.01 59.92 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.347 0.499 . . . . 0.34000000000000002 112.347 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.536 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -69.61 -46.81 65.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.573 -0.74 . . . . 1.6499999999999999 110.625 -170.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.55 72.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.789 -0.641 . . . . 0.27000000000000002 110.905 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.551 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 36.1 ttmt -61.55 -57.12 13.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 1.52 110.683 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 56.4 pttt -62.77 -31.26 72.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 1.1399999999999999 110.708 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.71 -44.42 93.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 1.78 109.643 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.782 ' HB3' HD22 ' A' ' 86' ' ' LEU . 43.1 mtt -67.49 -30.67 70.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.806 -0.634 . . . . 0.85999999999999999 111.151 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -70.59 -34.93 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.672 0.749 . . . . 1.52 109.339 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 4.3 mptp? -78.44 -12.12 59.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.925 -1.034 . . . . 3.3300000000000001 110.838 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 49.3 m -76.47 -13.17 60.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 0.91000000000000003 110.518 175.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 79' ' ' SER . 69.8 mmtt 73.28 16.68 4.12 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.66 -0.7 . . . . 2.9700000000000002 111.523 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.662 ' HB2' HD21 ' A' ' 86' ' ' LEU . 79.8 mt -93.08 147.02 33.05 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 1.4099999999999999 110.922 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.528 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 11.2 Cg_endo -56.45 149.04 59.15 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.64 2.893 . . . . 0.32000000000000001 112.848 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -56.13 -38.95 71.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.766 -0.652 . . . . 2.0499999999999998 111.36 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -62.28 -46.85 86.96 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.984 -0.553 . . . . 0.83999999999999997 111.618 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.702 HG11 ' HD2' ' A' ' 116' ' ' LYS . 95.8 t -64.25 -45.37 96.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 109.972 -0.381 . . . . 0.26000000000000001 109.972 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.782 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.7 mt -58.79 -42.84 89.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.28999999999999998 111.153 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.82 -40.75 93.45 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.999 -0.62 . . . . 0.35999999999999999 112.145 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' NZ ' ' HA ' ' A' ' 85' ' ' VAL . 30.8 mtmm -72.04 -37.82 69.64 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.612 -0.346 . . . . 1.29 110.473 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.1 mt -63.1 -43.97 99.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.346 . . . . 0.27000000000000002 110.407 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -63.75 -41.22 98.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.497 -0.319 . . . . 0.37 110.208 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.67 -29.83 70.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.243 -0.435 . . . . 2.54 111.095 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.473 ' HB3' HD21 ' A' ' 126' ' ' LEU . 85.5 mt -89.99 -46.91 8.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.102 -0.499 . . . . 1.5 111.363 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.501 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -65.46 -42.97 91.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.985 -0.552 . . . . 0.53000000000000003 111.574 -173.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.694 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 47.3 t0 -86.24 87.99 7.53 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.248 -1.019 . . . . 0.5 108.248 175.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.536 HG21 ' HD2' ' A' ' 132' ' ' PRO . 15.1 t -68.72 -43.71 82.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.435 -0.802 . . . . 0.64000000000000001 110.259 -174.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.46 -21.5 30.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.314 -0.857 . . . . 1.46 110.56 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.694 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 48.3 mttp 60.22 73.86 0.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.82 . . . . 2.7400000000000002 111.462 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.615 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 14.7 p-10 -121.6 9.9 10.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.61 -1.177 . . . . 0.56000000000000005 111.058 -173.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.94 1.21 67.09 Favored Glycine 0 CA--C 1.516 0.109 0 C-N-CA 120.676 -0.773 . . . . 0.48999999999999999 112.114 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.615 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 42.9 mt -127.73 152.45 47.72 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.108 -0.701 . . . . 0.53000000000000003 109.108 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.2 mt -114.2 120.42 40.41 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.803 -0.443 . . . . 0.33000000000000002 109.803 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.419 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 15.7 m-20 -68.45 173.62 4.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.24 -1.022 . . . . 1.8500000000000001 108.24 171.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -63.62 -26.91 68.89 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.641 -0.503 . . . . 0.84999999999999998 109.641 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 23.4 mt-10 -66.22 -56.06 13.14 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.352 0.596 . . . . 2.0800000000000001 109.865 173.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.501 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 13.6 mt-10 -66.49 -34.5 78.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.93 -1.032 . . . . 0.47999999999999998 110.574 -171.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.452 ' CD1' HD11 ' A' ' 67' ' ' ILE . 55.7 t80 -71.17 -43.11 68.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.332 -0.394 . . . . 0.40999999999999998 110.214 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.433 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -60.98 -39.27 89.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.23000000000000001 110.575 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.448 HD22 HG21 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -61.26 -47.9 83.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.865 -0.607 . . . . 1.29 109.491 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.87 -47.33 85.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.804 -0.635 . . . . 0.23000000000000001 110.791 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -34.32 77.63 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.155 -0.475 . . . . 0.77000000000000002 111.315 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -68.41 -40.37 81.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.764 0.316 . . . . 0.33000000000000002 110.387 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.705 ' HB3' HD23 ' A' ' 122' ' ' LEU . 95.0 mt -68.58 -41.54 79.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.275 0.56 . . . . 0.28000000000000003 110.551 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.548 HD11 ' HG2' ' A' ' 76' ' ' MET . 96.0 mt -65.86 -38.66 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.902 -0.59 . . . . 0.69999999999999996 109.872 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.727 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 13.9 ttpp -57.69 -53.43 58.3 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.844 -0.616 . . . . 1.77 110.211 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.8 m -62.79 -38.64 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 112.055 0.391 . . . . 0.53000000000000003 112.055 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.702 ' HD2' HG11 ' A' ' 85' ' ' VAL . 1.1 mmpm? -51.58 -40.97 60.8 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.468 0.175 . . . . 1.8899999999999999 111.393 169.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 92.4 mt -78.97 -29.16 43.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.465 -0.334 . . . . 0.73999999999999999 111.511 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.727 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 10.8 mm-40 -67.37 -24.53 65.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.075 0.464 . . . . 1.98 110.223 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.68 16.75 23.37 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.916 -0.659 . . . . 0.87 111.595 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -108.76 162.44 14.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.237 -0.653 . . . . 1.0700000000000001 109.237 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.449 ' CD ' ' HZ1' ' A' ' 116' ' ' LYS . 60.1 mm-40 -108.7 129.1 55.35 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.873 0.368 . . . . 3.0600000000000001 111.249 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -77.76 139.78 62.71 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 115.956 -0.566 . . . . 1.0900000000000001 109.902 172.045 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.11 -4.4 14.8 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.31 2.007 . . . . 0.80000000000000004 113.692 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.463 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 64.44 20.39 12.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.377 0.608 . . . . 0.64000000000000001 110.347 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -131.05 163.53 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.836 . . . . 1.97 109.4 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 92' ' ' LEU . 77.2 mt -110.08 96.1 24.1 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.735 -0.211 . . . . 0.67000000000000004 111.04 174.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 30.3 Cg_endo -65.37 159.12 49.0 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.602 2.201 . . . . 0.52000000000000002 111.649 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.41 -7.89 9.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.192 2.595 . . . . 0.63 114.138 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -111.22 11.09 21.78 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.094 -0.379 . . . . 0.85999999999999999 111.488 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.8 mt -118.74 -26.2 6.16 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.953 -0.299 . . . . 1.1899999999999999 111.301 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.38 116.93 20.02 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.717 -0.22 . . . . 1.3400000000000001 110.92 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.536 ' HD2' HG21 ' A' ' 95' ' ' VAL . 86.5 Cg_exo . . . . . 0 C--N 1.346 0.418 0 C-N-CA 123.929 3.086 . . . . 0.90000000000000002 113.506 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 53.0 t-20 . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 109.709 -0.478 . . . . 0.83999999999999997 109.709 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 24.7 Cg_exo -64.06 -16.66 56.19 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.106 2.537 . . . . 0.66000000000000003 113.327 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 95.0 m-85 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.895 0.379 . . . . 0.68000000000000005 110.885 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 108.395 -0.965 . . . . 0.66000000000000003 108.395 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.51 -40.85 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 121.818 0.818 . . . . 1.4099999999999999 110.66 -166.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.445 HG21 HD22 ' A' ' 108' ' ' LEU . 18.7 m -91.53 0.44 9.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.484 -1.235 . . . . 1.01 111.339 -172.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.06 -31.49 20.07 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.586 -1.406 . . . . 0.62 109.586 169.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -81.17 -29.61 34.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.974 -0.613 . . . . 2.6699999999999999 109.974 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.36 32.49 4.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.85 -0.796 . . . . 1.71 108.85 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.644 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 11.4 tmtt? -81.53 -47.12 1.07 Allowed Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 113.303 0.853 . . . . 1.2 113.303 -169.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.7 Cg_endo -44.16 -37.86 10.29 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 123.142 2.561 . . . . 0.62 113.845 -176.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -70.63 -46.67 62.89 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 120.965 0.412 . . . . 0.71999999999999997 111.346 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 2.6 m-85 -72.82 -22.3 60.83 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.092 -0.707 . . . . 0.65000000000000002 109.092 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -75.32 -42.03 55.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.814 -1.085 . . . . 1.03 109.475 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.54 -55.22 31.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.446 -0.797 . . . . 2.1499999999999999 109.814 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.19 -26.26 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.826 -0.624 . . . . 0.70999999999999996 111.389 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.409 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 87.4 t80 -69.58 -50.37 45.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.223 0.535 . . . . 0.31 110.259 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -74.33 -23.63 59.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.913 -0.585 . . . . 0.80000000000000004 111.859 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.3 p -74.67 -1.52 22.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.844 0.354 . . . . 0.60999999999999999 111.619 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.67 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 95.9 mt -108.49 6.07 25.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.852 -0.425 . . . . 0.40999999999999998 109.852 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.8 m 63.17 86.86 0.14 Allowed Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 115.379 -0.828 . . . . 1.24 111.754 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -88.51 138.86 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.753 2.302 . . . . 0.58999999999999997 112.972 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.564 HG12 ' ND2' ' A' ' 64' ' ' ASN . 14.7 t -118.01 132.09 68.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.799 -0.637 . . . . 1.3100000000000001 109.917 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.564 ' ND2' HG12 ' A' ' 63' ' ' VAL . 44.6 m-80 62.71 20.02 11.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.47 0.708 . . . . 1.8899999999999999 110.471 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.16 13.26 60.63 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.151 -0.931 . . . . 0.62 112.029 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HE2' ' OD2' ' A' ' 102' ' ' ASP . 94.2 mttt -136.25 171.17 14.88 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.383 0.611 . . . . 1.8100000000000001 111.642 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 106' ' ' PHE . 26.7 pt -121.62 143.11 35.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.927 -1.033 . . . . 0.29999999999999999 109.449 171.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.1 p -78.31 171.42 15.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.179 -0.464 . . . . 0.44 110.112 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.35 -29.7 53.63 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 120.927 -0.654 . . . . 0.33000000000000002 112.258 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.97 83.41 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.033 0.444 . . . . 0.34000000000000002 111.843 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.67 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.4 m120 -76.73 -42.35 41.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.777 -0.647 . . . . 1.6499999999999999 110.343 -170.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -69.15 -29.94 68.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.868 -0.606 . . . . 0.27000000000000002 110.545 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.598 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 63.0 tttt -68.85 -50.18 52.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.215 -0.448 . . . . 1.52 110.838 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HA ' HG22 ' A' ' 77' ' ' VAL . 17.3 ptpt -61.42 -39.01 89.23 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.036 0.446 . . . . 1.1399999999999999 110.465 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.56 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 18.5 tp10 -61.42 -49.28 77.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.518 . . . . 1.78 110.237 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.972 ' HB3' HD22 ' A' ' 86' ' ' LEU . 49.8 mtt -65.46 -32.36 73.93 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.209 0.448 . . . . 0.85999999999999999 112.209 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 74' ' ' LYS . 33.5 m -78.75 -16.54 13.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.362 -0.535 . . . . 1.52 111.54 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.56 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -95.54 -9.05 33.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.335 -0.546 . . . . 3.3300000000000001 110.201 172.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 70.9 m -74.19 -2.43 24.72 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.46 0.541 . . . . 0.91000000000000003 112.46 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 79' ' ' SER . 5.7 mptp? 74.95 16.9 2.84 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.889 0.476 . . . . 2.9700000000000002 112.26 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.477 ' HB2' HD21 ' A' ' 86' ' ' LEU . 10.9 mp -99.37 147.05 32.79 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-O 120.854 0.359 . . . . 1.4099999999999999 111.144 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.2 Cg_endo -62.4 148.83 92.65 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.87 2.38 . . . . 0.32000000000000001 112.575 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -53.41 -39.1 64.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.454 -0.794 . . . . 2.0499999999999998 111.51 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.5 m -62.45 -52.72 62.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.475 . . . . 0.83999999999999997 111.302 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.52 ' CG2' ' HG2' ' A' ' 82' ' ' PRO . 69.1 t -58.75 -38.54 72.74 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.051 0 CA-C-O 120.617 0.246 . . . . 0.26000000000000001 110.629 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.972 HD22 ' HB3' ' A' ' 76' ' ' MET . 82.3 mt -59.98 -42.42 94.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.28999999999999998 110.818 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.64 -42.29 98.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.852 -0.69 . . . . 0.35999999999999999 111.792 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 55.3 mtpt -61.26 -46.76 89.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.832 0.349 . . . . 1.29 110.398 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.52 HG23 HD12 ' A' ' 112' ' ' LEU . 82.6 mt -62.46 -44.48 99.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.27000000000000002 111.311 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -57.33 -45.74 83.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.65 0.262 . . . . 0.37 110.774 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.08 -28.45 69.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.11 0.481 . . . . 2.54 110.907 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 126' ' ' LEU . 46.3 mt -94.52 -16.77 23.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 1.5 111.856 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.27 -42.38 11.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.569 -0.287 . . . . 0.53000000000000003 111.133 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -86.42 84.62 7.4 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.115 -0.698 . . . . 0.5 109.115 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.473 HG21 ' HD2' ' A' ' 132' ' ' PRO . 10.7 t -70.87 -36.69 65.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.595 -0.729 . . . . 0.64000000000000001 110.856 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.64 -11.39 57.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.008 -0.542 . . . . 1.46 110.473 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt 55.57 53.96 9.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.959 -1.019 . . . . 2.7400000000000002 111.167 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 13.2 p-10 -109.91 7.86 24.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.059 -0.519 . . . . 0.56000000000000005 110.583 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.91 1.35 67.42 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.12 -0.562 . . . . 0.48999999999999999 112.083 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 74.9 mt -127.05 144.55 51.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.013 0.435 . . . . 0.53000000000000003 109.902 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 67.3 mt -104.55 113.45 27.04 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.413 -0.515 . . . . 0.33000000000000002 110.095 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.442 ' OD2' ' HE2' ' A' ' 66' ' ' LYS . 4.2 m-20 -69.35 172.29 7.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.558 -0.904 . . . . 1.8500000000000001 108.558 169.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -60.27 -30.92 69.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.549 0.214 . . . . 0.84999999999999998 110.721 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -71.79 -45.28 62.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.107 0.479 . . . . 2.0800000000000001 110.866 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -70.7 -33.0 70.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.919 0.39 . . . . 0.47999999999999998 110.747 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' HD11 ' A' ' 67' ' ' ILE . 27.7 t80 -75.16 -30.98 60.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.79 -0.448 . . . . 0.40999999999999998 109.79 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.79 82.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.195 0.522 . . . . 0.23000000000000001 110.039 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.511 HD21 ' O ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -65.09 -51.25 62.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 1.29 110.556 175.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.37 -50.57 69.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.702 -0.681 . . . . 0.23000000000000001 110.822 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -61.82 -33.81 74.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.618 -0.719 . . . . 0.77000000000000002 111.298 -178.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -68.41 -42.97 78.23 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.8 -0.36 . . . . 0.33000000000000002 110.855 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.52 HD12 HG23 ' A' ' 89' ' ' ILE . 72.6 mt -65.59 -38.39 89.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.208 0.527 . . . . 0.28000000000000003 110.504 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.68 HD11 ' HG2' ' A' ' 76' ' ' MET . 66.6 mt -68.39 -41.03 83.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.042 -0.526 . . . . 0.69999999999999996 110.592 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 32.4 ttpt -59.09 -48.99 79.59 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.64 -0.255 . . . . 1.77 110.408 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.8 m -63.44 -36.01 74.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 120.642 -0.423 . . . . 0.53000000000000003 111.119 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.842 ' HD3' HD23 ' A' ' 122' ' ' LEU . 3.9 mmmp? -58.19 -37.88 75.64 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.444 -0.502 . . . . 1.8899999999999999 110.703 172.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 96.1 mt -73.6 -22.78 59.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 0.73999999999999999 110.916 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 13.6 mt-10 -83.5 2.14 38.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.194 -0.457 . . . . 1.98 110.55 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.77 23.7 45.09 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.784 -0.722 . . . . 0.87 111.848 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.608 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 90.4 m-70 -117.92 161.27 20.05 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.725 -0.472 . . . . 1.0700000000000001 109.725 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -115.64 149.04 38.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.34 -0.391 . . . . 3.0600000000000001 109.975 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.842 HD23 ' HD3' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -89.66 146.77 36.27 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.124 -0.695 . . . . 1.0900000000000001 109.124 -178.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -66.62 -6.85 16.35 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.783 2.322 . . . . 0.80000000000000004 112.937 -172.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.81 18.52 9.69 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.469 -0.787 . . . . 0.64000000000000001 110.773 -176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -135.64 163.7 29.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.2 -0.667 . . . . 1.97 109.2 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 92' ' ' LEU . 96.0 mt -111.98 92.72 18.77 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 111.633 0.234 . . . . 0.67000000000000004 111.633 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.501 ' HD2' HD12 ' A' ' 130' ' ' LEU . 17.6 Cg_endo -58.86 153.61 49.49 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.395 2.064 . . . . 0.52000000000000002 111.568 171.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.47 -33.27 46.55 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.508 2.805 . . . . 0.63 114.146 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -82.64 7.21 15.37 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.336 0.495 . . . . 0.85999999999999999 112.336 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.511 ' O ' HD21 ' A' ' 108' ' ' LEU . 49.2 mt -111.38 -29.12 7.92 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.891 -0.324 . . . . 1.1899999999999999 111.243 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 39.3 t -65.52 120.39 67.76 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.5 -0.318 . . . . 1.3400000000000001 110.838 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.473 ' HD2' HG21 ' A' ' 95' ' ' VAL . 10.0 Cg_endo . . . . . 0 C--O 1.239 0.562 0 C-N-CA 123.092 2.528 . . . . 0.90000000000000002 112.387 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.01 0.434 . . . . 0.83999999999999997 110.67 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.45 -7.85 20.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.45 2.767 . . . . 0.66000000000000003 113.154 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 90.9 m-85 . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 112.008 0.373 . . . . 0.68000000000000005 112.008 -177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.9 t90 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 109.411 -0.588 . . . . 0.66000000000000003 109.411 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.18 -23.45 11.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.309 0.485 . . . . 1.4099999999999999 112.309 -168.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -88.28 0.22 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.315 -0.554 . . . . 1.01 111.271 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 -25.5 68.57 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.952 -0.642 . . . . 0.62 112.166 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.58 ' HG3' ' OD1' ' A' ' 49' ' ' ASP . 15.5 pttp -80.21 -27.76 38.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.611 0.243 . . . . 2.6699999999999999 111.523 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.58 ' OD1' ' HG3' ' A' ' 48' ' ' LYS . 1.2 m-20 -104.13 31.98 4.25 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.725 -0.472 . . . . 1.71 109.725 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -79.84 -51.24 1.16 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 113.275 0.843 . . . . 1.2 113.275 -172.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.5 -26.56 54.85 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.056 1.837 . . . . 0.62 112.743 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.41 -45.45 46.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.717 0.294 . . . . 0.71999999999999997 110.912 177.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.4 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 11.4 m-30 -70.36 -24.05 62.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.1 -0.704 . . . . 0.65000000000000002 109.1 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.553 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -73.75 -43.76 58.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.083 -0.962 . . . . 1.03 110.262 176.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.94 -38.03 75.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.865 -0.607 . . . . 2.1499999999999999 110.229 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.1 mt -75.53 -35.39 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.573 0.702 . . . . 0.70999999999999996 110.641 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 66' ' ' LYS . 62.3 t80 -63.54 -43.06 98.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.287 -0.869 . . . . 0.31 111.018 -176.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.553 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 30.8 m-85 -67.64 -23.29 65.33 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.363 0.505 . . . . 0.80000000000000004 112.363 -177.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.1 p -85.37 8.68 17.9 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.532 -0.467 . . . . 0.60999999999999999 111.742 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 95.1 mt -112.23 6.9 19.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.29 -0.413 . . . . 0.40999999999999998 111.105 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t 65.84 88.48 0.11 Allowed Pre-proline 0 N--CA 1.469 0.479 0 O-C-N 123.547 0.529 . . . . 1.24 111.009 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -94.06 132.28 0.73 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.925 2.417 . . . . 0.58999999999999997 113.428 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.0 134.1 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.288 -0.869 . . . . 1.3100000000000001 109.429 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 62.62 26.94 15.95 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.851 0.358 . . . . 1.8899999999999999 110.719 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.6 36.31 67.83 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.611 -0.804 . . . . 0.62 111.916 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.856 ' HB3' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -168.04 175.65 6.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.59 0.233 . . . . 1.8100000000000001 110.67 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.7 pt -131.35 155.36 41.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.215 0.531 . . . . 0.29999999999999999 112.122 -172.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.465 ' HA ' HD23 ' A' ' 100' ' ' LEU . 40.9 p -79.19 166.92 21.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.069 -0.969 . . . . 0.44 110.4 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.44 ' HA3' ' HG3' ' B' ' 150' ' ' PRO . . . -59.19 -27.52 62.86 Favored Glycine 0 C--O 1.221 -0.662 0 C-N-CA 120.991 -0.624 . . . . 0.33000000000000002 112.99 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.22 82.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.39 0.515 . . . . 0.34000000000000002 112.39 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.488 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -76.13 -42.43 46.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.18 -0.464 . . . . 1.6499999999999999 110.238 -172.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.81 71.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.27000000000000002 110.161 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 59.7 tttt -69.3 -54.76 12.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.979 -0.555 . . . . 1.52 110.495 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 17.3 ptpt -57.78 -34.41 69.56 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.888 -0.325 . . . . 1.1399999999999999 110.74 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.77 -53.5 46.09 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.404 0.621 . . . . 1.78 110.425 175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.695 ' HB3' HD22 ' A' ' 86' ' ' LEU . 93.0 mtp -68.96 -24.89 64.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.503 -0.772 . . . . 0.85999999999999999 112.142 -173.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 74' ' ' LYS . 35.6 m -87.47 -35.91 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-O 121.067 0.461 . . . . 1.52 110.821 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -79.52 -8.19 58.98 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.482 0.658 . . . . 3.3300000000000001 109.624 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.5 m -69.86 -11.34 60.79 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.5 -0.773 . . . . 0.91000000000000003 110.502 168.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 71.68 44.77 0.48 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.504 0.722 . . . . 2.9700000000000002 111.862 177.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.471 ' HB2' HD21 ' A' ' 86' ' ' LEU . 86.9 mt -119.62 146.86 42.43 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.117 -0.492 . . . . 1.4099999999999999 109.852 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.557 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.5 Cg_endo -58.99 141.22 98.1 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.986 2.457 . . . . 0.32000000000000001 112.955 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -62.64 -30.52 71.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.614 -0.721 . . . . 2.0499999999999998 111.644 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.0 m -61.12 -53.13 60.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 0.83999999999999997 110.085 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 t -55.41 -45.84 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.829 -0.623 . . . . 0.26000000000000001 110.927 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 76' ' ' MET . 77.1 mt -60.77 -42.12 96.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.28999999999999998 110.721 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.35 -33.79 88.18 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.701 -0.681 . . . . 0.35999999999999999 112.358 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 33.1 mttt -68.0 -45.29 74.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.911 0.386 . . . . 1.29 110.077 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.619 HG23 HD12 ' A' ' 112' ' ' LEU . 81.9 mt -59.58 -44.33 92.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.863 -0.608 . . . . 0.27000000000000002 111.463 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -60.18 -39.82 87.82 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.921 -0.4 . . . . 0.37 109.921 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -64.82 -23.01 67.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 2.54 111.172 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.665 ' HB3' HD21 ' A' ' 126' ' ' LEU . 70.9 mt -93.39 -38.52 11.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.615 -0.721 . . . . 1.5 110.722 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.758 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -78.93 -42.64 26.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.53000000000000003 111.819 -173.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 25.3 t0 -86.42 73.53 10.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.286 0.565 . . . . 0.5 109.565 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.8 t -64.65 -37.89 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 115.29 -0.868 . . . . 0.64000000000000001 110.798 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.39 -20.4 61.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.526 -0.761 . . . . 1.46 109.926 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 96.4 mttt 56.83 37.79 29.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.838 0.828 . . . . 2.7400000000000002 109.333 -175.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.2 p-10 -89.59 8.95 28.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.654 -1.157 . . . . 0.56000000000000005 110.972 -174.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.38 -2.96 26.35 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.055 -0.593 . . . . 0.48999999999999999 112.572 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 36.1 mt -125.81 146.74 49.67 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.649 -0.5 . . . . 0.53000000000000003 109.649 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.6 mt -105.74 112.4 25.45 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.282 -0.636 . . . . 0.33000000000000002 109.282 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.856 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . 2.0 p30 -75.31 176.44 7.42 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.489 -0.484 . . . . 1.8500000000000001 109.723 174.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -59.19 -28.76 66.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.697 -0.228 . . . . 0.84999999999999998 111.538 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.404 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . 7.7 mm-40 -76.08 -50.39 14.85 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.877 0.37 . . . . 2.0800000000000001 110.689 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.649 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 49.3 mt-10 -58.09 -43.17 86.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.257 0.551 . . . . 0.47999999999999998 110.61 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HD2' ' HB2' ' A' ' 57' ' ' PHE . 33.3 t80 -69.94 -29.57 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.835 -0.62 . . . . 0.40999999999999998 110.115 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -65.47 -43.34 90.61 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.425 0.631 . . . . 0.23000000000000001 109.889 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.758 HD23 ' HA ' ' A' ' 93' ' ' ALA . 23.7 tp -62.89 -46.45 87.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.452 -0.794 . . . . 1.29 110.369 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.4 -44.79 89.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.54 -0.754 . . . . 0.23000000000000001 111.074 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -65.41 -33.36 75.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.059 -0.518 . . . . 0.77000000000000002 111.506 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -67.86 -40.23 83.68 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.904 -0.319 . . . . 0.33000000000000002 110.241 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.798 ' HB3' HD23 ' A' ' 122' ' ' LEU . 96.4 mt -65.76 -36.3 83.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 0.28000000000000003 110.629 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.8 -38.06 64.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.094 -0.503 . . . . 0.69999999999999996 110.777 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -57.61 -49.8 75.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.366 -0.379 . . . . 1.77 110.388 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 120' ' ' HIS . 13.9 m -67.16 -40.17 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 120.563 -0.455 . . . . 0.53000000000000003 111.291 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -51.55 -47.28 63.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.806 0.275 . . . . 1.8899999999999999 111.339 171.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.71 -35.94 75.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.73999999999999999 110.722 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -74.19 -5.35 41.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.83 -0.623 . . . . 1.98 111.805 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.36 30.55 9.83 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.175 -1.012 . . . . 0.87 112.544 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 90.6 m-70 -126.44 117.39 22.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.103 0.477 . . . . 1.0700000000000001 109.946 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -78.01 117.2 19.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.57 -0.741 . . . . 3.0600000000000001 110.526 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.798 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -60.59 141.17 92.29 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 1.0900000000000001 110.437 173.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.65 -1.77 10.84 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.449 2.099 . . . . 0.80000000000000004 113.764 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 63.26 24.27 14.22 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.512 0.508 . . . . 0.64000000000000001 110.769 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -133.67 158.5 43.1 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.352 -0.61 . . . . 1.97 109.352 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 92' ' ' LEU . 94.5 mt -111.81 92.34 17.29 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 111.926 0.343 . . . . 0.67000000000000004 111.926 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.634 ' HD2' HD12 ' A' ' 130' ' ' LEU . 35.3 Cg_endo -66.95 160.4 47.3 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.46 2.107 . . . . 0.52000000000000002 110.968 167.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.49 -42.23 28.88 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.124 2.55 . . . . 0.63 113.828 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -77.86 10.19 2.98 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.761 0.652 . . . . 0.85999999999999999 112.761 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.634 HD12 ' HD2' ' A' ' 127' ' ' PRO . 52.8 mt -122.23 3.46 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.215 -0.194 . . . . 1.1899999999999999 111.287 176.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.6 115.62 64.87 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 121.164 -0.215 . . . . 1.3400000000000001 110.733 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.904 2.403 . . . . 0.90000000000000002 112.307 179.361 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.406 ' HB2' ' HD2' ' B' ' 150' ' ' PRO . 22.3 p30 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.227 0.537 . . . . 0.83999999999999997 111.885 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.44 ' HG3' ' HA3' ' A' ' 69' ' ' GLY . 34.4 Cg_endo -66.05 -3.69 8.9 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.382 2.721 . . . . 0.66000000000000003 113.581 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.46 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 80.3 m-85 . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 111.981 0.364 . . . . 0.68000000000000005 111.981 -173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.6 t90 . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 108.042 -1.095 . . . . 0.66000000000000003 108.042 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.5 t -56.62 -24.07 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 112.118 -171.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.434 HG21 HD22 ' A' ' 108' ' ' LEU . 97.4 t -76.54 -23.05 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.765 0.316 . . . . 1.01 111.169 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.74 -18.68 70.55 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.573 -0.822 . . . . 0.62 112.465 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -18.33 23.73 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.143 -0.623 . . . . 2.6699999999999999 111.733 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -121.22 31.99 6.12 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.95 -0.759 . . . . 1.71 108.95 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 8.7 tmtm? -74.86 -47.43 4.95 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 1.2 111.774 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 49.0 Cg_exo -56.04 -27.67 65.62 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.967 1.778 . . . . 0.62 112.56 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 m -75.71 -46.32 31.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.604 -0.271 . . . . 0.71999999999999997 111.142 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -70.34 -23.06 62.75 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.679 -0.86 . . . . 0.65000000000000002 108.679 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.75 -44.68 63.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.733 -1.121 . . . . 1.03 109.862 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.86 -40.79 89.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.027 -0.988 . . . . 2.1499999999999999 110.055 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.26 -38.37 77.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.01 -0.541 . . . . 0.70999999999999996 110.797 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HE1' HG12 ' A' ' 67' ' ' ILE . 83.1 t80 -62.27 -41.13 98.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.924 -0.58 . . . . 0.31 110.631 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -82.08 14.59 2.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.451 -0.795 . . . . 0.80000000000000004 112.416 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.1 p -113.7 2.06 15.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.144 0.497 . . . . 0.60999999999999999 110.988 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 89.0 mt -108.51 14.6 24.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 111.147 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.8 t 61.2 80.92 0.25 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.722 -0.672 . . . . 1.24 111.575 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -85.63 105.65 0.86 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.514 2.142 . . . . 0.58999999999999997 113.134 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.3 m -89.78 135.36 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.717 -0.674 . . . . 1.3100000000000001 109.839 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 62.4 21.06 12.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.19 -0.459 . . . . 1.8899999999999999 110.412 -174.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.51 9.48 83.32 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.572 -0.823 . . . . 0.62 111.873 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 56.7 mtmt -138.33 148.52 44.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.368 . . . . 1.8100000000000001 110.947 -177.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.476 HD11 ' CD1' ' A' ' 106' ' ' PHE . 11.3 pt -97.34 144.16 11.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.017 0.437 . . . . 0.29999999999999999 110.701 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.548 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 12.1 p -71.18 161.6 30.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.295 -0.866 . . . . 0.44 110.837 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.26 -32.22 60.12 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.135 -0.555 . . . . 0.33000000000000002 112.021 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.63 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -49.85 -65.81 0.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.559 0.344 . . . . 0.34000000000000002 111.72 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 48.0 m-80 -69.45 -39.46 77.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.089 -0.505 . . . . 1.6499999999999999 111.717 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.11 97.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.422 -0.354 . . . . 0.27000000000000002 110.38 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 34.4 ttpt -62.43 -42.28 99.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.469 -0.567 . . . . 1.52 109.469 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 52.0 mtpt -51.8 -55.53 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.5 -0.773 . . . . 1.1399999999999999 110.916 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -59.07 -46.53 88.02 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.348 0.595 . . . . 1.78 110.657 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.713 ' HB3' HD22 ' A' ' 86' ' ' LEU . 84.3 mtp -64.69 -29.22 70.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.846 -0.615 . . . . 0.85999999999999999 110.992 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.21 -37.37 45.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.239 0.542 . . . . 1.52 109.897 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -80.86 2.91 24.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.91 -0.586 . . . . 3.3300000000000001 111.061 177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m -77.56 -10.24 59.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.307 -0.406 . . . . 0.91000000000000003 110.338 169.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 69.68 21.37 6.6 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.299 0.639 . . . . 2.9700000000000002 111.615 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.471 ' HB2' HD21 ' A' ' 86' ' ' LEU . 94.2 mt -100.8 153.14 37.9 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.614 -0.721 . . . . 1.4099999999999999 110.964 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.503 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 9.8 Cg_endo -54.82 141.12 77.67 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.155 2.57 . . . . 0.32000000000000001 112.631 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -63.95 -28.43 69.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.463 -0.789 . . . . 2.0499999999999998 111.443 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 p -67.22 -44.73 78.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.842 0.353 . . . . 0.83999999999999997 110.887 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.46 -44.3 98.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.26000000000000001 110.01 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 76' ' ' MET . 78.4 mt -60.75 -41.41 95.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.767 -0.651 . . . . 0.28999999999999998 110.489 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.612 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -57.17 -49.73 69.94 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.697 -0.683 . . . . 0.35999999999999999 111.541 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.504 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 93.6 mttt -56.05 -51.05 69.22 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 122.518 0.327 . . . . 1.29 110.974 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.631 HG23 HD12 ' A' ' 112' ' ' LEU . 83.0 mt -55.52 -42.67 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.695 -0.684 . . . . 0.27000000000000002 111.217 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.437 ' HB3' ' ND2' ' B' ' 149' ' ' ASN . 15.0 t-105 -61.93 -44.91 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.478 -0.328 . . . . 0.37 110.956 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 60.7 mttm -63.28 -22.82 67.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 2.54 110.961 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.568 ' O ' HD11 ' A' ' 126' ' ' LEU . 27.7 mt -93.51 -38.01 11.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 1.5 110.528 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -72.61 -42.67 64.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.713 -0.676 . . . . 0.53000000000000003 111.019 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.508 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 44.2 t0 -81.46 78.94 8.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.897 -0.779 . . . . 0.5 108.897 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.13 -36.04 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.493 -0.776 . . . . 0.64000000000000001 110.827 -174.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.17 -11.08 57.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 1.46 109.727 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.508 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 62.2 mtpt 51.63 66.04 1.31 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.808 -1.087 . . . . 2.7400000000000002 111.564 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 10.5 p-10 -115.31 9.2 15.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.335 -0.848 . . . . 0.56000000000000005 110.412 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.16 2.76 67.45 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.882 -0.675 . . . . 0.48999999999999999 112.183 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.548 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 81.2 mt -131.73 164.75 25.29 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.377 -0.601 . . . . 0.53000000000000003 109.377 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.1 mt -120.56 116.65 25.79 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.649 -0.42 . . . . 0.33000000000000002 110.482 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.479 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.7 p30 -78.62 -176.89 5.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.144 -0.688 . . . . 1.8500000000000001 109.144 170.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -66.4 -29.6 69.79 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.961 -0.295 . . . . 0.84999999999999998 111.528 -176.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -69.55 -53.83 17.04 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.213 -0.662 . . . . 2.0800000000000001 109.213 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.493 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 28.7 mt-10 -63.06 -39.6 95.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.919 -1.037 . . . . 0.47999999999999998 111.436 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.476 ' CD1' HD11 ' A' ' 67' ' ' ILE . 48.6 t80 -69.48 -40.36 77.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.40999999999999998 110.249 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.58 75.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.92 -0.582 . . . . 0.23000000000000001 110.373 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -63.85 -48.44 76.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.947 -0.569 . . . . 1.29 109.475 175.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.78 76.71 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.617 -0.72 . . . . 0.23000000000000001 110.611 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.31 -28.36 69.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.711 -0.677 . . . . 0.77000000000000002 111.543 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 56.8 t60 -81.24 -32.67 33.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.815 -0.354 . . . . 0.33000000000000002 110.871 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.631 HD12 HG23 ' A' ' 89' ' ' ILE . 93.4 mt -71.12 -37.28 72.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.331 0.586 . . . . 0.28000000000000003 109.568 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.499 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 76.0 mt -70.78 -32.73 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.905 -0.589 . . . . 0.69999999999999996 109.941 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 14.3 tppt? -53.4 -55.42 25.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.044 -0.526 . . . . 1.77 110.728 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.3 m -65.94 -36.31 77.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 120.563 -0.455 . . . . 0.53000000000000003 111.47 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.461 ' HG2' HD23 ' A' ' 122' ' ' LEU . 25.7 mmmt -58.67 -42.03 87.53 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.562 -0.455 . . . . 1.8899999999999999 111.702 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 81.6 mt -70.09 -22.32 63.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.73999999999999999 110.97 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.472 ' HB2' ' CD2' ' A' ' 120' ' ' HIS . 49.1 mt-10 -82.73 -8.17 59.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.914 -0.584 . . . . 1.98 110.893 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.56 30.16 16.68 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.576 -0.821 . . . . 0.87 111.861 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.472 ' CD2' ' HB2' ' A' ' 118' ' ' GLU . 66.8 m-70 -110.24 174.08 6.03 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.646 -0.501 . . . . 1.0700000000000001 109.646 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.442 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 16.2 mm-40 -109.21 136.69 48.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.79 -0.641 . . . . 3.0600000000000001 109.535 171.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 116' ' ' LYS . 1.3 pp -82.93 139.59 43.0 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.335 -0.617 . . . . 1.0900000000000001 109.335 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 23.7 Cg_exo -62.53 -13.97 36.64 Favored 'Trans proline' 0 N--CA 1.476 0.467 0 C-N-CA 123.332 2.688 . . . . 0.80000000000000004 113.694 -169.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 63.53 16.42 9.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.645 -0.707 . . . . 0.64000000000000001 111.425 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -136.26 171.54 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.304 -0.628 . . . . 1.97 109.304 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.866 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 98.9 mt -115.85 90.51 27.54 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.505 -0.316 . . . . 0.67000000000000004 110.794 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.65 154.85 66.63 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.478 2.119 . . . . 0.52000000000000002 111.723 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -50.27 -24.36 11.5 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.583 2.856 . . . . 0.63 114.969 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -96.31 5.27 51.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.952 0.406 . . . . 0.85999999999999999 111.508 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.438 ' O ' HD21 ' A' ' 108' ' ' LEU . 64.8 mt -123.61 -34.08 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.29 -0.414 . . . . 1.1899999999999999 110.786 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.866 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.8 p -77.61 121.55 84.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.026 0.441 . . . . 1.3400000000000001 110.654 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 131' ' ' VAL . 12.4 Cg_endo . . . . . 0 N--CA 1.462 -0.331 0 C-N-CA 122.754 2.303 . . . . 0.90000000000000002 112.065 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.612 HD21 ' HA2' ' A' ' 87' ' ' GLY . 24.8 t-20 . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 109.729 -0.471 . . . . 0.83999999999999997 109.729 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 16.5 Cg_exo -68.46 -6.87 18.67 Favored 'Trans proline' 0 N--CA 1.474 0.326 0 C-N-CA 123.361 2.707 . . . . 0.66000000000000003 113.284 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.538 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 99.2 m-85 . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 121.182 0.515 . . . . 0.68000000000000005 110.196 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.3 t90 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 108.31 -0.996 . . . . 0.66000000000000003 108.31 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.5 t -53.31 -35.68 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.513 0.56 . . . . 1.4099999999999999 112.513 -172.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 31.3 t -72.16 -17.0 18.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.372 -0.376 . . . . 1.01 111.26 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.55 -1.25 52.0 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.366 -0.921 . . . . 0.62 112.188 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -86.55 -31.04 21.44 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.22 0.533 . . . . 2.6699999999999999 110.878 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -141.39 35.16 1.67 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 122.224 1.011 . . . . 1.71 110.229 -172.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 15.1 tmtt? -76.86 -42.56 2.82 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 114.015 -1.448 . . . . 1.2 111.535 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 50' ' ' LYS . 82.2 Cg_exo -46.21 -35.0 14.55 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.726 2.284 . . . . 0.62 113.598 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.584 ' O ' HG12 ' A' ' 56' ' ' ILE . 9.3 m -69.83 -45.66 67.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.732 -0.387 . . . . 0.71999999999999997 110.449 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -72.16 -22.76 61.25 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.467 -0.568 . . . . 0.65000000000000002 109.467 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.476 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 18.0 t70 -67.2 -41.18 86.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.137 -0.938 . . . . 1.03 109.078 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -66.85 -35.59 80.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.21 -0.904 . . . . 2.1499999999999999 110.239 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 52' ' ' THR . 23.0 mm -66.03 -31.48 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.731 0.777 . . . . 0.70999999999999996 109.707 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 87.6 t80 -72.91 -45.55 57.53 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.094 -0.957 . . . . 0.31 110.804 -175.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.476 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 51.2 m-85 -75.49 -19.89 59.1 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.114 -0.493 . . . . 0.80000000000000004 111.952 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.2 p -83.45 -5.16 59.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 0.60999999999999999 111.164 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.62 8.98 39.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 0.40999999999999998 111.246 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.1 t 64.32 83.41 0.2 Allowed Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 123.743 0.652 . . . . 1.24 110.955 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.43 118.13 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.766 2.311 . . . . 0.58999999999999997 112.812 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.91 134.7 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.744 . . . . 1.3100000000000001 110.66 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 57.92 19.92 6.24 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.457 0.703 . . . . 1.8899999999999999 111.377 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.71 7.27 63.17 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.907 -0.588 . . . . 0.62 112.258 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 54.4 mtmt -137.45 173.42 11.68 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 110.111 -0.329 . . . . 1.8100000000000001 110.111 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.433 HD11 ' CD1' ' A' ' 106' ' ' PHE . 25.0 pt -118.39 154.12 20.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.87 -0.418 . . . . 0.29999999999999999 109.87 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.589 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 70.7 p -80.95 166.94 20.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.896 -0.593 . . . . 0.44 110.201 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.536 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -58.87 -22.46 54.39 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.642 -0.79 . . . . 0.33000000000000002 111.888 175.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.57 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -61.42 -59.91 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.34000000000000002 111.556 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -65.8 -42.75 90.33 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.689 -0.687 . . . . 1.6499999999999999 111.332 -170.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.16 -36.14 83.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.27000000000000002 110.522 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 32.0 tttp -62.27 -43.39 98.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.894 -0.594 . . . . 1.52 110.019 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.571 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 24.8 mtpt -58.76 -51.1 71.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.687 -0.688 . . . . 1.1399999999999999 110.576 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -57.98 -43.7 86.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.529 0.681 . . . . 1.78 110.457 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.723 ' HB3' HD22 ' A' ' 86' ' ' LEU . 94.4 mtp -69.16 -26.91 65.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.792 -0.64 . . . . 0.85999999999999999 112.276 -175.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 74' ' ' LYS . 25.6 m -83.16 -22.82 8.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 120.126 -0.63 . . . . 1.52 109.602 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 5.6 mptp? -77.6 -12.94 60.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 3.3300000000000001 110.099 173.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.0 m -75.2 -7.93 55.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.91000000000000003 111.62 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? 67.39 34.66 4.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.986 0.422 . . . . 2.9700000000000002 111.374 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.58 ' HB2' HD21 ' A' ' 86' ' ' LEU . 95.3 mt -112.74 146.65 35.49 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.106 -0.497 . . . . 1.4099999999999999 110.982 -176.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.7 Cg_endo -61.62 153.14 69.05 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.064 2.509 . . . . 0.32000000000000001 112.854 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -59.62 -32.74 70.7 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.948 -0.569 . . . . 2.0499999999999998 111.601 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.46 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -64.73 -50.47 66.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.922 0.391 . . . . 0.83999999999999997 110.951 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . 42.8 t -60.27 -44.26 95.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.26000000000000001 110.418 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.723 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.4 mt -63.84 -38.84 92.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.809 -0.632 . . . . 0.28999999999999998 110.774 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.674 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.88 -42.68 99.71 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.039 -0.6 . . . . 0.35999999999999999 112.551 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 85' ' ' VAL . 41.1 mtmt -68.18 -42.9 79.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.744 -0.095 . . . . 1.29 110.744 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.545 HD11 ' CE ' ' A' ' 116' ' ' LYS . 93.8 mt -55.83 -52.2 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.384 0.428 . . . . 0.27000000000000002 111.071 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.536 ' CH2' ' HA2' ' A' ' 69' ' ' GLY . 39.0 t-105 -62.98 -49.59 74.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.794 0.331 . . . . 0.37 111.348 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -59.64 -30.93 69.06 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.139 -0.482 . . . . 2.54 111.232 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -92.53 -41.02 10.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 1.5 111.2 -176.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.464 ' N ' ' HG ' ' A' ' 92' ' ' LEU . . . -69.53 -36.32 76.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.536 0.569 . . . . 0.53000000000000003 112.536 -175.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.595 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 42.5 t0 -74.18 95.47 2.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.895 -0.779 . . . . 0.5 108.895 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 t -79.75 -39.91 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 110.942 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -80.68 -13.92 58.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 1.46 109.68 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.595 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 6.1 mtpp 51.64 72.91 0.34 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.496 -1.229 . . . . 2.7400000000000002 111.31 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.625 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.1 p-10 -128.33 9.1 6.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.962 -1.017 . . . . 0.56000000000000005 110.825 -175.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.23 10.84 70.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.48999999999999999 111.841 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.625 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 43.8 mt -134.31 157.45 46.3 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.217 -0.66 . . . . 0.53000000000000003 109.217 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.0 mt -121.77 118.81 29.97 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.776 -0.37 . . . . 0.33000000000000002 110.196 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.6 p30 -74.67 -177.63 3.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.077 -0.712 . . . . 1.8500000000000001 109.077 168.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -66.08 -27.05 67.78 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.088 0.403 . . . . 0.84999999999999998 112.088 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 85.7 mt-10 -75.89 -47.32 25.87 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.749 -0.463 . . . . 2.0800000000000001 109.749 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -66.3 -37.7 86.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.89 -0.596 . . . . 0.47999999999999998 110.492 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.433 ' CD1' HD11 ' A' ' 67' ' ' ILE . 23.7 t80 -70.34 -38.56 74.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.168 -0.469 . . . . 0.40999999999999998 110.303 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.88 99.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.045 -0.525 . . . . 0.23000000000000001 110.401 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -59.38 -49.88 76.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 1.29 109.574 177.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -55.61 -46.92 77.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.905 -0.589 . . . . 0.23000000000000001 111.552 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -66.68 -38.4 86.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.446 . . . . 0.77000000000000002 111.407 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -64.92 -32.61 74.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.098 0.475 . . . . 0.33000000000000002 109.934 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.717 ' HB3' HD23 ' A' ' 122' ' ' LEU . 97.8 mt -67.09 -35.02 78.9 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.954 -0.567 . . . . 0.28000000000000003 109.997 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 109' ' ' ALA . 38.7 mm -61.26 -47.1 95.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.158 -0.682 . . . . 0.69999999999999996 109.158 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -59.06 -44.06 91.79 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.417 -0.811 . . . . 1.77 112.033 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 112' ' ' LEU . 11.6 m -64.56 -38.79 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 120.062 -0.655 . . . . 0.53000000000000003 111.344 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.612 ' HE3' HD21 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -51.97 -48.51 64.32 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 120.526 -0.47 . . . . 1.8899999999999999 111.262 167.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.38 -29.37 68.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.933 -0.576 . . . . 0.73999999999999999 111.23 -177.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -70.91 -20.01 62.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.968 -0.56 . . . . 1.98 111.233 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.39 22.67 10.24 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.693 -0.765 . . . . 0.87 112.004 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -119.36 158.57 25.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.589 -0.523 . . . . 1.0700000000000001 109.589 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.9 130.61 55.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.201 0.524 . . . . 3.0600000000000001 110.564 174.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.717 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -68.79 146.5 97.55 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 1.0900000000000001 110.407 172.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 2.2 Cg_endo -80.22 1.7 9.05 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.719 2.279 . . . . 0.80000000000000004 112.86 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.488 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 64.53 19.69 11.89 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.985 -0.552 . . . . 0.64000000000000001 110.892 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -133.85 169.72 16.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.696 -0.684 . . . . 1.97 109.383 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 63.6 mt -111.97 91.26 15.04 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 123.082 0.239 . . . . 0.67000000000000004 111.516 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 29.0 Cg_endo -64.54 154.41 72.09 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.71 2.273 . . . . 0.52000000000000002 111.208 170.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.27 -40.24 52.34 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.537 2.825 . . . . 0.63 113.77 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -79.14 7.65 7.17 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.088 0.403 . . . . 0.85999999999999999 112.088 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.401 HD12 ' HG2' ' A' ' 127' ' ' PRO . 70.5 mt -126.34 5.61 7.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.547 0.213 . . . . 1.1899999999999999 111.557 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.32 118.31 69.75 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.033 -0.267 . . . . 1.3400000000000001 110.915 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 64.5 Cg_exo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 123.139 2.56 . . . . 0.90000000000000002 112.135 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.674 HD21 ' HA2' ' A' ' 87' ' ' GLY . 48.6 t-20 . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 109.448 -0.575 . . . . 0.83999999999999997 109.448 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 21.1 Cg_exo -66.59 -3.14 8.62 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.45 2.766 . . . . 0.66000000000000003 113.684 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.516 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 83.6 m-85 . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.987 0.422 . . . . 0.68000000000000005 110.533 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.8 t90 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 108.703 -0.851 . . . . 0.66000000000000003 108.703 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 m -57.57 -26.71 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.578 -0.737 . . . . 1.4099999999999999 112.172 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HA ' ' OD1' ' A' ' 49' ' ' ASP . 24.1 t -73.41 -16.34 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.032 -0.531 . . . . 1.01 111.227 -174.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.01 -8.81 58.82 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.604 -0.808 . . . . 0.62 112.396 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -93.88 -28.78 15.65 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.395 0.617 . . . . 2.6699999999999999 110.721 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.501 ' OD1' ' HA ' ' A' ' 46' ' ' VAL . 10.8 p-10 -120.94 33.7 5.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.211 -0.904 . . . . 1.71 109.714 -172.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.06 -46.51 0.47 Allowed Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 114.391 -1.277 . . . . 1.2 112.263 -174.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.39 -26.61 8.84 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 122.754 2.303 . . . . 0.62 114.06 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -68.83 -45.86 70.04 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.384 0.611 . . . . 0.71999999999999997 110.126 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -78.14 -20.72 51.49 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.706 -0.679 . . . . 0.65000000000000002 109.178 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.6 -45.19 94.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.614 -0.721 . . . . 1.03 109.505 173.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -62.05 -50.0 73.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.203 -0.908 . . . . 2.1499999999999999 110.089 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.9 mt -60.71 -35.42 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.063 -0.517 . . . . 0.70999999999999996 111.008 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.499 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 92.6 t80 -65.13 -40.33 94.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.637 -0.71 . . . . 0.31 110.05 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -74.75 -25.01 58.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.959 -0.564 . . . . 0.80000000000000004 111.726 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.6 p -82.53 1.87 35.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.088 0.47 . . . . 0.60999999999999999 111.374 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.75 1.85 23.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.714 -0.476 . . . . 0.40999999999999998 109.714 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.5 m 63.3 88.88 0.11 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.054 -0.975 . . . . 1.24 111.593 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -86.92 122.5 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.71 2.273 . . . . 0.58999999999999997 112.592 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.9 m -101.2 130.9 49.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.001 -0.545 . . . . 1.3100000000000001 109.781 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 65.91 21.85 11.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.002 -0.545 . . . . 1.8899999999999999 110.046 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.18 1.53 78.85 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.912 -0.586 . . . . 0.62 112.549 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.64 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 51.5 mtmt -135.59 156.44 48.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.021 -0.363 . . . . 1.8100000000000001 110.021 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.547 HD11 ' CD1' ' A' ' 106' ' ' PHE . 15.4 pt -102.33 146.14 10.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 120.57 -0.452 . . . . 0.29999999999999999 110.663 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.581 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 68.5 p -73.16 163.97 27.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.089 -0.505 . . . . 0.44 110.293 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.99 -24.76 55.24 Favored Glycine 0 C--O 1.221 -0.708 0 C-N-CA 120.796 -0.716 . . . . 0.33000000000000002 112.469 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -59.35 -58.07 10.21 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.119 0.485 . . . . 0.34000000000000002 111.601 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.463 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -67.54 -41.12 84.8 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.719 -0.673 . . . . 1.6499999999999999 110.363 -173.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -65.29 -31.54 72.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.483 -0.781 . . . . 0.27000000000000002 110.524 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 70.9 tttt -67.86 -43.48 79.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.213 -0.449 . . . . 1.52 109.954 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.736 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.9 mtmt -55.29 -49.12 72.92 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.515 -0.766 . . . . 1.1399999999999999 110.106 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 28.9 tp10 -57.92 -44.21 86.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.325 0.583 . . . . 1.78 110.749 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.602 ' HB3' HD22 ' A' ' 86' ' ' LEU . 23.9 mmt -63.9 -36.48 84.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.923 -0.58 . . . . 0.85999999999999999 111.884 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -81.16 -35.75 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.435 -0.506 . . . . 1.52 111.674 -173.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.736 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -81.93 -8.34 59.67 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 119.99 -0.684 . . . . 3.3300000000000001 110.97 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.0 m -75.35 -20.35 59.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.163 0.506 . . . . 0.91000000000000003 109.716 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 mmmp? 69.6 51.01 0.48 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.038 -0.983 . . . . 2.9700000000000002 111.775 175.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.518 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.8 mp -110.99 145.31 32.17 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.872 -1.058 . . . . 1.4099999999999999 109.018 170.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 20.9 Cg_endo -62.93 146.7 94.96 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.998 2.465 . . . . 0.32000000000000001 112.427 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -56.73 -31.16 64.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.26 -0.427 . . . . 2.0499999999999998 111.724 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.8 m -62.51 -48.63 78.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.135 0.493 . . . . 0.83999999999999997 110.267 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.707 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 69.1 t -66.51 -43.06 91.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.26000000000000001 110.212 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 76' ' ' MET . 80.9 mt -59.87 -36.39 76.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.055 -0.52 . . . . 0.28999999999999998 110.196 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.915 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.7 -46.07 94.98 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.739 -0.664 . . . . 0.35999999999999999 112.043 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.707 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 17.7 mtpp -61.17 -47.32 86.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.361 -0.237 . . . . 1.29 110.361 177.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.422 ' HA ' HD23 ' A' ' 92' ' ' LEU . 88.6 mt -60.77 -48.42 88.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.873 -0.603 . . . . 0.27000000000000002 111.357 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -64.04 -48.97 74.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.915 0.388 . . . . 0.37 111.179 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.24 -27.82 68.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.894 -0.594 . . . . 2.54 111.353 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -94.32 -33.21 13.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.863 -0.608 . . . . 1.5 111.331 -177.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -73.48 -42.49 61.8 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.137 0.421 . . . . 0.53000000000000003 112.137 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.63 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 50.6 t0 -78.16 95.55 4.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.869 -0.789 . . . . 0.5 108.869 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 t -70.38 -44.44 77.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.406 -0.816 . . . . 0.64000000000000001 110.38 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -88.35 -17.18 31.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.317 -0.856 . . . . 1.46 110.755 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 50.8 mttp 58.03 73.39 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.152 0.977 . . . . 2.7400000000000002 112.094 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 12.9 p-10 -117.67 10.21 13.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.291 -1.322 . . . . 0.56000000000000005 110.576 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.29 -0.88 62.36 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.054 -0.593 . . . . 0.48999999999999999 112.156 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.581 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 47.5 mt -129.87 149.42 51.61 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.054 -0.721 . . . . 0.53000000000000003 109.054 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.7 mt -98.99 112.31 24.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.359 0.6 . . . . 0.33000000000000002 109.858 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.653 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 7.5 t70 -70.39 166.3 20.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.826 -1.079 . . . . 1.8500000000000001 109.122 173.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -57.47 -37.99 73.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 118.006 0.366 . . . . 0.84999999999999998 111.692 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.727 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 81.3 mt-10 -70.98 -40.38 71.94 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.671 -0.412 . . . . 2.0800000000000001 110.663 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.653 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 18.2 mt-10 -70.68 -31.94 69.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.47999999999999998 110.697 -174.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD1' HD11 ' A' ' 67' ' ' ILE . 66.8 t80 -74.37 -44.39 52.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.788 -0.642 . . . . 0.40999999999999998 109.887 177.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.7 87.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.742 -0.663 . . . . 0.23000000000000001 109.82 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 93' ' ' ALA . 18.3 tp -60.57 -50.56 73.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.437 -0.801 . . . . 1.29 109.834 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -56.9 -46.64 81.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.23000000000000001 111.155 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.85 -34.41 75.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.177 -0.465 . . . . 0.77000000000000002 111.355 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.425 ' CG ' HG22 ' A' ' 46' ' ' VAL . 40.9 t60 -65.41 -39.14 91.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.696 -0.483 . . . . 0.33000000000000002 109.696 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.6 ' HB3' HD22 ' A' ' 122' ' ' LEU . 74.9 mt -63.69 -43.34 96.93 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.957 -0.565 . . . . 0.28000000000000003 110.044 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.488 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 33.7 mm -54.08 -50.58 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.637 -0.711 . . . . 0.69999999999999996 110.115 173.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 27.3 ttpp -58.51 -49.95 75.52 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.548 -0.751 . . . . 1.77 111.435 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.7 m -61.51 -40.1 85.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.537 -0.465 . . . . 0.53000000000000003 111.217 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.545 ' HG2' HD23 ' A' ' 122' ' ' LEU . 24.8 mmmt -58.71 -40.56 84.04 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.221 -0.192 . . . . 1.8899999999999999 111.403 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 92.6 mt -71.19 -32.24 68.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.168 0.508 . . . . 0.73999999999999999 110.868 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.576 ' HB2' ' HD2' ' A' ' 120' ' ' HIS . 47.1 mt-10 -77.72 2.29 17.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.842 -0.617 . . . . 1.98 111.106 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.12 24.18 41.86 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.781 -0.723 . . . . 0.87 112.401 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.576 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 84.3 m-70 -114.53 175.13 5.62 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.502 -0.555 . . . . 1.0700000000000001 109.502 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -117.96 136.55 53.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.955 0.407 . . . . 3.0600000000000001 111.195 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 112' ' ' LEU . 3.0 pp -89.41 134.33 32.95 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.44 -0.578 . . . . 1.0900000000000001 109.44 173.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 37.3 Cg_exo -60.93 -18.66 58.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.168 2.579 . . . . 0.80000000000000004 113.768 -172.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.427 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 65.0 17.87 11.27 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.822 -0.626 . . . . 0.64000000000000001 110.94 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -133.95 173.81 11.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.236 -0.893 . . . . 1.97 108.635 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.4 mt -113.2 90.46 16.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.817 0.302 . . . . 0.67000000000000004 111.817 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.74 160.53 37.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.504 2.136 . . . . 0.52000000000000002 110.712 169.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.71 -34.3 53.26 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.278 2.652 . . . . 0.63 113.711 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -86.94 -2.16 58.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.733 -0.387 . . . . 0.85999999999999999 111.659 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -99.37 -25.7 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.979 0.418 . . . . 1.1899999999999999 110.356 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 60.4 t -70.88 119.56 73.93 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.849 -0.614 . . . . 1.3400000000000001 111.163 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.727 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 51.6 Cg_exo . . . . . 0 CA--C 1.533 0.449 0 C-N-CA 123.291 2.661 . . . . 0.90000000000000002 112.716 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.915 HD21 ' HA2' ' A' ' 87' ' ' GLY . 33.6 t-20 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 121.031 0.443 . . . . 0.83999999999999997 111.565 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.09 -4.87 15.11 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.919 3.08 . . . . 0.66000000000000003 113.302 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.561 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 72.4 m-85 . . . . . 0 C--N 1.331 -0.205 0 N-CA-C 112.055 0.391 . . . . 0.68000000000000005 112.055 -175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.648 -0.581 . . . . 9.3800000000000008 111.648 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -68.47 -53.16 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.924 2.416 . . . . 8.6300000000000008 112.519 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.19 -67.7 0.98 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.994 0.426 . . . . 8.9499999999999993 111.165 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.24 -50.1 3.3 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.538 -0.839 . . . . 5.8600000000000003 111.907 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -65.07 -59.5 4.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.045 0.45 . . . . 6.0 110.214 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.32 93.85 6.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.76 -0.654 . . . . 3.9399999999999999 109.949 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -124.96 68.9 1.11 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.567 -0.901 . . . . 3.2799999999999998 108.567 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 p -93.97 143.88 10.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.202 -0.908 . . . . 1.8899999999999999 111.088 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.18 113.68 17.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.813 -0.631 . . . . 2.4900000000000002 110.963 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -71.26 113.0 7.84 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.071 -0.715 . . . . 0.66000000000000003 109.071 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 48.1 t -54.42 -32.05 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.053 -0.521 . . . . 1.4099999999999999 111.996 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.82 -22.09 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.386 -0.37 . . . . 1.01 111.311 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.58 -10.05 62.93 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.301 -0.952 . . . . 0.62 112.74 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 52.4 pttt -93.98 -18.59 21.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 117.289 0.545 . . . . 2.6699999999999999 111.426 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -136.67 33.71 2.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.265 1.031 . . . . 1.71 109.218 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.612 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 6.4 tmtm? -75.07 -46.08 4.76 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.528 -1.215 . . . . 1.2 111.908 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.6 Cg_endo -50.86 -26.37 17.85 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.803 2.335 . . . . 0.62 113.257 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.5 m -76.03 -46.84 27.26 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.929 -0.308 . . . . 0.71999999999999997 111.091 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -72.62 -22.32 60.98 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.858 -0.793 . . . . 0.65000000000000002 108.858 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 28.3 t70 -71.29 -43.21 67.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.546 -1.207 . . . . 1.03 109.452 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.29 -43.89 97.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.149 -0.932 . . . . 2.1499999999999999 109.991 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.5 -30.8 51.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.014 -0.539 . . . . 0.70999999999999996 110.457 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.482 ' HE1' HG12 ' A' ' 67' ' ' ILE . 79.9 t80 -65.06 -40.87 95.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.889 -0.596 . . . . 0.31 110.072 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.451 ' HE2' ' OD2' ' A' ' 54' ' ' ASP . 57.8 m-85 -72.88 -23.44 60.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.676 -0.693 . . . . 0.80000000000000004 111.904 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.5 p -79.8 -2.36 42.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.799 -0.36 . . . . 0.60999999999999999 111.451 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 83.0 mt -105.19 7.22 33.57 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.077 -0.249 . . . . 0.40999999999999998 111.038 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 t 65.87 84.0 0.18 Allowed Pre-proline 0 C--O 1.234 0.268 0 O-C-N 123.844 0.715 . . . . 1.24 111.076 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.403 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 44.4 Cg_endo -85.31 114.1 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.453 2.102 . . . . 0.58999999999999997 112.61 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -89.12 137.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.724 -0.671 . . . . 1.3100000000000001 109.869 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 p30 46.13 23.64 0.21 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.943 0.897 . . . . 1.8899999999999999 112.663 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.21 6.55 61.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.349 -0.453 . . . . 0.62 113.643 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 0.4 OUTLIER -134.36 174.61 10.34 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.312 0.577 . . . . 1.8100000000000001 110.837 177.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.493 HD11 ' CD1' ' A' ' 106' ' ' PHE . 16.8 pt -123.56 148.58 27.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.322 -0.854 . . . . 0.29999999999999999 109.574 172.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.9 p -83.37 179.2 7.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.584 -0.734 . . . . 0.44 110.114 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.11 -34.07 77.71 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.751 -0.737 . . . . 0.33000000000000002 112.272 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.41 96.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.138 0.494 . . . . 0.34000000000000002 112.12 -176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.517 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.2 m120 -76.03 -47.1 26.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.342 0.592 . . . . 1.6499999999999999 110.244 -172.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.59 -22.88 63.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.023 -0.535 . . . . 0.27000000000000002 110.247 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 41.5 ttmt -68.18 -54.36 18.44 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.242 -0.435 . . . . 1.52 109.976 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 17.5 ptpt -59.22 -33.15 70.65 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.82 0.343 . . . . 1.1399999999999999 110.23 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.583 ' CD ' ' HZ3' ' A' ' 78' ' ' LYS . 14.1 tp10 -60.45 -53.48 57.01 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.321 0.581 . . . . 1.78 110.132 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 1.057 ' HB3' HD22 ' A' ' 86' ' ' LEU . 54.6 mtt -70.73 -22.6 62.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.671 . . . . 0.85999999999999999 110.852 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 73' ' ' LYS . 3.9 t -63.17 -47.17 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.927 -0.579 . . . . 1.52 110.581 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -94.61 -1.61 52.93 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.386 -0.926 . . . . 3.3300000000000001 111.792 -175.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.0 p -66.89 -19.75 65.79 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.817 0.342 . . . . 0.91000000000000003 110.178 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.4 tptt 75.58 22.97 1.51 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.879 0.872 . . . . 2.9700000000000002 111.443 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 86' ' ' LEU . 11.2 mp -92.0 151.45 41.93 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.306 -0.257 . . . . 1.4099999999999999 110.306 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.577 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 14.5 Cg_endo -59.94 148.18 89.79 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.649 2.233 . . . . 0.32000000000000001 112.731 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -55.93 -39.49 71.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.454 -0.794 . . . . 2.0499999999999998 111.188 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.7 m -61.1 -45.95 92.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.996 -0.547 . . . . 0.83999999999999997 111.374 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.502 ' CG2' ' HG2' ' A' ' 82' ' ' PRO . 55.0 t -64.45 -42.22 94.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.26000000000000001 110.376 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.057 HD22 ' HB3' ' A' ' 76' ' ' MET . 64.0 mt -57.65 -46.4 84.24 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.051 0.453 . . . . 0.28999999999999998 110.695 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.678 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -64.84 -34.65 90.46 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.832 -0.699 . . . . 0.35999999999999999 112.13 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -70.54 -41.43 72.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.272 0.558 . . . . 1.29 110.455 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.63 HG23 HD12 ' A' ' 112' ' ' LEU . 83.7 mt -62.38 -42.93 97.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.625 -0.716 . . . . 0.27000000000000002 110.937 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -59.39 -40.69 87.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.966 0.412 . . . . 0.37 110.077 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -62.99 -25.96 68.62 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.54 -0.754 . . . . 2.54 111.026 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.436 HD11 ' HA ' ' A' ' 124' ' ' ALA . 66.1 mt -90.35 -33.28 16.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.296 -0.411 . . . . 1.5 111.336 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.32 -43.63 63.84 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.83 0.678 . . . . 0.53000000000000003 112.83 -170.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.618 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 23.3 t0 -88.35 68.85 9.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.43 0.633 . . . . 0.5 110.156 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.466 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 2.7 t -66.11 -21.69 29.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.297 -0.865 . . . . 0.64000000000000001 109.699 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -79.7 -23.37 42.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.882 -1.054 . . . . 1.46 110.754 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 59.91 51.85 5.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.219 -0.9 . . . . 2.7400000000000002 111.907 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.693 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 11.8 p-10 -118.63 7.54 11.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.969 0.414 . . . . 0.56000000000000005 109.997 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.78 -1.51 30.0 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.987 -0.625 . . . . 0.48999999999999999 112.79 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.526 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 64.2 mt -123.77 155.68 37.48 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.807 -0.442 . . . . 0.53000000000000003 109.807 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -110.16 110.78 21.76 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.501 -0.48 . . . . 0.33000000000000002 110.53 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HA ' ' HG3' ' A' ' 66' ' ' LYS . 2.4 m-20 -70.97 169.08 15.63 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.103 -0.702 . . . . 1.8500000000000001 109.103 168.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -57.8 -29.89 65.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.593 -0.276 . . . . 0.84999999999999998 111.115 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.07 -51.92 61.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.847 0.832 . . . . 2.0800000000000001 109.579 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -71.31 -35.98 71.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.536 -1.211 . . . . 0.47999999999999998 110.966 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.493 ' CD1' HD11 ' A' ' 67' ' ' ILE . 58.8 t80 -70.51 -36.37 73.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.19 -0.459 . . . . 0.40999999999999998 110.279 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.74 84.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.23000000000000001 110.184 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -64.23 -46.52 83.47 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.989 -0.551 . . . . 1.29 109.552 177.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.46 94.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.3 -0.864 . . . . 0.23000000000000001 111.296 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.03 -31.55 72.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.17 -0.468 . . . . 0.77000000000000002 111.101 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -66.25 -40.69 90.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.932 -0.395 . . . . 0.33000000000000002 109.932 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.63 HD12 HG23 ' A' ' 89' ' ' ILE . 89.4 mt -65.6 -39.47 91.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.882 -0.599 . . . . 0.28000000000000003 110.438 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 62.7 mt -70.66 -37.77 70.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.002 -0.545 . . . . 0.69999999999999996 110.927 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 26.1 ttpp -63.2 -45.78 90.08 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.913 -0.315 . . . . 1.77 110.532 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.61 -35.24 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.095 -0.642 . . . . 0.53000000000000003 110.465 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.658 ' HD3' HD23 ' A' ' 122' ' ' LEU . 25.0 mmmt -56.21 -45.6 79.81 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.39 -0.368 . . . . 1.8899999999999999 111.163 171.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 84.1 mt -67.2 -33.85 76.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.272 0.558 . . . . 0.73999999999999999 110.646 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.6 mt-10 -78.0 4.39 12.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.663 -0.698 . . . . 1.98 111.386 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.65 34.91 14.65 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.99 -0.624 . . . . 0.87 112.54 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -122.91 171.42 9.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.806 0.336 . . . . 1.0700000000000001 110.25 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -111.82 150.55 30.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.062 -0.517 . . . . 3.0600000000000001 109.804 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.658 HD23 ' HD3' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -95.69 138.35 21.79 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.216 -1.031 . . . . 1.0900000000000001 108.216 173.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.79 -9.76 17.5 Favored 'Trans proline' 0 N--CA 1.473 0.297 0 C-N-CA 122.947 2.431 . . . . 0.80000000000000004 114.095 -171.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.436 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 62.86 17.57 10.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.585 0.707 . . . . 0.64000000000000001 110.489 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.03 161.68 34.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.906 -1.043 . . . . 1.97 108.85 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.414 ' HG ' HD22 ' A' ' 92' ' ' LEU . 96.3 mt -110.52 90.81 10.9 Favored Pre-proline 0 C--N 1.322 -0.614 0 C-N-CA 120.916 -0.314 . . . . 0.67000000000000004 111.346 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 50.2 Cg_endo -70.31 158.95 54.65 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.691 2.26 . . . . 0.52000000000000002 111.553 171.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 34.5 Cg_exo -59.13 -7.79 5.42 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.521 2.814 . . . . 0.63 114.241 -176.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -108.42 -2.59 18.94 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.367 -0.533 . . . . 0.85999999999999999 111.191 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -101.7 -36.67 8.64 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.117 0.484 . . . . 1.1899999999999999 110.358 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 7.7 p -78.43 124.27 85.55 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.681 -0.69 . . . . 1.3400000000000001 111.005 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 131' ' ' VAL . 22.1 Cg_exo -64.29 132.44 33.8 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.743 2.295 . . . . 0.90000000000000002 111.707 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.39 -1.99 5.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 123.097 2.531 . . . . 1.4399999999999999 112.125 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.3 t -78.06 -11.93 59.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.361 -0.836 . . . . 1.77 110.574 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.466 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 1.8 mptp? -112.83 10.13 19.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.35 -0.387 . . . . 1.2 111.148 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -98.73 92.25 5.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.505 -0.316 . . . . 3.9399999999999999 110.17 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -96.46 116.25 28.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.535 -0.302 . . . . 5.0800000000000001 110.227 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -110.15 134.46 52.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.219 -0.446 . . . . 6.3499999999999996 110.827 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--O 1.244 0.792 0 CA-C-O 118.207 -0.901 . . . . 8.2100000000000009 108.868 169.579 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.78 0.324 . . . . 12.91 110.284 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' B' ' 145' ' ' TYR . 25.1 t30 -139.63 -54.8 0.56 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.032 -0.531 . . . . 7.96 109.738 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' B' ' 144' ' ' ASN . 52.4 m-85 70.9 157.9 0.18 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.033 0.833 . . . . 10.06 112.446 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -82.29 94.79 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.103 -0.953 . . . . 5.3600000000000003 110.373 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 20.9 t -70.29 118.01 12.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.139 -0.482 . . . . 3.46 110.55 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 3.0 m -106.53 20.02 19.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.751 0.786 . . . . 1.49 109.677 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.678 HD21 ' HA2' ' A' ' 87' ' ' GLY . 27.0 t-20 -99.23 110.62 58.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.506 -0.77 . . . . 0.83999999999999997 110.28 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 8.0 Cg_exo -73.14 -2.87 12.7 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.53 2.82 . . . . 0.66000000000000003 113.028 -176.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 96.8 m-85 -91.72 -19.73 22.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.46 -0.336 . . . . 0.68000000000000005 110.867 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 10.2 t -114.39 -42.73 3.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.752 -0.379 . . . . 1.8300000000000001 111.149 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 64.22 -67.2 0.11 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.465 0.706 . . . . 3.77 112.395 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? . . . . . 0 C--O 1.245 0.843 0 C-N-CA 123.959 0.904 . . . . 6.4400000000000004 110.783 -179.065 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.693 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.798 -0.521 . . . . 9.3800000000000008 111.798 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.13 162.94 37.77 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.682 2.255 . . . . 8.6300000000000008 111.913 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 tt -88.67 -52.88 4.91 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.626 -0.509 . . . . 8.9499999999999993 109.626 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 126.62 119.64 2.3 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.836 -0.906 . . . . 5.8600000000000003 110.836 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.0 t -108.17 70.56 0.77 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.122 0.461 . . . . 6.0 111.708 -171.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -118.62 111.78 19.0 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.173 -0.677 . . . . 3.9399999999999999 109.173 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -98.27 106.1 18.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.423 -0.353 . . . . 3.2799999999999998 110.368 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.17 134.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.159 0.504 . . . . 1.8899999999999999 111.76 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.48 111.14 23.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.8 -0.636 . . . . 2.4900000000000002 110.476 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.494 ' HD1' ' O ' ' A' ' 129' ' ' HIS . 10.2 t90 -84.99 107.88 17.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.112 -0.699 . . . . 0.66000000000000003 109.112 176.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -69.34 5.2 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.746 0.647 . . . . 1.4099999999999999 112.746 -172.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG21 HD22 ' A' ' 108' ' ' LEU . 97.0 t -105.97 -19.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.96 0.409 . . . . 1.01 110.292 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.573 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -68.39 -18.2 71.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.634 -0.793 . . . . 0.62 111.557 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -74.76 -27.4 60.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.54 -0.33 . . . . 2.6699999999999999 111.292 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -127.61 33.49 4.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.909 0.385 . . . . 1.71 110.612 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.625 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 6.8 mmmm -64.62 -45.27 76.14 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.837 0.68 . . . . 1.2 112.837 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.5 Cg_endo -49.85 -35.22 39.21 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 122.397 2.064 . . . . 0.62 112.415 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 56' ' ' ILE . 11.5 m -73.53 -46.43 47.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.517 -0.31 . . . . 0.71999999999999997 111.302 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -71.56 -23.28 61.72 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.766 -0.457 . . . . 0.65000000000000002 109.766 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.42 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 15.2 t70 -73.86 -44.52 55.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.47 -0.786 . . . . 1.03 109.265 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 59' ' ' THR . 35.3 tt0 -57.02 -46.54 82.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.143 -0.935 . . . . 2.1499999999999999 110.358 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 52' ' ' THR . 58.9 mt -67.11 -49.21 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.137 -0.483 . . . . 0.70999999999999996 110.789 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.46 ' HE1' HG12 ' A' ' 67' ' ' ILE . 77.8 t80 -51.25 -46.44 62.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.853 -0.612 . . . . 0.31 111.682 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 29.3 m-85 -74.19 -12.37 60.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.684 0.624 . . . . 0.80000000000000004 112.684 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 55' ' ' GLU . 70.1 p -90.96 4.37 52.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.114 0.483 . . . . 0.60999999999999999 110.737 177.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 82.3 mt -105.91 6.58 31.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.768 -0.456 . . . . 0.40999999999999998 109.768 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.7 m 65.59 82.49 0.2 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.185 -0.916 . . . . 1.24 111.43 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 61.5 Cg_endo -92.04 113.84 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.737 2.291 . . . . 0.58999999999999997 113.287 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.8 146.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.625 -0.88 . . . . 1.3100000000000001 108.625 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.0 p30 50.33 22.35 0.98 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.746 0.818 . . . . 1.8899999999999999 112.136 -174.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.61 29.62 47.64 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.238 -0.506 . . . . 0.62 111.872 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.737 ' HE2' ' HB3' ' A' ' 102' ' ' ASP . 32.4 ttmt -156.19 146.81 21.82 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 120.902 0.382 . . . . 1.8100000000000001 110.719 -173.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.46 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.5 pt -103.14 156.31 5.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.224 0.535 . . . . 0.29999999999999999 110.43 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.419 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 73.2 p -89.39 178.1 6.41 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.602 -0.726 . . . . 0.44 109.972 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.686 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -65.19 -17.62 63.95 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.979 -0.629 . . . . 0.33000000000000002 112.299 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.73 -47.29 63.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.216 0.531 . . . . 0.34000000000000002 111.332 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.66 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.3 m120 -73.79 -41.45 62.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.587 -0.733 . . . . 1.6499999999999999 110.367 -173.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.4 -19.79 60.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.188 -0.46 . . . . 0.27000000000000002 110.193 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.686 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 3.6 ttmp? -68.38 -51.59 42.54 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.754 -0.461 . . . . 1.52 109.754 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.52 ' HA ' HG22 ' A' ' 77' ' ' VAL . 18.6 ptpt -63.33 -32.94 74.5 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.965 -0.562 . . . . 1.1399999999999999 110.391 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.53 -53.82 51.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.792 -0.447 . . . . 1.78 109.792 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.424 ' HB3' HD22 ' A' ' 86' ' ' LEU . 57.5 mtt -69.5 -33.61 73.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.032 -0.531 . . . . 0.85999999999999999 112.198 -173.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 74' ' ' LYS . 30.9 m -77.0 -19.04 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.644 -0.422 . . . . 1.52 109.914 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 12.7 mptt -87.47 -12.33 46.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.911 -0.586 . . . . 3.3300000000000001 110.453 174.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.5 m -86.75 -5.1 59.22 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.876 -0.602 . . . . 0.91000000000000003 111.092 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.4 mptt 68.24 29.0 6.22 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.297 0.639 . . . . 2.9700000000000002 111.786 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.724 ' HB2' HD21 ' A' ' 86' ' ' LEU . 24.3 mt -98.14 143.38 26.17 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.428 -0.351 . . . . 1.4099999999999999 111.068 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.499 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.5 Cg_endo -61.64 150.9 83.57 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.257 2.638 . . . . 0.32000000000000001 113.51 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -55.99 -42.27 76.11 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.697 -0.683 . . . . 2.0499999999999998 111.85 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.1 m -58.04 -54.13 50.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.306 -0.406 . . . . 0.83999999999999997 110.909 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.469 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 47.0 t -57.71 -44.13 85.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.103 -0.499 . . . . 0.26000000000000001 110.87 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.724 HD21 ' HB2' ' A' ' 81' ' ' LEU . 56.6 mt -63.42 -36.04 82.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.28999999999999998 111.229 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.764 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.59 -42.71 99.31 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.846 -0.692 . . . . 0.35999999999999999 111.656 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 20.6 mtpp -68.47 -46.18 70.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.5 -0.35 . . . . 1.29 110.353 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.465 ' HA ' HD23 ' A' ' 92' ' ' LEU . 88.2 mt -56.83 -52.13 58.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 123.512 0.507 . . . . 0.27000000000000002 110.85 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -60.43 -53.66 54.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.448 -0.342 . . . . 0.37 111.66 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -65.1 -23.28 67.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.038 0.447 . . . . 2.54 111.238 -172.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -92.75 -39.45 11.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.849 -0.614 . . . . 1.5 110.229 -177.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.485 ' N ' ' HG ' ' A' ' 92' ' ' LEU . . . -70.28 -39.28 74.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.53000000000000003 111.047 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.653 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 47.0 t0 -74.47 93.47 2.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.658 -0.867 . . . . 0.5 108.658 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.707 HG21 ' HD2' ' A' ' 132' ' ' PRO . 32.5 t -69.29 -51.07 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.337 -0.847 . . . . 0.64000000000000001 110.28 -174.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.612 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 1.8 p30 -76.34 -21.24 56.4 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.278 -0.873 . . . . 1.46 111.225 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.585 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 40.8 mttp 56.71 65.78 1.33 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.131 -0.94 . . . . 2.7400000000000002 110.74 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 23.1 p-10 -108.93 10.97 26.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.256 -1.338 . . . . 0.56000000000000005 109.832 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.56 11.78 80.3 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.313 -0.858 . . . . 0.48999999999999999 111.879 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.492 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 33.8 mt -144.28 161.55 38.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.344 -0.613 . . . . 0.53000000000000003 109.344 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.407 ' C ' ' HG3' ' A' ' 66' ' ' LYS . 71.1 mt -124.8 115.47 20.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.163 -0.31 . . . . 0.33000000000000002 110.163 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.737 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 1.7 p30 -77.82 -176.41 4.41 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.303 -0.629 . . . . 1.8500000000000001 109.303 171.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -63.62 -27.02 68.95 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.934 -0.306 . . . . 0.84999999999999998 111.474 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 86.7 mt-10 -85.03 -39.07 18.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.212 -0.195 . . . . 2.0800000000000001 110.918 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.424 ' HG2' ' HE3' ' A' ' 135' ' ' LYS . 21.8 mt-10 -69.34 -37.5 77.7 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.256 0.55 . . . . 0.47999999999999998 110.182 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -66.86 -42.38 85.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.749 -0.659 . . . . 0.40999999999999998 109.886 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.08 91.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 0.23000000000000001 110.831 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -61.29 -46.82 88.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.814 -0.63 . . . . 1.29 109.728 177.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.11 -49.33 78.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.23000000000000001 111.636 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -33.47 76.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.77000000000000002 110.856 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.43 ' O ' HG22 ' A' ' 115' ' ' VAL . 38.7 t60 -67.72 -36.39 80.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.036 -0.357 . . . . 0.33000000000000002 110.036 177.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.586 HD13 HD21 ' A' ' 92' ' ' LEU . 91.8 mt -66.15 -39.25 89.68 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.927 -0.579 . . . . 0.28000000000000003 110.587 176.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 81' ' ' LEU . 54.9 mt -69.07 -37.69 77.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.747 -0.66 . . . . 0.69999999999999996 110.326 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 42.1 tttp -61.88 -47.32 85.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.992 -0.549 . . . . 1.77 110.686 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 111' ' ' HIS . 6.7 m -68.11 -31.16 50.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 120.547 -0.461 . . . . 0.53000000000000003 111.322 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 116' ' ' LYS . 25.5 mmmt -56.14 -45.07 79.75 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.066 -0.253 . . . . 1.8899999999999999 110.385 168.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.74 -29.78 63.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.263 -0.426 . . . . 0.73999999999999999 110.885 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.578 ' HB2' ' HD2' ' A' ' 120' ' ' HIS . 59.7 mm-40 -65.95 -21.96 66.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.873 -0.603 . . . . 1.98 110.489 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.52 36.03 3.92 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.752 -0.737 . . . . 0.87 112.13 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.578 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 74.4 m-70 -126.96 150.07 49.55 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.847 -0.427 . . . . 1.0700000000000001 109.847 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -95.95 130.0 43.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.942 0.401 . . . . 3.0600000000000001 110.725 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.44 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER -81.95 134.63 49.47 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.048 -0.524 . . . . 1.0900000000000001 110.005 174.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.01 2.7 6.34 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.908 2.405 . . . . 0.80000000000000004 113.745 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.575 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 58.78 22.68 10.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.427 0.632 . . . . 0.64000000000000001 110.306 -176.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.86 162.12 32.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.194 -0.912 . . . . 1.97 109.882 -172.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 52.1 mt -112.69 94.0 26.4 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 123.262 0.351 . . . . 0.67000000000000004 111.781 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.91 ' HG2' ' HB2' ' A' ' 130' ' ' LEU . 14.0 Cg_endo -58.63 153.31 49.87 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.866 2.377 . . . . 0.52000000000000002 111.333 169.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.35 -10.03 17.33 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.921 2.414 . . . . 0.63 113.308 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.494 ' O ' ' HD1' ' A' ' 44' ' ' TRP . 26.4 p-80 -108.4 1.51 21.79 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.159 -0.338 . . . . 0.85999999999999999 110.397 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.91 ' HB2' ' HG2' ' A' ' 127' ' ' PRO . 1.4 mp -103.85 -7.63 20.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.885 0.374 . . . . 1.1899999999999999 111.038 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -87.42 117.8 69.03 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.248 -0.433 . . . . 1.3400000000000001 110.887 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.707 ' HD2' HG21 ' A' ' 95' ' ' VAL . 53.1 Cg_exo -56.74 138.37 85.04 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.943 2.429 . . . . 0.90000000000000002 111.952 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.465 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 54.6 Cg_endo -70.97 -7.39 21.31 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 123.001 2.468 . . . . 1.4399999999999999 113.484 -173.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.8 m -82.72 0.41 43.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.353 0.597 . . . . 1.77 110.225 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.536 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 3.3 mptp? -117.51 31.06 6.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.591 -0.731 . . . . 1.2 109.118 177.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' A' ' 133' ' ' PRO . 3.9 mmp_? -103.58 146.83 27.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.569 -0.741 . . . . 3.9399999999999999 109.963 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -134.01 143.48 48.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.044 -0.525 . . . . 5.0800000000000001 109.635 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -110.53 136.45 49.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.162 -0.681 . . . . 6.3499999999999996 109.162 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 . . . . . 0 C--O 1.246 0.875 0 O-C-N 123.953 0.783 . . . . 8.2100000000000009 110.968 -177.809 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 69.3 t80 . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.88 0.371 . . . . 12.91 110.738 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -121.54 163.17 19.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.412 -0.358 . . . . 7.96 110.36 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -157.86 170.19 22.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.399 -0.364 . . . . 10.06 110.321 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -133.6 113.98 13.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.135 -0.484 . . . . 5.3600000000000003 109.722 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 28.3 p -93.41 75.4 4.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.914 0.388 . . . . 3.46 109.989 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -21.56 46.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 1.49 110.738 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.764 HD21 ' HA2' ' A' ' 87' ' ' GLY . 25.2 t-20 -119.23 107.06 42.02 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.991 0.424 . . . . 0.83999999999999997 110.176 175.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 7.4 Cg_exo -73.42 -1.45 10.68 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.521 2.814 . . . . 0.66000000000000003 112.948 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -101.1 -6.76 23.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.497 -0.32 . . . . 0.68000000000000005 111.662 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 12.3 p -134.11 102.58 5.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.279 0.561 . . . . 1.8300000000000001 111.307 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -114.5 134.08 55.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 3.77 110.434 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt . . . . . 0 C--O 1.244 0.775 0 CA-C-O 118.306 -0.854 . . . . 6.4400000000000004 109.764 178.063 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.653 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.796 -0.522 . . . . 9.3800000000000008 111.796 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -86.72 166.44 8.78 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.674 2.249 . . . . 8.6300000000000008 112.269 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.9 tp -103.52 101.15 11.02 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.062 -0.718 . . . . 8.9499999999999993 109.062 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.07 139.05 15.06 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.842 -0.694 . . . . 5.8600000000000003 112.868 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.7 m -153.57 156.44 38.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.143 -0.688 . . . . 6.0 109.143 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -91.72 118.05 30.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.327 0.584 . . . . 3.9399999999999999 111.08 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -94.92 75.94 3.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.091 -1.078 . . . . 3.2799999999999998 108.091 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.0 p -93.97 137.33 23.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.438 -0.801 . . . . 1.8899999999999999 110.458 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -94.08 104.08 16.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.163 -0.471 . . . . 2.4900000000000002 110.759 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -81.55 106.72 13.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.809 -0.812 . . . . 0.66000000000000003 108.809 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.2 m -66.73 -1.15 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.83 -0.623 . . . . 1.4099999999999999 112.521 -171.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.5 -17.51 7.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.139 -0.482 . . . . 1.01 110.275 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.31 -10.56 74.69 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.634 -0.793 . . . . 0.62 112.549 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -89.28 -28.11 20.12 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.653 -0.322 . . . . 2.6699999999999999 111.362 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -112.58 33.13 5.14 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.72 -0.844 . . . . 1.71 108.72 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.561 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 9.1 tmtt? -72.47 -49.98 8.45 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 114.76 -1.109 . . . . 1.2 112.313 -169.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.5 Cg_endo -54.35 -29.58 58.79 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.628 2.219 . . . . 0.62 113.235 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.0 m -70.28 -39.5 74.86 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.036 0.446 . . . . 0.71999999999999997 110.335 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -70.91 -22.97 62.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.23 -0.441 . . . . 0.65000000000000002 109.955 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.46 -44.69 70.7 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.129 0.49 . . . . 1.03 110.018 172.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -57.6 -42.2 82.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.346 -0.843 . . . . 2.1499999999999999 110.267 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.412 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 50.2 mt -79.19 -28.88 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 0.70999999999999996 111.18 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -71.37 -45.84 61.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.246 0.546 . . . . 0.31 110.686 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -76.48 -13.08 60.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.78 -0.645 . . . . 0.80000000000000004 112.065 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.2 p -94.09 1.57 56.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.128 0.49 . . . . 0.60999999999999999 111.214 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 58.2 mt -110.02 8.82 24.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.0 -0.545 . . . . 0.40999999999999998 110.125 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 m 67.79 82.2 0.19 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.317 -0.856 . . . . 1.24 111.54 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -90.46 116.68 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.629 2.219 . . . . 0.58999999999999997 112.555 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -88.37 134.62 27.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.628 -0.508 . . . . 1.3100000000000001 109.628 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 47.05 25.7 0.53 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.792 0.837 . . . . 1.8899999999999999 112.749 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.93 19.75 33.05 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.333 -0.46 . . . . 0.62 112.509 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 66' ' ' LYS . 31.1 ttmt -150.52 144.46 25.35 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 110.453 -0.203 . . . . 1.8100000000000001 110.453 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.483 HD11 ' CD1' ' A' ' 106' ' ' PHE . 19.8 pt -100.43 149.37 6.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 C-N-CA 120.55 -0.46 . . . . 0.29999999999999999 110.355 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.555 ' HA ' HD22 ' A' ' 100' ' ' LEU . 81.4 p -76.66 166.82 22.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.068 -0.515 . . . . 0.44 110.034 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.89 -32.52 70.52 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.589 -0.815 . . . . 0.33000000000000002 112.103 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.502 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -49.18 -55.75 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.375 0.509 . . . . 0.34000000000000002 112.375 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -70.68 -41.86 71.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.172 0.51 . . . . 1.6499999999999999 110.989 -169.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.487 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -71.36 -33.41 69.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.916 -0.584 . . . . 0.27000000000000002 110.582 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.582 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 28.1 ttpp -63.9 -52.65 58.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.91 -0.587 . . . . 1.52 110.727 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.601 ' O ' HG22 ' A' ' 77' ' ' VAL . 17.3 ptmt -62.93 -32.89 74.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.983 -0.553 . . . . 1.1399999999999999 110.607 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.583 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 35.3 tp10 -62.54 -38.88 91.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.307 0.575 . . . . 1.78 110.204 175.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.915 ' HB3' HD22 ' A' ' 86' ' ' LEU . 50.7 mtt -77.07 -20.47 55.78 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.632 -0.427 . . . . 0.85999999999999999 111.67 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 74' ' ' LYS . 9.9 m -81.09 -23.45 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.045 -0.662 . . . . 1.52 110.747 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -87.15 -11.12 50.94 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.364 -0.534 . . . . 3.3300000000000001 110.232 170.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.7 m -69.5 -17.48 63.6 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.948 -0.569 . . . . 0.91000000000000003 110.061 169.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 17.5 tptp 69.27 24.25 5.99 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.645 -0.707 . . . . 2.9700000000000002 111.65 171.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.625 ' HB2' HD21 ' A' ' 86' ' ' LEU . 59.0 mt -100.78 153.34 37.79 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.807 -0.633 . . . . 1.4099999999999999 110.004 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.49 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 12.1 Cg_endo -57.36 141.7 94.85 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.813 2.342 . . . . 0.32000000000000001 112.39 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -59.45 -34.2 72.24 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.139 -0.482 . . . . 2.0499999999999998 111.252 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -47.85 83.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.154 -0.475 . . . . 0.83999999999999997 110.822 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.696 HG11 ' HD2' ' A' ' 116' ' ' LYS . 75.8 t -63.72 -41.73 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.588 -0.733 . . . . 0.26000000000000001 110.477 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.915 HD22 ' HB3' ' A' ' 76' ' ' MET . 57.5 mt -58.8 -45.85 88.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.098 0.475 . . . . 0.28999999999999998 110.392 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.581 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.91 -37.79 94.34 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.845 -0.616 . . . . 0.35999999999999999 112.235 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.568 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 46.2 mtpt -69.53 -39.74 77.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.955 0.407 . . . . 1.29 110.418 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.93 -37.91 80.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.711 -0.677 . . . . 0.27000000000000002 110.252 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.485 ' CZ3' ' HG ' ' A' ' 101' ' ' LEU . 31.1 t-105 -61.88 -46.04 91.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.246 -0.434 . . . . 0.37 110.356 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -59.79 -37.0 77.89 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.212 0.529 . . . . 2.54 110.641 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 86.2 mt -70.22 -41.99 72.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.473 -0.785 . . . . 1.5 110.748 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -73.59 -43.72 58.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.646 -0.707 . . . . 0.53000000000000003 111.737 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.633 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 35.6 t0 -84.13 81.58 8.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.369 0.604 . . . . 0.5 109.955 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.475 HG21 ' HD2' ' A' ' 132' ' ' PRO . 13.5 t -69.2 -44.31 80.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.271 -0.877 . . . . 0.64000000000000001 110.64 -176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.604 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.5 OUTLIER -75.18 -17.94 60.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.372 -0.831 . . . . 1.46 111.108 -177.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.587 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 9.8 mtpm? 58.07 56.88 4.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.39 -0.823 . . . . 2.7400000000000002 111.001 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -106.92 10.17 30.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.66 -0.7 . . . . 0.56000000000000005 111.042 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.06 10.12 72.76 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.025 -0.607 . . . . 0.48999999999999999 112.341 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' A' ' 68' ' ' THR . 66.9 mt -139.3 152.84 47.56 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.387 -0.968 . . . . 0.53000000000000003 108.387 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.487 HD12 ' CB ' ' A' ' 72' ' ' ALA . 19.6 mt -99.69 110.73 23.12 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.588 -0.845 . . . . 0.33000000000000002 110.285 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.757 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 12.7 t70 -70.73 171.99 9.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.779 -1.1 . . . . 1.8500000000000001 108.422 173.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.64 -43.26 89.67 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.625 0.25 . . . . 0.84999999999999998 111.266 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.621 ' OE1' ' HB3' ' A' ' 134' ' ' SER . 31.5 mt-10 -61.51 -44.38 97.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.797 0.808 . . . . 2.0800000000000001 109.856 176.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.757 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 15.1 mt-10 -68.2 -39.39 82.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.452 -1.249 . . . . 0.47999999999999998 110.521 -173.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CD1' HD11 ' A' ' 67' ' ' ILE . 65.8 t80 -68.28 -42.67 79.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.296 -0.411 . . . . 0.40999999999999998 110.215 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.27 93.72 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.751 -0.658 . . . . 0.23000000000000001 110.272 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 93' ' ' ALA . 17.8 tp -62.01 -45.48 93.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.754 -0.657 . . . . 1.29 110.137 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.518 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -57.37 -47.78 80.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.451 -0.795 . . . . 0.23000000000000001 111.364 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -28.88 67.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.418 -0.355 . . . . 0.77000000000000002 111.249 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -68.48 -37.88 80.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.192 0.52 . . . . 0.33000000000000002 110.093 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HA ' HG22 ' A' ' 115' ' ' VAL . 59.7 mt -69.05 -36.39 77.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.665 -0.698 . . . . 0.28000000000000003 110.247 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 109' ' ' ALA . 46.4 mm -59.25 -44.25 91.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.02 -0.536 . . . . 0.69999999999999996 110.163 173.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 49.8 tttp -63.85 -47.38 80.94 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.82 -0.627 . . . . 1.77 111.111 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 112' ' ' LEU . 14.7 m -64.29 -36.7 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.358 -0.537 . . . . 0.53000000000000003 111.496 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.696 ' HD2' HG11 ' A' ' 85' ' ' VAL . 2.1 mmtm -56.35 -42.79 78.33 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 121.299 -0.161 . . . . 1.8899999999999999 111.317 170.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 98.0 mt -71.52 -34.01 69.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.763 0.316 . . . . 0.73999999999999999 110.836 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 81.0 mm-40 -68.85 -14.06 62.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 1.98 110.473 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.84 17.41 58.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.84 -0.695 . . . . 0.87 112.436 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -103.24 164.06 11.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.717 0.294 . . . . 1.0700000000000001 110.301 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -88.68 140.53 29.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.214 0.53 . . . . 3.0600000000000001 112.145 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.585 HD23 ' HG2' ' A' ' 116' ' ' LYS . 4.1 pp -110.51 127.04 27.65 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 107.266 -1.383 . . . . 1.0900000000000001 107.266 165.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 1.8 Cg_endo -74.53 -15.12 22.16 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.375 2.05 . . . . 0.80000000000000004 113.743 -166.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.477 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . . . 69.51 19.12 7.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.669 0.747 . . . . 0.64000000000000001 109.663 -170.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -124.42 156.9 36.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.962 -1.017 . . . . 1.97 108.639 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 87.8 mt -116.49 96.22 47.53 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.834 0.349 . . . . 0.67000000000000004 111.577 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 29.5 Cg_endo -65.37 155.11 70.45 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.615 2.21 . . . . 0.52000000000000002 111.65 173.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.09 -26.92 27.41 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.252 2.635 . . . . 0.63 113.689 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -91.84 18.4 7.79 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.998 0.369 . . . . 0.85999999999999999 111.998 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 44.7 mt -129.94 3.41 4.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.664 -0.244 . . . . 1.1899999999999999 111.015 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.6 t -87.55 116.58 66.61 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.404 . . . . 1.3400000000000001 111.028 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.649 ' HB2' ' HD2' ' A' ' 135' ' ' LYS . 77.1 Cg_exo -52.04 134.16 48.58 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.05 2.5 . . . . 0.90000000000000002 111.885 176.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 10.5 Cg_exo -70.27 -20.88 31.86 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.878 2.385 . . . . 1.4399999999999999 113.886 -173.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.621 ' HB3' ' OE1' ' A' ' 104' ' ' GLU . 8.2 t -88.54 8.75 26.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.445 0.64 . . . . 1.77 110.168 -174.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.649 ' HD2' ' HB2' ' A' ' 132' ' ' PRO . 3.4 mptp? -113.23 3.35 15.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.731 0.777 . . . . 1.2 109.413 172.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -110.59 147.14 34.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.917 -1.038 . . . . 3.9399999999999999 109.914 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -58.4 124.38 19.34 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.017 -0.734 . . . . 5.0800000000000001 109.017 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -113.59 106.03 14.04 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.531 -0.304 . . . . 6.3499999999999996 111.129 -171.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 . . . . . 0 C--O 1.246 0.914 0 O-C-N 124.071 0.857 . . . . 8.2100000000000009 111.378 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.45 0.167 . . . . 12.91 110.778 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -73.72 -62.24 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 7.96 110.392 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -163.38 109.75 1.14 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.808 -0.812 . . . . 10.06 108.808 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -69.14 138.64 54.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.827 -0.624 . . . . 5.3600000000000003 109.616 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 28.5 t -61.87 98.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.186 0.517 . . . . 3.46 110.838 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 13.3 t -130.5 2.38 4.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.683 -0.689 . . . . 1.49 109.923 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.581 HD21 ' HA2' ' A' ' 87' ' ' GLY . 45.1 t-20 -146.29 111.32 4.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.825 . . . . 0.83999999999999997 109.247 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 38.3 Cg_endo -67.11 -14.72 44.38 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.106 2.537 . . . . 0.66000000000000003 113.64 -175.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.582 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 62.6 m-85 -73.67 -37.18 65.34 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.724 0.268 . . . . 0.68000000000000005 111.724 -176.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 8.5 t -163.35 85.41 0.5 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.896 0.855 . . . . 1.8300000000000001 110.812 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.73 25.32 7.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.501 -0.772 . . . . 3.77 110.654 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 55.4 mttm . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.584 -0.722 . . . . 6.4400000000000004 109.709 178.423 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.633 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.848 0 N-CA-C 111.959 -0.456 . . . . 9.3800000000000008 111.959 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.28 -64.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.652 2.235 . . . . 8.6300000000000008 111.702 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.1 mt -141.71 -51.89 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.462 0.649 . . . . 8.9499999999999993 109.571 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.34 116.88 0.6 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.293 -1.123 . . . . 5.8600000000000003 110.293 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -63.12 -53.27 56.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.703 0.287 . . . . 6.0 110.996 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.56 93.59 4.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.451 -0.341 . . . . 3.9399999999999999 111.38 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -104.58 112.37 25.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.575 0.702 . . . . 3.2799999999999998 109.405 171.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.1 t -106.47 137.72 35.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.62 -0.718 . . . . 1.8899999999999999 111.043 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -111.84 138.3 48.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 2.4900000000000002 110.823 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' CZ2' ' HB3' ' A' ' 132' ' ' PRO . 5.2 t90 -95.38 108.81 21.02 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.318 -0.623 . . . . 0.66000000000000003 109.318 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.21 -17.9 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 1.4099999999999999 112.116 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.32 -18.15 15.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.19 0.519 . . . . 1.01 110.047 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.3 -13.1 73.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.793 -0.718 . . . . 0.62 112.104 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -78.64 -29.21 45.7 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.198 0.523 . . . . 2.6699999999999999 110.484 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -128.5 33.24 4.71 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.372 -0.831 . . . . 1.71 109.934 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.595 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 4.0 tmtm? -72.26 -47.95 10.29 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.282 -0.872 . . . . 1.2 111.914 -174.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.4 Cg_endo -53.23 -29.56 47.22 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.545 2.163 . . . . 0.62 113.151 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.4 m -71.92 -44.14 64.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.801 0.334 . . . . 0.71999999999999997 110.482 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -70.43 -22.6 62.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.422 -0.585 . . . . 0.65000000000000002 109.422 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.428 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 7.9 t70 -72.96 -44.96 60.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.534 -0.757 . . . . 1.03 109.851 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.91 -43.03 95.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.941 -1.027 . . . . 2.1499999999999999 110.799 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.14 -33.73 56.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.247 0.546 . . . . 0.70999999999999996 110.575 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.522 ' HE1' HG12 ' A' ' 67' ' ' ILE . 71.0 t80 -64.03 -49.27 73.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.626 -0.716 . . . . 0.31 110.596 -175.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.428 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 43.1 m-85 -70.47 -21.51 62.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.811 -0.632 . . . . 0.80000000000000004 112.532 -174.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.7 p -79.18 -0.48 32.06 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.507 -0.477 . . . . 0.60999999999999999 111.502 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 94.0 mt -105.42 7.28 33.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.533 -0.303 . . . . 0.40999999999999998 111.116 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.5 t 63.09 89.91 0.1 OUTLIER Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 115.921 -0.581 . . . . 1.24 111.179 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -84.67 117.62 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.361 2.041 . . . . 0.58999999999999997 112.954 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.18 128.02 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.585 . . . . 1.3100000000000001 110.02 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.59 21.48 12.75 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.643 -0.503 . . . . 1.8899999999999999 109.643 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.05 3.53 90.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.808 -0.711 . . . . 0.62 112.443 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -125.32 143.41 50.98 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.686 0.279 . . . . 1.8100000000000001 110.415 177.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.522 HG12 ' HE1' ' A' ' 57' ' ' PHE . 9.6 pt -84.14 143.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 119.996 -0.682 . . . . 0.29999999999999999 110.505 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.5 p -74.74 162.7 28.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.044 -0.98 . . . . 0.44 110.624 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 73' ' ' LYS . . . -56.78 -31.07 60.49 Favored Glycine 0 C--O 1.218 -0.863 0 C-N-CA 120.905 -0.664 . . . . 0.33000000000000002 112.173 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.1 -53.45 53.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.459 0.54 . . . . 0.34000000000000002 112.459 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.59 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 58.6 m-80 -79.54 -35.7 39.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.118 -0.492 . . . . 1.6499999999999999 111.693 -171.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.99 -26.88 65.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.156 0.503 . . . . 0.27000000000000002 109.768 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.574 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 38.7 ttmt -68.56 -54.62 15.5 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.579 -0.737 . . . . 1.52 110.367 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 18.2 ptpt -58.02 -38.94 77.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 1.1399999999999999 110.416 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.04 -44.99 94.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.184 0.516 . . . . 1.78 110.167 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.89 ' HB3' HD22 ' A' ' 86' ' ' LEU . 42.9 mtt -67.41 -27.9 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.85999999999999999 110.777 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 73' ' ' LYS . 55.7 t -70.66 -38.09 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.289 0.566 . . . . 1.52 109.65 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 74' ' ' LYS . 16.9 mmtp -72.04 -13.01 61.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.776 -0.647 . . . . 3.3300000000000001 110.749 176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.8 m -80.9 -14.79 57.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.91000000000000003 110.591 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mptt 72.24 18.92 4.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.648 0.779 . . . . 2.9700000000000002 111.875 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.589 ' HB2' HD21 ' A' ' 86' ' ' LEU . 3.9 mm? -87.19 144.48 36.22 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.985 0.422 . . . . 1.4099999999999999 110.5 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.557 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.0 Cg_endo -61.19 151.39 79.19 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.137 2.558 . . . . 0.32000000000000001 112.713 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -58.65 -33.94 70.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.933 -0.576 . . . . 2.0499999999999998 111.495 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.3 m -60.56 -51.28 70.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.198 0.523 . . . . 0.83999999999999997 110.473 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.636 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 71.5 t -64.13 -40.24 88.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.745 -0.661 . . . . 0.26000000000000001 110.76 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.89 HD22 ' HB3' ' A' ' 76' ' ' MET . 58.7 mt -61.73 -41.24 97.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.968 -0.56 . . . . 0.28999999999999998 110.817 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.556 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -62.21 -42.07 99.72 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.116 -0.564 . . . . 0.35999999999999999 111.924 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.636 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 51.0 mtpt -57.41 -51.39 69.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.159 0.504 . . . . 1.29 110.447 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.53 HG12 HD21 ' A' ' 122' ' ' LEU . 84.6 mt -64.54 -38.27 82.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.47 -0.787 . . . . 0.27000000000000002 111.333 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -62.05 -49.06 77.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.714 0.292 . . . . 0.37 110.903 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -64.35 -24.63 67.71 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.124 -0.489 . . . . 2.54 111.308 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.578 ' O ' HD11 ' A' ' 126' ' ' LEU . 88.2 mt -88.61 -48.64 7.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.077 -0.511 . . . . 1.5 111.379 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -64.68 -36.46 84.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.842 -0.617 . . . . 0.53000000000000003 111.067 -173.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.645 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 42.7 t0 -79.68 82.74 5.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.8 -0.815 . . . . 0.5 108.8 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.937 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 6.4 t -71.28 -40.63 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.65 -0.704 . . . . 0.64000000000000001 109.956 -174.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.622 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 14.4 p-10 -81.42 -18.0 46.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 1.46 110.207 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.591 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 22.6 mttp 59.96 59.12 2.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.065 -0.971 . . . . 2.7400000000000002 110.942 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 14.4 p-10 -107.78 8.96 29.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.908 -1.042 . . . . 0.56000000000000005 110.023 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.54 9.03 81.84 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.756 -0.656 . . . . 0.48999999999999999 111.876 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.677 ' HB3' ' HB3' ' A' ' 66' ' ' LYS . 60.1 mt -139.27 167.93 20.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.621 -0.511 . . . . 0.53000000000000003 109.621 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.2 mt -124.96 116.48 22.24 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.174 -0.306 . . . . 0.33000000000000002 110.174 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' CA ' ' HG3' ' A' ' 66' ' ' LYS . 3.0 p30 -78.75 177.86 8.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.137 -0.69 . . . . 1.8500000000000001 109.137 171.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -61.16 -25.39 66.98 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.6 0.593 . . . . 0.84999999999999998 112.6 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -81.63 -40.25 23.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.028 0.442 . . . . 2.0800000000000001 110.311 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.461 ' HG3' ' OD2' ' A' ' 102' ' ' ASP . 20.0 mt-10 -67.58 -36.55 81.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.368 0.604 . . . . 0.47999999999999998 109.486 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' A' ' 67' ' ' ILE . 31.8 t80 -74.21 -33.15 63.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.838 -0.619 . . . . 0.40999999999999998 110.171 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.33 94.33 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.279 0.562 . . . . 0.23000000000000001 109.861 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 93' ' ' ALA . 16.0 tp -61.26 -44.91 96.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.221 -0.9 . . . . 1.29 110.035 176.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.06 -49.99 72.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.666 -0.697 . . . . 0.23000000000000001 110.92 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -39.24 87.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 0.77000000000000002 111.038 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -69.05 -38.46 79.13 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.947 -0.301 . . . . 0.33000000000000002 110.749 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.702 ' HB3' HD23 ' A' ' 122' ' ' LEU . 92.8 mt -66.94 -38.59 86.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.257 -0.429 . . . . 0.28000000000000003 110.907 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 76' ' ' MET . 79.9 mt -70.37 -32.94 51.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.101 0.477 . . . . 0.69999999999999996 110.049 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 4.0 tppp? -59.04 -53.32 59.71 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 115.919 -0.582 . . . . 1.77 110.514 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.3 m -64.14 -34.64 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 121.11 -0.236 . . . . 0.53000000000000003 111.391 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 116' ' ' LYS . 27.0 mmmt -53.59 -48.89 68.82 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.596 0.236 . . . . 1.8899999999999999 111.446 167.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.3 -22.62 62.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.902 0.382 . . . . 0.73999999999999999 110.942 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 6.2 mm-40 -75.35 -2.4 28.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.924 -0.58 . . . . 1.98 110.771 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.5 35.81 11.45 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.65 -0.786 . . . . 0.87 111.988 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -130.87 172.48 11.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.988 0.423 . . . . 1.0700000000000001 110.594 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -122.46 121.9 37.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.679 -0.691 . . . . 3.0600000000000001 109.846 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -60.87 146.6 86.75 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.052 -0.522 . . . . 1.0900000000000001 110.097 169.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.74 6.12 2.57 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.51 2.14 . . . . 0.80000000000000004 113.225 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.509 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 60.38 17.79 7.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.813 -0.631 . . . . 0.64000000000000001 111.763 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -136.17 166.9 22.32 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.359 -0.608 . . . . 1.97 109.359 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.578 HD11 ' O ' ' A' ' 92' ' ' LEU . 82.1 mt -114.88 93.17 33.12 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.701 0.286 . . . . 0.67000000000000004 111.618 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.663 ' HD2' HD12 ' A' ' 130' ' ' LEU . 34.4 Cg_endo -66.44 166.22 22.4 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.797 2.331 . . . . 0.52000000000000002 111.537 169.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.69 3.42 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.237 2.625 . . . . 0.63 114.334 -176.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -114.03 6.7 16.55 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.545 -0.462 . . . . 0.85999999999999999 111.219 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.663 HD12 ' HD2' ' A' ' 127' ' ' PRO . 42.3 mt -115.9 -34.31 4.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.497 -0.32 . . . . 1.1899999999999999 110.912 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.57 115.18 43.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.855 -0.424 . . . . 1.3400000000000001 109.855 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 44' ' ' TRP . 37.1 Cg_endo -67.28 152.76 78.81 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.734 2.289 . . . . 0.90000000000000002 112.612 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.556 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 37.6 Cg_exo -61.68 -10.1 15.8 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.881 2.387 . . . . 1.4399999999999999 111.635 175.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.4 t -67.02 -19.33 65.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.604 -0.726 . . . . 1.77 109.738 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.937 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 5.3 mptt -113.15 34.36 4.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.828 -0.623 . . . . 1.2 110.701 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 133' ' ' PRO . 5.6 mmp_? -102.43 128.63 48.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.215 -0.661 . . . . 3.9399999999999999 109.215 170.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -78.05 109.43 12.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.188 0.518 . . . . 5.0800000000000001 110.771 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -132.6 110.9 10.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.741 . . . . 6.3499999999999996 109.388 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.906 -0.569 . . . . 8.2100000000000009 109.475 176.403 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.68 0.276 . . . . 12.91 110.31 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -76.88 122.99 25.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.853 -0.425 . . . . 7.96 109.853 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -70.87 172.97 7.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.231 -0.44 . . . . 10.06 110.991 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -93.02 93.19 8.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.103 0.478 . . . . 5.3600000000000003 110.709 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -131.07 -42.98 1.08 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.627 -0.715 . . . . 3.46 109.281 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.94 12.13 11.88 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.555 -0.748 . . . . 1.49 110.784 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.556 HD21 ' HA2' ' A' ' 87' ' ' GLY . 47.4 t-20 -98.1 119.43 62.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.999 -0.546 . . . . 0.83999999999999997 109.715 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 24.4 Cg_exo -64.36 -16.41 54.96 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.16 2.573 . . . . 0.66000000000000003 113.393 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 82.5 m-85 -81.69 -17.82 46.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.739 0.274 . . . . 0.68000000000000005 111.739 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 10.0 t -159.82 116.94 2.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.238 0.542 . . . . 1.8300000000000001 109.678 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.49 178.99 5.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 3.77 112.002 -171.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.167 -0.92 . . . . 6.4400000000000004 110.421 -178.452 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.645 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.105 -0.398 . . . . 9.3800000000000008 112.105 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.78 152.99 79.48 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.98 2.453 . . . . 8.6300000000000008 112.564 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.0 mt 69.34 100.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.037 0.836 . . . . 8.9499999999999993 111.3 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.66 -161.12 9.82 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.711 -0.757 . . . . 5.8600000000000003 112.164 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.4 t -115.63 114.27 24.68 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.143 -0.688 . . . . 6.0 109.143 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -76.97 130.93 38.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.315 -0.402 . . . . 3.9399999999999999 111.067 -175.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -77.99 110.16 12.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.034 -0.728 . . . . 3.2799999999999998 109.034 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.8 p -76.91 144.75 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 1.8899999999999999 111.595 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -84.14 100.81 11.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 2.4900000000000002 110.266 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -76.77 96.13 4.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.272 -1.01 . . . . 0.66000000000000003 108.272 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.553 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 87.2 t -50.76 -33.03 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.682 -0.69 . . . . 1.4099999999999999 112.192 -174.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.448 HG21 HD22 ' A' ' 108' ' ' LEU . 22.1 t -70.26 -17.86 21.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.073 -0.512 . . . . 1.01 111.516 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.14 -17.15 71.68 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.879 -0.677 . . . . 0.62 112.347 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 46.9 pttt -87.25 -29.41 21.7 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.181 -0.608 . . . . 2.6699999999999999 111.191 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -108.11 31.14 5.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.339 -0.985 . . . . 1.71 108.339 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 11.0 tmtt? -78.27 -47.27 2.06 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.584 -0.735 . . . . 1.2 111.963 -170.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.6 Cg_endo -51.1 -33.12 42.18 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.275 1.983 . . . . 0.62 112.748 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.9 m -71.35 -45.75 62.16 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.904 0.383 . . . . 0.71999999999999997 111.069 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.433 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 9.6 m-85 -72.26 -22.7 61.19 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.508 -0.553 . . . . 0.65000000000000002 109.508 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 5.9 t70 -71.62 -44.31 64.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.301 -0.863 . . . . 1.03 109.32 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.32 -53.8 54.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.42 -0.809 . . . . 2.1499999999999999 110.058 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.37 -36.83 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.973 0.416 . . . . 0.70999999999999996 110.951 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.468 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 86.5 t80 -62.1 -42.04 98.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.361 0.601 . . . . 0.31 110.015 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.413 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 24.8 m-85 -81.21 -22.97 38.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.511 -0.768 . . . . 0.80000000000000004 112.243 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.7 p -75.82 -10.78 59.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.975 0.417 . . . . 0.60999999999999999 111.082 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 79.3 mt -99.31 5.48 46.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.164 -0.471 . . . . 0.40999999999999998 111.098 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.2 t 65.25 81.41 0.22 Allowed Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 123.711 0.632 . . . . 1.24 111.405 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.66 131.42 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.199 1.933 . . . . 0.58999999999999997 112.422 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 m -99.93 140.82 18.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.891 -0.595 . . . . 1.3100000000000001 109.909 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.403 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 2.5 p-10 45.45 33.04 1.2 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.484 0.714 . . . . 1.8899999999999999 112.311 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.8 19.29 73.47 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.104 -0.498 . . . . 0.62 114.026 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 2.6 mtmm -145.84 159.84 42.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.771 -0.455 . . . . 1.8100000000000001 109.771 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.452 HD11 ' CD1' ' A' ' 106' ' ' PHE . 23.8 pt -107.2 148.37 11.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.437 -0.505 . . . . 0.29999999999999999 110.099 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.601 ' HA ' HD23 ' A' ' 100' ' ' LEU . 73.2 p -76.85 167.04 22.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.692 -0.686 . . . . 0.44 110.074 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.44 -33.16 58.45 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.87 -0.681 . . . . 0.33000000000000002 112.708 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.01 59.92 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.347 0.499 . . . . 0.34000000000000002 112.347 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.536 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -69.61 -46.81 65.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.573 -0.74 . . . . 1.6499999999999999 110.625 -170.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.55 72.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.789 -0.641 . . . . 0.27000000000000002 110.905 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.551 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 36.1 ttmt -61.55 -57.12 13.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 1.52 110.683 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 56.4 pttt -62.77 -31.26 72.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 1.1399999999999999 110.708 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.71 -44.42 93.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 1.78 109.643 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.782 ' HB3' HD22 ' A' ' 86' ' ' LEU . 43.1 mtt -67.49 -30.67 70.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.806 -0.634 . . . . 0.85999999999999999 111.151 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -70.59 -34.93 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.672 0.749 . . . . 1.52 109.339 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 4.3 mptp? -78.44 -12.12 59.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.925 -1.034 . . . . 3.3300000000000001 110.838 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 49.3 m -76.47 -13.17 60.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 0.91000000000000003 110.518 175.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 79' ' ' SER . 69.8 mmtt 73.28 16.68 4.12 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.66 -0.7 . . . . 2.9700000000000002 111.523 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.662 ' HB2' HD21 ' A' ' 86' ' ' LEU . 79.8 mt -93.08 147.02 33.05 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 1.4099999999999999 110.922 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.528 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 11.2 Cg_endo -56.45 149.04 59.15 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.64 2.893 . . . . 0.32000000000000001 112.848 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -56.13 -38.95 71.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.766 -0.652 . . . . 2.0499999999999998 111.36 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -62.28 -46.85 86.96 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.984 -0.553 . . . . 0.83999999999999997 111.618 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.702 HG11 ' HD2' ' A' ' 116' ' ' LYS . 95.8 t -64.25 -45.37 96.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 109.972 -0.381 . . . . 0.26000000000000001 109.972 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.782 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.7 mt -58.79 -42.84 89.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.28999999999999998 111.153 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.82 -40.75 93.45 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.999 -0.62 . . . . 0.35999999999999999 112.145 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' NZ ' ' HA ' ' A' ' 85' ' ' VAL . 30.8 mtmm -72.04 -37.82 69.64 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.612 -0.346 . . . . 1.29 110.473 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.1 mt -63.1 -43.97 99.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.346 . . . . 0.27000000000000002 110.407 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 24.8 t-105 -63.75 -41.22 98.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.497 -0.319 . . . . 0.37 110.208 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.67 -29.83 70.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.243 -0.435 . . . . 2.54 111.095 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.473 ' HB3' HD21 ' A' ' 126' ' ' LEU . 85.5 mt -89.99 -46.91 8.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.102 -0.499 . . . . 1.5 111.363 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.501 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -65.46 -42.97 91.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.985 -0.552 . . . . 0.53000000000000003 111.574 -173.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.694 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 47.3 t0 -86.24 87.99 7.53 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.248 -1.019 . . . . 0.5 108.248 175.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.785 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 15.1 t -68.72 -43.71 82.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.435 -0.802 . . . . 0.64000000000000001 110.259 -174.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.587 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 6.6 p-10 -84.46 -21.5 30.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.314 -0.857 . . . . 1.46 110.56 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.694 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 48.3 mttp 60.22 73.86 0.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.82 . . . . 2.7400000000000002 111.462 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.615 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 14.7 p-10 -121.6 9.9 10.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.61 -1.177 . . . . 0.56000000000000005 111.058 -173.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.94 1.21 67.09 Favored Glycine 0 CA--C 1.516 0.109 0 C-N-CA 120.676 -0.773 . . . . 0.48999999999999999 112.114 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.615 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 42.9 mt -127.73 152.45 47.72 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.108 -0.701 . . . . 0.53000000000000003 109.108 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.2 mt -114.2 120.42 40.41 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.803 -0.443 . . . . 0.33000000000000002 109.803 173.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.419 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 15.7 m-20 -68.45 173.62 4.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.24 -1.022 . . . . 1.8500000000000001 108.24 171.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -63.62 -26.91 68.89 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.641 -0.503 . . . . 0.84999999999999998 109.641 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.441 ' OE1' ' HB3' ' A' ' 134' ' ' SER . 23.4 mt-10 -66.22 -56.06 13.14 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.352 0.596 . . . . 2.0800000000000001 109.865 173.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.501 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 13.6 mt-10 -66.49 -34.5 78.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.93 -1.032 . . . . 0.47999999999999998 110.574 -171.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.452 ' CD1' HD11 ' A' ' 67' ' ' ILE . 55.7 t80 -71.17 -43.11 68.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.332 -0.394 . . . . 0.40999999999999998 110.214 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.433 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -60.98 -39.27 89.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.23000000000000001 110.575 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.448 HD22 HG21 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -61.26 -47.9 83.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.865 -0.607 . . . . 1.29 109.491 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.87 -47.33 85.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.804 -0.635 . . . . 0.23000000000000001 110.791 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -34.32 77.63 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.155 -0.475 . . . . 0.77000000000000002 111.315 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -68.41 -40.37 81.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.764 0.316 . . . . 0.33000000000000002 110.387 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.705 ' HB3' HD23 ' A' ' 122' ' ' LEU . 95.0 mt -68.58 -41.54 79.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.275 0.56 . . . . 0.28000000000000003 110.551 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.548 HD11 ' HG2' ' A' ' 76' ' ' MET . 96.0 mt -65.86 -38.66 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.902 -0.59 . . . . 0.69999999999999996 109.872 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.727 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 13.9 ttpp -57.69 -53.43 58.3 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.844 -0.616 . . . . 1.77 110.211 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.8 m -62.79 -38.64 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 112.055 0.391 . . . . 0.53000000000000003 112.055 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.702 ' HD2' HG11 ' A' ' 85' ' ' VAL . 1.1 mmpm? -51.58 -40.97 60.8 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.468 0.175 . . . . 1.8899999999999999 111.393 169.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 92.4 mt -78.97 -29.16 43.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.465 -0.334 . . . . 0.73999999999999999 111.511 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.727 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 10.8 mm-40 -67.37 -24.53 65.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.075 0.464 . . . . 1.98 110.223 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.68 16.75 23.37 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.916 -0.659 . . . . 0.87 111.595 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -108.76 162.44 14.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.237 -0.653 . . . . 1.0700000000000001 109.237 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.449 ' CD ' ' HZ1' ' A' ' 116' ' ' LYS . 60.1 mm-40 -108.7 129.1 55.35 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.873 0.368 . . . . 3.0600000000000001 111.249 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -77.76 139.78 62.71 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 115.956 -0.566 . . . . 1.0900000000000001 109.902 172.045 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.11 -4.4 14.8 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.31 2.007 . . . . 0.80000000000000004 113.692 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.463 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 64.44 20.39 12.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.377 0.608 . . . . 0.64000000000000001 110.347 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -131.05 163.53 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.836 . . . . 1.97 109.4 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 92' ' ' LEU . 77.2 mt -110.08 96.1 24.1 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.735 -0.211 . . . . 0.67000000000000004 111.04 174.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 30.3 Cg_endo -65.37 159.12 49.0 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.602 2.201 . . . . 0.52000000000000002 111.649 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.41 -7.89 9.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.192 2.595 . . . . 0.63 114.138 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -111.22 11.09 21.78 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.094 -0.379 . . . . 0.85999999999999999 111.488 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.8 mt -118.74 -26.2 6.16 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.953 -0.299 . . . . 1.1899999999999999 111.301 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.84 ' HB ' HH21 ' A' ' 136' ' ' ARG . 47.5 t -60.38 116.93 20.02 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.717 -0.22 . . . . 1.3400000000000001 110.92 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.585 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 86.5 Cg_exo -48.39 142.06 17.94 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.929 3.086 . . . . 0.90000000000000002 113.506 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.56 -29.94 85.31 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 123.164 2.576 . . . . 1.4399999999999999 113.832 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.441 ' HB3' ' OE1' ' A' ' 104' ' ' GLU . 39.8 t -84.62 -7.07 59.37 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.545 -0.462 . . . . 1.77 111.129 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.785 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 11.1 mptt -100.03 -5.02 28.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.89 0.376 . . . . 1.2 110.986 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.84 HH21 ' HB ' ' A' ' 131' ' ' VAL . 18.3 ptp180 -110.89 129.02 55.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.299 -0.41 . . . . 3.9399999999999999 110.285 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -114.34 114.52 26.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.151 0.501 . . . . 5.0800000000000001 110.943 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -91.09 136.21 33.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.701 -0.681 . . . . 6.3499999999999996 109.914 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 C--O 1.251 1.169 0 N-CA-C 108.756 -0.831 . . . . 8.2100000000000009 108.756 177.081 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 48.6 t80 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.342 -0.614 . . . . 12.91 109.342 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -85.36 166.06 16.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.905 -0.776 . . . . 7.96 108.905 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -108.18 2.54 22.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.098 0.475 . . . . 10.06 110.999 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -97.69 132.52 43.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.724 -0.671 . . . . 5.3600000000000003 109.535 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.484 ' CB ' ' HA ' ' B' ' 153' ' ' ALA . 28.6 p -99.31 104.03 15.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.881 0.372 . . . . 3.46 110.993 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.2 m -85.12 -16.24 41.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.232 -0.44 . . . . 1.49 110.335 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 53.0 t-20 -91.69 120.7 68.0 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.709 -0.478 . . . . 0.83999999999999997 109.709 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 24.7 Cg_exo -64.06 -16.66 56.19 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.106 2.537 . . . . 0.66000000000000003 113.327 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 95.0 m-85 -91.3 -45.28 8.69 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.895 0.379 . . . . 0.68000000000000005 110.885 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 40.7 p -106.98 103.92 13.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.204 -0.453 . . . . 1.8300000000000001 110.877 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . 0.484 ' HA ' ' CB ' ' B' ' 147' ' ' SER . . . -97.98 -54.02 3.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.052 -0.522 . . . . 3.77 110.257 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 93.9 mttt . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.684 -0.674 . . . . 6.4400000000000004 109.483 176.709 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.623 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.453 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.892 -0.483 . . . . 9.3800000000000008 111.892 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.453 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 3.2 Cg_exo -73.87 146.73 38.14 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.946 2.43 . . . . 8.6300000000000008 111.976 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.4 mt -98.93 89.8 4.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.171 -0.468 . . . . 8.9499999999999993 110.141 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.18 -168.67 35.87 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.17 -0.772 . . . . 5.8600000000000003 111.17 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.3 m 62.22 27.07 16.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.177 0.513 . . . . 6.0 110.881 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.12 119.31 35.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.711 -0.677 . . . . 3.9399999999999999 110.754 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -123.0 141.05 52.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.788 -0.642 . . . . 3.2799999999999998 110.134 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.15 140.28 16.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.602 -0.272 . . . . 1.8899999999999999 110.398 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.14 105.09 5.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.397 . . . . 2.4900000000000002 110.213 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -82.59 111.15 18.3 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.395 -0.965 . . . . 0.66000000000000003 108.395 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.51 -40.85 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 121.818 0.818 . . . . 1.4099999999999999 110.66 -166.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.445 HG21 HD22 ' A' ' 108' ' ' LEU . 18.7 m -91.53 0.44 9.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.484 -1.235 . . . . 1.01 111.339 -172.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.06 -31.49 20.07 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 109.586 -1.406 . . . . 0.62 109.586 169.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -81.17 -29.61 34.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.974 -0.613 . . . . 2.6699999999999999 109.974 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.36 32.49 4.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.85 -0.796 . . . . 1.71 108.85 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.644 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 11.4 tmtt? -81.53 -47.12 1.07 Allowed Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 113.303 0.853 . . . . 1.2 113.303 -169.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.7 Cg_endo -44.16 -37.86 10.29 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 123.142 2.561 . . . . 0.62 113.845 -176.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -70.63 -46.67 62.89 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 120.965 0.412 . . . . 0.71999999999999997 111.346 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 2.6 m-85 -72.82 -22.3 60.83 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.092 -0.707 . . . . 0.65000000000000002 109.092 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -75.32 -42.03 55.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.814 -1.085 . . . . 1.03 109.475 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -54.54 -55.22 31.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.446 -0.797 . . . . 2.1499999999999999 109.814 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.19 -26.26 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.826 -0.624 . . . . 0.70999999999999996 111.389 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.409 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 87.4 t80 -69.58 -50.37 45.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.223 0.535 . . . . 0.31 110.259 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -74.33 -23.63 59.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.913 -0.585 . . . . 0.80000000000000004 111.859 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.3 p -74.67 -1.52 22.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.844 0.354 . . . . 0.60999999999999999 111.619 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.67 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 95.9 mt -108.49 6.07 25.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.852 -0.425 . . . . 0.40999999999999998 109.852 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.8 m 63.17 86.86 0.14 Allowed Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 115.379 -0.828 . . . . 1.24 111.754 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -88.51 138.86 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.753 2.302 . . . . 0.58999999999999997 112.972 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.564 HG12 ' ND2' ' A' ' 64' ' ' ASN . 14.7 t -118.01 132.09 68.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.799 -0.637 . . . . 1.3100000000000001 109.917 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.564 ' ND2' HG12 ' A' ' 63' ' ' VAL . 44.6 m-80 62.71 20.02 11.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.47 0.708 . . . . 1.8899999999999999 110.471 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.16 13.26 60.63 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.151 -0.931 . . . . 0.62 112.029 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HE2' ' OD2' ' A' ' 102' ' ' ASP . 94.2 mttt -136.25 171.17 14.88 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.383 0.611 . . . . 1.8100000000000001 111.642 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 106' ' ' PHE . 26.7 pt -121.62 143.11 35.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.927 -1.033 . . . . 0.29999999999999999 109.449 171.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.1 p -78.31 171.42 15.09 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.179 -0.464 . . . . 0.44 110.112 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.35 -29.7 53.63 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 120.927 -0.654 . . . . 0.33000000000000002 112.258 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.97 83.41 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.033 0.444 . . . . 0.34000000000000002 111.843 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.67 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 2.4 m120 -76.73 -42.35 41.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.777 -0.647 . . . . 1.6499999999999999 110.343 -170.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -69.15 -29.94 68.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.868 -0.606 . . . . 0.27000000000000002 110.545 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.598 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 63.0 tttt -68.85 -50.18 52.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.215 -0.448 . . . . 1.52 110.838 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HA ' HG22 ' A' ' 77' ' ' VAL . 17.3 ptpt -61.42 -39.01 89.23 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.036 0.446 . . . . 1.1399999999999999 110.465 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.56 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 18.5 tp10 -61.42 -49.28 77.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.518 . . . . 1.78 110.237 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.972 ' HB3' HD22 ' A' ' 86' ' ' LEU . 49.8 mtt -65.46 -32.36 73.93 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.209 0.448 . . . . 0.85999999999999999 112.209 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 74' ' ' LYS . 33.5 m -78.75 -16.54 13.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.362 -0.535 . . . . 1.52 111.54 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.56 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -95.54 -9.05 33.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.335 -0.546 . . . . 3.3300000000000001 110.201 172.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 70.9 m -74.19 -2.43 24.72 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.46 0.541 . . . . 0.91000000000000003 112.46 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 79' ' ' SER . 5.7 mptp? 74.95 16.9 2.84 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.889 0.476 . . . . 2.9700000000000002 112.26 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.477 ' HB2' HD21 ' A' ' 86' ' ' LEU . 10.9 mp -99.37 147.05 32.79 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-O 120.854 0.359 . . . . 1.4099999999999999 111.144 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.2 Cg_endo -62.4 148.83 92.65 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.87 2.38 . . . . 0.32000000000000001 112.575 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -53.41 -39.1 64.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.454 -0.794 . . . . 2.0499999999999998 111.51 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.5 m -62.45 -52.72 62.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.475 . . . . 0.83999999999999997 111.302 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.52 ' CG2' ' HG2' ' A' ' 82' ' ' PRO . 69.1 t -58.75 -38.54 72.74 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.051 0 CA-C-O 120.617 0.246 . . . . 0.26000000000000001 110.629 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.972 HD22 ' HB3' ' A' ' 76' ' ' MET . 82.3 mt -59.98 -42.42 94.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.28999999999999998 110.818 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.64 -42.29 98.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.852 -0.69 . . . . 0.35999999999999999 111.792 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 55.3 mtpt -61.26 -46.76 89.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.832 0.349 . . . . 1.29 110.398 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.52 HG23 HD12 ' A' ' 112' ' ' LEU . 82.6 mt -62.46 -44.48 99.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.27000000000000002 111.311 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -57.33 -45.74 83.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.65 0.262 . . . . 0.37 110.774 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.08 -28.45 69.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.11 0.481 . . . . 2.54 110.907 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 126' ' ' LEU . 46.3 mt -94.52 -16.77 23.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.873 -0.603 . . . . 1.5 111.856 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.27 -42.38 11.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.569 -0.287 . . . . 0.53000000000000003 111.133 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.66 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 31.4 t0 -86.42 84.62 7.4 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.115 -0.698 . . . . 0.5 109.115 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.473 HG21 ' HD2' ' A' ' 132' ' ' PRO . 10.7 t -70.87 -36.69 65.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.595 -0.729 . . . . 0.64000000000000001 110.856 -172.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 11.1 p-10 -83.64 -11.39 57.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.008 -0.542 . . . . 1.46 110.473 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt 55.57 53.96 9.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.959 -1.019 . . . . 2.7400000000000002 111.167 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 13.2 p-10 -109.91 7.86 24.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.059 -0.519 . . . . 0.56000000000000005 110.583 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.91 1.35 67.42 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 121.12 -0.562 . . . . 0.48999999999999999 112.083 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 74.9 mt -127.05 144.55 51.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.013 0.435 . . . . 0.53000000000000003 109.902 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 67.3 mt -104.55 113.45 27.04 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.413 -0.515 . . . . 0.33000000000000002 110.095 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.442 ' OD2' ' HE2' ' A' ' 66' ' ' LYS . 4.2 m-20 -69.35 172.29 7.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.558 -0.904 . . . . 1.8500000000000001 108.558 169.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -60.27 -30.92 69.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.549 0.214 . . . . 0.84999999999999998 110.721 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -71.79 -45.28 62.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.107 0.479 . . . . 2.0800000000000001 110.866 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -70.7 -33.0 70.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.919 0.39 . . . . 0.47999999999999998 110.747 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' HD11 ' A' ' 67' ' ' ILE . 27.7 t80 -75.16 -30.98 60.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.79 -0.448 . . . . 0.40999999999999998 109.79 177.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.79 82.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.195 0.522 . . . . 0.23000000000000001 110.039 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.511 HD21 ' O ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -65.09 -51.25 62.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 1.29 110.556 175.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.37 -50.57 69.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.702 -0.681 . . . . 0.23000000000000001 110.822 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -61.82 -33.81 74.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.618 -0.719 . . . . 0.77000000000000002 111.298 -178.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -68.41 -42.97 78.23 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.8 -0.36 . . . . 0.33000000000000002 110.855 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.52 HD12 HG23 ' A' ' 89' ' ' ILE . 72.6 mt -65.59 -38.39 89.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.208 0.527 . . . . 0.28000000000000003 110.504 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.68 HD11 ' HG2' ' A' ' 76' ' ' MET . 66.6 mt -68.39 -41.03 83.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.042 -0.526 . . . . 0.69999999999999996 110.592 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 32.4 ttpt -59.09 -48.99 79.59 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.64 -0.255 . . . . 1.77 110.408 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.8 m -63.44 -36.01 74.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 120.642 -0.423 . . . . 0.53000000000000003 111.119 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.842 ' HD3' HD23 ' A' ' 122' ' ' LEU . 3.9 mmmp? -58.19 -37.88 75.64 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.444 -0.502 . . . . 1.8899999999999999 110.703 172.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 96.1 mt -73.6 -22.78 59.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 0.73999999999999999 110.916 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 13.6 mt-10 -83.5 2.14 38.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.194 -0.457 . . . . 1.98 110.55 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.77 23.7 45.09 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.784 -0.722 . . . . 0.87 111.848 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.608 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 90.4 m-70 -117.92 161.27 20.05 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.725 -0.472 . . . . 1.0700000000000001 109.725 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -115.64 149.04 38.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.34 -0.391 . . . . 3.0600000000000001 109.975 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.842 HD23 ' HD3' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -89.66 146.77 36.27 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.124 -0.695 . . . . 1.0900000000000001 109.124 -178.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -66.62 -6.85 16.35 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.783 2.322 . . . . 0.80000000000000004 112.937 -172.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.81 18.52 9.69 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.469 -0.787 . . . . 0.64000000000000001 110.773 -176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -135.64 163.7 29.55 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.2 -0.667 . . . . 1.97 109.2 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 92' ' ' LEU . 96.0 mt -111.98 92.72 18.77 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 111.633 0.234 . . . . 0.67000000000000004 111.633 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.501 ' HD2' HD12 ' A' ' 130' ' ' LEU . 17.6 Cg_endo -58.86 153.61 49.49 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.395 2.064 . . . . 0.52000000000000002 111.568 171.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.47 -33.27 46.55 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.508 2.805 . . . . 0.63 114.146 -174.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -82.64 7.21 15.37 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.336 0.495 . . . . 0.85999999999999999 112.336 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.511 ' O ' HD21 ' A' ' 108' ' ' LEU . 49.2 mt -111.38 -29.12 7.92 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.891 -0.324 . . . . 1.1899999999999999 111.243 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 39.3 t -65.52 120.39 67.76 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.5 -0.318 . . . . 1.3400000000000001 110.838 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.705 ' HG2' ' HD3' ' A' ' 135' ' ' LYS . 10.0 Cg_endo -53.26 142.96 54.79 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 123.092 2.528 . . . . 0.90000000000000002 112.387 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.627 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 14.1 Cg_exo -68.35 -14.73 40.88 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.236 2.624 . . . . 1.4399999999999999 113.219 -172.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.6 p -79.69 -18.98 50.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.097 0.475 . . . . 1.77 110.21 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.705 ' HD3' ' HG2' ' A' ' 132' ' ' PRO . 2.2 mptp? -106.59 34.56 3.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.968 -0.56 . . . . 1.2 110.195 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.638 ' HA ' ' NE ' ' A' ' 136' ' ' ARG . 3.3 mmp_? -91.48 150.67 21.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.263 0.554 . . . . 3.9399999999999999 111.114 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -119.84 137.91 53.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.304 -0.862 . . . . 5.0800000000000001 108.688 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -100.4 137.71 38.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.09 0.471 . . . . 6.3499999999999996 110.905 -174.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.063 -0.97 . . . . 8.2100000000000009 108.965 175.183 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.544 0.211 . . . . 12.91 111.048 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -97.88 128.12 44.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.707 0.289 . . . . 7.96 111.065 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 12.5 t80 61.73 84.44 0.14 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.359 -0.837 . . . . 10.06 111.361 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.48 -49.3 0.31 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.544 -0.753 . . . . 5.3600000000000003 110.67 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 47.2 m -131.51 97.65 4.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.928 0.395 . . . . 3.46 110.044 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 12.8 p -113.09 -41.28 3.75 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.386 0.513 . . . . 1.49 112.386 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -73.91 114.61 34.32 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-O 121.01 0.434 . . . . 0.83999999999999997 110.67 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.45 -7.85 20.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.45 2.767 . . . . 0.66000000000000003 113.154 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 90.9 m-85 -94.48 -45.84 7.25 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.008 0.373 . . . . 0.68000000000000005 112.008 -177.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 14.7 t -158.07 165.58 34.67 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.74 -0.384 . . . . 1.8300000000000001 111.393 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' B' ' 154' ' ' LYS . . . -168.7 -33.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.472 -0.785 . . . . 3.77 110.258 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' B' ' 153' ' ' ALA . 23.7 mtpp . . . . . 0 C--O 1.245 0.846 0 O-C-N 123.828 0.705 . . . . 6.4400000000000004 110.856 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.66 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 111.891 -0.483 . . . . 9.3800000000000008 111.891 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 38.5 Cg_exo -59.96 141.74 97.08 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.928 2.418 . . . . 8.6300000000000008 111.538 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 9.9 mp 72.83 -30.97 0.22 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.176 0.59 . . . . 8.9499999999999993 111.925 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 36' ' ' PRO . . . 121.37 -142.98 15.75 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.56 -0.616 . . . . 5.8600000000000003 111.56 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 t -156.39 119.49 4.19 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.989 -0.374 . . . . 6.0 109.989 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -84.21 92.37 7.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.844 0.831 . . . . 3.9399999999999999 109.587 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -108.6 108.92 20.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.093 -0.958 . . . . 3.2799999999999998 109.246 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.06 146.42 6.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.743 -0.662 . . . . 1.8899999999999999 111.192 -173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -141.97 148.32 38.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 2.4900000000000002 109.28 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -93.78 128.64 40.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.411 -0.588 . . . . 0.66000000000000003 109.411 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.18 -23.45 11.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.309 0.485 . . . . 1.4099999999999999 112.309 -168.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -88.28 0.22 7.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.315 -0.554 . . . . 1.01 111.271 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 -25.5 68.57 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.952 -0.642 . . . . 0.62 112.166 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.58 ' HG3' ' OD1' ' A' ' 49' ' ' ASP . 15.5 pttp -80.21 -27.76 38.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.611 0.243 . . . . 2.6699999999999999 111.523 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.58 ' OD1' ' HG3' ' A' ' 48' ' ' LYS . 1.2 m-20 -104.13 31.98 4.25 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.725 -0.472 . . . . 1.71 109.725 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -79.84 -51.24 1.16 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 113.275 0.843 . . . . 1.2 113.275 -172.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.5 -26.56 54.85 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.056 1.837 . . . . 0.62 112.743 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.41 -45.45 46.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.717 0.294 . . . . 0.71999999999999997 110.912 177.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.4 ' HD2' ' HB1' ' A' ' 107' ' ' ALA . 11.4 m-30 -70.36 -24.05 62.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.1 -0.704 . . . . 0.65000000000000002 109.1 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.553 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -73.75 -43.76 58.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.083 -0.962 . . . . 1.03 110.262 176.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.94 -38.03 75.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.865 -0.607 . . . . 2.1499999999999999 110.229 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.1 mt -75.53 -35.39 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.573 0.702 . . . . 0.70999999999999996 110.641 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 66' ' ' LYS . 62.3 t80 -63.54 -43.06 98.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.287 -0.869 . . . . 0.31 111.018 -176.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.553 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 30.8 m-85 -67.64 -23.29 65.33 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.363 0.505 . . . . 0.80000000000000004 112.363 -177.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.1 p -85.37 8.68 17.9 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.532 -0.467 . . . . 0.60999999999999999 111.742 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 95.1 mt -112.23 6.9 19.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.29 -0.413 . . . . 0.40999999999999998 111.105 178.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t 65.84 88.48 0.11 Allowed Pre-proline 0 N--CA 1.469 0.479 0 O-C-N 123.547 0.529 . . . . 1.24 111.009 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -94.06 132.28 0.73 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.925 2.417 . . . . 0.58999999999999997 113.428 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.0 134.1 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.288 -0.869 . . . . 1.3100000000000001 109.429 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 62.62 26.94 15.95 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.851 0.358 . . . . 1.8899999999999999 110.719 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.6 36.31 67.83 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.611 -0.804 . . . . 0.62 111.916 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.856 ' HB3' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -168.04 175.65 6.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.59 0.233 . . . . 1.8100000000000001 110.67 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.7 pt -131.35 155.36 41.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.215 0.531 . . . . 0.29999999999999999 112.122 -172.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.465 ' HA ' HD23 ' A' ' 100' ' ' LEU . 40.9 p -79.19 166.92 21.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.069 -0.969 . . . . 0.44 110.4 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.44 ' HA3' ' HG3' ' B' ' 150' ' ' PRO . . . -59.19 -27.52 62.86 Favored Glycine 0 C--O 1.221 -0.662 0 C-N-CA 120.991 -0.624 . . . . 0.33000000000000002 112.99 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.41 -48.22 82.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.39 0.515 . . . . 0.34000000000000002 112.39 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.488 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -76.13 -42.43 46.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.18 -0.464 . . . . 1.6499999999999999 110.238 -172.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.81 71.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.27000000000000002 110.161 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 59.7 tttt -69.3 -54.76 12.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.979 -0.555 . . . . 1.52 110.495 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 17.3 ptpt -57.78 -34.41 69.56 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.888 -0.325 . . . . 1.1399999999999999 110.74 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.77 -53.5 46.09 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.404 0.621 . . . . 1.78 110.425 175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.695 ' HB3' HD22 ' A' ' 86' ' ' LEU . 93.0 mtp -68.96 -24.89 64.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.503 -0.772 . . . . 0.85999999999999999 112.142 -173.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 74' ' ' LYS . 35.6 m -87.47 -35.91 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 CA-C-O 121.067 0.461 . . . . 1.52 110.821 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -79.52 -8.19 58.98 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.482 0.658 . . . . 3.3300000000000001 109.624 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.5 m -69.86 -11.34 60.79 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.5 -0.773 . . . . 0.91000000000000003 110.502 168.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 71.68 44.77 0.48 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.504 0.722 . . . . 2.9700000000000002 111.862 177.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.471 ' HB2' HD21 ' A' ' 86' ' ' LEU . 86.9 mt -119.62 146.86 42.43 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.117 -0.492 . . . . 1.4099999999999999 109.852 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.557 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 18.5 Cg_endo -58.99 141.22 98.1 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.986 2.457 . . . . 0.32000000000000001 112.955 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -62.64 -30.52 71.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.614 -0.721 . . . . 2.0499999999999998 111.644 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.0 m -61.12 -53.13 60.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 0.83999999999999997 110.085 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.5 t -55.41 -45.84 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.829 -0.623 . . . . 0.26000000000000001 110.927 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 76' ' ' MET . 77.1 mt -60.77 -42.12 96.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.28999999999999998 110.721 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.35 -33.79 88.18 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.701 -0.681 . . . . 0.35999999999999999 112.358 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 33.1 mttt -68.0 -45.29 74.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.911 0.386 . . . . 1.29 110.077 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.619 HG23 HD12 ' A' ' 112' ' ' LEU . 81.9 mt -59.58 -44.33 92.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.863 -0.608 . . . . 0.27000000000000002 111.463 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -60.18 -39.82 87.82 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.921 -0.4 . . . . 0.37 109.921 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -64.82 -23.01 67.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 2.54 111.172 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.665 ' HB3' HD21 ' A' ' 126' ' ' LEU . 70.9 mt -93.39 -38.52 11.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.615 -0.721 . . . . 1.5 110.722 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.758 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -78.93 -42.64 26.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.53000000000000003 111.819 -173.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 25.3 t0 -86.42 73.53 10.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.286 0.565 . . . . 0.5 109.565 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.593 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 12.8 t -64.65 -37.89 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 115.29 -0.868 . . . . 0.64000000000000001 110.798 -175.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.52 ' OD2' ' HG3' ' A' ' 135' ' ' LYS . 0.7 OUTLIER -72.39 -20.4 61.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.526 -0.761 . . . . 1.46 109.926 -178.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 96.4 mttt 56.83 37.79 29.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.838 0.828 . . . . 2.7400000000000002 109.333 -175.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 9.2 p-10 -89.59 8.95 28.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.654 -1.157 . . . . 0.56000000000000005 110.972 -174.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.38 -2.96 26.35 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.055 -0.593 . . . . 0.48999999999999999 112.572 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 36.1 mt -125.81 146.74 49.67 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.649 -0.5 . . . . 0.53000000000000003 109.649 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.6 mt -105.74 112.4 25.45 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.282 -0.636 . . . . 0.33000000000000002 109.282 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.856 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . 2.0 p30 -75.31 176.44 7.42 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.489 -0.484 . . . . 1.8500000000000001 109.723 174.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -59.19 -28.76 66.93 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.697 -0.228 . . . . 0.84999999999999998 111.538 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.404 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . 7.7 mm-40 -76.08 -50.39 14.85 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.877 0.37 . . . . 2.0800000000000001 110.689 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.649 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 49.3 mt-10 -58.09 -43.17 86.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.257 0.551 . . . . 0.47999999999999998 110.61 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HD2' ' HB2' ' A' ' 57' ' ' PHE . 33.3 t80 -69.94 -29.57 66.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.835 -0.62 . . . . 0.40999999999999998 110.115 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -65.47 -43.34 90.61 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.425 0.631 . . . . 0.23000000000000001 109.889 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.758 HD23 ' HA ' ' A' ' 93' ' ' ALA . 23.7 tp -62.89 -46.45 87.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.452 -0.794 . . . . 1.29 110.369 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.4 -44.79 89.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.54 -0.754 . . . . 0.23000000000000001 111.074 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -65.41 -33.36 75.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.059 -0.518 . . . . 0.77000000000000002 111.506 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -67.86 -40.23 83.68 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.904 -0.319 . . . . 0.33000000000000002 110.241 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.798 ' HB3' HD23 ' A' ' 122' ' ' LEU . 96.4 mt -65.76 -36.3 83.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 0.28000000000000003 110.629 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.8 -38.06 64.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.094 -0.503 . . . . 0.69999999999999996 110.777 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -57.61 -49.8 75.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.366 -0.379 . . . . 1.77 110.388 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 120' ' ' HIS . 13.9 m -67.16 -40.17 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 120.563 -0.455 . . . . 0.53000000000000003 111.291 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -51.55 -47.28 63.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.806 0.275 . . . . 1.8899999999999999 111.339 171.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.71 -35.94 75.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.73999999999999999 110.722 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -74.19 -5.35 41.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.83 -0.623 . . . . 1.98 111.805 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.36 30.55 9.83 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.175 -1.012 . . . . 0.87 112.544 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 90.6 m-70 -126.44 117.39 22.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.103 0.477 . . . . 1.0700000000000001 109.946 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -78.01 117.2 19.11 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.57 -0.741 . . . . 3.0600000000000001 110.526 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.798 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -60.59 141.17 92.29 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 1.0900000000000001 110.437 173.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.65 -1.77 10.84 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.449 2.099 . . . . 0.80000000000000004 113.764 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 63.26 24.27 14.22 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.512 0.508 . . . . 0.64000000000000001 110.769 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -133.67 158.5 43.1 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.352 -0.61 . . . . 1.97 109.352 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 92' ' ' LEU . 94.5 mt -111.81 92.34 17.29 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 111.926 0.343 . . . . 0.67000000000000004 111.926 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.634 ' HD2' HD12 ' A' ' 130' ' ' LEU . 35.3 Cg_endo -66.95 160.4 47.3 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.46 2.107 . . . . 0.52000000000000002 110.968 167.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.49 -42.23 28.88 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.124 2.55 . . . . 0.63 113.828 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -77.86 10.19 2.98 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.761 0.652 . . . . 0.85999999999999999 112.761 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.634 HD12 ' HD2' ' A' ' 127' ' ' PRO . 52.8 mt -122.23 3.46 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 121.215 -0.194 . . . . 1.1899999999999999 111.287 176.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.6 115.62 64.87 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 121.164 -0.215 . . . . 1.3400000000000001 110.733 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.724 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 51.9 Cg_exo -55.24 122.99 12.71 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.904 2.403 . . . . 0.90000000000000002 112.307 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 12.6 Cg_exo -69.7 -4.85 14.82 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.309 2.672 . . . . 1.4399999999999999 112.679 -176.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.5 t -75.08 -20.76 59.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.638 0.732 . . . . 1.77 109.265 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.724 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -95.83 27.49 3.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.445 -0.798 . . . . 1.2 109.67 -176.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.458 ' HA ' ' HE ' ' A' ' 136' ' ' ARG . 2.7 mmp_? -103.22 90.86 3.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 3.9399999999999999 109.856 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -119.49 136.08 54.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.279 -0.419 . . . . 5.0800000000000001 110.674 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -95.47 105.92 17.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.063 -0.517 . . . . 6.3499999999999996 110.055 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--O 1.25 1.101 0 CA-C-N 115.317 -0.856 . . . . 8.2100000000000009 110.729 178.443 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 120.84 0.352 . . . . 12.91 110.541 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -108.24 -51.11 2.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.673 -0.492 . . . . 7.96 109.673 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 55.41 89.86 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.549 -0.75 . . . . 10.06 112.32 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -75.96 137.62 40.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.424 -0.807 . . . . 5.3600000000000003 111.093 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 5.0 p -107.84 52.93 0.7 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.594 0.711 . . . . 3.46 109.778 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.22 33.81 0.24 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.794 -1.094 . . . . 1.49 112.904 -169.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.406 ' HB2' ' HD2' ' B' ' 150' ' ' PRO . 22.3 p30 -122.38 151.29 59.15 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 121.634 -0.667 . . . . 0.83999999999999997 111.885 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.44 ' HG3' ' HA3' ' A' ' 69' ' ' GLY . 34.4 Cg_endo -66.05 -3.69 8.9 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.382 2.721 . . . . 0.66000000000000003 113.581 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.46 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 80.3 m-85 -82.27 -10.78 58.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.981 0.364 . . . . 0.68000000000000005 111.981 -173.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 15.1 t -137.78 13.83 2.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.069 0.462 . . . . 1.8300000000000001 110.8 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.34 -20.82 3.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.394 0.516 . . . . 3.77 112.394 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 47.9 tptt . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.416 -0.802 . . . . 6.4400000000000004 111.003 -174.507 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.616 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 111.533 -0.627 . . . . 9.3800000000000008 111.533 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.43 -25.12 42.05 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.583 2.189 . . . . 8.6300000000000008 112.544 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 69.0 mt 71.72 -33.19 0.26 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.596 0.758 . . . . 8.9499999999999993 111.883 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.07 -23.71 12.52 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.654 -0.784 . . . . 5.8600000000000003 112.327 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.0 m 57.3 39.76 28.26 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.131 0.491 . . . . 6.0 110.92 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.93 113.68 13.7 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.578 -0.737 . . . . 3.9399999999999999 109.641 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -127.72 121.53 30.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.058 -0.519 . . . . 3.2799999999999998 109.952 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 83.5 t -86.95 111.72 22.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 120.805 0.336 . . . . 1.8899999999999999 110.339 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -82.06 135.97 35.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.089 -0.505 . . . . 2.4900000000000002 111.035 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -88.03 105.09 17.24 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.042 -1.095 . . . . 0.66000000000000003 108.042 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.5 t -56.62 -24.07 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 112.118 -171.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.434 HG21 HD22 ' A' ' 108' ' ' LEU . 97.4 t -76.54 -23.05 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.765 0.316 . . . . 1.01 111.169 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.74 -18.68 70.55 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.573 -0.822 . . . . 0.62 112.465 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -18.33 23.73 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.143 -0.623 . . . . 2.6699999999999999 111.733 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -121.22 31.99 6.12 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.95 -0.759 . . . . 1.71 108.95 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 8.7 tmtm? -74.86 -47.43 4.95 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.533 -0.758 . . . . 1.2 111.774 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 49.0 Cg_exo -56.04 -27.67 65.62 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.967 1.778 . . . . 0.62 112.56 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 m -75.71 -46.32 31.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.604 -0.271 . . . . 0.71999999999999997 111.142 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -70.34 -23.06 62.75 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.679 -0.86 . . . . 0.65000000000000002 108.679 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.75 -44.68 63.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.733 -1.121 . . . . 1.03 109.862 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.86 -40.79 89.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.027 -0.988 . . . . 2.1499999999999999 110.055 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.26 -38.37 77.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.01 -0.541 . . . . 0.70999999999999996 110.797 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HE1' HG12 ' A' ' 67' ' ' ILE . 83.1 t80 -62.27 -41.13 98.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.924 -0.58 . . . . 0.31 110.631 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -82.08 14.59 2.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.451 -0.795 . . . . 0.80000000000000004 112.416 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.1 p -113.7 2.06 15.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.144 0.497 . . . . 0.60999999999999999 110.988 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 89.0 mt -108.51 14.6 24.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 111.147 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.8 t 61.2 80.92 0.25 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.722 -0.672 . . . . 1.24 111.575 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -85.63 105.65 0.86 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.514 2.142 . . . . 0.58999999999999997 113.134 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.3 m -89.78 135.36 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.717 -0.674 . . . . 1.3100000000000001 109.839 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 62.4 21.06 12.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.19 -0.459 . . . . 1.8899999999999999 110.412 -174.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.51 9.48 83.32 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.572 -0.823 . . . . 0.62 111.873 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 56.7 mtmt -138.33 148.52 44.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.368 . . . . 1.8100000000000001 110.947 -177.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.476 HD11 ' CD1' ' A' ' 106' ' ' PHE . 11.3 pt -97.34 144.16 11.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.017 0.437 . . . . 0.29999999999999999 110.701 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.548 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 12.1 p -71.18 161.6 30.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.295 -0.866 . . . . 0.44 110.837 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.26 -32.22 60.12 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.135 -0.555 . . . . 0.33000000000000002 112.021 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.63 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -49.85 -65.81 0.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.559 0.344 . . . . 0.34000000000000002 111.72 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 48.0 m-80 -69.45 -39.46 77.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.089 -0.505 . . . . 1.6499999999999999 111.717 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.11 97.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.422 -0.354 . . . . 0.27000000000000002 110.38 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.538 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 34.4 ttpt -62.43 -42.28 99.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.469 -0.567 . . . . 1.52 109.469 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 52.0 mtpt -51.8 -55.53 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.5 -0.773 . . . . 1.1399999999999999 110.916 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -59.07 -46.53 88.02 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.348 0.595 . . . . 1.78 110.657 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.713 ' HB3' HD22 ' A' ' 86' ' ' LEU . 84.3 mtp -64.69 -29.22 70.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.846 -0.615 . . . . 0.85999999999999999 110.992 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.21 -37.37 45.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.239 0.542 . . . . 1.52 109.897 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -80.86 2.91 24.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.91 -0.586 . . . . 3.3300000000000001 111.061 177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m -77.56 -10.24 59.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.307 -0.406 . . . . 0.91000000000000003 110.338 169.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 69.68 21.37 6.6 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.299 0.639 . . . . 2.9700000000000002 111.615 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.471 ' HB2' HD21 ' A' ' 86' ' ' LEU . 94.2 mt -100.8 153.14 37.9 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.614 -0.721 . . . . 1.4099999999999999 110.964 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.503 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 9.8 Cg_endo -54.82 141.12 77.67 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.155 2.57 . . . . 0.32000000000000001 112.631 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -63.95 -28.43 69.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.463 -0.789 . . . . 2.0499999999999998 111.443 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 p -67.22 -44.73 78.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.842 0.353 . . . . 0.83999999999999997 110.887 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.46 -44.3 98.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.26000000000000001 110.01 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 76' ' ' MET . 78.4 mt -60.75 -41.41 95.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.767 -0.651 . . . . 0.28999999999999998 110.489 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.612 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -57.17 -49.73 69.94 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.697 -0.683 . . . . 0.35999999999999999 111.541 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.504 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 93.6 mttt -56.05 -51.05 69.22 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 122.518 0.327 . . . . 1.29 110.974 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.631 HG23 HD12 ' A' ' 112' ' ' LEU . 83.0 mt -55.52 -42.67 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.695 -0.684 . . . . 0.27000000000000002 111.217 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.437 ' HB3' ' ND2' ' B' ' 149' ' ' ASN . 15.0 t-105 -61.93 -44.91 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.478 -0.328 . . . . 0.37 110.956 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 60.7 mttm -63.28 -22.82 67.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 2.54 110.961 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.568 ' O ' HD11 ' A' ' 126' ' ' LEU . 27.7 mt -93.51 -38.01 11.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.869 -0.605 . . . . 1.5 110.528 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -72.61 -42.67 64.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.713 -0.676 . . . . 0.53000000000000003 111.019 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 44.2 t0 -81.46 78.94 8.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.897 -0.779 . . . . 0.5 108.897 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.432 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 11.2 t -70.13 -36.04 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.493 -0.776 . . . . 0.64000000000000001 110.827 -174.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.623 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 4.8 p-10 -84.17 -11.08 57.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 1.46 109.727 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.508 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 62.2 mtpt 51.63 66.04 1.31 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.808 -1.087 . . . . 2.7400000000000002 111.564 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.593 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 10.5 p-10 -115.31 9.2 15.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.335 -0.848 . . . . 0.56000000000000005 110.412 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.16 2.76 67.45 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.882 -0.675 . . . . 0.48999999999999999 112.183 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.548 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 81.2 mt -131.73 164.75 25.29 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.377 -0.601 . . . . 0.53000000000000003 109.377 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.1 mt -120.56 116.65 25.79 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.649 -0.42 . . . . 0.33000000000000002 110.482 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.479 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.7 p30 -78.62 -176.89 5.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.144 -0.688 . . . . 1.8500000000000001 109.144 170.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -66.4 -29.6 69.79 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.961 -0.295 . . . . 0.84999999999999998 111.528 -176.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -69.55 -53.83 17.04 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.213 -0.662 . . . . 2.0800000000000001 109.213 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.493 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 28.7 mt-10 -63.06 -39.6 95.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.919 -1.037 . . . . 0.47999999999999998 111.436 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.476 ' CD1' HD11 ' A' ' 67' ' ' ILE . 48.6 t80 -69.48 -40.36 77.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.40999999999999998 110.249 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.58 75.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.92 -0.582 . . . . 0.23000000000000001 110.373 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -63.85 -48.44 76.73 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.947 -0.569 . . . . 1.29 109.475 175.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.78 76.71 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.617 -0.72 . . . . 0.23000000000000001 110.611 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.31 -28.36 69.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.711 -0.677 . . . . 0.77000000000000002 111.543 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 114' ' ' LYS . 56.8 t60 -81.24 -32.67 33.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.815 -0.354 . . . . 0.33000000000000002 110.871 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.631 HD12 HG23 ' A' ' 89' ' ' ILE . 93.4 mt -71.12 -37.28 72.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.331 0.586 . . . . 0.28000000000000003 109.568 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.499 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 76.0 mt -70.78 -32.73 49.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.905 -0.589 . . . . 0.69999999999999996 109.941 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 14.3 tppt? -53.4 -55.42 25.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.044 -0.526 . . . . 1.77 110.728 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.3 m -65.94 -36.31 77.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 120.563 -0.455 . . . . 0.53000000000000003 111.47 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.461 ' HG2' HD23 ' A' ' 122' ' ' LEU . 25.7 mmmt -58.67 -42.03 87.53 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.562 -0.455 . . . . 1.8899999999999999 111.702 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 81.6 mt -70.09 -22.32 63.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.73999999999999999 110.97 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.472 ' HB2' ' CD2' ' A' ' 120' ' ' HIS . 49.1 mt-10 -82.73 -8.17 59.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.914 -0.584 . . . . 1.98 110.893 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.56 30.16 16.68 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.576 -0.821 . . . . 0.87 111.861 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.472 ' CD2' ' HB2' ' A' ' 118' ' ' GLU . 66.8 m-70 -110.24 174.08 6.03 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.646 -0.501 . . . . 1.0700000000000001 109.646 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.442 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 16.2 mm-40 -109.21 136.69 48.28 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.79 -0.641 . . . . 3.0600000000000001 109.535 171.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 116' ' ' LYS . 1.3 pp -82.93 139.59 43.0 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.335 -0.617 . . . . 1.0900000000000001 109.335 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 23.7 Cg_exo -62.53 -13.97 36.64 Favored 'Trans proline' 0 N--CA 1.476 0.467 0 C-N-CA 123.332 2.688 . . . . 0.80000000000000004 113.694 -169.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 63.53 16.42 9.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.645 -0.707 . . . . 0.64000000000000001 111.425 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -136.26 171.54 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.304 -0.628 . . . . 1.97 109.304 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.866 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 98.9 mt -115.85 90.51 27.54 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.505 -0.316 . . . . 0.67000000000000004 110.794 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.65 154.85 66.63 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.478 2.119 . . . . 0.52000000000000002 111.723 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -50.27 -24.36 11.5 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.583 2.856 . . . . 0.63 114.969 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -96.31 5.27 51.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.952 0.406 . . . . 0.85999999999999999 111.508 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.438 ' O ' HD21 ' A' ' 108' ' ' LEU . 64.8 mt -123.61 -34.08 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.29 -0.414 . . . . 1.1899999999999999 110.786 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.866 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.8 p -77.61 121.55 84.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.026 0.441 . . . . 1.3400000000000001 110.654 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 131' ' ' VAL . 12.4 Cg_endo -57.63 129.42 33.61 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.754 2.303 . . . . 0.90000000000000002 112.065 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.41 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 33.5 Cg_endo -65.61 -6.12 13.12 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.463 2.775 . . . . 1.4399999999999999 112.959 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 p -75.9 -12.84 60.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.938 0.399 . . . . 1.77 111.08 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.432 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 3.9 mptp? -119.76 20.32 12.3 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.392 -0.367 . . . . 1.2 111.017 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.41 ' NH2' ' HB3' ' A' ' 133' ' ' PRO . 17.2 mtm180 -110.29 141.36 43.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 110.135 -0.32 . . . . 3.9399999999999999 110.135 177.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -141.24 148.53 40.03 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.035 0.445 . . . . 5.0800000000000001 111.544 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -132.44 141.4 48.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.814 -0.63 . . . . 6.3499999999999996 109.646 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.504 -0.76 . . . . 8.2100000000000009 109.221 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.678 -0.49 . . . . 12.91 109.678 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -95.25 166.05 12.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.182 -0.463 . . . . 7.96 110.708 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -108.8 152.94 24.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.38 -0.373 . . . . 10.06 110.843 -173.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -105.18 102.18 11.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.152 -0.476 . . . . 5.3600000000000003 110.518 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m 58.36 83.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.722 -0.672 . . . . 3.46 112.28 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 1.5 p -95.16 12.16 29.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.983 0.421 . . . . 1.49 111.157 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.612 HD21 ' HA2' ' A' ' 87' ' ' GLY . 24.8 t-20 -101.44 112.45 65.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.132 -0.486 . . . . 0.83999999999999997 109.729 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 16.5 Cg_exo -68.46 -6.87 18.67 Favored 'Trans proline' 0 N--CA 1.474 0.326 0 C-N-CA 123.361 2.707 . . . . 0.66000000000000003 113.284 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.538 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 99.2 m-85 -85.96 -36.43 19.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.182 0.515 . . . . 0.68000000000000005 110.196 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 38.3 p -104.22 90.86 3.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.958 -0.565 . . . . 1.8300000000000001 110.78 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -157.19 174.58 15.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.165 -0.471 . . . . 3.77 110.55 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' B' ' 154' ' ' LYS . 3.6 ptmm? . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.837 -0.601 . . . . 6.4400000000000004 110.345 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.637 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.81 0 N-CA-C 111.692 -0.563 . . . . 9.3800000000000008 111.692 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 2.3 Cg_endo -83.5 -12.56 8.91 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.06 2.507 . . . . 8.6300000000000008 112.969 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.3 mp 63.37 15.74 8.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.012 0.525 . . . . 8.9499999999999993 112.182 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.25 56.07 0.49 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.465 -0.874 . . . . 5.8600000000000003 112.153 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.3 p -126.31 131.73 51.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.814 0.34 . . . . 6.0 110.89 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -107.62 105.8 15.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.811 -0.632 . . . . 3.9399999999999999 109.78 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -139.56 133.75 31.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.194 0.521 . . . . 3.2799999999999998 110.944 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.1 p -104.09 148.64 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.604 -0.725 . . . . 1.8899999999999999 109.278 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.22 130.88 51.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.254 0.549 . . . . 2.4900000000000002 111.515 -175.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -81.38 110.57 16.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.31 -0.996 . . . . 0.66000000000000003 108.31 172.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.5 t -53.31 -35.68 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 112.513 0.56 . . . . 1.4099999999999999 112.513 -172.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 31.3 t -72.16 -17.0 18.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.372 -0.376 . . . . 1.01 111.26 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.55 -1.25 52.0 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.366 -0.921 . . . . 0.62 112.188 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -86.55 -31.04 21.44 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.22 0.533 . . . . 2.6699999999999999 110.878 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -141.39 35.16 1.67 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 122.224 1.011 . . . . 1.71 110.229 -172.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 15.1 tmtt? -76.86 -42.56 2.82 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 114.015 -1.448 . . . . 1.2 111.535 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 50' ' ' LYS . 82.2 Cg_exo -46.21 -35.0 14.55 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.726 2.284 . . . . 0.62 113.598 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.584 ' O ' HG12 ' A' ' 56' ' ' ILE . 9.3 m -69.83 -45.66 67.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.732 -0.387 . . . . 0.71999999999999997 110.449 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -72.16 -22.76 61.25 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.467 -0.568 . . . . 0.65000000000000002 109.467 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.476 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 18.0 t70 -67.2 -41.18 86.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.137 -0.938 . . . . 1.03 109.078 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -66.85 -35.59 80.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.21 -0.904 . . . . 2.1499999999999999 110.239 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 52' ' ' THR . 23.0 mm -66.03 -31.48 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.731 0.777 . . . . 0.70999999999999996 109.707 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 87.6 t80 -72.91 -45.55 57.53 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.094 -0.957 . . . . 0.31 110.804 -175.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.476 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 51.2 m-85 -75.49 -19.89 59.1 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.114 -0.493 . . . . 0.80000000000000004 111.952 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.2 p -83.45 -5.16 59.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 0.60999999999999999 111.164 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.62 8.98 39.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 0.40999999999999998 111.246 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.1 t 64.32 83.41 0.2 Allowed Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 123.743 0.652 . . . . 1.24 110.955 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.43 118.13 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.766 2.311 . . . . 0.58999999999999997 112.812 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.91 134.7 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.744 . . . . 1.3100000000000001 110.66 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 57.92 19.92 6.24 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.457 0.703 . . . . 1.8899999999999999 111.377 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.71 7.27 63.17 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.907 -0.588 . . . . 0.62 112.258 174.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 57' ' ' PHE . 54.4 mtmt -137.45 173.42 11.68 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 110.111 -0.329 . . . . 1.8100000000000001 110.111 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.433 HD11 ' CD1' ' A' ' 106' ' ' PHE . 25.0 pt -118.39 154.12 20.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.87 -0.418 . . . . 0.29999999999999999 109.87 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.589 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 70.7 p -80.95 166.94 20.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.896 -0.593 . . . . 0.44 110.201 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.536 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -58.87 -22.46 54.39 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.642 -0.79 . . . . 0.33000000000000002 111.888 175.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.57 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -61.42 -59.91 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.34000000000000002 111.556 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -65.8 -42.75 90.33 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.689 -0.687 . . . . 1.6499999999999999 111.332 -170.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.16 -36.14 83.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.27000000000000002 110.522 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 32.0 tttp -62.27 -43.39 98.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.894 -0.594 . . . . 1.52 110.019 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.571 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 24.8 mtpt -58.76 -51.1 71.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.687 -0.688 . . . . 1.1399999999999999 110.576 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -57.98 -43.7 86.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.529 0.681 . . . . 1.78 110.457 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.723 ' HB3' HD22 ' A' ' 86' ' ' LEU . 94.4 mtp -69.16 -26.91 65.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.792 -0.64 . . . . 0.85999999999999999 112.276 -175.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 74' ' ' LYS . 25.6 m -83.16 -22.82 8.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 120.126 -0.63 . . . . 1.52 109.602 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HD3' ' O ' ' A' ' 74' ' ' LYS . 5.6 mptp? -77.6 -12.94 60.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 3.3300000000000001 110.099 173.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.0 m -75.2 -7.93 55.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.91000000000000003 111.62 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? 67.39 34.66 4.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.986 0.422 . . . . 2.9700000000000002 111.374 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.58 ' HB2' HD21 ' A' ' 86' ' ' LEU . 95.3 mt -112.74 146.65 35.49 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.106 -0.497 . . . . 1.4099999999999999 110.982 -176.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.7 Cg_endo -61.62 153.14 69.05 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.064 2.509 . . . . 0.32000000000000001 112.854 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -59.62 -32.74 70.7 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.948 -0.569 . . . . 2.0499999999999998 111.601 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.46 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -64.73 -50.47 66.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.922 0.391 . . . . 0.83999999999999997 110.951 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.464 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . 42.8 t -60.27 -44.26 95.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.26000000000000001 110.418 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.723 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.4 mt -63.84 -38.84 92.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.809 -0.632 . . . . 0.28999999999999998 110.774 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.674 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.88 -42.68 99.71 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.039 -0.6 . . . . 0.35999999999999999 112.551 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 85' ' ' VAL . 41.1 mtmt -68.18 -42.9 79.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.744 -0.095 . . . . 1.29 110.744 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.545 HD11 ' CE ' ' A' ' 116' ' ' LYS . 93.8 mt -55.83 -52.2 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.384 0.428 . . . . 0.27000000000000002 111.071 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.536 ' CH2' ' HA2' ' A' ' 69' ' ' GLY . 39.0 t-105 -62.98 -49.59 74.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.794 0.331 . . . . 0.37 111.348 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -59.64 -30.93 69.06 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.139 -0.482 . . . . 2.54 111.232 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -92.53 -41.02 10.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.871 -0.604 . . . . 1.5 111.2 -176.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' N ' ' HG ' ' A' ' 92' ' ' LEU . . . -69.53 -36.32 76.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.536 0.569 . . . . 0.53000000000000003 112.536 -175.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.602 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 42.5 t0 -74.18 95.47 2.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.895 -0.779 . . . . 0.5 108.895 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.789 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 8.1 t -79.75 -39.91 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 110.942 -171.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -80.68 -13.92 58.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 1.46 109.68 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.595 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 6.1 mtpp 51.64 72.91 0.34 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.496 -1.229 . . . . 2.7400000000000002 111.31 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.625 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.1 p-10 -128.33 9.1 6.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.962 -1.017 . . . . 0.56000000000000005 110.825 -175.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.23 10.84 70.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.48999999999999999 111.841 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.625 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 43.8 mt -134.31 157.45 46.3 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.217 -0.66 . . . . 0.53000000000000003 109.217 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.0 mt -121.77 118.81 29.97 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.776 -0.37 . . . . 0.33000000000000002 110.196 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . 2.6 p30 -74.67 -177.63 3.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.077 -0.712 . . . . 1.8500000000000001 109.077 168.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -66.08 -27.05 67.78 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.088 0.403 . . . . 0.84999999999999998 112.088 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 85.7 mt-10 -75.89 -47.32 25.87 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.749 -0.463 . . . . 2.0800000000000001 109.749 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -66.3 -37.7 86.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.89 -0.596 . . . . 0.47999999999999998 110.492 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.433 ' CD1' HD11 ' A' ' 67' ' ' ILE . 23.7 t80 -70.34 -38.56 74.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.168 -0.469 . . . . 0.40999999999999998 110.303 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.88 99.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.045 -0.525 . . . . 0.23000000000000001 110.401 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -59.38 -49.88 76.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 1.29 109.574 177.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -55.61 -46.92 77.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.905 -0.589 . . . . 0.23000000000000001 111.552 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -66.68 -38.4 86.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.446 . . . . 0.77000000000000002 111.407 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -64.92 -32.61 74.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.098 0.475 . . . . 0.33000000000000002 109.934 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.717 ' HB3' HD23 ' A' ' 122' ' ' LEU . 97.8 mt -67.09 -35.02 78.9 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.954 -0.567 . . . . 0.28000000000000003 109.997 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 109' ' ' ALA . 38.7 mm -61.26 -47.1 95.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.158 -0.682 . . . . 0.69999999999999996 109.158 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -59.06 -44.06 91.79 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.417 -0.811 . . . . 1.77 112.033 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 112' ' ' LEU . 11.6 m -64.56 -38.79 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 120.062 -0.655 . . . . 0.53000000000000003 111.344 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.612 ' HE3' HD21 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -51.97 -48.51 64.32 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 120.526 -0.47 . . . . 1.8899999999999999 111.262 167.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.38 -29.37 68.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.933 -0.576 . . . . 0.73999999999999999 111.23 -177.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -70.91 -20.01 62.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.968 -0.56 . . . . 1.98 111.233 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.39 22.67 10.24 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.693 -0.765 . . . . 0.87 112.004 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -119.36 158.57 25.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.589 -0.523 . . . . 1.0700000000000001 109.589 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -109.9 130.61 55.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.201 0.524 . . . . 3.0600000000000001 110.564 174.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.717 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -68.79 146.5 97.55 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 1.0900000000000001 110.407 172.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 2.2 Cg_endo -80.22 1.7 9.05 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.719 2.279 . . . . 0.80000000000000004 112.86 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.488 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 64.53 19.69 11.89 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.985 -0.552 . . . . 0.64000000000000001 110.892 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -133.85 169.72 16.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.696 -0.684 . . . . 1.97 109.383 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 63.6 mt -111.97 91.26 15.04 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 123.082 0.239 . . . . 0.67000000000000004 111.516 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 29.0 Cg_endo -64.54 154.41 72.09 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.71 2.273 . . . . 0.52000000000000002 111.208 170.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.27 -40.24 52.34 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.537 2.825 . . . . 0.63 113.77 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -79.14 7.65 7.17 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.088 0.403 . . . . 0.85999999999999999 112.088 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.401 HD12 ' HG2' ' A' ' 127' ' ' PRO . 70.5 mt -126.34 5.61 7.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.547 0.213 . . . . 1.1899999999999999 111.557 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.32 118.31 69.75 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.033 -0.267 . . . . 1.3400000000000001 110.915 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.837 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 64.5 Cg_exo -53.76 124.57 16.17 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.139 2.56 . . . . 0.90000000000000002 112.135 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 28.3 Cg_exo -62.58 -22.93 74.53 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.143 2.562 . . . . 1.4399999999999999 114.296 -172.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 57.0 m -72.5 -15.67 61.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.199 0.523 . . . . 1.77 110.258 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.837 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 10.0 mptt -101.31 26.05 7.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.922 -0.581 . . . . 1.2 110.102 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.546 ' HA ' ' NE ' ' A' ' 136' ' ' ARG . 5.4 mmp_? -89.56 149.7 22.74 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.391 -0.596 . . . . 3.9399999999999999 109.391 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -78.65 90.51 4.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.388 0.613 . . . . 5.0800000000000001 110.103 -174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -91.29 121.42 33.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 6.3499999999999996 110.855 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.012 -0.995 . . . . 8.2100000000000009 110.852 -176.553 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 57.7 t80 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 110.295 -0.261 . . . . 12.91 110.295 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -72.07 -75.1 0.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.185 0.517 . . . . 7.96 110.156 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -125.48 -66.64 0.94 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.395 -0.965 . . . . 10.06 108.395 173.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -132.21 136.74 47.24 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.685 -0.857 . . . . 5.3600000000000003 108.685 172.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 5.2 p -167.51 106.9 0.56 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.96 0.409 . . . . 3.46 111.063 -174.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.5 p -97.11 6.7 48.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.06 -0.518 . . . . 1.49 111.235 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.735 ' HB3' ' O ' ' B' ' 152' ' ' THR . 48.6 t-20 -157.54 125.41 2.79 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.915 -0.584 . . . . 0.83999999999999997 109.448 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 21.1 Cg_exo -66.59 -3.14 8.62 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.45 2.766 . . . . 0.66000000000000003 113.684 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.516 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 83.6 m-85 -104.75 -27.19 11.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.987 0.422 . . . . 0.68000000000000005 110.533 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' B' ' 149' ' ' ASN . 3.5 t -167.38 133.78 2.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.876 -0.602 . . . . 1.8300000000000001 110.433 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.9 -5.55 53.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.278 0.561 . . . . 3.77 110.215 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp . . . . . 0 C--O 1.254 1.298 0 CA-C-N 115.47 -0.786 . . . . 6.4400000000000004 109.617 -177.051 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.602 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.663 -0.575 . . . . 9.3800000000000008 111.663 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.57 141.15 90.45 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.855 2.37 . . . . 8.6300000000000008 112.071 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.8 160.43 15.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.063 -0.517 . . . . 8.9499999999999993 111.206 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.55 171.07 32.37 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.2 -1.16 . . . . 5.8600000000000003 110.2 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.1 m 66.9 -166.02 0.22 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.068 0.461 . . . . 6.0 110.659 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -113.11 135.09 54.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.086 -0.507 . . . . 3.9399999999999999 109.767 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.01 111.28 4.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.153 0.502 . . . . 3.2799999999999998 110.984 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 p -76.66 134.76 28.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.767 -0.651 . . . . 1.8899999999999999 110.843 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.73 86.94 5.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.247 -0.433 . . . . 2.4900000000000002 110.975 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -80.68 98.54 7.75 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.703 -0.851 . . . . 0.66000000000000003 108.703 174.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 m -57.57 -26.71 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.578 -0.737 . . . . 1.4099999999999999 112.172 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HA ' ' OD1' ' A' ' 49' ' ' ASP . 24.1 t -73.41 -16.34 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.032 -0.531 . . . . 1.01 111.227 -174.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.01 -8.81 58.82 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.604 -0.808 . . . . 0.62 112.396 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -93.88 -28.78 15.65 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.395 0.617 . . . . 2.6699999999999999 110.721 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.501 ' OD1' ' HA ' ' A' ' 46' ' ' VAL . 10.8 p-10 -120.94 33.7 5.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.211 -0.904 . . . . 1.71 109.714 -172.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.06 -46.51 0.47 Allowed Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 114.391 -1.277 . . . . 1.2 112.263 -174.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.39 -26.61 8.84 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 122.754 2.303 . . . . 0.62 114.06 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 m -68.83 -45.86 70.04 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.384 0.611 . . . . 0.71999999999999997 110.126 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -78.14 -20.72 51.49 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.706 -0.679 . . . . 0.65000000000000002 109.178 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.6 -45.19 94.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.614 -0.721 . . . . 1.03 109.505 173.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -62.05 -50.0 73.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.203 -0.908 . . . . 2.1499999999999999 110.089 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.9 mt -60.71 -35.42 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.063 -0.517 . . . . 0.70999999999999996 111.008 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.499 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 92.6 t80 -65.13 -40.33 94.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.637 -0.71 . . . . 0.31 110.05 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -74.75 -25.01 58.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.959 -0.564 . . . . 0.80000000000000004 111.726 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.6 p -82.53 1.87 35.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.088 0.47 . . . . 0.60999999999999999 111.374 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.75 1.85 23.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.714 -0.476 . . . . 0.40999999999999998 109.714 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.5 m 63.3 88.88 0.11 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.054 -0.975 . . . . 1.24 111.593 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -86.92 122.5 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.71 2.273 . . . . 0.58999999999999997 112.592 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.9 m -101.2 130.9 49.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.001 -0.545 . . . . 1.3100000000000001 109.781 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 65.91 21.85 11.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.002 -0.545 . . . . 1.8899999999999999 110.046 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.18 1.53 78.85 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.912 -0.586 . . . . 0.62 112.549 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.64 ' HG2' ' HA ' ' A' ' 102' ' ' ASP . 51.5 mtmt -135.59 156.44 48.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.021 -0.363 . . . . 1.8100000000000001 110.021 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.547 HD11 ' CD1' ' A' ' 106' ' ' PHE . 15.4 pt -102.33 146.14 10.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 120.57 -0.452 . . . . 0.29999999999999999 110.663 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.581 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 68.5 p -73.16 163.97 27.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.089 -0.505 . . . . 0.44 110.293 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.99 -24.76 55.24 Favored Glycine 0 C--O 1.221 -0.708 0 C-N-CA 120.796 -0.716 . . . . 0.33000000000000002 112.469 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -59.35 -58.07 10.21 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.119 0.485 . . . . 0.34000000000000002 111.601 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.463 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -67.54 -41.12 84.8 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.719 -0.673 . . . . 1.6499999999999999 110.363 -173.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -65.29 -31.54 72.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.483 -0.781 . . . . 0.27000000000000002 110.524 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 70.9 tttt -67.86 -43.48 79.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.213 -0.449 . . . . 1.52 109.954 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.736 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.9 mtmt -55.29 -49.12 72.92 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.515 -0.766 . . . . 1.1399999999999999 110.106 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 28.9 tp10 -57.92 -44.21 86.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.325 0.583 . . . . 1.78 110.749 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.602 ' HB3' HD22 ' A' ' 86' ' ' LEU . 23.9 mmt -63.9 -36.48 84.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.923 -0.58 . . . . 0.85999999999999999 111.884 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -81.16 -35.75 14.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.435 -0.506 . . . . 1.52 111.674 -173.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.736 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -81.93 -8.34 59.67 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 119.99 -0.684 . . . . 3.3300000000000001 110.97 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.0 m -75.35 -20.35 59.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.163 0.506 . . . . 0.91000000000000003 109.716 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 mmmp? 69.6 51.01 0.48 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.038 -0.983 . . . . 2.9700000000000002 111.775 175.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.518 ' HB2' HD21 ' A' ' 86' ' ' LEU . 8.8 mp -110.99 145.31 32.17 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.872 -1.058 . . . . 1.4099999999999999 109.018 170.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 20.9 Cg_endo -62.93 146.7 94.96 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.998 2.465 . . . . 0.32000000000000001 112.427 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -56.73 -31.16 64.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.26 -0.427 . . . . 2.0499999999999998 111.724 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.8 m -62.51 -48.63 78.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.135 0.493 . . . . 0.83999999999999997 110.267 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.707 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 69.1 t -66.51 -43.06 91.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.26000000000000001 110.212 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 76' ' ' MET . 80.9 mt -59.87 -36.39 76.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.055 -0.52 . . . . 0.28999999999999998 110.196 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.915 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.7 -46.07 94.98 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.739 -0.664 . . . . 0.35999999999999999 112.043 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.707 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 17.7 mtpp -61.17 -47.32 86.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.361 -0.237 . . . . 1.29 110.361 177.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.422 ' HA ' HD23 ' A' ' 92' ' ' LEU . 88.6 mt -60.77 -48.42 88.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.873 -0.603 . . . . 0.27000000000000002 111.357 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -64.04 -48.97 74.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.915 0.388 . . . . 0.37 111.179 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -65.24 -27.82 68.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.894 -0.594 . . . . 2.54 111.353 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -94.32 -33.21 13.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.863 -0.608 . . . . 1.5 111.331 -177.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -73.48 -42.49 61.8 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.137 0.421 . . . . 0.53000000000000003 112.137 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.639 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 50.6 t0 -78.16 95.55 4.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.869 -0.789 . . . . 0.5 108.869 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 t -70.38 -44.44 77.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.406 -0.816 . . . . 0.64000000000000001 110.38 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.628 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 6.4 p-10 -88.35 -17.18 31.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.317 -0.856 . . . . 1.46 110.755 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 50.8 mttp 58.03 73.39 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.152 0.977 . . . . 2.7400000000000002 112.094 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.603 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 12.9 p-10 -117.67 10.21 13.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.291 -1.322 . . . . 0.56000000000000005 110.576 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.29 -0.88 62.36 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.054 -0.593 . . . . 0.48999999999999999 112.156 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.581 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 47.5 mt -129.87 149.42 51.61 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.054 -0.721 . . . . 0.53000000000000003 109.054 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.7 mt -98.99 112.31 24.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.359 0.6 . . . . 0.33000000000000002 109.858 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.653 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 7.5 t70 -70.39 166.3 20.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.826 -1.079 . . . . 1.8500000000000001 109.122 173.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -57.47 -37.99 73.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 118.006 0.366 . . . . 0.84999999999999998 111.692 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.727 ' HB3' ' HB3' ' A' ' 132' ' ' PRO . 81.3 mt-10 -70.98 -40.38 71.94 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.671 -0.412 . . . . 2.0800000000000001 110.663 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.653 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 18.2 mt-10 -70.68 -31.94 69.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.47999999999999998 110.697 -174.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD1' HD11 ' A' ' 67' ' ' ILE . 66.8 t80 -74.37 -44.39 52.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.788 -0.642 . . . . 0.40999999999999998 109.887 177.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.7 87.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.742 -0.663 . . . . 0.23000000000000001 109.82 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 93' ' ' ALA . 18.3 tp -60.57 -50.56 73.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.437 -0.801 . . . . 1.29 109.834 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -56.9 -46.64 81.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.23000000000000001 111.155 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.85 -34.41 75.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.177 -0.465 . . . . 0.77000000000000002 111.355 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.425 ' CG ' HG22 ' A' ' 46' ' ' VAL . 40.9 t60 -65.41 -39.14 91.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.696 -0.483 . . . . 0.33000000000000002 109.696 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.6 ' HB3' HD22 ' A' ' 122' ' ' LEU . 74.9 mt -63.69 -43.34 96.93 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.957 -0.565 . . . . 0.28000000000000003 110.044 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.488 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 33.7 mm -54.08 -50.58 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.637 -0.711 . . . . 0.69999999999999996 110.115 173.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 27.3 ttpp -58.51 -49.95 75.52 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.548 -0.751 . . . . 1.77 111.435 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.7 m -61.51 -40.1 85.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.537 -0.465 . . . . 0.53000000000000003 111.217 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.545 ' HG2' HD23 ' A' ' 122' ' ' LEU . 24.8 mmmt -58.71 -40.56 84.04 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.221 -0.192 . . . . 1.8899999999999999 111.403 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 92.6 mt -71.19 -32.24 68.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.168 0.508 . . . . 0.73999999999999999 110.868 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.576 ' HB2' ' HD2' ' A' ' 120' ' ' HIS . 47.1 mt-10 -77.72 2.29 17.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.842 -0.617 . . . . 1.98 111.106 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.12 24.18 41.86 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.781 -0.723 . . . . 0.87 112.401 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.576 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 84.3 m-70 -114.53 175.13 5.62 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.502 -0.555 . . . . 1.0700000000000001 109.502 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -117.96 136.55 53.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.955 0.407 . . . . 3.0600000000000001 111.195 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 112' ' ' LEU . 3.0 pp -89.41 134.33 32.95 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.44 -0.578 . . . . 1.0900000000000001 109.44 173.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 37.3 Cg_exo -60.93 -18.66 58.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.168 2.579 . . . . 0.80000000000000004 113.768 -172.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.427 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 65.0 17.87 11.27 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.822 -0.626 . . . . 0.64000000000000001 110.94 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -133.95 173.81 11.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.236 -0.893 . . . . 1.97 108.635 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.4 mt -113.2 90.46 16.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.817 0.302 . . . . 0.67000000000000004 111.817 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.74 160.53 37.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.504 2.136 . . . . 0.52000000000000002 110.712 169.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.71 -34.3 53.26 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.278 2.652 . . . . 0.63 113.711 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -86.94 -2.16 58.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.733 -0.387 . . . . 0.85999999999999999 111.659 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -99.37 -25.7 14.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.979 0.418 . . . . 1.1899999999999999 110.356 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 60.4 t -70.88 119.56 73.93 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.849 -0.614 . . . . 1.3400000000000001 111.163 -177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.727 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 51.6 Cg_exo -55.37 146.32 62.72 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.291 2.661 . . . . 0.90000000000000002 112.716 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 33.4 Cg_exo -60.45 -21.34 67.61 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.452 2.768 . . . . 1.4399999999999999 114.577 -170.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.7 m -84.1 -26.26 29.09 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.191 -0.604 . . . . 1.77 111.643 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.619 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -120.42 31.56 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 1.2 111.324 -177.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -82.26 146.47 29.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 3.9399999999999999 111.162 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -92.04 142.96 26.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 5.0800000000000001 110.448 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -97.71 129.22 44.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.521 -0.309 . . . . 6.3499999999999996 110.672 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.365 -0.826 . . . . 8.2100000000000009 109.766 171.972 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.458 -0.571 . . . . 12.91 109.458 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -113.95 -73.72 0.65 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.98 -0.288 . . . . 7.96 110.876 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 63.08 79.32 0.26 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.715 0.634 . . . . 10.06 110.798 -176.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.18 -54.52 6.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.819 -0.628 . . . . 5.3600000000000003 110.413 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 50.5 m -150.14 129.52 12.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.661 -0.7 . . . . 3.46 109.948 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 1.5 m -125.03 24.9 7.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.218 0.533 . . . . 1.49 110.419 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.915 HD21 ' HA2' ' A' ' 87' ' ' GLY . 33.6 t-20 -115.53 115.88 41.71 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.031 0.443 . . . . 0.83999999999999997 111.565 -173.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.09 -4.87 15.11 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.919 3.08 . . . . 0.66000000000000003 113.302 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.561 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 72.4 m-85 -101.47 4.98 41.75 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.055 0.391 . . . . 0.68000000000000005 112.055 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 38.7 p -127.8 162.36 26.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.777 0.658 . . . . 1.8300000000000001 112.777 -171.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 73.88 -92.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.113 -0.949 . . . . 3.77 112.488 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 63.0 mttp . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.2 -0.905 . . . . 6.4400000000000004 110.612 -176.58 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.639 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_